data_1w4j_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1w4j _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.464 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . . . . . . 0 N--CA 1.454 -0.266 0 CA-C-O 120.936 0.398 . . . . 0.0 110.874 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -152.27 95.5 2.06 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.866 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.403 ' HG2' ' O ' ' A' ' 158' ' ' ILE . 18.0 ptp -47.43 166.95 0.18 Allowed Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.768 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -65.91 -47.48 3.68 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.756 2.304 . . . . 0.0 112.857 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.19 -51.04 65.65 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.522 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.468 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -69.68 -33.57 72.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.051 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -68.49 -48.12 65.29 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.251 0.548 . . . . 0.0 110.547 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -58.88 -54.72 43.89 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.851 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.517 HD11 ' C ' ' A' ' 138' ' ' LEU . 4.3 pp -62.62 -39.48 93.93 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.527 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.402 ' N ' ' CD1' ' A' ' 138' ' ' LEU . . . -58.72 -39.62 81.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.886 0.374 . . . . 0.0 110.827 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.19 -29.76 57.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.783 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -81.85 -23.94 36.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.926 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.415 ' CD1' HD11 ' A' ' 138' ' ' LEU . 1.5 mt -90.56 -28.95 18.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.843 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.17 35.55 8.81 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.72 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.473 ' CD1' ' CE3' ' A' ' 166' ' ' TRP . 1.5 tt -116.39 142.32 30.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.781 0.324 . . . . 0.0 111.34 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.486 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 1.9 t0 -73.95 101.02 3.69 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.425 ' CB ' ' CD1' ' A' ' 158' ' ' ILE . . . -49.84 -28.03 5.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.277 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.73 -37.26 84.3 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.486 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -65.94 -21.14 66.41 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 177.349 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.455 ' CG2' HD11 ' A' ' 144' ' ' ILE . 21.7 t -89.93 88.12 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.455 179.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.7 ttmt -50.82 91.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.001 0.429 . . . . 0.0 111.206 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.477 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -70.18 133.76 24.48 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 121.015 -0.612 . . . . 0.0 113.198 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.421 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.4 OUTLIER -118.47 14.18 13.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.847 0.356 . . . . 0.0 110.766 179.563 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.452 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -73.18 155.34 50.43 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.709 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -44.37 106.5 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.097 2.531 . . . . 0.0 112.851 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.14 19.79 22.67 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.245 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 74.61 22.17 77.62 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.598 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.464 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.3 m -85.77 126.29 40.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 117.042 0.421 . . . . 0.0 111.067 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.665 ' O ' HG13 ' A' ' 158' ' ' ILE . 19.1 pt -64.98 111.94 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.504 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 61.7 p -75.02 156.48 36.16 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.558 0.694 . . . . 0.0 111.657 -177.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.451 ' CG1' ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -56.08 -39.91 61.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.715 -179.464 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.569 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 1.2 tp10 -65.82 -28.05 68.71 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.907 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.504 ' HB2' ' O ' ' A' ' 159' ' ' THR . 82.1 m-20 -68.49 -53.41 23.49 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.198 0.523 . . . . 0.0 110.225 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.503 ' HB ' HD12 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -65.64 -41.27 90.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.62 -179.729 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.55 -48.03 73.83 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 120.942 0.401 . . . . 0.0 111.465 -178.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.569 ' HG3' ' O ' ' A' ' 161' ' ' GLU . 21.6 mtt180 -60.63 -40.29 91.36 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.89 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . 0.473 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 27.5 t90 -70.65 -48.99 52.13 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.661 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -50.52 -39.02 47.68 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.968 0.413 . . . . 0.0 110.486 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -77.33 -31.3 54.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.356 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.953 0.406 . . . . 0.0 110.402 179.518 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.456 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . . . . . . 0 N--CA 1.455 -0.203 0 CA-C-O 120.917 0.389 . . . . 0.0 110.846 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -153.37 95.49 1.93 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.897 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.4 ' HB2' ' CD ' ' A' ' 133' ' ' PRO . 19.9 ptm -48.14 167.42 0.19 Allowed Pre-proline 0 CA--C 1.532 0.26 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.793 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.4 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.8 Cg_exo -65.54 -45.56 6.7 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.807 2.338 . . . . 0.0 112.918 -178.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.29 -52.71 60.59 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.423 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.474 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -69.25 -33.3 73.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.165 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 12.1 mtm180 -67.99 -49.17 63.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.524 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -58.29 -54.33 48.2 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.893 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.508 HD11 ' C ' ' A' ' 138' ' ' LEU . 4.4 pp -63.05 -38.92 93.1 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.417 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -58.31 -39.93 80.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.722 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -76.62 -29.81 56.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.726 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 -81.95 -20.02 39.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.059 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.409 ' CD1' HD11 ' A' ' 138' ' ' LEU . 1.3 mt -94.88 -28.85 15.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.927 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.64 35.98 8.2 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.812 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.493 ' CD1' ' CE3' ' A' ' 166' ' ' TRP . 1.5 tt -118.22 141.34 37.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.832 0.348 . . . . 0.0 111.183 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.478 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.6 OUTLIER -72.93 101.05 3.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.805 179.229 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.424 ' CB ' ' CD1' ' A' ' 158' ' ' ILE . . . -49.73 -28.71 6.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.641 0.257 . . . . 0.0 111.321 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.78 -36.98 85.06 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -66.52 -22.48 66.17 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.453 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.458 ' CG2' HD11 ' A' ' 144' ' ' ILE . 21.8 t -86.87 84.77 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.646 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 6.4 ttmt -50.73 90.82 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.976 0.417 . . . . 0.0 111.14 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.476 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -66.5 142.94 43.29 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.809 -0.632 . . . . 0.0 113.295 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.45 0.9 11.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.688 0.28 . . . . 0.0 110.885 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.426 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -65.99 151.96 51.93 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.747 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.423 ' O ' HG12 ' A' ' 157' ' ' VAL . 84.8 Cg_exo -42.04 120.67 1.58 Allowed 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.234 2.622 . . . . 0.0 113.182 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 89.55 -0.68 80.73 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.715 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 94.53 22.24 24.65 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.694 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.456 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -83.49 126.38 40.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 117.017 0.408 . . . . 0.0 111.107 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.635 ' O ' HG13 ' A' ' 158' ' ' ILE . 19.0 pt -65.89 111.82 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.514 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 44.0 p -75.3 156.53 35.5 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.575 0.702 . . . . 0.0 111.816 -177.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.465 ' CG1' ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -56.01 -40.16 61.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.805 -179.431 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.503 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 5.6 mt-10 -64.89 -27.61 68.98 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.834 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.514 ' HB2' ' O ' ' A' ' 159' ' ' THR . 88.1 m-20 -70.2 -53.97 14.85 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.522 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.504 ' HB ' HD12 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -65.16 -42.71 94.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.794 -179.37 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.9 mmtt -66.38 -52.11 50.16 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.953 0.406 . . . . 0.0 111.486 -178.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.503 ' HG3' ' O ' ' A' ' 161' ' ' GLU . 27.1 mtp180 -59.24 -35.88 74.47 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.035 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . 0.493 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 32.9 t90 -70.66 -50.05 40.77 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.791 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -50.66 -41.26 55.29 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-O 120.97 0.414 . . . . 0.0 110.411 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.4 ' HG2' ' HA ' ' A' ' 165' ' ' ARG . 7.6 pt-20 -74.04 -31.88 63.08 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.048 179.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 . . . . . 0 N--CA 1.456 -0.169 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.278 179.458 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.429 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . . . . . . 0 C--O 1.233 0.192 0 CA-C-O 120.846 0.355 . . . . 0.0 110.824 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -154.88 96.22 1.83 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.134 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 19.0 ptp -47.81 167.59 0.18 Allowed Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.57 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -65.49 -47.12 4.52 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.778 2.319 . . . . 0.0 112.809 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.27 -51.48 64.41 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.475 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.476 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -69.23 -33.36 73.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.277 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.69 -48.75 63.1 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.296 0.57 . . . . 0.0 110.371 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -57.77 -54.2 49.57 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.98 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.494 HD12 ' HB ' ' A' ' 163' ' ' VAL . 4.3 pp -63.49 -41.23 98.57 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.553 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.408 ' N ' ' CD1' ' A' ' 138' ' ' LEU . . . -58.47 -37.64 75.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.743 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.92 -29.81 55.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.754 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -83.36 -20.52 34.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.997 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.5 mt -94.22 -28.92 15.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.863 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.75 38.68 7.96 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.543 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.489 ' CD1' ' CE3' ' A' ' 166' ' ' TRP . 1.3 tt -118.4 140.39 42.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.742 0.306 . . . . 0.0 111.305 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.491 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 1.5 t0 -71.97 100.97 2.58 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.434 ' CB ' ' CD1' ' A' ' 158' ' ' ILE . . . -50.6 -28.84 9.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.681 0.277 . . . . 0.0 111.271 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.69 -36.97 85.15 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 178.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -64.97 -23.88 67.35 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 177.283 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.479 ' CG2' HD11 ' A' ' 144' ' ' ILE . 21.2 t -87.44 89.15 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.324 179.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.64 90.93 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.937 0.399 . . . . 0.0 111.14 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.487 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -68.55 130.03 25.63 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.837 -0.696 . . . . 0.0 113.104 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.479 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.1 OUTLIER -118.5 24.13 11.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.136 0.493 . . . . 0.0 110.495 179.658 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.427 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -84.63 157.16 32.44 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.758 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_exo -43.37 102.89 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.227 2.618 . . . . 0.0 112.993 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 99.3 23.52 11.18 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.212 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 71.23 22.18 78.52 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.601 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.429 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -85.43 128.35 39.21 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.957 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.669 ' O ' HG13 ' A' ' 158' ' ' ILE . 18.6 pt -66.65 112.11 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.499 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 55.7 p -75.14 156.35 36.05 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.532 0.682 . . . . 0.0 111.533 -177.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.458 ' CG1' ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -56.41 -39.46 61.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.706 -179.582 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.582 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 6.1 mm-40 -65.67 -27.79 68.62 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.944 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.499 ' HB2' ' O ' ' A' ' 159' ' ' THR . 83.0 m-20 -69.31 -54.6 13.75 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.223 0.535 . . . . 0.0 110.322 179.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.494 ' HB ' HD12 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -64.09 -40.83 90.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.648 -179.612 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.61 -47.57 78.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.9 0.381 . . . . 0.0 111.445 -178.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.582 ' HG3' ' O ' ' A' ' 161' ' ' GLU . 65.2 mtt-85 -60.83 -42.0 96.87 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.05 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . 0.489 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 18.1 t90 -67.98 -50.18 57.23 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.915 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -50.94 -41.1 58.75 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.919 0.39 . . . . 0.0 110.725 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -74.9 -29.47 61.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.321 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . 0.406 ' OE1' ' CD1' ' A' ' 166' ' ' TRP . 0.4 OUTLIER . . . . . 0 N--CA 1.454 -0.264 0 CA-C-O 121.224 0.535 . . . . 0.0 110.096 179.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.444 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . . . . . . 0 N--CA 1.456 -0.174 0 CA-C-O 120.931 0.396 . . . . 0.0 110.892 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -152.12 95.43 2.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.965 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.408 ' HB2' ' CD ' ' A' ' 133' ' ' PRO . 14.0 ptp -46.91 167.74 0.15 Allowed Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.863 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.408 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.2 Cg_exo -65.76 -47.59 3.75 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.799 2.333 . . . . 0.0 112.822 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.3 -51.61 64.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.372 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.459 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -69.48 -34.21 74.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.911 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -66.53 -48.53 69.42 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.501 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.401 ' CZ ' ' HB2' ' A' ' 137' ' ' ARG . 26.4 ttm105 -59.93 -55.38 34.8 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.154 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.489 ' CD1' ' HB ' ' A' ' 163' ' ' VAL . 4.3 pp -61.54 -41.03 96.75 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.716 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.404 ' N ' ' CD1' ' A' ' 138' ' ' LEU . . . -58.11 -37.95 75.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.994 0.426 . . . . 0.0 110.809 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.3 tptt -76.48 -29.81 57.02 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.825 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -84.32 -19.38 33.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.12 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.411 ' CD1' HD11 ' A' ' 138' ' ' LEU . 1.4 mt -94.49 -28.89 15.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.719 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.72 38.28 8.19 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.505 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.481 ' CD1' ' CE3' ' A' ' 166' ' ' TRP . 1.4 tt -118.31 141.6 36.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.744 0.307 . . . . 0.0 111.248 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.489 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 1.9 t0 -72.94 101.02 3.08 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.415 ' CB ' ' CD1' ' A' ' 158' ' ' ILE . . . -50.45 -28.85 9.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.735 0.302 . . . . 0.0 111.182 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.92 -36.93 85.96 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 178.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.489 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -66.59 -23.37 66.18 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 177.666 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.457 ' CG2' HD11 ' A' ' 144' ' ' ILE . 20.1 t -86.7 84.15 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.625 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.74 91.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.911 0.386 . . . . 0.0 111.113 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.516 ' HA2' ' HA ' ' A' ' 158' ' ' ILE . . . -69.17 141.55 36.0 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.098 -0.572 . . . . 0.0 113.488 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.61 11.06 12.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.743 0.306 . . . . 0.0 110.786 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.439 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -73.4 152.21 46.17 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.842 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_exo -43.83 112.29 0.31 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.092 2.528 . . . . 0.0 112.832 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 95.54 13.12 52.32 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.374 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 79.62 22.11 65.1 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.776 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.444 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.3 m -83.98 126.92 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 117.122 0.461 . . . . 0.0 111.06 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.64 ' O ' HG13 ' A' ' 158' ' ' ILE . 17.7 pt -66.94 111.79 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.523 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 75.3 p -75.07 156.46 36.07 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.505 0.669 . . . . 0.0 111.735 -177.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.447 ' CG1' ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.58 -40.71 60.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.697 -179.56 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.402 ' O ' ' HG2' ' A' ' 165' ' ' ARG . 1.8 tt0 -64.29 -27.51 69.09 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.114 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.523 ' HB2' ' O ' ' A' ' 159' ' ' THR . 82.6 m-20 -71.45 -53.27 14.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.835 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.489 ' HB ' ' CD1' ' A' ' 138' ' ' LEU . 0.1 OUTLIER -64.43 -45.77 94.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.687 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -61.47 -48.64 80.21 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.043 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.457 ' HG3' ' N ' ' A' ' 166' ' ' TRP . 0.8 OUTLIER -57.71 -39.75 77.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.903 -179.718 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . 0.481 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 23.9 t90 -72.39 -48.36 42.14 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.754 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -52.21 -38.37 57.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.975 0.417 . . . . 0.0 110.445 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -77.3 -33.15 55.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.243 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 . . . . . 0 C--N 1.331 -0.197 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.577 179.789 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.476 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . . . . . . 0 N--CA 1.455 -0.207 0 CA-C-O 121.022 0.439 . . . . 0.0 111.098 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -153.83 94.33 1.75 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.645 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 20.2 ptm -47.03 166.64 0.18 Allowed Pre-proline 0 CA--C 1.533 0.306 0 CA-C-O 120.582 0.23 . . . . 0.0 110.936 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -65.62 -44.85 7.64 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.868 2.379 . . . . 0.0 112.826 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.21 -53.62 51.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.372 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.468 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -68.29 -33.88 75.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.024 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.65 -49.88 64.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.587 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -58.28 -55.58 33.16 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.133 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.499 ' CD1' ' HB ' ' A' ' 163' ' ' VAL . 4.4 pp -60.98 -40.67 94.33 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.615 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.55 -37.71 73.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.853 0.358 . . . . 0.0 110.66 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.8 tptp -76.9 -30.07 56.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.771 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -83.32 -19.92 35.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.061 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.414 ' CD1' HD11 ' A' ' 138' ' ' LEU . 1.5 mt -94.5 -28.89 15.21 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.864 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.53 37.76 7.95 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.607 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.487 ' CD1' ' CE3' ' A' ' 166' ' ' TRP . 1.4 tt -118.36 143.07 30.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.809 0.337 . . . . 0.0 111.181 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.9 OUTLIER -74.63 101.12 4.14 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.372 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.402 ' CB ' ' CD1' ' A' ' 158' ' ' ILE . . . -49.78 -28.81 6.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.689 0.28 . . . . 0.0 111.099 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.42 -37.65 87.56 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.5 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -66.25 -22.23 66.31 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 177.578 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.462 ' CG2' HD11 ' A' ' 144' ' ' ILE . 21.3 t -88.37 85.58 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.623 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.5 ptmt -50.7 92.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.986 0.422 . . . . 0.0 111.149 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.479 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -68.02 136.29 30.71 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.064 -0.589 . . . . 0.0 113.339 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.52 10.71 12.7 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.738 0.304 . . . . 0.0 110.819 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.452 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -72.29 154.68 50.82 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.771 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -43.99 107.65 0.1 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.111 2.541 . . . . 0.0 112.886 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.51 18.38 28.36 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.364 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.58 22.27 75.54 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.634 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.476 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -84.6 124.21 39.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 117.069 0.434 . . . . 0.0 111.063 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.645 ' O ' HG13 ' A' ' 158' ' ' ILE . 19.6 pt -63.59 111.59 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.531 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 48.9 p -75.4 156.53 35.28 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.555 0.693 . . . . 0.0 111.904 -177.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.463 ' CG1' ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.54 -41.48 63.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.78 -179.524 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -64.26 -27.44 69.05 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.125 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.531 ' HB2' ' O ' ' A' ' 159' ' ' THR . 84.1 m-20 -70.61 -52.58 20.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.512 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.499 ' HB ' ' CD1' ' A' ' 138' ' ' LEU . 0.1 OUTLIER -65.98 -45.77 90.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.579 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 10.5 mttm -62.71 -50.94 69.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.616 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.516 ' HG3' ' O ' ' A' ' 162' ' ' ASP . 1.8 ppt_? -57.83 -39.07 76.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.607 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . 0.487 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 26.6 t90 -71.49 -48.42 49.18 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.59 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -51.66 -38.3 54.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.52 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -77.24 -32.81 56.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.158 179.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.983 0.421 . . . . 0.0 110.35 179.462 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.449 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.977 0.418 . . . . 0.0 111.019 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -152.52 95.27 2.0 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.862 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 9.8 ptp -47.44 166.93 0.18 Allowed Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.842 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -65.67 -46.28 5.43 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.859 2.373 . . . . 0.0 112.943 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.28 -52.42 61.48 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.401 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.454 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -68.34 -34.19 75.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.124 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.74 -49.34 63.06 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.252 0.548 . . . . 0.0 110.585 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 7.5 tpt180 -57.37 -55.55 33.3 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.838 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.481 HD11 ' C ' ' A' ' 138' ' ' LEU . 4.3 pp -62.33 -41.14 98.32 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.562 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.402 ' N ' ' CD1' ' A' ' 138' ' ' LEU . . . -56.45 -39.72 73.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.974 0.416 . . . . 0.0 110.956 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.65 -29.86 56.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.75 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -82.41 -19.04 39.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.083 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.414 ' CD1' HD11 ' A' ' 138' ' ' LEU . 1.4 mt -95.64 -28.86 14.61 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.866 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.05 37.08 7.95 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.661 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.455 HD11 ' CG2' ' A' ' 149' ' ' VAL . 1.8 tt -118.34 143.02 30.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.803 0.335 . . . . 0.0 111.232 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.523 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 1.9 t0 -74.47 101.1 4.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.803 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.424 ' CB ' ' CD1' ' A' ' 158' ' ' ILE . . . -49.6 -28.95 6.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.595 0.236 . . . . 0.0 111.294 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.08 -36.98 84.63 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.523 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -66.68 -21.44 66.09 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 177.46 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.455 ' CG2' HD11 ' A' ' 144' ' ' ILE . 21.4 t -89.16 86.02 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.497 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.71 93.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.965 0.412 . . . . 0.0 111.124 -179.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.466 ' HA2' ' HA ' ' A' ' 158' ' ' ILE . . . -70.82 139.2 29.56 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 121.001 -0.619 . . . . 0.0 113.419 -179.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -118.56 10.38 12.56 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.721 0.296 . . . . 0.0 110.846 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.465 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -71.19 152.69 50.2 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.746 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -44.68 111.04 0.26 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.059 2.506 . . . . 0.0 112.722 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 96.43 14.22 45.25 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.289 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 79.41 22.11 65.6 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.674 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.465 HG21 ' HA2' ' A' ' 153' ' ' GLY . 1.2 m -85.22 125.66 40.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 117.121 0.461 . . . . 0.0 110.961 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.648 ' O ' HG13 ' A' ' 158' ' ' ILE . 18.8 pt -65.33 111.74 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.524 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 55.0 p -75.15 156.43 35.94 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.523 0.678 . . . . 0.0 111.723 -177.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.463 ' CG1' ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.33 -40.78 58.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.787 -179.503 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.432 ' O ' ' HG2' ' A' ' 165' ' ' ARG . 55.7 tt0 -64.62 -27.47 68.96 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.171 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.524 ' HB2' ' O ' ' A' ' 159' ' ' THR . 72.4 m-20 -70.74 -53.6 14.94 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.749 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.481 ' HB ' ' CD1' ' A' ' 138' ' ' LEU . 0.1 OUTLIER -63.62 -48.15 88.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.406 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 16.9 mttp -60.24 -46.34 90.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.561 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.485 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 24.8 ptt180 -60.1 -39.23 85.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.779 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . 0.455 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 30.2 t90 -72.73 -48.15 41.03 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.843 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -52.47 -37.78 57.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.997 0.427 . . . . 0.0 110.476 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -77.26 -33.66 55.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.056 179.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.149 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.271 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.489 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . . . . . . 0 N--CA 1.453 -0.281 0 CA-C-O 121.11 0.481 . . . . 0.0 111.052 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -151.54 94.71 2.04 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.688 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 22.4 ptm -48.63 166.66 0.22 Allowed Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.005 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -66.19 -45.25 5.84 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.878 2.385 . . . . 0.0 112.818 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.32 -52.2 62.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.268 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.455 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -70.28 -32.45 70.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.875 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.02 -47.94 67.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.256 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -59.97 -54.81 41.67 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.033 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.499 HD12 ' HB ' ' A' ' 163' ' ' VAL . 4.3 pp -62.52 -40.8 97.93 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.589 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.08 -38.81 73.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.892 0.377 . . . . 0.0 110.683 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.97 -29.81 55.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.827 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -82.4 -21.21 35.91 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.069 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.6 mt -94.02 -28.91 15.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.925 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.75 38.39 8.11 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.461 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.48 ' CD1' ' CE3' ' A' ' 166' ' ' TRP . 0.6 OUTLIER -116.6 143.21 27.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.865 0.365 . . . . 0.0 111.19 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.443 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.9 OUTLIER -74.84 100.88 4.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.469 . . . . 0.0 109.852 179.185 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.407 ' CB ' ' CD1' ' A' ' 158' ' ' ILE . . . -53.27 -33.81 54.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.665 0.269 . . . . 0.0 111.109 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.9 -36.69 75.12 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.051 0.453 . . . . 0.0 109.805 179.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.518 ' HE2' ' CE2' ' A' ' 166' ' ' TRP . 0.0 OUTLIER -67.92 -30.45 69.78 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.846 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.472 ' HA ' ' HE3' ' A' ' 148' ' ' LYS . 8.1 t -78.2 81.79 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.379 179.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.47 ' O ' ' HG3' ' A' ' 150' ' ' LYS . 2.0 ptpp? -50.51 93.25 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.266 0.555 . . . . 0.0 111.105 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.52 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -63.1 139.04 44.18 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.605 -0.725 . . . . 0.0 113.492 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.55 13.66 13.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.752 0.311 . . . . 0.0 110.608 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.421 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -80.14 154.97 37.76 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.736 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_exo -43.23 108.79 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.161 2.574 . . . . 0.0 112.972 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 96.95 16.94 34.06 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.377 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 76.17 22.33 73.91 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.634 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.489 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -83.0 125.6 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.173 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.66 ' O ' HG13 ' A' ' 158' ' ' ILE . 18.2 pt -64.4 111.23 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.487 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 25.7 p -75.29 156.32 35.75 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.639 0.733 . . . . 0.0 111.792 -177.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.473 ' CG1' ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -56.59 -39.82 65.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.649 -179.643 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.592 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 0.4 OUTLIER -63.69 -29.75 70.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.921 179.413 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' A' ' 159' ' ' THR . 91.8 m-20 -68.97 -54.07 17.31 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.9 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.499 ' HB ' HD12 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -63.98 -41.91 94.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.766 -178.762 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.53 ' CG ' ' HA ' ' A' ' 161' ' ' GLU . 0.0 OUTLIER -64.84 -48.83 72.92 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.024 0.44 . . . . 0.0 111.418 -178.64 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.592 ' HG3' ' O ' ' A' ' 161' ' ' GLU . 8.5 mtm105 -57.62 -43.33 84.72 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.981 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . 0.518 ' CE2' ' HE2' ' A' ' 148' ' ' LYS . 61.9 t90 -68.09 -49.86 58.57 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.606 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -50.58 -39.55 49.93 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.856 0.36 . . . . 0.0 110.746 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.407 ' HG2' ' HA ' ' A' ' 165' ' ' ARG . 11.1 pt-20 -77.17 -29.18 54.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.485 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.455 -0.195 0 CA-C-O 121.208 0.528 . . . . 0.0 109.985 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.465 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . . . . . . 0 N--CA 1.456 -0.159 0 CA-C-O 121.039 0.447 . . . . 0.0 110.973 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -155.11 95.21 1.71 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.801 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.425 ' HB2' ' CD ' ' A' ' 133' ' ' PRO . 19.2 ptm -47.35 168.65 0.13 Allowed Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.873 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.425 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.0 Cg_exo -66.07 -45.34 5.98 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.772 2.315 . . . . 0.0 112.949 -178.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.24 -53.35 54.83 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.442 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.45 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -69.63 -32.03 70.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.823 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.41 -48.74 66.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.434 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -59.97 -55.13 37.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.042 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.489 ' CD1' ' HB ' ' A' ' 163' ' ' VAL . 4.3 pp -62.52 -41.11 98.63 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.83 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -55.99 -41.76 75.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.863 0.363 . . . . 0.0 110.939 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -75.42 -29.84 59.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.9 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -80.9 -22.74 39.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.075 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.408 ' CD1' HD11 ' A' ' 138' ' ' LEU . 1.6 mt -92.09 -28.91 16.83 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.879 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.46 37.48 8.12 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.439 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.483 ' CD1' ' CE3' ' A' ' 166' ' ' TRP . 1.4 tt -117.85 141.53 36.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.828 0.347 . . . . 0.0 111.188 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.472 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 1.2 t0 -72.94 101.05 3.1 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.418 ' CB ' ' CD1' ' A' ' 158' ' ' ILE . . . -49.64 -28.59 6.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.688 0.28 . . . . 0.0 111.241 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.9 -37.27 85.67 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.472 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -65.8 -22.64 66.58 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 177.399 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.47 ' CG2' HD11 ' A' ' 144' ' ' ILE . 20.7 t -88.22 87.94 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.404 179.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.75 91.02 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.015 0.436 . . . . 0.0 111.267 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.475 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -68.51 132.86 27.54 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.904 -0.665 . . . . 0.0 113.093 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.433 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.2 OUTLIER -118.49 16.75 13.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.952 0.406 . . . . 0.0 110.812 179.624 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.449 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -77.67 154.32 41.69 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.655 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -43.93 107.56 0.1 OUTLIER 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.087 2.524 . . . . 0.0 112.813 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.75 18.76 26.68 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.236 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 74.94 22.18 77.26 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.671 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.465 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -84.76 125.47 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 CA-C-N 117.027 0.414 . . . . 0.0 110.992 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.631 ' O ' HG13 ' A' ' 158' ' ' ILE . 19.1 pt -65.4 112.34 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.517 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 60.8 p -75.33 156.5 35.46 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.533 0.682 . . . . 0.0 111.891 -177.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.459 ' CG1' ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.91 -40.55 63.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.743 -179.492 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.421 ' O ' ' HG2' ' A' ' 165' ' ' ARG . 20.2 mm-40 -65.21 -27.43 68.67 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.199 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.517 ' HB2' ' O ' ' A' ' 159' ' ' THR . 81.6 m-20 -70.43 -53.98 14.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.608 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.489 ' HB ' ' CD1' ' A' ' 138' ' ' LEU . 0.1 OUTLIER -63.39 -47.71 90.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.412 179.928 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 10.7 mttm -60.41 -48.66 80.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.502 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.483 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 10.4 ptt180 -57.8 -39.98 78.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.882 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . 0.483 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 23.7 t90 -72.04 -48.14 46.66 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.778 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -52.19 -38.4 57.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.947 0.404 . . . . 0.0 110.58 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -77.24 -33.53 56.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.262 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 . . . . . 0 C--N 1.332 -0.163 0 CA-C-O 120.974 0.416 . . . . 0.0 110.443 179.579 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.437 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . . . . . . 0 N--CA 1.453 -0.279 0 CA-C-O 120.937 0.399 . . . . 0.0 110.789 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -151.13 94.98 2.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.857 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.413 ' HB2' ' CD ' ' A' ' 133' ' ' PRO . 9.5 ptm -46.96 167.73 0.15 Allowed Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.98 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.413 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.8 Cg_exo -65.49 -45.58 6.77 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.794 2.329 . . . . 0.0 112.885 -178.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.2 -53.48 52.91 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.365 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.46 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -68.99 -32.13 71.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.919 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.36 -48.69 64.13 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.486 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.2 ttp85 -59.04 -55.74 31.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.073 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.491 ' CD1' ' HB ' ' A' ' 163' ' ' VAL . 4.3 pp -61.36 -41.04 96.43 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.647 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.4 -38.15 73.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.864 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.98 -29.78 55.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.767 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -83.83 -18.15 38.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.981 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.42 ' CD1' HD11 ' A' ' 138' ' ' LEU . 1.3 mt -96.14 -28.81 14.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.828 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.36 37.66 8.09 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.555 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.482 ' CD1' ' CE3' ' A' ' 166' ' ' TRP . 1.4 tt -118.45 142.33 33.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.717 0.294 . . . . 0.0 111.28 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.485 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.3 OUTLIER -73.96 101.09 3.72 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.899 179.282 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.415 ' CB ' ' CD1' ' A' ' 158' ' ' ILE . . . -49.91 -29.0 7.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.64 0.257 . . . . 0.0 111.204 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 32.3 t -65.03 -37.09 86.46 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.485 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -66.73 -22.91 66.05 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 177.679 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.454 ' CG2' HD11 ' A' ' 144' ' ' ILE . 20.3 t -86.9 84.03 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.72 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.76 92.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.012 0.434 . . . . 0.0 111.066 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.487 ' HA2' ' HA ' ' A' ' 158' ' ' ILE . . . -68.59 142.1 38.02 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.795 -0.639 . . . . 0.0 113.571 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.6 10.78 12.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.73 0.3 . . . . 0.0 110.779 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.457 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -75.19 151.92 42.8 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.771 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.4 ' O ' HG12 ' A' ' 157' ' ' VAL . 93.5 Cg_exo -43.86 114.74 0.57 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.057 2.505 . . . . 0.0 112.928 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 94.03 9.06 59.86 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.542 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 84.36 22.26 54.64 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.825 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.457 HG21 ' HA2' ' A' ' 153' ' ' GLY . 1.2 m -84.3 126.08 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 CA-C-N 117.055 0.428 . . . . 0.0 111.084 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.646 ' O ' HG13 ' A' ' 158' ' ' ILE . 16.9 pt -66.57 111.49 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.527 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 45.6 p -75.33 156.53 35.45 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.584 0.706 . . . . 0.0 111.773 -177.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.459 ' CG1' ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.31 -40.76 58.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.895 -179.483 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -64.22 -27.41 69.04 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.139 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.527 ' HB2' ' O ' ' A' ' 159' ' ' THR . 77.2 m-20 -71.47 -53.02 15.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.775 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.491 ' HB ' ' CD1' ' A' ' 138' ' ' LEU . 0.1 OUTLIER -64.61 -45.5 95.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.321 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.409 ' CG ' ' N ' ' A' ' 165' ' ' ARG . 7.7 pttt -61.58 -49.08 78.08 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.209 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.464 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 4.2 ptm180 -57.96 -39.72 78.81 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.866 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . 0.482 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 23.2 t90 -72.16 -48.12 45.76 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.818 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -52.47 -38.3 59.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.035 0.445 . . . . 0.0 110.396 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -77.27 -32.38 55.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.12 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.456 -0.167 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.321 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.434 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . . . . . . 0 N--CA 1.455 -0.182 0 CA-C-O 120.916 0.389 . . . . 0.0 110.931 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.449 ' O ' ' HG3' ' A' ' 136' ' ' ARG . . . -151.61 96.3 2.23 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.859 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.404 ' HB2' ' CD ' ' A' ' 133' ' ' PRO . 15.3 ptp -47.88 167.94 0.17 Allowed Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.718 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.404 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.0 Cg_exo -65.79 -47.29 3.99 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.81 2.34 . . . . 0.0 112.965 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.28 -50.76 66.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.43 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.468 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -69.2 -34.7 75.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.236 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 131' ' ' ALA . 0.9 OUTLIER -67.6 -48.54 66.52 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.265 0.555 . . . . 0.0 110.397 179.484 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 66.2 ttt180 -57.59 -54.42 47.08 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.931 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.497 HD11 ' C ' ' A' ' 138' ' ' LEU . 4.3 pp -64.15 -40.85 97.03 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.51 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.409 ' N ' ' CD1' ' A' ' 138' ' ' LEU . . . -58.92 -37.98 77.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.92 0.39 . . . . 0.0 110.803 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.02 -29.77 55.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.662 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -81.59 -24.92 36.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.966 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.7 mt -90.88 -28.93 17.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.068 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.36 38.91 7.5 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.846 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.478 ' CD1' ' CE3' ' A' ' 166' ' ' TRP . 1.2 tt -118.62 140.74 41.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.735 0.302 . . . . 0.0 111.229 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.532 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.6 OUTLIER -71.57 100.89 2.36 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.299 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.446 ' CB ' ' CD1' ' A' ' 158' ' ' ILE . . . -50.51 -31.12 14.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.44 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 29.5 m -64.6 -36.1 83.16 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.532 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -65.44 -25.15 67.39 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 177.31 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.467 ' CG2' HD11 ' A' ' 144' ' ' ILE . 21.9 t -84.2 85.99 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.449 178.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.73 90.75 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.111 0.481 . . . . 0.0 111.224 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.466 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -66.06 141.28 41.2 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.82 -0.627 . . . . 0.0 113.247 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.46 10.95 12.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.707 0.289 . . . . 0.0 110.739 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.415 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -77.42 151.91 38.85 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.569 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.42 ' O ' HG12 ' A' ' 157' ' ' VAL . 82.2 Cg_exo -41.43 122.05 1.69 Allowed 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.244 2.629 . . . . 0.0 113.244 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 88.31 -2.93 85.42 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.773 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 96.79 22.21 18.92 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.674 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.434 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -83.5 127.37 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.156 0 CA-C-N 117.092 0.446 . . . . 0.0 111.221 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.653 ' O ' HG13 ' A' ' 158' ' ' ILE . 15.1 pt -67.85 111.87 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 178.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.523 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 62.9 p -75.08 156.49 36.03 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.625 0.726 . . . . 0.0 111.693 -177.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.455 ' CG1' ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.59 -41.0 62.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.917 -179.407 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.543 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 0.9 OUTLIER -64.0 -27.73 69.32 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.919 179.387 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.523 ' HB2' ' O ' ' A' ' 159' ' ' THR . 87.3 m-20 -69.98 -54.37 13.58 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.318 0.58 . . . . 0.0 110.495 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.495 ' HB ' HD12 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -65.19 -40.81 89.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.725 -179.59 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -65.61 -46.66 78.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.903 0.382 . . . . 0.0 111.428 -178.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.543 ' HG3' ' O ' ' A' ' 161' ' ' GLU . 26.8 mtp180 -62.6 -38.57 90.68 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.885 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . 0.478 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 19.6 t90 -71.4 -50.12 35.17 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.71 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -51.93 -38.36 56.09 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.002 0.43 . . . . 0.0 110.571 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.439 ' HG2' ' HA ' ' A' ' 165' ' ' ARG . 8.4 pt-20 -76.78 -31.35 56.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.254 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 . . . . . 0 N--CA 1.456 -0.143 0 CA-C-O 120.957 0.408 . . . . 0.0 110.535 179.524 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.44 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . . . . . . 0 N--CA 1.454 -0.234 0 CA-C-O 120.866 0.365 . . . . 0.0 110.762 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -151.44 95.79 2.19 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.983 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.411 ' HB2' ' CD ' ' A' ' 133' ' ' PRO . 18.3 ptm -47.88 167.76 0.17 Allowed Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.664 -0.244 . . . . 0.0 110.805 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.411 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.4 Cg_exo -65.75 -46.26 5.31 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.776 2.317 . . . . 0.0 112.963 -178.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.28 -52.41 61.52 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.449 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.456 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -68.78 -33.56 74.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.019 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.7 mtp180 -68.37 -48.89 63.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.553 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.2 tpt85 -57.78 -55.73 31.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.734 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.511 HD11 ' C ' ' A' ' 138' ' ' LEU . 4.4 pp -61.65 -38.71 88.74 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.329 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -58.98 -39.47 81.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.807 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.19 -29.82 57.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.757 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -81.54 -24.35 36.65 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.993 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.429 ' CD1' HD11 ' A' ' 138' ' ' LEU . 1.5 mt -90.27 -28.89 18.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.018 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.05 37.37 7.82 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.836 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.477 ' CD1' ' CE3' ' A' ' 166' ' ' TRP . 1.4 tt -119.07 142.47 34.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.788 0.328 . . . . 0.0 111.213 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.519 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.6 OUTLIER -73.78 101.06 3.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.871 179.394 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.433 ' CB ' ' CD1' ' A' ' 158' ' ' ILE . . . -49.49 -30.56 8.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.735 0.302 . . . . 0.0 111.303 -179.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 20.4 m -65.11 -36.46 84.37 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.519 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -66.27 -23.79 66.46 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.415 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.462 ' CG2' HD11 ' A' ' 144' ' ' ILE . 22.0 t -85.27 85.01 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.478 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.65 90.99 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.096 0.474 . . . . 0.0 111.175 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.474 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -66.27 142.67 43.19 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.798 -0.637 . . . . 0.0 113.394 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.46 1.27 11.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.692 0.282 . . . . 0.0 110.838 179.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.424 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -66.56 152.25 52.37 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.551 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.424 ' O ' HG12 ' A' ' 157' ' ' VAL . 86.6 Cg_exo -42.32 120.09 1.52 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.179 2.586 . . . . 0.0 113.126 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 90.12 -0.24 78.4 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.682 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 93.89 22.25 26.15 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.697 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.44 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -83.51 126.09 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 CA-C-N 117.038 0.419 . . . . 0.0 111.214 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.648 ' O ' HG13 ' A' ' 158' ' ' ILE . 16.4 pt -65.69 111.31 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 178.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.548 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 55.4 p -75.22 156.5 35.7 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.487 0.66 . . . . 0.0 111.909 -177.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.457 ' CG1' ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.73 -41.86 58.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.888 -179.425 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.4 ' O ' ' CG ' ' A' ' 165' ' ' ARG . 21.7 tt0 -63.99 -27.48 69.15 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.069 179.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.548 ' HB2' ' O ' ' A' ' 159' ' ' THR . 83.9 m-20 -70.75 -52.16 22.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.648 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.491 ' HB ' ' CD1' ' A' ' 138' ' ' LEU . 0.1 OUTLIER -65.95 -46.76 87.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.489 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.2 mtmp? -61.3 -51.22 69.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.468 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.547 ' HG3' ' O ' ' A' ' 162' ' ' ASP . 0.1 OUTLIER -57.74 -38.8 75.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.895 -179.787 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . 0.477 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 27.3 t90 -71.53 -48.2 50.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.784 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -52.22 -37.91 56.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.976 0.417 . . . . 0.0 110.559 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -77.2 -32.3 55.88 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.083 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 . . . . . 0 C--N 1.333 -0.146 0 CA-C-O 120.956 0.408 . . . . 0.0 110.383 179.487 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.45 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . . . . . . 0 N--CA 1.454 -0.244 0 CA-C-O 120.949 0.404 . . . . 0.0 110.852 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -147.83 94.67 2.38 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.848 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.401 ' HB2' ' CD ' ' A' ' 133' ' ' PRO . 17.9 ptp -47.3 166.56 0.19 Allowed Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.064 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.401 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 21.8 Cg_exo -65.74 -46.57 4.9 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.883 2.389 . . . . 0.0 112.867 -179.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.29 -50.84 66.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.259 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.467 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -70.49 -36.08 73.61 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.018 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.87 -46.83 80.17 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.359 0.6 . . . . 0.0 110.135 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.55 -58.71 7.42 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.031 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.503 HD12 ' HB ' ' A' ' 163' ' ' VAL . 3.9 pp -59.91 -43.93 94.57 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.516 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.412 ' N ' ' CD1' ' A' ' 138' ' ' LEU . . . -53.5 -41.12 65.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.982 0.42 . . . . 0.0 110.828 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -73.02 -32.55 65.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.898 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -73.88 -46.51 44.2 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.001 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.507 ' N ' HD11 ' A' ' 142' ' ' LEU . 8.9 mp -72.21 -29.03 63.57 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.082 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.83 37.71 7.22 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.772 -0.728 . . . . 0.0 113.104 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.491 ' CD1' ' CE3' ' A' ' 166' ' ' TRP . 1.5 tt -114.5 141.94 29.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.736 0.303 . . . . 0.0 111.084 179.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.458 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 1.2 t0 -72.47 101.25 2.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.06 179.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -49.31 -28.29 4.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.764 0.316 . . . . 0.0 111.353 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 37.1 t -66.42 -37.77 85.94 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.463 ' CE ' ' CH2' ' A' ' 166' ' ' TRP . 0.0 OUTLIER -66.13 -21.04 66.33 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.4 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.439 ' CG2' HD11 ' A' ' 144' ' ' ILE . 21.3 t -89.48 88.29 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.565 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 6.5 ttpt -50.62 93.66 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.009 0.433 . . . . 0.0 111.17 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.493 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -72.74 130.25 14.45 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.146 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.456 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.2 OUTLIER -118.48 20.15 13.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.024 0.44 . . . . 0.0 110.702 179.585 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.448 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -78.59 156.92 43.39 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.741 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.401 ' O ' HG12 ' A' ' 157' ' ' VAL . 91.8 Cg_exo -43.82 103.95 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.086 2.524 . . . . 0.0 112.992 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.73 22.17 14.55 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.2 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 72.99 22.15 79.34 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.637 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.45 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -85.45 125.82 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 CA-C-N 117.031 0.415 . . . . 0.0 111.191 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.668 ' O ' HG13 ' A' ' 158' ' ' ILE . 17.6 pt -65.49 110.67 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.51 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 71.8 p -75.12 156.37 36.08 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.491 0.663 . . . . 0.0 111.62 -177.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.461 ' CG1' ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -56.5 -39.66 63.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.511 -179.724 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.613 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 0.5 OUTLIER -63.25 -28.51 70.08 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.768 179.1 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.51 ' HB2' ' O ' ' A' ' 159' ' ' THR . 91.1 m-20 -71.35 -52.56 18.06 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.826 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.503 ' HB ' HD12 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -67.21 -37.16 78.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.872 -179.183 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.469 ' HG3' ' N ' ' A' ' 165' ' ' ARG . 5.3 ptpt -70.9 -51.37 26.6 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.192 0.52 . . . . 0.0 111.14 -179.289 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.613 ' HG3' ' O ' ' A' ' 161' ' ' GLU . 49.3 mtm180 -57.81 -37.62 74.09 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.005 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . 0.491 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 46.8 t90 -68.9 -50.04 53.0 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.716 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -50.41 -43.11 54.63 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.507 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.416 ' HG2' ' HA ' ' A' ' 165' ' ' ARG . 7.2 pt-20 -71.26 -32.37 68.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.897 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 . . . . . 0 N--CA 1.456 -0.156 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.231 179.279 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.467 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . . . . . . 0 N--CA 1.455 -0.192 0 CA-C-O 120.855 0.36 . . . . 0.0 110.682 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -154.62 95.42 1.78 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.045 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.636 ' HB2' ' HD2' ' A' ' 133' ' ' PRO . 19.5 ptm -46.46 167.76 0.14 Allowed Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.558 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.636 ' HD2' ' HB2' ' A' ' 132' ' ' MET . 50.4 Cg_endo -71.88 -34.35 8.79 Favored 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 122.122 1.882 . . . . 0.0 112.5 -178.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.71 -54.47 45.98 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.242 0.544 . . . . 0.0 110.649 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.459 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -69.53 -33.26 72.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.507 179.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 16.6 mmm-85 -66.49 -47.76 71.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.383 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.02 -55.89 28.43 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.9 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.508 ' CD1' ' HB ' ' A' ' 163' ' ' VAL . 4.4 pp -61.04 -40.19 92.68 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.536 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.87 -38.44 75.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.974 0.416 . . . . 0.0 110.791 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.52 -30.05 57.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.713 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -83.08 -19.85 36.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.953 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.439 ' CD1' HD11 ' A' ' 138' ' ' LEU . 1.3 mt -94.02 -28.88 15.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.886 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.71 37.36 8.03 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.746 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.479 ' CD1' ' CE3' ' A' ' 166' ' ' TRP . 1.6 tt -118.67 143.48 29.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.788 0.327 . . . . 0.0 111.306 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.507 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 1.3 t0 -74.39 101.04 3.96 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.437 ' CB ' ' CD1' ' A' ' 158' ' ' ILE . . . -50.2 -28.57 7.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.662 0.268 . . . . 0.0 111.37 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.19 -36.92 84.35 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.507 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -66.54 -21.91 66.16 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 177.524 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.449 ' CG2' HD11 ' A' ' 144' ' ' ILE . 21.7 t -88.0 85.76 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.61 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -50.7 92.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.988 0.423 . . . . 0.0 111.304 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.516 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -69.47 138.14 30.1 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.809 -0.632 . . . . 0.0 113.525 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.54 12.02 13.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.795 0.331 . . . . 0.0 110.788 179.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.436 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -74.5 154.76 47.78 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.786 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -43.85 108.23 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.034 2.489 . . . . 0.0 112.878 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.16 18.79 27.95 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.296 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 74.62 22.18 77.59 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.801 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.467 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -83.68 126.09 40.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 117.069 0.435 . . . . 0.0 111.192 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.64 ' O ' HG13 ' A' ' 158' ' ' ILE . 19.0 pt -64.79 111.52 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 178.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.537 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 36.9 p -75.36 156.52 35.37 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.565 0.697 . . . . 0.0 111.813 -177.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.466 ' CG1' ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.03 -41.27 58.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.719 -179.429 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -63.94 -27.51 69.19 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.183 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.537 ' HB2' ' O ' ' A' ' 159' ' ' THR . 83.1 m-20 -71.35 -51.59 23.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.731 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.508 ' HB ' ' CD1' ' A' ' 138' ' ' LEU . 0.1 OUTLIER -66.9 -45.3 87.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.512 -179.884 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.423 ' CG ' ' N ' ' A' ' 165' ' ' ARG . 2.0 pttt -62.85 -50.34 71.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.385 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.517 ' HG3' ' O ' ' A' ' 162' ' ' ASP . 6.8 ppt_? -58.54 -40.01 81.81 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.895 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . 0.479 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 29.4 t90 -70.08 -48.55 57.27 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.85 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -51.99 -38.81 58.04 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.937 0.399 . . . . 0.0 110.68 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -76.48 -31.43 57.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.027 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 . . . . . 0 N--CA 1.455 -0.213 0 CA-C-O 120.926 0.393 . . . . 0.0 110.364 179.398 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.457 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . . . . . . 0 N--CA 1.454 -0.229 0 CA-C-O 121.061 0.457 . . . . 0.0 111.085 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -147.83 94.2 2.31 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.712 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.421 ' HG2' ' O ' ' A' ' 158' ' ' ILE . 14.8 ptp -47.41 166.04 0.2 Allowed Pre-proline 0 CA--C 1.532 0.252 0 CA-C-O 120.665 0.269 . . . . 0.0 110.991 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -66.21 -47.97 2.95 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.883 2.389 . . . . 0.0 113.069 -178.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.26 -48.38 71.25 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.666 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.458 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -71.16 -35.13 71.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.855 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 28.8 mtt180 -68.0 -45.76 73.16 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.155 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.3 tpt180 -59.12 -56.98 15.28 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.853 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.49 ' CD1' ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -61.1 -41.49 96.77 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.624 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.408 ' N ' ' CD1' ' A' ' 138' ' ' LEU . . . -56.47 -38.37 71.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.925 0.393 . . . . 0.0 110.907 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 9.6 ttmm -77.02 -30.73 55.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.799 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 51.5 tp10 -83.23 -16.18 47.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.185 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.431 ' CD1' HD11 ' A' ' 138' ' ' LEU . 1.1 mt -98.45 -28.92 13.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.915 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.72 35.35 8.48 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.672 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.485 ' CD1' ' CE3' ' A' ' 166' ' ' TRP . 1.5 tt -116.56 143.53 26.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.834 0.35 . . . . 0.0 111.241 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.465 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 1.9 t0 -76.07 101.47 5.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.917 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -49.4 -28.25 4.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.673 0.273 . . . . 0.0 111.075 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.4 p -65.96 -37.76 86.83 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.465 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -66.4 -21.24 66.22 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 177.573 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.463 ' CG2' HD11 ' A' ' 144' ' ' ILE . 20.4 t -89.69 86.45 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.696 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.2 ptmm? -50.67 93.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.934 0.397 . . . . 0.0 110.98 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.471 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -69.56 133.39 25.5 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.969 -0.634 . . . . 0.0 113.192 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.421 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.4 OUTLIER -118.46 15.56 13.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.963 0.411 . . . . 0.0 110.739 179.545 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.462 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -74.9 155.61 48.23 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.717 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -44.74 105.84 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.138 2.559 . . . . 0.0 112.824 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.35 20.16 21.04 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.209 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 74.81 22.07 77.57 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.674 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.462 HG21 ' HA2' ' A' ' 153' ' ' GLY . 1.1 m -85.91 125.08 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-N 117.08 0.44 . . . . 0.0 111.183 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.671 ' O ' HG13 ' A' ' 158' ' ' ILE . 15.2 pt -64.69 110.31 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.525 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 67.0 p -75.16 156.58 35.76 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.611 0.719 . . . . 0.0 111.812 -177.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.453 HG12 HD22 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.97 -41.34 67.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.67 -179.656 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -63.78 -27.44 69.19 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.056 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 159' ' ' THR . 85.1 m-20 -71.49 -53.0 15.36 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.673 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.49 ' HB ' ' CD1' ' A' ' 138' ' ' LEU . 0.1 OUTLIER -65.49 -45.23 93.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.364 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.41 ' CG ' ' N ' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -61.6 -49.1 77.96 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.11 -179.787 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.486 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 11.5 ptm180 -57.71 -40.4 79.45 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.755 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . 0.485 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 26.2 t90 -71.05 -48.83 50.49 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.747 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -51.55 -38.34 53.8 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.9 0.381 . . . . 0.0 110.592 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -77.21 -32.28 55.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.094 179.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 . . . . . 0 N--CA 1.456 -0.16 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.227 179.386 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.472 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . . . . . . 0 N--CA 1.454 -0.232 0 CA-C-O 120.895 0.379 . . . . 0.0 110.957 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -151.41 94.91 2.08 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.874 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.412 ' HB2' ' CD ' ' A' ' 133' ' ' PRO . 9.5 ptm -48.09 167.5 0.19 Allowed Pre-proline 0 CA--C 1.531 0.226 0 CA-C-O 120.61 0.243 . . . . 0.0 110.941 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.412 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.3 Cg_exo -65.9 -45.55 6.03 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.879 2.386 . . . . 0.0 112.864 -179.01 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.28 -53.1 58.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.397 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.468 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -69.55 -32.62 71.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.865 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 14.9 mmm-85 -67.82 -48.03 67.36 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.376 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 13.8 ttt85 -59.85 -55.39 34.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.083 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.49 HD11 ' C ' ' A' ' 138' ' ' LEU . 4.3 pp -61.67 -41.13 97.13 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.678 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.406 ' N ' ' CD1' ' A' ' 138' ' ' LEU . . . -56.49 -40.88 75.69 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.954 0.407 . . . . 0.0 110.998 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.3 mtmm -75.9 -29.74 58.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.97 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -82.3 -19.83 38.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.163 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.41 ' CD1' HD11 ' A' ' 138' ' ' LEU . 1.4 mt -95.0 -28.82 14.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.87 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.75 37.91 7.75 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.484 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.477 HD11 ' CG2' ' A' ' 149' ' ' VAL . 0.6 OUTLIER -117.86 143.85 27.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.738 0.304 . . . . 0.0 111.201 -179.956 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.449 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.5 OUTLIER -76.11 100.97 5.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.013 179.415 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.407 ' CB ' ' CD1' ' A' ' 158' ' ' ILE . . . -51.85 -34.83 42.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.644 0.259 . . . . 0.0 111.252 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.16 -36.59 75.56 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.516 ' HE2' ' CD1' ' A' ' 166' ' ' TRP . 0.0 OUTLIER -67.61 -30.5 70.11 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 177.666 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.477 ' CG2' HD11 ' A' ' 144' ' ' ILE . 10.7 t -78.0 83.28 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.384 178.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.53 94.39 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.142 0.496 . . . . 0.0 111.115 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.504 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -68.18 137.38 31.4 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.695 -0.684 . . . . 0.0 113.36 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.54 13.21 13.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.767 0.318 . . . . 0.0 110.748 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.437 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -76.13 155.75 46.33 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.679 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_exo -43.26 106.41 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.133 2.555 . . . . 0.0 112.92 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.81 20.15 22.44 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.362 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 73.94 22.21 78.28 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.7 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.472 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -84.01 125.58 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 117.016 0.408 . . . . 0.0 111.031 -179.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.656 ' O ' HG13 ' A' ' 158' ' ' ILE . 19.9 pt -64.57 111.35 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.533 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 38.6 p -75.33 156.43 35.53 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.559 0.695 . . . . 0.0 111.689 -177.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.452 ' CG1' ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.76 -41.06 64.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.887 -179.4 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -64.58 -27.56 69.03 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.124 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.533 ' HB2' ' O ' ' A' ' 159' ' ' THR . 89.7 m-20 -69.47 -55.34 10.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.372 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.476 ' HB ' ' CD1' ' A' ' 138' ' ' LEU . 0.1 OUTLIER -63.25 -44.19 99.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.683 -179.917 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 160' ' ' VAL . 11.8 mttp -64.0 -40.89 97.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.391 -179.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.541 ' HG3' ' N ' ' A' ' 166' ' ' TRP . 0.0 OUTLIER -64.24 -38.48 91.2 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.83 -179.801 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . 0.541 ' N ' ' HG3' ' A' ' 165' ' ' ARG . 62.8 t90 -73.88 -47.77 35.7 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.659 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -54.14 -37.08 64.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.919 0.39 . . . . 0.0 110.443 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.41 ' HG2' ' HA ' ' A' ' 165' ' ' ARG . 8.3 pt-20 -77.25 -33.34 56.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.074 179.174 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.165 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.443 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.457 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . . . . . . 0 N--CA 1.456 -0.162 0 CA-C-O 121.063 0.458 . . . . 0.0 110.788 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -153.99 95.52 1.86 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.841 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.414 ' HB2' ' CD ' ' A' ' 133' ' ' PRO . 16.7 ptm -47.22 168.02 0.15 Allowed Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.673 -0.239 . . . . 0.0 110.865 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.414 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 23.3 Cg_exo -65.41 -44.84 8.11 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.669 2.246 . . . . 0.0 112.922 -178.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.32 -52.9 60.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.367 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.475 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -69.09 -33.2 73.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.052 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.36 -48.54 67.16 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.274 0.559 . . . . 0.0 110.322 179.338 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 18.2 ttp180 -58.63 -54.23 49.36 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.188 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.507 HD12 ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -64.08 -41.64 97.24 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.804 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.422 ' N ' ' CD1' ' A' ' 138' ' ' LEU . . . -58.08 -38.82 77.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.925 0.393 . . . . 0.0 110.985 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.97 -29.86 55.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.671 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -83.28 -17.92 40.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.124 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.4 mt -96.88 -28.89 14.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.872 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.69 37.7 7.88 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.455 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.482 HD11 ' CG2' ' A' ' 149' ' ' VAL . 1.4 tt -117.85 141.02 38.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.831 0.348 . . . . 0.0 111.288 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.481 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.6 OUTLIER -73.09 101.06 3.18 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.159 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.417 ' CB ' ' CD1' ' A' ' 158' ' ' ILE . . . -50.16 -28.63 7.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.307 -179.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.98 -37.04 84.96 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.481 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -65.09 -23.27 67.11 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 177.237 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.482 ' CG2' HD11 ' A' ' 144' ' ' ILE . 19.0 t -88.54 90.22 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.328 179.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.62 91.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.085 0.469 . . . . 0.0 111.125 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.488 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -69.36 125.88 18.46 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.934 -0.65 . . . . 0.0 113.047 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.468 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.1 OUTLIER -118.56 31.87 6.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.159 0.504 . . . . 0.0 110.292 179.708 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.448 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -91.47 156.76 24.25 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.679 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_exo -43.46 101.1 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 123.065 2.51 . . . . 0.0 113.022 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 99.83 25.77 8.91 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.315 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 70.16 22.1 77.28 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.602 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.457 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -86.27 126.46 40.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.017 -179.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.667 ' O ' HG13 ' A' ' 158' ' ' ILE . 18.9 pt -66.06 112.01 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.515 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 47.4 p -75.33 156.43 35.54 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.485 0.66 . . . . 0.0 111.668 -177.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.47 ' CG1' ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -56.98 -40.31 71.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.681 -179.721 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.556 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 2.1 tt0 -62.76 -27.73 69.49 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.863 179.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.515 ' HB2' ' O ' ' A' ' 159' ' ' THR . 91.2 m-20 -71.45 -53.9 12.44 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.342 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.507 ' HB ' HD12 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -67.08 -34.48 69.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.413 -179.479 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.428 ' HB3' ' O ' ' A' ' 160' ' ' VAL . 0.0 OUTLIER -69.28 -47.84 63.42 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-O 121.047 0.451 . . . . 0.0 110.892 -179.387 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.556 ' HG3' ' O ' ' A' ' 161' ' ' GLU . 15.1 mtp180 -60.39 -41.53 94.02 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.176 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . 0.478 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 13.4 t90 -70.67 -50.16 39.66 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.826 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -50.56 -38.69 46.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.002 0.429 . . . . 0.0 110.682 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -77.28 -32.54 55.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.555 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 . . . . . 0 C--N 1.333 -0.117 0 CA-C-O 120.933 0.397 . . . . 0.0 110.564 179.714 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.459 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . . . . . . 0 N--CA 1.454 -0.252 0 CA-C-O 120.964 0.411 . . . . 0.0 111.114 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.401 ' O ' ' HG3' ' A' ' 136' ' ' ARG . . . -151.23 95.79 2.21 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.693 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.405 ' HB2' ' CD ' ' A' ' 133' ' ' PRO . 16.0 ptp -47.02 167.74 0.15 Allowed Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.917 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.405 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.1 Cg_exo -65.86 -47.66 3.58 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.811 2.341 . . . . 0.0 112.746 -179.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.28 -50.38 67.41 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.347 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.47 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -69.9 -33.87 72.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.013 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 131' ' ' ALA . 0.2 OUTLIER -67.75 -47.71 68.46 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.324 0.583 . . . . 0.0 110.329 179.339 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.15 -54.42 47.2 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.217 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.507 HD12 ' HB ' ' A' ' 163' ' ' VAL . 4.3 pp -63.59 -42.08 98.31 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.784 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.423 ' N ' ' CD1' ' A' ' 138' ' ' LEU . . . -58.59 -37.25 75.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.865 0.364 . . . . 0.0 110.791 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -77.0 -29.75 55.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.781 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -81.97 -24.78 35.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.038 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.9 mt -90.99 -28.85 17.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.876 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.53 36.62 8.57 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.545 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.484 ' CD1' ' CE3' ' A' ' 166' ' ' TRP . 1.4 tt -114.87 142.37 27.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.875 0.369 . . . . 0.0 111.243 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.474 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 1.9 t0 -74.45 101.03 4.0 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.414 ' CB ' ' CD1' ' A' ' 158' ' ' ILE . . . -50.22 -28.44 7.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.703 0.287 . . . . 0.0 111.301 -179.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.54 -37.27 86.22 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.474 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -65.85 -22.63 66.55 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.514 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.471 ' CG2' HD11 ' A' ' 144' ' ' ILE . 20.1 t -88.41 86.48 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.589 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.5 tppt? -50.78 92.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.033 0.444 . . . . 0.0 110.976 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.462 ' HA2' ' HA ' ' A' ' 158' ' ' ILE . . . -70.01 140.52 32.91 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 115.876 -0.602 . . . . 0.0 113.122 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.46 9.46 12.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.677 0.275 . . . . 0.0 110.881 179.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.455 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -70.89 150.36 47.65 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.613 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.422 ' O ' HG12 ' A' ' 157' ' ' VAL . 94.3 Cg_exo -42.77 123.86 3.2 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.137 2.558 . . . . 0.0 113.081 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 87.82 -5.86 84.3 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.601 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 100.74 22.25 11.34 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.705 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.459 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -86.09 127.13 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 CA-C-N 117.087 0.443 . . . . 0.0 111.198 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.652 ' O ' HG13 ' A' ' 158' ' ' ILE . 14.5 pt -67.35 111.96 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 177.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.521 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 76.1 p -75.1 156.54 35.92 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.54 0.686 . . . . 0.0 111.536 -177.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.465 HG12 HD22 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -56.37 -40.72 68.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.873 -179.348 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.552 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 0.1 OUTLIER -62.81 -29.15 70.5 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.748 179.364 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.521 ' HB2' ' O ' ' A' ' 159' ' ' THR . 87.3 m-20 -69.36 -54.38 14.77 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.371 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.507 ' HB ' HD12 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -65.79 -34.62 71.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.0 -179.584 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.409 ' HB3' ' O ' ' A' ' 160' ' ' VAL . 0.2 OUTLIER -67.23 -47.67 70.12 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 121.014 0.435 . . . . 0.0 110.735 -179.64 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.552 ' HG3' ' O ' ' A' ' 161' ' ' GLU . 68.6 mtt-85 -59.26 -44.48 92.41 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.043 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . 0.484 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 10.4 t90 -70.06 -50.1 44.5 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.959 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -50.53 -38.43 44.66 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.937 0.399 . . . . 0.0 110.627 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -77.31 -31.69 54.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.503 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.902 0.382 . . . . 0.0 110.593 179.698 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.403 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . . . . . . 0 CA--C 1.522 -0.126 0 CA-C-O 120.882 0.373 . . . . 0.0 110.567 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -153.07 96.64 2.1 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.206 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.655 ' HB2' ' HD2' ' A' ' 133' ' ' PRO . 14.9 ptp -45.64 168.34 0.1 Allowed Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.546 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.655 ' HD2' ' HB2' ' A' ' 132' ' ' MET . 50.0 Cg_endo -71.44 -35.64 7.92 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.062 1.841 . . . . 0.0 112.363 -179.064 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.79 -52.45 65.01 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.759 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.471 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -70.43 -32.73 70.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.672 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 2.3 mmt85 -68.3 -46.11 71.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.079 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.63 -55.66 31.6 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.831 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.487 HD11 ' C ' ' A' ' 138' ' ' LEU . 4.2 pp -62.59 -42.08 99.34 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.641 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.415 ' N ' ' CD1' ' A' ' 138' ' ' LEU . . . -57.99 -36.75 73.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.92 0.391 . . . . 0.0 110.778 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 3.8 mtmt -77.02 -30.76 55.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.555 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -82.93 -18.5 39.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.1 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.421 ' CD1' HD11 ' A' ' 138' ' ' LEU . 1.5 mt -96.66 -28.83 14.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.91 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.56 38.8 8.01 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.521 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.477 ' CD1' ' CE3' ' A' ' 166' ' ' TRP . 1.3 tt -118.43 141.72 36.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.696 0.284 . . . . 0.0 111.33 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.521 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.7 OUTLIER -73.18 100.97 3.21 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.181 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.443 ' CB ' ' CD1' ' A' ' 158' ' ' ILE . . . -50.45 -30.46 12.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.47 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 15.8 m -64.61 -36.16 83.34 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.521 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -66.05 -24.9 66.83 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 177.417 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.462 ' CG2' HD11 ' A' ' 144' ' ' ILE . 20.6 t -84.46 85.2 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.458 179.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.6 91.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.045 0.45 . . . . 0.0 111.124 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.521 ' HA2' ' HA ' ' A' ' 158' ' ' ILE . . . -70.03 143.09 37.3 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.808 -0.633 . . . . 0.0 113.415 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.56 9.1 12.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.714 0.292 . . . . 0.0 110.793 179.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.421 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -72.84 151.29 45.76 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.698 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.433 ' O ' HG12 ' A' ' 157' ' ' VAL . 86.5 Cg_exo -41.57 124.59 2.54 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.2 2.6 . . . . 0.0 113.197 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 86.48 -5.66 84.07 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.631 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 100.0 22.24 12.38 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.719 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.433 HG12 ' O ' ' A' ' 154' ' ' PRO . 1.2 m -84.47 128.84 38.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 117.096 0.448 . . . . 0.0 111.236 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.658 ' O ' HG13 ' A' ' 158' ' ' ILE . 14.5 pt -68.61 111.75 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 177.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.526 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 72.2 p -75.0 156.45 36.25 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.495 0.664 . . . . 0.0 111.637 -177.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.461 HG12 HD22 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.55 -40.69 60.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.877 -179.467 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.533 ' O ' ' CG ' ' A' ' 165' ' ' ARG . 0.6 OUTLIER -63.6 -27.8 69.49 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.835 179.434 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.526 ' HB2' ' O ' ' A' ' 159' ' ' THR . 86.6 m-20 -70.99 -53.71 13.87 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.593 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.487 ' HB ' ' CD1' ' A' ' 138' ' ' LEU . 0.1 OUTLIER -65.36 -37.87 81.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.155 -179.585 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.9 pttt -65.61 -47.35 75.97 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.977 0.418 . . . . 0.0 110.793 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.533 ' CG ' ' O ' ' A' ' 161' ' ' GLU . 4.9 mmt180 -59.61 -42.54 92.85 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.089 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . 0.477 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 13.1 t90 -69.83 -50.12 45.9 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.599 -0.441 . . . . 0.0 110.952 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -50.64 -38.84 48.41 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.843 0.354 . . . . 0.0 110.614 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -77.3 -31.61 54.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.37 179.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.953 0.406 . . . . 0.0 110.435 179.577 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.463 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . . . . . . 0 C--O 1.232 0.142 0 CA-C-O 121.109 0.48 . . . . 0.0 111.157 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.405 ' O ' ' HG3' ' A' ' 136' ' ' ARG . . . -151.36 95.28 2.13 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.801 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.416 ' HG2' ' O ' ' A' ' 158' ' ' ILE . 18.1 ptp -47.47 166.54 0.19 Allowed Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.985 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -66.24 -47.31 3.41 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.814 2.342 . . . . 0.0 112.978 -178.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.1 -50.62 66.43 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.456 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.474 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -69.29 -34.9 75.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.22 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 131' ' ' ALA . 0.2 OUTLIER -67.93 -48.49 65.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.156 0.503 . . . . 0.0 110.453 179.495 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.8 ttp-105 -57.53 -55.2 37.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.971 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.485 HD11 ' C ' ' A' ' 138' ' ' LEU . 4.4 pp -61.93 -41.14 97.62 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.486 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.405 ' N ' ' CD1' ' A' ' 138' ' ' LEU . . . -57.9 -38.04 75.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.965 0.412 . . . . 0.0 110.868 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -76.85 -29.68 55.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.784 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -83.58 -20.08 34.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.033 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.402 ' CD1' HD11 ' A' ' 138' ' ' LEU . 1.4 mt -94.5 -28.95 15.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.851 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.98 35.67 8.88 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.645 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.491 HD11 ' CG2' ' A' ' 149' ' ' VAL . 1.9 tt -115.77 142.75 27.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.792 0.33 . . . . 0.0 111.3 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.523 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.9 OUTLIER -75.22 101.11 4.52 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.2 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.429 ' CB ' ' CD1' ' A' ' 158' ' ' ILE . . . -49.15 -29.04 4.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.672 0.272 . . . . 0.0 111.301 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.29 -37.43 85.43 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.523 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -65.78 -21.07 66.47 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 177.269 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.491 ' CG2' HD11 ' A' ' 144' ' ' ILE . 19.6 t -91.17 90.15 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.403 179.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.54 93.91 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.036 0.446 . . . . 0.0 111.015 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.488 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -72.79 126.34 10.64 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.815 -0.629 . . . . 0.0 113.035 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.492 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -118.49 31.62 6.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.153 0.501 . . . . 0.0 110.42 179.707 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.436 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -89.15 158.07 27.59 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.571 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.401 ' O ' HG12 ' A' ' 157' ' ' VAL . 89.6 Cg_exo -43.82 102.06 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.043 2.496 . . . . 0.0 112.945 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.78 24.58 10.6 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.382 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 71.71 22.17 78.74 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.748 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.463 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -87.03 126.99 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 CA-C-N 117.06 0.43 . . . . 0.0 111.328 -179.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.678 ' O ' HG13 ' A' ' 158' ' ' ILE . 19.7 pt -65.77 111.9 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 177.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.508 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 70.2 p -75.07 156.32 36.23 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.612 0.72 . . . . 0.0 111.595 -177.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.463 HG12 HD22 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -56.24 -40.06 63.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.876 -179.561 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.587 ' O ' ' CG ' ' A' ' 165' ' ' ARG . 1.2 tp10 -65.28 -30.22 71.06 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.781 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.508 ' HB2' ' O ' ' A' ' 159' ' ' THR . 80.5 m-20 -65.7 -56.05 14.15 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.308 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.479 ' HB ' HD12 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -62.14 -41.39 91.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.165 -179.988 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -65.19 -41.72 94.28 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.555 -179.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.587 ' CG ' ' O ' ' A' ' 161' ' ' GLU . 0.1 OUTLIER -62.46 -44.59 96.04 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.661 179.916 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . 0.445 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 18.5 t90 -68.32 -50.18 55.23 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.856 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -51.19 -39.4 56.39 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.887 0.375 . . . . 0.0 110.684 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -76.27 -29.13 57.32 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.277 179.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . 0.401 ' OE1' ' CD1' ' A' ' 166' ' ' TRP . 0.5 OUTLIER . . . . . 0 N--CA 1.455 -0.217 0 CA-C-O 121.194 0.521 . . . . 0.0 110.048 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.408 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . . . . . . 0 N--CA 1.456 -0.145 0 CA-C-O 120.864 0.364 . . . . 0.0 110.72 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.412 ' O ' ' HG3' ' A' ' 136' ' ' ARG . . . -153.98 96.32 1.95 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.098 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.421 ' HB2' ' CD ' ' A' ' 133' ' ' PRO . 16.6 ptp -47.24 168.52 0.13 Allowed Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.725 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.421 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.7 Cg_exo -65.54 -47.6 3.99 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.687 2.258 . . . . 0.0 112.806 -178.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.18 -50.78 66.25 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.398 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.471 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -69.71 -34.52 74.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.084 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.412 ' HG3' ' O ' ' A' ' 131' ' ' ALA . 0.9 OUTLIER -66.48 -47.96 71.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.314 0.578 . . . . 0.0 110.296 179.367 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 11.4 ttt-85 -59.48 -55.24 37.16 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.259 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.511 ' CD1' ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -62.58 -42.16 99.38 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.799 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.419 ' N ' ' CD1' ' A' ' 138' ' ' LEU . . . -57.8 -36.68 72.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.912 0.387 . . . . 0.0 110.726 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.07 -30.76 55.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.705 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -84.45 -15.93 44.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.203 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.415 ' CD1' HD11 ' A' ' 138' ' ' LEU . 1.1 mt -98.12 -28.85 13.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.799 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.58 36.53 8.6 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.66 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.491 ' CD1' ' CE3' ' A' ' 166' ' ' TRP . 1.3 tt -118.31 140.25 42.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.739 0.304 . . . . 0.0 111.258 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.527 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.6 OUTLIER -71.47 100.93 2.32 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.293 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.431 ' CB ' ' CD1' ' A' ' 158' ' ' ILE . . . -50.02 -30.36 10.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.764 0.316 . . . . 0.0 111.441 -179.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 17.0 m -65.14 -36.69 85.05 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.527 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -65.76 -23.82 66.81 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.408 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.462 ' CG2' HD11 ' A' ' 144' ' ' ILE . 21.9 t -84.9 85.6 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.458 179.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 5.0 ttpp -50.66 90.61 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.971 0.415 . . . . 0.0 111.29 -179.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.51 ' HA2' ' HA ' ' A' ' 158' ' ' ILE . . . -69.91 139.76 31.83 Favored Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 115.777 -0.647 . . . . 0.0 113.383 -179.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.48 13.53 13.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.764 0.316 . . . . 0.0 110.638 179.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.415 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -76.08 153.45 43.42 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.799 -179.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_exo -43.59 109.73 0.16 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.129 2.553 . . . . 0.0 112.873 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 96.59 16.47 36.68 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.294 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 76.2 22.21 74.11 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.72 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.415 HG21 ' HA2' ' A' ' 153' ' ' GLY . 1.3 m -83.59 126.67 40.16 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 CA-C-N 117.031 0.416 . . . . 0.0 111.025 -179.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.655 ' O ' HG13 ' A' ' 158' ' ' ILE . 17.3 pt -66.55 111.51 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.195 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.509 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 70.6 p -75.14 156.39 36.0 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.4 0.619 . . . . 0.0 111.261 -177.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.465 ' CG1' ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -56.18 -39.53 59.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.583 -179.664 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.637 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 27.3 tt0 -63.6 -27.91 69.56 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.814 179.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.509 ' HB2' ' O ' ' A' ' 159' ' ' THR . 88.7 m-20 -71.92 -52.59 16.48 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.711 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.511 ' HB ' ' CD1' ' A' ' 138' ' ' LEU . 0.1 OUTLIER -67.68 -35.89 74.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.636 -179.378 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -69.52 -49.27 56.05 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.075 0.464 . . . . 0.0 110.832 -179.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.637 ' HG3' ' O ' ' A' ' 161' ' ' GLU . 42.3 mtp180 -61.58 -36.37 80.48 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.253 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' TRP . . . . . 0.491 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 24.4 t90 -71.21 -50.32 34.24 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.948 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -51.94 -40.74 61.28 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.944 0.402 . . . . 0.0 110.39 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.41 ' HG2' ' HA ' ' A' ' 165' ' ' ARG . 8.4 pt-20 -74.28 -31.12 62.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.09 179.01 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 . . . . . 0 N--CA 1.456 -0.128 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.301 179.517 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -87.28 -18.82 29.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.615 0.245 . . . . 0.0 111.188 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 7.0 mtp180 -96.47 31.97 2.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.856 0.36 . . . . 0.0 111.066 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -152.93 137.28 16.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.886 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.1 t -93.04 126.57 45.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.917 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.464 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . -96.27 154.25 17.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.936 0.398 . . . . 0.0 110.874 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -152.27 95.5 2.06 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.866 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.403 ' HG2' ' O ' ' A' ' 158' ' ' ILE . 18.0 ptp -47.43 166.95 0.18 Allowed Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.768 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -65.91 -47.48 3.68 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.756 2.304 . . . . 0.0 112.857 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.19 -51.04 65.65 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.522 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.468 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -69.68 -33.57 72.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.051 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -68.49 -48.12 65.29 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.251 0.548 . . . . 0.0 110.547 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -58.88 -54.72 43.89 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.851 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.517 HD11 ' C ' ' A' ' 138' ' ' LEU . 4.3 pp -62.62 -39.48 93.93 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.527 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.402 ' N ' ' CD1' ' A' ' 138' ' ' LEU . . . -58.72 -39.62 81.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.886 0.374 . . . . 0.0 110.827 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.19 -29.76 57.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.783 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -81.85 -23.94 36.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.926 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.415 ' CD1' HD11 ' A' ' 138' ' ' LEU . 1.5 mt -90.56 -28.95 18.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.843 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.17 35.55 8.81 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.72 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.473 ' CD1' ' CE3' ' A' ' 166' ' ' TRP . 1.5 tt -116.39 142.32 30.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.781 0.324 . . . . 0.0 111.34 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.486 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 1.9 t0 -73.95 101.02 3.69 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.425 ' CB ' ' CD1' ' A' ' 158' ' ' ILE . . . -49.84 -28.03 5.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.277 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.73 -37.26 84.3 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.486 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -65.94 -21.14 66.41 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 177.349 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.455 ' CG2' HD11 ' A' ' 144' ' ' ILE . 21.7 t -89.93 88.12 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.455 179.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.7 ttmt -50.82 91.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.001 0.429 . . . . 0.0 111.206 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.477 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -70.18 133.76 24.48 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 121.015 -0.612 . . . . 0.0 113.198 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.421 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.4 OUTLIER -118.47 14.18 13.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.847 0.356 . . . . 0.0 110.766 179.563 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.452 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -73.18 155.34 50.43 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.709 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -44.37 106.5 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.097 2.531 . . . . 0.0 112.851 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.14 19.79 22.67 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.245 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 74.61 22.17 77.62 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.598 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.464 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.3 m -85.77 126.29 40.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 117.042 0.421 . . . . 0.0 111.067 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.665 ' O ' HG13 ' A' ' 158' ' ' ILE . 19.1 pt -64.98 111.94 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.504 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 61.7 p -75.02 156.48 36.16 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.558 0.694 . . . . 0.0 111.657 -177.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.451 ' CG1' ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -56.08 -39.91 61.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.715 -179.464 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.569 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 1.2 tp10 -65.82 -28.05 68.71 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.907 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.504 ' HB2' ' O ' ' A' ' 159' ' ' THR . 82.1 m-20 -68.49 -53.41 23.49 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.198 0.523 . . . . 0.0 110.225 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.503 ' HB ' HD12 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -65.64 -41.27 90.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.62 -179.729 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.55 -48.03 73.83 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 120.942 0.401 . . . . 0.0 111.465 -178.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.569 ' HG3' ' O ' ' A' ' 161' ' ' GLU . 21.6 mtt180 -60.63 -40.29 91.36 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.89 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.473 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 27.5 t90 -70.65 -48.99 52.13 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.661 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -50.52 -39.02 47.68 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.968 0.413 . . . . 0.0 110.486 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -77.33 -31.3 54.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.356 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -59.58 -30.06 68.39 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 120.953 0.406 . . . . 0.0 110.402 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.449 ' CG2' ' CZ3' ' A' ' 166' ' ' TRP . 19.0 p -75.36 -50.74 15.01 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.351 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -66.61 -31.17 71.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.388 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 7.3 mttm -61.04 -32.78 72.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.477 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.94 116.12 9.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.012 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -87.61 -66.98 0.86 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.893 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.274 -0.869 . . . . 0.0 111.131 179.968 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 112.439 -0.264 . . . . 0.0 112.439 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 9.0 p -87.83 -55.54 3.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.786 0.327 . . . . 0.0 110.912 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.14 -66.17 1.1 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.924 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 62.58 148.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.947 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.6 t -115.12 134.94 56.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.043 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.456 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . -104.21 154.69 19.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.917 0.389 . . . . 0.0 110.846 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -153.37 95.49 1.93 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.897 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.4 ' HB2' ' CD ' ' A' ' 133' ' ' PRO . 19.9 ptm -48.14 167.42 0.19 Allowed Pre-proline 0 CA--C 1.532 0.26 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.793 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.4 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.8 Cg_exo -65.54 -45.56 6.7 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.807 2.338 . . . . 0.0 112.918 -178.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.29 -52.71 60.59 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.423 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.474 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -69.25 -33.3 73.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.165 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 12.1 mtm180 -67.99 -49.17 63.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.524 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -58.29 -54.33 48.2 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.893 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.508 HD11 ' C ' ' A' ' 138' ' ' LEU . 4.4 pp -63.05 -38.92 93.1 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.417 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -58.31 -39.93 80.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.722 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -76.62 -29.81 56.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.726 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 -81.95 -20.02 39.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.059 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.409 ' CD1' HD11 ' A' ' 138' ' ' LEU . 1.3 mt -94.88 -28.85 15.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.927 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.64 35.98 8.2 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.812 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.493 ' CD1' ' CE3' ' A' ' 166' ' ' TRP . 1.5 tt -118.22 141.34 37.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.832 0.348 . . . . 0.0 111.183 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.478 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.6 OUTLIER -72.93 101.05 3.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.805 179.229 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.424 ' CB ' ' CD1' ' A' ' 158' ' ' ILE . . . -49.73 -28.71 6.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.641 0.257 . . . . 0.0 111.321 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.78 -36.98 85.06 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -66.52 -22.48 66.17 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.453 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.458 ' CG2' HD11 ' A' ' 144' ' ' ILE . 21.8 t -86.87 84.77 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.646 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 6.4 ttmt -50.73 90.82 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.976 0.417 . . . . 0.0 111.14 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.476 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -66.5 142.94 43.29 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.809 -0.632 . . . . 0.0 113.295 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.45 0.9 11.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.688 0.28 . . . . 0.0 110.885 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.426 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -65.99 151.96 51.93 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.747 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.423 ' O ' HG12 ' A' ' 157' ' ' VAL . 84.8 Cg_exo -42.04 120.67 1.58 Allowed 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.234 2.622 . . . . 0.0 113.182 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 89.55 -0.68 80.73 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.715 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 94.53 22.24 24.65 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.694 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.456 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -83.49 126.38 40.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 117.017 0.408 . . . . 0.0 111.107 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.635 ' O ' HG13 ' A' ' 158' ' ' ILE . 19.0 pt -65.89 111.82 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.514 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 44.0 p -75.3 156.53 35.5 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.575 0.702 . . . . 0.0 111.816 -177.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.465 ' CG1' ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -56.01 -40.16 61.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.805 -179.431 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.503 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 5.6 mt-10 -64.89 -27.61 68.98 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.834 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.514 ' HB2' ' O ' ' A' ' 159' ' ' THR . 88.1 m-20 -70.2 -53.97 14.85 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.522 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.504 ' HB ' HD12 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -65.16 -42.71 94.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.794 -179.37 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.9 mmtt -66.38 -52.11 50.16 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.953 0.406 . . . . 0.0 111.486 -178.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.503 ' HG3' ' O ' ' A' ' 161' ' ' GLU . 27.1 mtp180 -59.24 -35.88 74.47 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.035 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.493 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 32.9 t90 -70.66 -50.05 40.77 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.791 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -50.66 -41.26 55.29 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-O 120.97 0.414 . . . . 0.0 110.411 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.4 ' HG2' ' HA ' ' A' ' 165' ' ' ARG . 7.6 pt-20 -74.04 -31.88 63.08 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.048 179.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -61.45 -29.46 69.97 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.278 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.438 HG23 ' CZ3' ' A' ' 166' ' ' TRP . 3.6 p -71.5 -52.24 19.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.263 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -70.09 -26.2 63.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.594 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -69.79 -36.33 75.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.768 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -74.45 135.19 42.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.145 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 6.6 t -107.38 -31.52 8.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.861 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.109 179.991 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.214 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.27 -53.02 2.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.801 0.334 . . . . 0.0 110.844 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 27.8 mtt180 -126.57 -64.58 1.02 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.857 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -66.64 -178.44 0.71 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.884 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.1 t -83.06 145.26 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.936 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.429 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . -85.91 159.06 19.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.846 0.355 . . . . 0.0 110.824 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -154.88 96.22 1.83 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.134 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 19.0 ptp -47.81 167.59 0.18 Allowed Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.57 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -65.49 -47.12 4.52 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.778 2.319 . . . . 0.0 112.809 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.27 -51.48 64.41 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.475 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.476 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -69.23 -33.36 73.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.277 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.69 -48.75 63.1 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.296 0.57 . . . . 0.0 110.371 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -57.77 -54.2 49.57 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.98 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.494 HD12 ' HB ' ' A' ' 163' ' ' VAL . 4.3 pp -63.49 -41.23 98.57 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.553 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.408 ' N ' ' CD1' ' A' ' 138' ' ' LEU . . . -58.47 -37.64 75.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.743 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.92 -29.81 55.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.754 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -83.36 -20.52 34.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.997 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.5 mt -94.22 -28.92 15.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.863 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.75 38.68 7.96 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.543 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.489 ' CD1' ' CE3' ' A' ' 166' ' ' TRP . 1.3 tt -118.4 140.39 42.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.742 0.306 . . . . 0.0 111.305 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.491 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 1.5 t0 -71.97 100.97 2.58 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.434 ' CB ' ' CD1' ' A' ' 158' ' ' ILE . . . -50.6 -28.84 9.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.681 0.277 . . . . 0.0 111.271 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.69 -36.97 85.15 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 178.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -64.97 -23.88 67.35 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 177.283 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.479 ' CG2' HD11 ' A' ' 144' ' ' ILE . 21.2 t -87.44 89.15 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.324 179.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.64 90.93 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.937 0.399 . . . . 0.0 111.14 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.487 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -68.55 130.03 25.63 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.837 -0.696 . . . . 0.0 113.104 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.479 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.1 OUTLIER -118.5 24.13 11.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.136 0.493 . . . . 0.0 110.495 179.658 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.427 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -84.63 157.16 32.44 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.758 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_exo -43.37 102.89 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.227 2.618 . . . . 0.0 112.993 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 99.3 23.52 11.18 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.212 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 71.23 22.18 78.52 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.601 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.429 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -85.43 128.35 39.21 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.957 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.669 ' O ' HG13 ' A' ' 158' ' ' ILE . 18.6 pt -66.65 112.11 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.499 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 55.7 p -75.14 156.35 36.05 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.532 0.682 . . . . 0.0 111.533 -177.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.458 ' CG1' ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -56.41 -39.46 61.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.706 -179.582 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.582 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 6.1 mm-40 -65.67 -27.79 68.62 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.944 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.499 ' HB2' ' O ' ' A' ' 159' ' ' THR . 83.0 m-20 -69.31 -54.6 13.75 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.223 0.535 . . . . 0.0 110.322 179.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.494 ' HB ' HD12 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -64.09 -40.83 90.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.648 -179.612 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.61 -47.57 78.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.9 0.381 . . . . 0.0 111.445 -178.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.582 ' HG3' ' O ' ' A' ' 161' ' ' GLU . 65.2 mtt-85 -60.83 -42.0 96.87 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.05 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.489 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 18.1 t90 -67.98 -50.18 57.23 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.915 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -50.94 -41.1 58.75 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.919 0.39 . . . . 0.0 110.725 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -74.9 -29.47 61.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.321 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.406 ' OE1' ' CD1' ' A' ' 166' ' ' TRP . 0.4 OUTLIER -61.16 -43.62 98.6 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 121.224 0.535 . . . . 0.0 110.096 179.41 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.449 HG23 ' CZ3' ' A' ' 166' ' ' TRP . 8.2 p -59.47 -52.24 66.43 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.404 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -66.65 -21.64 66.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.365 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.1 -36.65 64.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.811 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.04 134.63 35.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.17 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 64.8 p -122.9 157.1 33.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.891 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.232 -0.89 . . . . 0.0 111.122 -179.969 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.183 0 N-CA-C 112.537 -0.225 . . . . 0.0 112.537 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 70.0 m -118.76 145.32 45.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.821 0.343 . . . . 0.0 110.949 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -69.29 -38.62 78.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.962 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -158.83 154.51 26.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.935 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.3 t -101.95 137.76 28.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.9 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.444 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . -96.34 155.2 16.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.892 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -152.12 95.43 2.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.965 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.408 ' HB2' ' CD ' ' A' ' 133' ' ' PRO . 14.0 ptp -46.91 167.74 0.15 Allowed Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.863 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.408 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.2 Cg_exo -65.76 -47.59 3.75 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.799 2.333 . . . . 0.0 112.822 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.3 -51.61 64.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.372 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.459 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -69.48 -34.21 74.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.911 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -66.53 -48.53 69.42 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.501 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.401 ' CZ ' ' HB2' ' A' ' 137' ' ' ARG . 26.4 ttm105 -59.93 -55.38 34.8 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.154 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.489 ' CD1' ' HB ' ' A' ' 163' ' ' VAL . 4.3 pp -61.54 -41.03 96.75 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.716 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.404 ' N ' ' CD1' ' A' ' 138' ' ' LEU . . . -58.11 -37.95 75.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.994 0.426 . . . . 0.0 110.809 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.3 tptt -76.48 -29.81 57.02 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.825 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -84.32 -19.38 33.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.12 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.411 ' CD1' HD11 ' A' ' 138' ' ' LEU . 1.4 mt -94.49 -28.89 15.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.719 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.72 38.28 8.19 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.505 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.481 ' CD1' ' CE3' ' A' ' 166' ' ' TRP . 1.4 tt -118.31 141.6 36.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.744 0.307 . . . . 0.0 111.248 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.489 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 1.9 t0 -72.94 101.02 3.08 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.415 ' CB ' ' CD1' ' A' ' 158' ' ' ILE . . . -50.45 -28.85 9.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.735 0.302 . . . . 0.0 111.182 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.92 -36.93 85.96 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 178.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.489 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -66.59 -23.37 66.18 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 177.666 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.457 ' CG2' HD11 ' A' ' 144' ' ' ILE . 20.1 t -86.7 84.15 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.625 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.74 91.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.911 0.386 . . . . 0.0 111.113 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.516 ' HA2' ' HA ' ' A' ' 158' ' ' ILE . . . -69.17 141.55 36.0 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.098 -0.572 . . . . 0.0 113.488 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.61 11.06 12.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.743 0.306 . . . . 0.0 110.786 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.439 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -73.4 152.21 46.17 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.842 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_exo -43.83 112.29 0.31 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.092 2.528 . . . . 0.0 112.832 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 95.54 13.12 52.32 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.374 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 79.62 22.11 65.1 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.776 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.444 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.3 m -83.98 126.92 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 117.122 0.461 . . . . 0.0 111.06 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.64 ' O ' HG13 ' A' ' 158' ' ' ILE . 17.7 pt -66.94 111.79 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.523 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 75.3 p -75.07 156.46 36.07 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.505 0.669 . . . . 0.0 111.735 -177.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.447 ' CG1' ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.58 -40.71 60.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.697 -179.56 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.402 ' O ' ' HG2' ' A' ' 165' ' ' ARG . 1.8 tt0 -64.29 -27.51 69.09 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.114 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.523 ' HB2' ' O ' ' A' ' 159' ' ' THR . 82.6 m-20 -71.45 -53.27 14.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.835 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.489 ' HB ' ' CD1' ' A' ' 138' ' ' LEU . 0.1 OUTLIER -64.43 -45.77 94.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.687 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -61.47 -48.64 80.21 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.043 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.457 ' HG3' ' N ' ' A' ' 166' ' ' TRP . 0.8 OUTLIER -57.71 -39.75 77.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.903 -179.718 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.481 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 23.9 t90 -72.39 -48.36 42.14 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.754 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -52.21 -38.37 57.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.975 0.417 . . . . 0.0 110.445 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -77.3 -33.15 55.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.243 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -63.49 -27.61 69.39 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.577 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.426 HG23 ' CZ3' ' A' ' 166' ' ' TRP . 18.0 p -74.06 -52.06 13.84 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.555 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -73.14 -26.75 61.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.696 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -66.06 -34.88 79.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.79 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -67.51 -62.78 1.25 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.088 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 44.2 p -63.69 142.15 58.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.949 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.226 -0.892 . . . . 0.0 111.056 -179.989 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.193 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 11.4 p -99.14 31.76 2.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.811 0.338 . . . . 0.0 110.87 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.67 82.25 1.46 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.854 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -150.22 138.46 20.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.889 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.1 t -96.94 117.11 40.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.861 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.476 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . -96.82 151.45 19.65 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.022 0.439 . . . . 0.0 111.098 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -153.83 94.33 1.75 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.645 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 20.2 ptm -47.03 166.64 0.18 Allowed Pre-proline 0 CA--C 1.533 0.306 0 CA-C-O 120.582 0.23 . . . . 0.0 110.936 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -65.62 -44.85 7.64 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.868 2.379 . . . . 0.0 112.826 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.21 -53.62 51.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.372 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.468 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -68.29 -33.88 75.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.024 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.65 -49.88 64.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.587 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -58.28 -55.58 33.16 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.133 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.499 ' CD1' ' HB ' ' A' ' 163' ' ' VAL . 4.4 pp -60.98 -40.67 94.33 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.615 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.55 -37.71 73.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.853 0.358 . . . . 0.0 110.66 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.8 tptp -76.9 -30.07 56.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.771 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -83.32 -19.92 35.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.061 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.414 ' CD1' HD11 ' A' ' 138' ' ' LEU . 1.5 mt -94.5 -28.89 15.21 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.864 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.53 37.76 7.95 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.607 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.487 ' CD1' ' CE3' ' A' ' 166' ' ' TRP . 1.4 tt -118.36 143.07 30.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.809 0.337 . . . . 0.0 111.181 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.9 OUTLIER -74.63 101.12 4.14 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.372 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.402 ' CB ' ' CD1' ' A' ' 158' ' ' ILE . . . -49.78 -28.81 6.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.689 0.28 . . . . 0.0 111.099 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.42 -37.65 87.56 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.5 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -66.25 -22.23 66.31 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 177.578 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.462 ' CG2' HD11 ' A' ' 144' ' ' ILE . 21.3 t -88.37 85.58 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.623 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.5 ptmt -50.7 92.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.986 0.422 . . . . 0.0 111.149 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.479 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -68.02 136.29 30.71 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.064 -0.589 . . . . 0.0 113.339 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.52 10.71 12.7 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.738 0.304 . . . . 0.0 110.819 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.452 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -72.29 154.68 50.82 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.771 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -43.99 107.65 0.1 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.111 2.541 . . . . 0.0 112.886 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.51 18.38 28.36 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.364 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.58 22.27 75.54 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.634 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.476 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -84.6 124.21 39.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 117.069 0.434 . . . . 0.0 111.063 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.645 ' O ' HG13 ' A' ' 158' ' ' ILE . 19.6 pt -63.59 111.59 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.531 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 48.9 p -75.4 156.53 35.28 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.555 0.693 . . . . 0.0 111.904 -177.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.463 ' CG1' ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.54 -41.48 63.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.78 -179.524 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -64.26 -27.44 69.05 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.125 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.531 ' HB2' ' O ' ' A' ' 159' ' ' THR . 84.1 m-20 -70.61 -52.58 20.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.512 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.499 ' HB ' ' CD1' ' A' ' 138' ' ' LEU . 0.1 OUTLIER -65.98 -45.77 90.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.579 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 10.5 mttm -62.71 -50.94 69.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.616 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.516 ' HG3' ' O ' ' A' ' 162' ' ' ASP . 1.8 ppt_? -57.83 -39.07 76.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.607 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.487 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 26.6 t90 -71.49 -48.42 49.18 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.59 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -51.66 -38.3 54.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.52 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -77.24 -32.81 56.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.158 179.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -59.61 -28.55 67.29 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.983 0.421 . . . . 0.0 110.35 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.419 HG23 ' CZ3' ' A' ' 166' ' ' TRP . 4.0 p -75.16 -51.44 13.39 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.352 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -65.4 -30.03 70.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.517 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -63.29 -30.87 71.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.654 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -69.46 -55.83 9.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.171 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 8.8 t -59.86 -28.64 67.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.031 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.254 -0.879 . . . . 0.0 111.138 179.994 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.184 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 19.4 m -160.15 177.0 11.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.798 0.333 . . . . 0.0 110.891 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 5.9 ttt85 -147.58 89.56 1.78 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.916 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -83.31 172.04 12.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.939 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.2 t -83.75 129.3 37.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.976 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.449 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . -91.61 153.4 19.74 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.977 0.418 . . . . 0.0 111.019 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -152.52 95.27 2.0 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.862 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 9.8 ptp -47.44 166.93 0.18 Allowed Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.842 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -65.67 -46.28 5.43 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.859 2.373 . . . . 0.0 112.943 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.28 -52.42 61.48 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.401 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.454 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -68.34 -34.19 75.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.124 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.74 -49.34 63.06 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.252 0.548 . . . . 0.0 110.585 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 7.5 tpt180 -57.37 -55.55 33.3 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.838 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.481 HD11 ' C ' ' A' ' 138' ' ' LEU . 4.3 pp -62.33 -41.14 98.32 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.562 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.402 ' N ' ' CD1' ' A' ' 138' ' ' LEU . . . -56.45 -39.72 73.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.974 0.416 . . . . 0.0 110.956 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.65 -29.86 56.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.75 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -82.41 -19.04 39.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.083 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.414 ' CD1' HD11 ' A' ' 138' ' ' LEU . 1.4 mt -95.64 -28.86 14.61 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.866 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.05 37.08 7.95 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.661 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.455 HD11 ' CG2' ' A' ' 149' ' ' VAL . 1.8 tt -118.34 143.02 30.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.803 0.335 . . . . 0.0 111.232 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.523 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 1.9 t0 -74.47 101.1 4.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.803 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.424 ' CB ' ' CD1' ' A' ' 158' ' ' ILE . . . -49.6 -28.95 6.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.595 0.236 . . . . 0.0 111.294 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.08 -36.98 84.63 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.523 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -66.68 -21.44 66.09 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 177.46 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.455 ' CG2' HD11 ' A' ' 144' ' ' ILE . 21.4 t -89.16 86.02 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.497 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.71 93.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.965 0.412 . . . . 0.0 111.124 -179.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.466 ' HA2' ' HA ' ' A' ' 158' ' ' ILE . . . -70.82 139.2 29.56 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 121.001 -0.619 . . . . 0.0 113.419 -179.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -118.56 10.38 12.56 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.721 0.296 . . . . 0.0 110.846 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.465 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -71.19 152.69 50.2 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.746 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -44.68 111.04 0.26 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.059 2.506 . . . . 0.0 112.722 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 96.43 14.22 45.25 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.289 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 79.41 22.11 65.6 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.674 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.465 HG21 ' HA2' ' A' ' 153' ' ' GLY . 1.2 m -85.22 125.66 40.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 117.121 0.461 . . . . 0.0 110.961 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.648 ' O ' HG13 ' A' ' 158' ' ' ILE . 18.8 pt -65.33 111.74 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.524 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 55.0 p -75.15 156.43 35.94 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.523 0.678 . . . . 0.0 111.723 -177.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.463 ' CG1' ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.33 -40.78 58.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.787 -179.503 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.432 ' O ' ' HG2' ' A' ' 165' ' ' ARG . 55.7 tt0 -64.62 -27.47 68.96 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.171 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.524 ' HB2' ' O ' ' A' ' 159' ' ' THR . 72.4 m-20 -70.74 -53.6 14.94 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.749 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.481 ' HB ' ' CD1' ' A' ' 138' ' ' LEU . 0.1 OUTLIER -63.62 -48.15 88.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.406 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 16.9 mttp -60.24 -46.34 90.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.561 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.485 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 24.8 ptt180 -60.1 -39.23 85.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.779 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.455 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 30.2 t90 -72.73 -48.15 41.03 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.843 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -52.47 -37.78 57.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.997 0.427 . . . . 0.0 110.476 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -77.26 -33.66 55.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.056 179.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.04 -31.35 69.89 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.271 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.422 HG23 ' CZ3' ' A' ' 166' ' ' TRP . 11.9 p -70.07 -52.04 27.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.183 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.37 -26.5 64.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.685 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.28 -32.15 71.13 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.733 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -54.39 -29.02 47.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.302 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 9.6 t -112.34 31.84 6.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.825 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.24 -0.886 . . . . 0.0 111.105 179.951 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.184 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 33.1 t -92.49 140.61 29.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.833 0.349 . . . . 0.0 110.894 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -126.37 -68.29 0.82 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.779 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.51 146.29 52.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.809 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.9 t -85.55 111.22 20.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.964 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.489 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . -103.08 151.28 22.73 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.11 0.481 . . . . 0.0 111.052 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -151.54 94.71 2.04 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.688 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 22.4 ptm -48.63 166.66 0.22 Allowed Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.005 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -66.19 -45.25 5.84 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.878 2.385 . . . . 0.0 112.818 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.32 -52.2 62.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.268 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.455 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -70.28 -32.45 70.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.875 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.02 -47.94 67.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.256 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -59.97 -54.81 41.67 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.033 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.499 HD12 ' HB ' ' A' ' 163' ' ' VAL . 4.3 pp -62.52 -40.8 97.93 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.589 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.08 -38.81 73.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.892 0.377 . . . . 0.0 110.683 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.97 -29.81 55.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.827 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -82.4 -21.21 35.91 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.069 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.6 mt -94.02 -28.91 15.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.925 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.75 38.39 8.11 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.461 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.48 ' CD1' ' CE3' ' A' ' 166' ' ' TRP . 0.6 OUTLIER -116.6 143.21 27.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.865 0.365 . . . . 0.0 111.19 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.443 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.9 OUTLIER -74.84 100.88 4.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.469 . . . . 0.0 109.852 179.185 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.407 ' CB ' ' CD1' ' A' ' 158' ' ' ILE . . . -53.27 -33.81 54.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.665 0.269 . . . . 0.0 111.109 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.9 -36.69 75.12 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.051 0.453 . . . . 0.0 109.805 179.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.518 ' HE2' ' CE2' ' A' ' 166' ' ' TRP . 0.0 OUTLIER -67.92 -30.45 69.78 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.846 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.472 ' HA ' ' HE3' ' A' ' 148' ' ' LYS . 8.1 t -78.2 81.79 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.379 179.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.47 ' O ' ' HG3' ' A' ' 150' ' ' LYS . 2.0 ptpp? -50.51 93.25 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.266 0.555 . . . . 0.0 111.105 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.52 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -63.1 139.04 44.18 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.605 -0.725 . . . . 0.0 113.492 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.55 13.66 13.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.752 0.311 . . . . 0.0 110.608 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.421 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -80.14 154.97 37.76 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.736 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_exo -43.23 108.79 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.161 2.574 . . . . 0.0 112.972 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 96.95 16.94 34.06 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.377 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 76.17 22.33 73.91 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.634 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.489 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -83.0 125.6 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.173 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.66 ' O ' HG13 ' A' ' 158' ' ' ILE . 18.2 pt -64.4 111.23 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.487 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 25.7 p -75.29 156.32 35.75 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.639 0.733 . . . . 0.0 111.792 -177.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.473 ' CG1' ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -56.59 -39.82 65.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.649 -179.643 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.592 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 0.4 OUTLIER -63.69 -29.75 70.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.921 179.413 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' A' ' 159' ' ' THR . 91.8 m-20 -68.97 -54.07 17.31 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.9 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.499 ' HB ' HD12 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -63.98 -41.91 94.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.766 -178.762 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.53 ' CG ' ' HA ' ' A' ' 161' ' ' GLU . 0.0 OUTLIER -64.84 -48.83 72.92 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.024 0.44 . . . . 0.0 111.418 -178.64 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.592 ' HG3' ' O ' ' A' ' 161' ' ' GLU . 8.5 mtm105 -57.62 -43.33 84.72 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.981 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.518 ' CE2' ' HE2' ' A' ' 148' ' ' LYS . 61.9 t90 -68.09 -49.86 58.57 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.606 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -50.58 -39.55 49.93 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.856 0.36 . . . . 0.0 110.746 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.407 ' HG2' ' HA ' ' A' ' 165' ' ' ARG . 11.1 pt-20 -77.17 -29.18 54.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.485 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.27 -41.95 94.37 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.208 0.528 . . . . 0.0 109.985 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.461 HG23 ' CH2' ' A' ' 166' ' ' TRP . 6.6 p -63.08 -52.2 63.63 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.413 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -70.91 -17.32 62.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.428 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -77.05 -32.45 56.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.608 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -63.72 -48.8 75.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.236 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 7.5 p 56.8 31.34 19.34 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.968 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.257 -0.878 . . . . 0.0 111.095 -179.977 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.185 0 N-CA-C 112.565 -0.214 . . . . 0.0 112.565 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -169.06 138.52 2.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.78 0.324 . . . . 0.0 110.946 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -119.31 97.09 5.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.803 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.33 168.9 10.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.854 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.2 t -79.99 131.52 33.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.992 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.465 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . -95.86 154.67 17.11 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.039 0.447 . . . . 0.0 110.973 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -155.11 95.21 1.71 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.801 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.425 ' HB2' ' CD ' ' A' ' 133' ' ' PRO . 19.2 ptm -47.35 168.65 0.13 Allowed Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.873 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.425 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.0 Cg_exo -66.07 -45.34 5.98 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.772 2.315 . . . . 0.0 112.949 -178.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.24 -53.35 54.83 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.442 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.45 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -69.63 -32.03 70.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.823 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.41 -48.74 66.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.434 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -59.97 -55.13 37.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.042 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.489 ' CD1' ' HB ' ' A' ' 163' ' ' VAL . 4.3 pp -62.52 -41.11 98.63 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.83 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -55.99 -41.76 75.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.863 0.363 . . . . 0.0 110.939 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -75.42 -29.84 59.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.9 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -80.9 -22.74 39.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.075 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.408 ' CD1' HD11 ' A' ' 138' ' ' LEU . 1.6 mt -92.09 -28.91 16.83 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.879 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.46 37.48 8.12 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.439 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.483 ' CD1' ' CE3' ' A' ' 166' ' ' TRP . 1.4 tt -117.85 141.53 36.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.828 0.347 . . . . 0.0 111.188 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.472 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 1.2 t0 -72.94 101.05 3.1 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.418 ' CB ' ' CD1' ' A' ' 158' ' ' ILE . . . -49.64 -28.59 6.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.688 0.28 . . . . 0.0 111.241 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.9 -37.27 85.67 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.472 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -65.8 -22.64 66.58 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 177.399 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.47 ' CG2' HD11 ' A' ' 144' ' ' ILE . 20.7 t -88.22 87.94 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.404 179.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.75 91.02 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.015 0.436 . . . . 0.0 111.267 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.475 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -68.51 132.86 27.54 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.904 -0.665 . . . . 0.0 113.093 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.433 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.2 OUTLIER -118.49 16.75 13.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.952 0.406 . . . . 0.0 110.812 179.624 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.449 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -77.67 154.32 41.69 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.655 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -43.93 107.56 0.1 OUTLIER 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.087 2.524 . . . . 0.0 112.813 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.75 18.76 26.68 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.236 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 74.94 22.18 77.26 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.671 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.465 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -84.76 125.47 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 CA-C-N 117.027 0.414 . . . . 0.0 110.992 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.631 ' O ' HG13 ' A' ' 158' ' ' ILE . 19.1 pt -65.4 112.34 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.517 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 60.8 p -75.33 156.5 35.46 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.533 0.682 . . . . 0.0 111.891 -177.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.459 ' CG1' ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.91 -40.55 63.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.743 -179.492 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.421 ' O ' ' HG2' ' A' ' 165' ' ' ARG . 20.2 mm-40 -65.21 -27.43 68.67 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.199 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.517 ' HB2' ' O ' ' A' ' 159' ' ' THR . 81.6 m-20 -70.43 -53.98 14.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.608 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.489 ' HB ' ' CD1' ' A' ' 138' ' ' LEU . 0.1 OUTLIER -63.39 -47.71 90.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.412 179.928 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 10.7 mttm -60.41 -48.66 80.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.502 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.483 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 10.4 ptt180 -57.8 -39.98 78.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.882 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.483 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 23.7 t90 -72.04 -48.14 46.66 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.778 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -52.19 -38.4 57.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.947 0.404 . . . . 0.0 110.58 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -77.24 -33.53 56.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.262 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -61.73 -29.53 70.17 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.974 0.416 . . . . 0.0 110.443 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.423 HG23 ' CZ3' ' A' ' 166' ' ' TRP . 12.0 p -72.07 -52.08 18.53 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.423 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.59 -22.92 61.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.739 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 9.9 mttp -73.65 -38.76 64.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.919 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -62.89 -43.22 99.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.14 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 32.4 p -59.27 175.11 0.34 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.93 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.195 -0.907 . . . . 0.0 111.072 179.992 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 112.441 -0.264 . . . . 0.0 112.441 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 12.3 p -110.58 77.99 1.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.856 0.36 . . . . 0.0 110.796 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.5 mtm105 -141.9 103.31 4.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.863 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -130.33 -45.12 1.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.922 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.1 t -90.74 111.71 23.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.061 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.437 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . -92.2 151.22 20.47 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.937 0.399 . . . . 0.0 110.789 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -151.13 94.98 2.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.857 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.413 ' HB2' ' CD ' ' A' ' 133' ' ' PRO . 9.5 ptm -46.96 167.73 0.15 Allowed Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.98 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.413 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.8 Cg_exo -65.49 -45.58 6.77 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.794 2.329 . . . . 0.0 112.885 -178.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.2 -53.48 52.91 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.365 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.46 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -68.99 -32.13 71.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.919 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.36 -48.69 64.13 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.486 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.2 ttp85 -59.04 -55.74 31.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.073 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.491 ' CD1' ' HB ' ' A' ' 163' ' ' VAL . 4.3 pp -61.36 -41.04 96.43 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.647 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.4 -38.15 73.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.864 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.98 -29.78 55.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.767 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -83.83 -18.15 38.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.981 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.42 ' CD1' HD11 ' A' ' 138' ' ' LEU . 1.3 mt -96.14 -28.81 14.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.828 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.36 37.66 8.09 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.555 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.482 ' CD1' ' CE3' ' A' ' 166' ' ' TRP . 1.4 tt -118.45 142.33 33.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.717 0.294 . . . . 0.0 111.28 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.485 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.3 OUTLIER -73.96 101.09 3.72 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.899 179.282 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.415 ' CB ' ' CD1' ' A' ' 158' ' ' ILE . . . -49.91 -29.0 7.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.64 0.257 . . . . 0.0 111.204 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 32.3 t -65.03 -37.09 86.46 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.485 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -66.73 -22.91 66.05 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 177.679 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.454 ' CG2' HD11 ' A' ' 144' ' ' ILE . 20.3 t -86.9 84.03 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.72 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.76 92.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.012 0.434 . . . . 0.0 111.066 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.487 ' HA2' ' HA ' ' A' ' 158' ' ' ILE . . . -68.59 142.1 38.02 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.795 -0.639 . . . . 0.0 113.571 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.6 10.78 12.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.73 0.3 . . . . 0.0 110.779 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.457 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -75.19 151.92 42.8 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.771 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.4 ' O ' HG12 ' A' ' 157' ' ' VAL . 93.5 Cg_exo -43.86 114.74 0.57 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.057 2.505 . . . . 0.0 112.928 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 94.03 9.06 59.86 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.542 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 84.36 22.26 54.64 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.825 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.457 HG21 ' HA2' ' A' ' 153' ' ' GLY . 1.2 m -84.3 126.08 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 CA-C-N 117.055 0.428 . . . . 0.0 111.084 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.646 ' O ' HG13 ' A' ' 158' ' ' ILE . 16.9 pt -66.57 111.49 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.527 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 45.6 p -75.33 156.53 35.45 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.584 0.706 . . . . 0.0 111.773 -177.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.459 ' CG1' ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.31 -40.76 58.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.895 -179.483 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -64.22 -27.41 69.04 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.139 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.527 ' HB2' ' O ' ' A' ' 159' ' ' THR . 77.2 m-20 -71.47 -53.02 15.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.775 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.491 ' HB ' ' CD1' ' A' ' 138' ' ' LEU . 0.1 OUTLIER -64.61 -45.5 95.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.321 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.409 ' CG ' ' N ' ' A' ' 165' ' ' ARG . 7.7 pttt -61.58 -49.08 78.08 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.209 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.464 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 4.2 ptm180 -57.96 -39.72 78.81 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.866 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.482 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 23.2 t90 -72.16 -48.12 45.76 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.818 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -52.47 -38.3 59.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.035 0.445 . . . . 0.0 110.396 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -77.27 -32.38 55.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.12 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.81 -31.12 70.53 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.321 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.426 HG23 ' CZ3' ' A' ' 166' ' ' TRP . 6.4 p -71.64 -51.92 20.66 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.33 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -68.82 -30.11 68.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.464 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.25 -22.62 66.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.867 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -87.68 10.15 19.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.67 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 51.43 30.09 5.88 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.827 0.346 . . . . 0.0 111.093 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.309 -0.853 . . . . 0.0 111.117 179.951 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.218 0 N-CA-C 112.459 -0.256 . . . . 0.0 112.459 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -155.18 -45.75 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.802 0.334 . . . . 0.0 110.916 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -101.7 79.8 1.97 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.042 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 61.66 168.33 0.11 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.97 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.3 t -81.57 128.33 38.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.952 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.434 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . -90.17 153.52 20.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.916 0.389 . . . . 0.0 110.931 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.449 ' O ' ' HG3' ' A' ' 136' ' ' ARG . . . -151.61 96.3 2.23 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.859 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.404 ' HB2' ' CD ' ' A' ' 133' ' ' PRO . 15.3 ptp -47.88 167.94 0.17 Allowed Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.718 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.404 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.0 Cg_exo -65.79 -47.29 3.99 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.81 2.34 . . . . 0.0 112.965 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.28 -50.76 66.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.43 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.468 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -69.2 -34.7 75.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.236 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 131' ' ' ALA . 0.9 OUTLIER -67.6 -48.54 66.52 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.265 0.555 . . . . 0.0 110.397 179.484 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 66.2 ttt180 -57.59 -54.42 47.08 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.931 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.497 HD11 ' C ' ' A' ' 138' ' ' LEU . 4.3 pp -64.15 -40.85 97.03 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.51 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.409 ' N ' ' CD1' ' A' ' 138' ' ' LEU . . . -58.92 -37.98 77.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.92 0.39 . . . . 0.0 110.803 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.02 -29.77 55.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.662 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -81.59 -24.92 36.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.966 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.7 mt -90.88 -28.93 17.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.068 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.36 38.91 7.5 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.846 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.478 ' CD1' ' CE3' ' A' ' 166' ' ' TRP . 1.2 tt -118.62 140.74 41.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.735 0.302 . . . . 0.0 111.229 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.532 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.6 OUTLIER -71.57 100.89 2.36 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.299 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.446 ' CB ' ' CD1' ' A' ' 158' ' ' ILE . . . -50.51 -31.12 14.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.44 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 29.5 m -64.6 -36.1 83.16 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.532 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -65.44 -25.15 67.39 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 177.31 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.467 ' CG2' HD11 ' A' ' 144' ' ' ILE . 21.9 t -84.2 85.99 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.449 178.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.73 90.75 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.111 0.481 . . . . 0.0 111.224 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.466 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -66.06 141.28 41.2 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.82 -0.627 . . . . 0.0 113.247 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.46 10.95 12.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.707 0.289 . . . . 0.0 110.739 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.415 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -77.42 151.91 38.85 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.569 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.42 ' O ' HG12 ' A' ' 157' ' ' VAL . 82.2 Cg_exo -41.43 122.05 1.69 Allowed 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.244 2.629 . . . . 0.0 113.244 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 88.31 -2.93 85.42 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.773 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 96.79 22.21 18.92 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.674 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.434 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -83.5 127.37 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.156 0 CA-C-N 117.092 0.446 . . . . 0.0 111.221 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.653 ' O ' HG13 ' A' ' 158' ' ' ILE . 15.1 pt -67.85 111.87 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 178.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.523 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 62.9 p -75.08 156.49 36.03 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.625 0.726 . . . . 0.0 111.693 -177.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.455 ' CG1' ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.59 -41.0 62.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.917 -179.407 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.543 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 0.9 OUTLIER -64.0 -27.73 69.32 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.919 179.387 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.523 ' HB2' ' O ' ' A' ' 159' ' ' THR . 87.3 m-20 -69.98 -54.37 13.58 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.318 0.58 . . . . 0.0 110.495 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.495 ' HB ' HD12 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -65.19 -40.81 89.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.725 -179.59 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -65.61 -46.66 78.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.903 0.382 . . . . 0.0 111.428 -178.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.543 ' HG3' ' O ' ' A' ' 161' ' ' GLU . 26.8 mtp180 -62.6 -38.57 90.68 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.885 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.478 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 19.6 t90 -71.4 -50.12 35.17 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.71 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -51.93 -38.36 56.09 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.002 0.43 . . . . 0.0 110.571 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.439 ' HG2' ' HA ' ' A' ' 165' ' ' ARG . 8.4 pt-20 -76.78 -31.35 56.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.254 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -61.45 -26.88 68.17 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 120.957 0.408 . . . . 0.0 110.535 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 3.7 p -75.95 -51.61 12.05 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.531 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -73.67 -28.04 61.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.772 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.59 -30.61 71.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.759 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -70.96 64.61 0.33 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.173 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 15.9 p 54.08 175.18 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.126 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.211 -0.9 . . . . 0.0 111.077 179.922 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 112.481 -0.247 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.7 -47.29 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.857 0.361 . . . . 0.0 110.894 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 5.9 mmt85 -105.12 131.17 52.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.933 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.51 136.57 40.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.917 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.1 t -98.96 114.7 37.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.129 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.44 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . -91.47 152.32 20.41 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.866 0.365 . . . . 0.0 110.762 179.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -151.44 95.79 2.19 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.983 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.411 ' HB2' ' CD ' ' A' ' 133' ' ' PRO . 18.3 ptm -47.88 167.76 0.17 Allowed Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.664 -0.244 . . . . 0.0 110.805 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.411 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.4 Cg_exo -65.75 -46.26 5.31 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.776 2.317 . . . . 0.0 112.963 -178.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.28 -52.41 61.52 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.449 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.456 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -68.78 -33.56 74.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.019 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.7 mtp180 -68.37 -48.89 63.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.553 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.2 tpt85 -57.78 -55.73 31.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.734 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.511 HD11 ' C ' ' A' ' 138' ' ' LEU . 4.4 pp -61.65 -38.71 88.74 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.329 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -58.98 -39.47 81.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.807 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.19 -29.82 57.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.757 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -81.54 -24.35 36.65 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.993 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.429 ' CD1' HD11 ' A' ' 138' ' ' LEU . 1.5 mt -90.27 -28.89 18.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.018 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.05 37.37 7.82 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.836 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.477 ' CD1' ' CE3' ' A' ' 166' ' ' TRP . 1.4 tt -119.07 142.47 34.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.788 0.328 . . . . 0.0 111.213 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.519 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.6 OUTLIER -73.78 101.06 3.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.871 179.394 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.433 ' CB ' ' CD1' ' A' ' 158' ' ' ILE . . . -49.49 -30.56 8.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.735 0.302 . . . . 0.0 111.303 -179.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 20.4 m -65.11 -36.46 84.37 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.519 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -66.27 -23.79 66.46 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.415 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.462 ' CG2' HD11 ' A' ' 144' ' ' ILE . 22.0 t -85.27 85.01 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.478 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.65 90.99 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.096 0.474 . . . . 0.0 111.175 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.474 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -66.27 142.67 43.19 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.798 -0.637 . . . . 0.0 113.394 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.46 1.27 11.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.692 0.282 . . . . 0.0 110.838 179.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.424 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -66.56 152.25 52.37 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.551 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.424 ' O ' HG12 ' A' ' 157' ' ' VAL . 86.6 Cg_exo -42.32 120.09 1.52 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.179 2.586 . . . . 0.0 113.126 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 90.12 -0.24 78.4 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.682 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 93.89 22.25 26.15 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.697 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.44 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -83.51 126.09 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 CA-C-N 117.038 0.419 . . . . 0.0 111.214 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.648 ' O ' HG13 ' A' ' 158' ' ' ILE . 16.4 pt -65.69 111.31 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 178.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.548 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 55.4 p -75.22 156.5 35.7 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.487 0.66 . . . . 0.0 111.909 -177.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.457 ' CG1' ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.73 -41.86 58.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.888 -179.425 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.4 ' O ' ' CG ' ' A' ' 165' ' ' ARG . 21.7 tt0 -63.99 -27.48 69.15 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.069 179.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.548 ' HB2' ' O ' ' A' ' 159' ' ' THR . 83.9 m-20 -70.75 -52.16 22.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.648 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.491 ' HB ' ' CD1' ' A' ' 138' ' ' LEU . 0.1 OUTLIER -65.95 -46.76 87.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.489 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.2 mtmp? -61.3 -51.22 69.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.468 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.547 ' HG3' ' O ' ' A' ' 162' ' ' ASP . 0.1 OUTLIER -57.74 -38.8 75.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.895 -179.787 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.477 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 27.3 t90 -71.53 -48.2 50.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.784 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -52.22 -37.91 56.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.976 0.417 . . . . 0.0 110.559 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -77.2 -32.3 55.88 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.083 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -60.05 -29.91 68.84 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.956 0.408 . . . . 0.0 110.383 179.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.418 HG23 ' CZ3' ' A' ' 166' ' ' TRP . 4.4 p -73.11 -52.04 15.74 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.324 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.11 -28.75 66.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.528 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.16 -26.86 67.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.808 179.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -94.19 43.15 1.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.087 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 7.6 p 55.86 -177.94 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.937 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.148 -179.963 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.182 0 N-CA-C 112.54 -0.224 . . . . 0.0 112.54 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.7 -42.98 2.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.821 0.343 . . . . 0.0 110.819 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -96.05 -27.43 15.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.982 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 69.25 -68.17 0.2 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.003 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.0 t -95.71 88.25 2.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.022 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.45 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . -85.21 148.78 25.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.949 0.404 . . . . 0.0 110.852 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -147.83 94.67 2.38 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.848 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.401 ' HB2' ' CD ' ' A' ' 133' ' ' PRO . 17.9 ptp -47.3 166.56 0.19 Allowed Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.064 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.401 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 21.8 Cg_exo -65.74 -46.57 4.9 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.883 2.389 . . . . 0.0 112.867 -179.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.29 -50.84 66.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.259 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.467 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -70.49 -36.08 73.61 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.018 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.87 -46.83 80.17 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.359 0.6 . . . . 0.0 110.135 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.55 -58.71 7.42 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.031 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.503 HD12 ' HB ' ' A' ' 163' ' ' VAL . 3.9 pp -59.91 -43.93 94.57 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.516 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.412 ' N ' ' CD1' ' A' ' 138' ' ' LEU . . . -53.5 -41.12 65.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.982 0.42 . . . . 0.0 110.828 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -73.02 -32.55 65.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.898 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -73.88 -46.51 44.2 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.001 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.507 ' N ' HD11 ' A' ' 142' ' ' LEU . 8.9 mp -72.21 -29.03 63.57 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.082 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.83 37.71 7.22 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.772 -0.728 . . . . 0.0 113.104 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.491 ' CD1' ' CE3' ' A' ' 166' ' ' TRP . 1.5 tt -114.5 141.94 29.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.736 0.303 . . . . 0.0 111.084 179.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.458 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 1.2 t0 -72.47 101.25 2.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.06 179.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -49.31 -28.29 4.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.764 0.316 . . . . 0.0 111.353 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 37.1 t -66.42 -37.77 85.94 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.463 ' CE ' ' CH2' ' A' ' 166' ' ' TRP . 0.0 OUTLIER -66.13 -21.04 66.33 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.4 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.439 ' CG2' HD11 ' A' ' 144' ' ' ILE . 21.3 t -89.48 88.29 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.565 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 6.5 ttpt -50.62 93.66 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.009 0.433 . . . . 0.0 111.17 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.493 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -72.74 130.25 14.45 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.146 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.456 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.2 OUTLIER -118.48 20.15 13.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.024 0.44 . . . . 0.0 110.702 179.585 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.448 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -78.59 156.92 43.39 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.741 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.401 ' O ' HG12 ' A' ' 157' ' ' VAL . 91.8 Cg_exo -43.82 103.95 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.086 2.524 . . . . 0.0 112.992 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.73 22.17 14.55 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.2 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 72.99 22.15 79.34 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.637 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.45 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -85.45 125.82 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 CA-C-N 117.031 0.415 . . . . 0.0 111.191 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.668 ' O ' HG13 ' A' ' 158' ' ' ILE . 17.6 pt -65.49 110.67 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.51 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 71.8 p -75.12 156.37 36.08 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.491 0.663 . . . . 0.0 111.62 -177.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.461 ' CG1' ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -56.5 -39.66 63.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.511 -179.724 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.613 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 0.5 OUTLIER -63.25 -28.51 70.08 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.768 179.1 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.51 ' HB2' ' O ' ' A' ' 159' ' ' THR . 91.1 m-20 -71.35 -52.56 18.06 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.826 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.503 ' HB ' HD12 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -67.21 -37.16 78.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.872 -179.183 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.469 ' HG3' ' N ' ' A' ' 165' ' ' ARG . 5.3 ptpt -70.9 -51.37 26.6 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.192 0.52 . . . . 0.0 111.14 -179.289 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.613 ' HG3' ' O ' ' A' ' 161' ' ' GLU . 49.3 mtm180 -57.81 -37.62 74.09 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.005 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.491 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 46.8 t90 -68.9 -50.04 53.0 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.716 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -50.41 -43.11 54.63 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.507 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.416 ' HG2' ' HA ' ' A' ' 165' ' ' ARG . 7.2 pt-20 -71.26 -32.37 68.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.897 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -62.31 -27.04 68.76 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.231 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.449 HG23 ' CZ3' ' A' ' 166' ' ' TRP . 2.5 p -71.17 -52.14 20.88 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.367 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -68.65 -23.3 64.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.693 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.42 -35.49 63.41 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.922 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -58.32 -55.5 34.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.164 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 34.0 p -74.39 73.6 1.87 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.845 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.258 -0.877 . . . . 0.0 111.166 -179.973 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.182 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.9 t -105.01 94.14 5.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.843 0.354 . . . . 0.0 110.925 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -95.56 171.5 8.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.794 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -154.71 -45.68 0.09 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.987 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.1 t -96.9 134.69 33.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.037 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.467 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . -107.83 156.19 19.42 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.682 179.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -154.62 95.42 1.78 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.045 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.636 ' HB2' ' HD2' ' A' ' 133' ' ' PRO . 19.5 ptm -46.46 167.76 0.14 Allowed Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.558 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.636 ' HD2' ' HB2' ' A' ' 132' ' ' MET . 50.4 Cg_endo -71.88 -34.35 8.79 Favored 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 122.122 1.882 . . . . 0.0 112.5 -178.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.71 -54.47 45.98 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.242 0.544 . . . . 0.0 110.649 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.459 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -69.53 -33.26 72.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.507 179.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 16.6 mmm-85 -66.49 -47.76 71.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.383 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.02 -55.89 28.43 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.9 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.508 ' CD1' ' HB ' ' A' ' 163' ' ' VAL . 4.4 pp -61.04 -40.19 92.68 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.536 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.87 -38.44 75.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.974 0.416 . . . . 0.0 110.791 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.52 -30.05 57.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.713 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -83.08 -19.85 36.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.953 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.439 ' CD1' HD11 ' A' ' 138' ' ' LEU . 1.3 mt -94.02 -28.88 15.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.886 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.71 37.36 8.03 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.746 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.479 ' CD1' ' CE3' ' A' ' 166' ' ' TRP . 1.6 tt -118.67 143.48 29.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.788 0.327 . . . . 0.0 111.306 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.507 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 1.3 t0 -74.39 101.04 3.96 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.437 ' CB ' ' CD1' ' A' ' 158' ' ' ILE . . . -50.2 -28.57 7.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.662 0.268 . . . . 0.0 111.37 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.19 -36.92 84.35 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.507 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -66.54 -21.91 66.16 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 177.524 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.449 ' CG2' HD11 ' A' ' 144' ' ' ILE . 21.7 t -88.0 85.76 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.61 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -50.7 92.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.988 0.423 . . . . 0.0 111.304 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.516 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -69.47 138.14 30.1 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.809 -0.632 . . . . 0.0 113.525 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.54 12.02 13.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.795 0.331 . . . . 0.0 110.788 179.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.436 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -74.5 154.76 47.78 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.786 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -43.85 108.23 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.034 2.489 . . . . 0.0 112.878 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.16 18.79 27.95 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.296 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 74.62 22.18 77.59 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.801 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.467 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -83.68 126.09 40.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 117.069 0.435 . . . . 0.0 111.192 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.64 ' O ' HG13 ' A' ' 158' ' ' ILE . 19.0 pt -64.79 111.52 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 178.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.537 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 36.9 p -75.36 156.52 35.37 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.565 0.697 . . . . 0.0 111.813 -177.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.466 ' CG1' ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.03 -41.27 58.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.719 -179.429 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -63.94 -27.51 69.19 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.183 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.537 ' HB2' ' O ' ' A' ' 159' ' ' THR . 83.1 m-20 -71.35 -51.59 23.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.731 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.508 ' HB ' ' CD1' ' A' ' 138' ' ' LEU . 0.1 OUTLIER -66.9 -45.3 87.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.512 -179.884 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.423 ' CG ' ' N ' ' A' ' 165' ' ' ARG . 2.0 pttt -62.85 -50.34 71.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.385 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.517 ' HG3' ' O ' ' A' ' 162' ' ' ASP . 6.8 ppt_? -58.54 -40.01 81.81 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.895 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.479 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 29.4 t90 -70.08 -48.55 57.27 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.85 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -51.99 -38.81 58.04 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.937 0.399 . . . . 0.0 110.68 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -76.48 -31.43 57.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.027 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -61.72 -27.64 68.85 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 120.926 0.393 . . . . 0.0 110.364 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.448 HG23 ' CZ3' ' A' ' 166' ' ' TRP . 4.6 p -74.37 -52.07 13.22 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.373 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -73.98 -19.19 60.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.84 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 13.2 ttpt -78.11 -32.04 50.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.835 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -75.58 -77.5 0.13 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.234 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 9.7 t -96.41 41.16 1.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.014 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.256 -0.878 . . . . 0.0 111.142 179.959 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.183 0 N-CA-C 112.481 -0.247 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.02 -30.7 44.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.866 0.365 . . . . 0.0 110.915 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.9 90.64 6.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.954 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -93.93 154.79 17.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.858 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.0 t -81.43 83.58 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.919 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.457 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . -85.95 146.82 26.52 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.061 0.457 . . . . 0.0 111.085 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -147.83 94.2 2.31 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.712 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.421 ' HG2' ' O ' ' A' ' 158' ' ' ILE . 14.8 ptp -47.41 166.04 0.2 Allowed Pre-proline 0 CA--C 1.532 0.252 0 CA-C-O 120.665 0.269 . . . . 0.0 110.991 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -66.21 -47.97 2.95 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.883 2.389 . . . . 0.0 113.069 -178.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.26 -48.38 71.25 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.666 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.458 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -71.16 -35.13 71.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.855 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 28.8 mtt180 -68.0 -45.76 73.16 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.155 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.3 tpt180 -59.12 -56.98 15.28 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.853 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.49 ' CD1' ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -61.1 -41.49 96.77 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.624 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.408 ' N ' ' CD1' ' A' ' 138' ' ' LEU . . . -56.47 -38.37 71.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.925 0.393 . . . . 0.0 110.907 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 9.6 ttmm -77.02 -30.73 55.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.799 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 51.5 tp10 -83.23 -16.18 47.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.185 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.431 ' CD1' HD11 ' A' ' 138' ' ' LEU . 1.1 mt -98.45 -28.92 13.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.915 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.72 35.35 8.48 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.672 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.485 ' CD1' ' CE3' ' A' ' 166' ' ' TRP . 1.5 tt -116.56 143.53 26.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.834 0.35 . . . . 0.0 111.241 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.465 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 1.9 t0 -76.07 101.47 5.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.917 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -49.4 -28.25 4.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.673 0.273 . . . . 0.0 111.075 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.4 p -65.96 -37.76 86.83 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.465 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -66.4 -21.24 66.22 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 177.573 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.463 ' CG2' HD11 ' A' ' 144' ' ' ILE . 20.4 t -89.69 86.45 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.696 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.2 ptmm? -50.67 93.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.934 0.397 . . . . 0.0 110.98 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.471 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -69.56 133.39 25.5 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.969 -0.634 . . . . 0.0 113.192 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.421 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.4 OUTLIER -118.46 15.56 13.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.963 0.411 . . . . 0.0 110.739 179.545 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.462 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -74.9 155.61 48.23 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.717 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -44.74 105.84 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.138 2.559 . . . . 0.0 112.824 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.35 20.16 21.04 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.209 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 74.81 22.07 77.57 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.674 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.462 HG21 ' HA2' ' A' ' 153' ' ' GLY . 1.1 m -85.91 125.08 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-N 117.08 0.44 . . . . 0.0 111.183 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.671 ' O ' HG13 ' A' ' 158' ' ' ILE . 15.2 pt -64.69 110.31 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.525 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 67.0 p -75.16 156.58 35.76 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.611 0.719 . . . . 0.0 111.812 -177.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.453 HG12 HD22 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.97 -41.34 67.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.67 -179.656 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -63.78 -27.44 69.19 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.056 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 159' ' ' THR . 85.1 m-20 -71.49 -53.0 15.36 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.673 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.49 ' HB ' ' CD1' ' A' ' 138' ' ' LEU . 0.1 OUTLIER -65.49 -45.23 93.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.364 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.41 ' CG ' ' N ' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -61.6 -49.1 77.96 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.11 -179.787 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.486 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 11.5 ptm180 -57.71 -40.4 79.45 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.755 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.485 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 26.2 t90 -71.05 -48.83 50.49 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.747 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -51.55 -38.34 53.8 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.9 0.381 . . . . 0.0 110.592 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -77.21 -32.28 55.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.094 179.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -60.31 -30.13 69.3 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.227 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.439 HG23 ' CZ3' ' A' ' 166' ' ' TRP . 4.2 p -72.35 -52.12 17.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.304 179.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -67.61 -26.56 66.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.601 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -68.77 -36.92 78.93 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.777 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -79.96 -52.8 7.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.148 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 17.2 p -106.71 107.77 18.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.902 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.236 -0.888 . . . . 0.0 111.094 179.954 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.227 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 56.9 m -84.51 -71.08 0.53 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.839 0.352 . . . . 0.0 110.914 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 5.3 mmt85 -111.98 -48.84 3.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.937 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -177.47 -38.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.02 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.1 t -77.83 125.1 37.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.989 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.472 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . -106.34 153.47 22.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.957 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -151.41 94.91 2.08 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.874 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.412 ' HB2' ' CD ' ' A' ' 133' ' ' PRO . 9.5 ptm -48.09 167.5 0.19 Allowed Pre-proline 0 CA--C 1.531 0.226 0 CA-C-O 120.61 0.243 . . . . 0.0 110.941 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.412 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.3 Cg_exo -65.9 -45.55 6.03 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.879 2.386 . . . . 0.0 112.864 -179.01 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.28 -53.1 58.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.397 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.468 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -69.55 -32.62 71.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.865 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 14.9 mmm-85 -67.82 -48.03 67.36 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.376 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 13.8 ttt85 -59.85 -55.39 34.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.083 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.49 HD11 ' C ' ' A' ' 138' ' ' LEU . 4.3 pp -61.67 -41.13 97.13 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.678 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.406 ' N ' ' CD1' ' A' ' 138' ' ' LEU . . . -56.49 -40.88 75.69 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.954 0.407 . . . . 0.0 110.998 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.3 mtmm -75.9 -29.74 58.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.97 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -82.3 -19.83 38.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.163 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.41 ' CD1' HD11 ' A' ' 138' ' ' LEU . 1.4 mt -95.0 -28.82 14.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.87 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.75 37.91 7.75 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.484 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.477 HD11 ' CG2' ' A' ' 149' ' ' VAL . 0.6 OUTLIER -117.86 143.85 27.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.738 0.304 . . . . 0.0 111.201 -179.956 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.449 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.5 OUTLIER -76.11 100.97 5.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.013 179.415 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.407 ' CB ' ' CD1' ' A' ' 158' ' ' ILE . . . -51.85 -34.83 42.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.644 0.259 . . . . 0.0 111.252 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.16 -36.59 75.56 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.516 ' HE2' ' CD1' ' A' ' 166' ' ' TRP . 0.0 OUTLIER -67.61 -30.5 70.11 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 177.666 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.477 ' CG2' HD11 ' A' ' 144' ' ' ILE . 10.7 t -78.0 83.28 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.384 178.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.53 94.39 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.142 0.496 . . . . 0.0 111.115 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.504 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -68.18 137.38 31.4 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.695 -0.684 . . . . 0.0 113.36 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.54 13.21 13.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.767 0.318 . . . . 0.0 110.748 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.437 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -76.13 155.75 46.33 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.679 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_exo -43.26 106.41 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.133 2.555 . . . . 0.0 112.92 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.81 20.15 22.44 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.362 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 73.94 22.21 78.28 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.7 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.472 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -84.01 125.58 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 117.016 0.408 . . . . 0.0 111.031 -179.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.656 ' O ' HG13 ' A' ' 158' ' ' ILE . 19.9 pt -64.57 111.35 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.533 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 38.6 p -75.33 156.43 35.53 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.559 0.695 . . . . 0.0 111.689 -177.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.452 ' CG1' ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.76 -41.06 64.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.887 -179.4 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -64.58 -27.56 69.03 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.124 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.533 ' HB2' ' O ' ' A' ' 159' ' ' THR . 89.7 m-20 -69.47 -55.34 10.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.372 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.476 ' HB ' ' CD1' ' A' ' 138' ' ' LEU . 0.1 OUTLIER -63.25 -44.19 99.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.683 -179.917 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 160' ' ' VAL . 11.8 mttp -64.0 -40.89 97.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.391 -179.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.541 ' HG3' ' N ' ' A' ' 166' ' ' TRP . 0.0 OUTLIER -64.24 -38.48 91.2 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.83 -179.801 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.541 ' N ' ' HG3' ' A' ' 165' ' ' ARG . 62.8 t90 -73.88 -47.77 35.7 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.659 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -54.14 -37.08 64.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.919 0.39 . . . . 0.0 110.443 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.41 ' HG2' ' HA ' ' A' ' 165' ' ' ARG . 8.3 pt-20 -77.25 -33.34 56.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.074 179.174 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.12 -26.98 68.61 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.443 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.465 HG23 ' CZ3' ' A' ' 166' ' ' TRP . 6.3 p -73.81 -52.12 14.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.556 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.52 -24.68 59.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.728 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.93 -29.87 66.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.809 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -55.58 107.18 0.31 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.217 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 10.1 t -148.82 138.38 21.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.887 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.24 -0.886 . . . . 0.0 111.137 179.952 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.195 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 44.8 p -153.04 36.63 0.48 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.843 0.354 . . . . 0.0 110.898 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 5.3 ttm-85 -100.16 48.19 0.93 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.907 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -61.81 -24.25 66.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.147 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.5 t -70.25 130.04 34.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.924 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.457 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . -95.96 154.32 17.3 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.063 0.458 . . . . 0.0 110.788 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -153.99 95.52 1.86 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.841 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.414 ' HB2' ' CD ' ' A' ' 133' ' ' PRO . 16.7 ptm -47.22 168.02 0.15 Allowed Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.673 -0.239 . . . . 0.0 110.865 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.414 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 23.3 Cg_exo -65.41 -44.84 8.11 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.669 2.246 . . . . 0.0 112.922 -178.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.32 -52.9 60.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.367 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.475 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -69.09 -33.2 73.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.052 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.36 -48.54 67.16 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.274 0.559 . . . . 0.0 110.322 179.338 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 18.2 ttp180 -58.63 -54.23 49.36 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.188 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.507 HD12 ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -64.08 -41.64 97.24 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.804 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.422 ' N ' ' CD1' ' A' ' 138' ' ' LEU . . . -58.08 -38.82 77.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.925 0.393 . . . . 0.0 110.985 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.97 -29.86 55.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.671 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -83.28 -17.92 40.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.124 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.4 mt -96.88 -28.89 14.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.872 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.69 37.7 7.88 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.455 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.482 HD11 ' CG2' ' A' ' 149' ' ' VAL . 1.4 tt -117.85 141.02 38.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.831 0.348 . . . . 0.0 111.288 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.481 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.6 OUTLIER -73.09 101.06 3.18 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.159 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.417 ' CB ' ' CD1' ' A' ' 158' ' ' ILE . . . -50.16 -28.63 7.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.307 -179.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.98 -37.04 84.96 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.481 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -65.09 -23.27 67.11 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 177.237 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.482 ' CG2' HD11 ' A' ' 144' ' ' ILE . 19.0 t -88.54 90.22 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.328 179.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.62 91.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.085 0.469 . . . . 0.0 111.125 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.488 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -69.36 125.88 18.46 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.934 -0.65 . . . . 0.0 113.047 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.468 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.1 OUTLIER -118.56 31.87 6.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.159 0.504 . . . . 0.0 110.292 179.708 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.448 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -91.47 156.76 24.25 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.679 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_exo -43.46 101.1 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 123.065 2.51 . . . . 0.0 113.022 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 99.83 25.77 8.91 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.315 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 70.16 22.1 77.28 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.602 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.457 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -86.27 126.46 40.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.017 -179.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.667 ' O ' HG13 ' A' ' 158' ' ' ILE . 18.9 pt -66.06 112.01 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.515 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 47.4 p -75.33 156.43 35.54 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.485 0.66 . . . . 0.0 111.668 -177.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.47 ' CG1' ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -56.98 -40.31 71.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.681 -179.721 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.556 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 2.1 tt0 -62.76 -27.73 69.49 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.863 179.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.515 ' HB2' ' O ' ' A' ' 159' ' ' THR . 91.2 m-20 -71.45 -53.9 12.44 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.342 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.507 ' HB ' HD12 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -67.08 -34.48 69.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.413 -179.479 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.428 ' HB3' ' O ' ' A' ' 160' ' ' VAL . 0.0 OUTLIER -69.28 -47.84 63.42 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-O 121.047 0.451 . . . . 0.0 110.892 -179.387 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.556 ' HG3' ' O ' ' A' ' 161' ' ' GLU . 15.1 mtp180 -60.39 -41.53 94.02 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.176 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.478 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 13.4 t90 -70.67 -50.16 39.66 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.826 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -50.56 -38.69 46.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.002 0.429 . . . . 0.0 110.682 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -77.28 -32.54 55.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.555 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -59.63 -28.22 67.03 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.933 0.397 . . . . 0.0 110.564 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 7.2 p -77.16 -50.32 13.25 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.395 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -67.81 -30.07 69.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.447 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 11.7 mttp -64.19 -30.21 71.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.635 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -79.28 61.23 3.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.992 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 9.7 p -101.96 125.21 48.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.98 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.114 179.964 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.248 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.74 134.38 33.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.802 0.334 . . . . 0.0 110.896 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.95 -50.99 2.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.966 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -96.16 -36.96 10.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.967 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.1 t -90.73 128.01 42.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.901 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.459 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . -100.85 153.47 19.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.964 0.411 . . . . 0.0 111.114 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.401 ' O ' ' HG3' ' A' ' 136' ' ' ARG . . . -151.23 95.79 2.21 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.693 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.405 ' HB2' ' CD ' ' A' ' 133' ' ' PRO . 16.0 ptp -47.02 167.74 0.15 Allowed Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.917 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.405 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.1 Cg_exo -65.86 -47.66 3.58 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.811 2.341 . . . . 0.0 112.746 -179.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.28 -50.38 67.41 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.347 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.47 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -69.9 -33.87 72.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.013 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 131' ' ' ALA . 0.2 OUTLIER -67.75 -47.71 68.46 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.324 0.583 . . . . 0.0 110.329 179.339 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.15 -54.42 47.2 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.217 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.507 HD12 ' HB ' ' A' ' 163' ' ' VAL . 4.3 pp -63.59 -42.08 98.31 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.784 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.423 ' N ' ' CD1' ' A' ' 138' ' ' LEU . . . -58.59 -37.25 75.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.865 0.364 . . . . 0.0 110.791 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -77.0 -29.75 55.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.781 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -81.97 -24.78 35.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.038 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.9 mt -90.99 -28.85 17.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.876 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.53 36.62 8.57 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.545 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.484 ' CD1' ' CE3' ' A' ' 166' ' ' TRP . 1.4 tt -114.87 142.37 27.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.875 0.369 . . . . 0.0 111.243 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.474 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 1.9 t0 -74.45 101.03 4.0 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.414 ' CB ' ' CD1' ' A' ' 158' ' ' ILE . . . -50.22 -28.44 7.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.703 0.287 . . . . 0.0 111.301 -179.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.54 -37.27 86.22 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.474 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -65.85 -22.63 66.55 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.514 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.471 ' CG2' HD11 ' A' ' 144' ' ' ILE . 20.1 t -88.41 86.48 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.589 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.5 tppt? -50.78 92.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.033 0.444 . . . . 0.0 110.976 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.462 ' HA2' ' HA ' ' A' ' 158' ' ' ILE . . . -70.01 140.52 32.91 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 115.876 -0.602 . . . . 0.0 113.122 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.46 9.46 12.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.677 0.275 . . . . 0.0 110.881 179.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.455 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -70.89 150.36 47.65 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.613 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.422 ' O ' HG12 ' A' ' 157' ' ' VAL . 94.3 Cg_exo -42.77 123.86 3.2 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.137 2.558 . . . . 0.0 113.081 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 87.82 -5.86 84.3 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.601 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 100.74 22.25 11.34 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.705 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.459 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -86.09 127.13 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 CA-C-N 117.087 0.443 . . . . 0.0 111.198 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.652 ' O ' HG13 ' A' ' 158' ' ' ILE . 14.5 pt -67.35 111.96 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 177.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.521 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 76.1 p -75.1 156.54 35.92 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.54 0.686 . . . . 0.0 111.536 -177.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.465 HG12 HD22 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -56.37 -40.72 68.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.873 -179.348 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.552 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 0.1 OUTLIER -62.81 -29.15 70.5 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.748 179.364 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.521 ' HB2' ' O ' ' A' ' 159' ' ' THR . 87.3 m-20 -69.36 -54.38 14.77 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.371 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.507 ' HB ' HD12 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -65.79 -34.62 71.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.0 -179.584 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.409 ' HB3' ' O ' ' A' ' 160' ' ' VAL . 0.2 OUTLIER -67.23 -47.67 70.12 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 121.014 0.435 . . . . 0.0 110.735 -179.64 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.552 ' HG3' ' O ' ' A' ' 161' ' ' GLU . 68.6 mtt-85 -59.26 -44.48 92.41 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.043 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.484 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 10.4 t90 -70.06 -50.1 44.5 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.959 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -50.53 -38.43 44.66 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.937 0.399 . . . . 0.0 110.627 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -77.31 -31.69 54.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.503 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -60.1 -28.07 67.54 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.902 0.382 . . . . 0.0 110.593 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 8.0 p -77.6 -50.21 13.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.439 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.27 -28.41 66.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.427 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 10.3 mtpt -66.83 -32.61 74.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.77 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -84.67 -48.87 9.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.011 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 8.9 t -129.08 146.94 50.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.842 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.231 -0.89 . . . . 0.0 111.163 179.999 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.216 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.57 -67.55 0.79 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.809 0.338 . . . . 0.0 110.853 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.62 79.78 1.89 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.888 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -76.42 133.88 39.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.873 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.1 t -99.23 136.21 31.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.999 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.403 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . -87.64 157.17 19.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.882 0.373 . . . . 0.0 110.567 179.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -153.07 96.64 2.1 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.206 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.655 ' HB2' ' HD2' ' A' ' 133' ' ' PRO . 14.9 ptp -45.64 168.34 0.1 Allowed Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.546 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.655 ' HD2' ' HB2' ' A' ' 132' ' ' MET . 50.0 Cg_endo -71.44 -35.64 7.92 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.062 1.841 . . . . 0.0 112.363 -179.064 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.79 -52.45 65.01 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.759 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.471 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -70.43 -32.73 70.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.672 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 2.3 mmt85 -68.3 -46.11 71.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.079 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.63 -55.66 31.6 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.831 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.487 HD11 ' C ' ' A' ' 138' ' ' LEU . 4.2 pp -62.59 -42.08 99.34 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.641 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.415 ' N ' ' CD1' ' A' ' 138' ' ' LEU . . . -57.99 -36.75 73.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.92 0.391 . . . . 0.0 110.778 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 3.8 mtmt -77.02 -30.76 55.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.555 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -82.93 -18.5 39.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.1 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.421 ' CD1' HD11 ' A' ' 138' ' ' LEU . 1.5 mt -96.66 -28.83 14.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.91 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.56 38.8 8.01 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.521 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.477 ' CD1' ' CE3' ' A' ' 166' ' ' TRP . 1.3 tt -118.43 141.72 36.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.696 0.284 . . . . 0.0 111.33 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.521 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.7 OUTLIER -73.18 100.97 3.21 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.181 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.443 ' CB ' ' CD1' ' A' ' 158' ' ' ILE . . . -50.45 -30.46 12.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.47 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 15.8 m -64.61 -36.16 83.34 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.521 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -66.05 -24.9 66.83 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 177.417 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.462 ' CG2' HD11 ' A' ' 144' ' ' ILE . 20.6 t -84.46 85.2 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.458 179.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.6 91.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.045 0.45 . . . . 0.0 111.124 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.521 ' HA2' ' HA ' ' A' ' 158' ' ' ILE . . . -70.03 143.09 37.3 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.808 -0.633 . . . . 0.0 113.415 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.56 9.1 12.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.714 0.292 . . . . 0.0 110.793 179.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.421 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -72.84 151.29 45.76 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.698 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.433 ' O ' HG12 ' A' ' 157' ' ' VAL . 86.5 Cg_exo -41.57 124.59 2.54 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.2 2.6 . . . . 0.0 113.197 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 86.48 -5.66 84.07 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.631 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 100.0 22.24 12.38 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.719 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.433 HG12 ' O ' ' A' ' 154' ' ' PRO . 1.2 m -84.47 128.84 38.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 117.096 0.448 . . . . 0.0 111.236 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.658 ' O ' HG13 ' A' ' 158' ' ' ILE . 14.5 pt -68.61 111.75 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 177.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.526 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 72.2 p -75.0 156.45 36.25 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.495 0.664 . . . . 0.0 111.637 -177.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.461 HG12 HD22 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.55 -40.69 60.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.877 -179.467 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.533 ' O ' ' CG ' ' A' ' 165' ' ' ARG . 0.6 OUTLIER -63.6 -27.8 69.49 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.835 179.434 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.526 ' HB2' ' O ' ' A' ' 159' ' ' THR . 86.6 m-20 -70.99 -53.71 13.87 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.593 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.487 ' HB ' ' CD1' ' A' ' 138' ' ' LEU . 0.1 OUTLIER -65.36 -37.87 81.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.155 -179.585 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.9 pttt -65.61 -47.35 75.97 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.977 0.418 . . . . 0.0 110.793 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.533 ' CG ' ' O ' ' A' ' 161' ' ' GLU . 4.9 mmt180 -59.61 -42.54 92.85 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.089 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.477 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 13.1 t90 -69.83 -50.12 45.9 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.599 -0.441 . . . . 0.0 110.952 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -50.64 -38.84 48.41 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.843 0.354 . . . . 0.0 110.614 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -77.3 -31.61 54.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.37 179.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -60.15 -29.99 69.02 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.953 0.406 . . . . 0.0 110.435 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 20.7 p -74.56 -51.34 14.9 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.305 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -67.1 -28.21 67.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.472 179.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.6 -34.39 76.91 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.664 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -84.66 103.46 13.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.233 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 2.9 p -145.98 80.55 1.58 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.883 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.127 179.987 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.267 0 N-CA-C 112.506 -0.238 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.2 p -98.84 38.51 1.37 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.883 0.373 . . . . 0.0 110.897 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -90.05 149.8 22.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.956 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -99.34 -167.49 1.48 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.694 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.4 t -71.57 117.64 15.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.766 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.463 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . -89.63 151.37 21.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.109 0.48 . . . . 0.0 111.157 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.405 ' O ' ' HG3' ' A' ' 136' ' ' ARG . . . -151.36 95.28 2.13 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.801 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.416 ' HG2' ' O ' ' A' ' 158' ' ' ILE . 18.1 ptp -47.47 166.54 0.19 Allowed Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.985 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -66.24 -47.31 3.41 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.814 2.342 . . . . 0.0 112.978 -178.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.1 -50.62 66.43 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.456 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.474 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -69.29 -34.9 75.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.22 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 131' ' ' ALA . 0.2 OUTLIER -67.93 -48.49 65.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.156 0.503 . . . . 0.0 110.453 179.495 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.8 ttp-105 -57.53 -55.2 37.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.971 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.485 HD11 ' C ' ' A' ' 138' ' ' LEU . 4.4 pp -61.93 -41.14 97.62 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.486 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.405 ' N ' ' CD1' ' A' ' 138' ' ' LEU . . . -57.9 -38.04 75.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.965 0.412 . . . . 0.0 110.868 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -76.85 -29.68 55.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.784 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -83.58 -20.08 34.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.033 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.402 ' CD1' HD11 ' A' ' 138' ' ' LEU . 1.4 mt -94.5 -28.95 15.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.851 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.98 35.67 8.88 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.645 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.491 HD11 ' CG2' ' A' ' 149' ' ' VAL . 1.9 tt -115.77 142.75 27.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.792 0.33 . . . . 0.0 111.3 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.523 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.9 OUTLIER -75.22 101.11 4.52 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.2 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.429 ' CB ' ' CD1' ' A' ' 158' ' ' ILE . . . -49.15 -29.04 4.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.672 0.272 . . . . 0.0 111.301 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.29 -37.43 85.43 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.523 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -65.78 -21.07 66.47 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 177.269 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.491 ' CG2' HD11 ' A' ' 144' ' ' ILE . 19.6 t -91.17 90.15 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.403 179.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.54 93.91 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.036 0.446 . . . . 0.0 111.015 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.488 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -72.79 126.34 10.64 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.815 -0.629 . . . . 0.0 113.035 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.492 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -118.49 31.62 6.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.153 0.501 . . . . 0.0 110.42 179.707 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.436 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -89.15 158.07 27.59 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.571 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.401 ' O ' HG12 ' A' ' 157' ' ' VAL . 89.6 Cg_exo -43.82 102.06 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.043 2.496 . . . . 0.0 112.945 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.78 24.58 10.6 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.382 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 71.71 22.17 78.74 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.748 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.463 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -87.03 126.99 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 CA-C-N 117.06 0.43 . . . . 0.0 111.328 -179.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.678 ' O ' HG13 ' A' ' 158' ' ' ILE . 19.7 pt -65.77 111.9 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 177.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.508 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 70.2 p -75.07 156.32 36.23 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.612 0.72 . . . . 0.0 111.595 -177.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.463 HG12 HD22 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -56.24 -40.06 63.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.876 -179.561 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.587 ' O ' ' CG ' ' A' ' 165' ' ' ARG . 1.2 tp10 -65.28 -30.22 71.06 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.781 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.508 ' HB2' ' O ' ' A' ' 159' ' ' THR . 80.5 m-20 -65.7 -56.05 14.15 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.308 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.479 ' HB ' HD12 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -62.14 -41.39 91.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.165 -179.988 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -65.19 -41.72 94.28 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.555 -179.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.587 ' CG ' ' O ' ' A' ' 161' ' ' GLU . 0.1 OUTLIER -62.46 -44.59 96.04 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.661 179.916 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.445 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 18.5 t90 -68.32 -50.18 55.23 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.856 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -51.19 -39.4 56.39 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.887 0.375 . . . . 0.0 110.684 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -76.27 -29.13 57.32 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.277 179.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.401 ' OE1' ' CD1' ' A' ' 166' ' ' TRP . 0.5 OUTLIER -61.21 -42.52 98.74 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 121.194 0.521 . . . . 0.0 110.048 179.302 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.443 HG23 ' CZ3' ' A' ' 166' ' ' TRP . 7.4 p -60.91 -52.27 65.74 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.447 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.25 -22.27 62.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.356 179.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -71.47 -31.45 67.17 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.669 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -57.59 -34.97 69.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.196 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 7.5 t -150.69 140.1 21.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.946 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.199 -0.905 . . . . 0.0 111.121 179.989 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.184 0 N-CA-C 112.539 -0.224 . . . . 0.0 112.539 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.4 m -60.25 175.21 0.44 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.885 0.374 . . . . 0.0 110.817 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.09 -51.73 4.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.864 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -142.24 130.35 22.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.953 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.2 t -101.11 138.55 24.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.886 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.408 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . -82.62 157.04 23.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.864 0.364 . . . . 0.0 110.72 179.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.412 ' O ' ' HG3' ' A' ' 136' ' ' ARG . . . -153.98 96.32 1.95 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.098 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.421 ' HB2' ' CD ' ' A' ' 133' ' ' PRO . 16.6 ptp -47.24 168.52 0.13 Allowed Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.725 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.421 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.7 Cg_exo -65.54 -47.6 3.99 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.687 2.258 . . . . 0.0 112.806 -178.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.18 -50.78 66.25 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.398 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.471 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -69.71 -34.52 74.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.084 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.412 ' HG3' ' O ' ' A' ' 131' ' ' ALA . 0.9 OUTLIER -66.48 -47.96 71.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.314 0.578 . . . . 0.0 110.296 179.367 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 11.4 ttt-85 -59.48 -55.24 37.16 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.259 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.511 ' CD1' ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -62.58 -42.16 99.38 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.799 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.419 ' N ' ' CD1' ' A' ' 138' ' ' LEU . . . -57.8 -36.68 72.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.912 0.387 . . . . 0.0 110.726 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.07 -30.76 55.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.705 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -84.45 -15.93 44.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.203 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.415 ' CD1' HD11 ' A' ' 138' ' ' LEU . 1.1 mt -98.12 -28.85 13.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.799 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.58 36.53 8.6 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.66 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.491 ' CD1' ' CE3' ' A' ' 166' ' ' TRP . 1.3 tt -118.31 140.25 42.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.739 0.304 . . . . 0.0 111.258 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.527 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.6 OUTLIER -71.47 100.93 2.32 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.293 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.431 ' CB ' ' CD1' ' A' ' 158' ' ' ILE . . . -50.02 -30.36 10.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.764 0.316 . . . . 0.0 111.441 -179.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 17.0 m -65.14 -36.69 85.05 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.527 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -65.76 -23.82 66.81 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.408 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.462 ' CG2' HD11 ' A' ' 144' ' ' ILE . 21.9 t -84.9 85.6 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.458 179.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 5.0 ttpp -50.66 90.61 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.971 0.415 . . . . 0.0 111.29 -179.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.51 ' HA2' ' HA ' ' A' ' 158' ' ' ILE . . . -69.91 139.76 31.83 Favored Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 115.777 -0.647 . . . . 0.0 113.383 -179.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.48 13.53 13.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.764 0.316 . . . . 0.0 110.638 179.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.415 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -76.08 153.45 43.42 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.799 -179.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_exo -43.59 109.73 0.16 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.129 2.553 . . . . 0.0 112.873 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 96.59 16.47 36.68 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.294 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 76.2 22.21 74.11 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.72 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.415 HG21 ' HA2' ' A' ' 153' ' ' GLY . 1.3 m -83.59 126.67 40.16 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 CA-C-N 117.031 0.416 . . . . 0.0 111.025 -179.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.655 ' O ' HG13 ' A' ' 158' ' ' ILE . 17.3 pt -66.55 111.51 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.195 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.509 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 70.6 p -75.14 156.39 36.0 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.4 0.619 . . . . 0.0 111.261 -177.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.465 ' CG1' ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -56.18 -39.53 59.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.583 -179.664 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.637 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 27.3 tt0 -63.6 -27.91 69.56 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.814 179.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.509 ' HB2' ' O ' ' A' ' 159' ' ' THR . 88.7 m-20 -71.92 -52.59 16.48 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.711 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.511 ' HB ' ' CD1' ' A' ' 138' ' ' LEU . 0.1 OUTLIER -67.68 -35.89 74.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.636 -179.378 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -69.52 -49.27 56.05 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.075 0.464 . . . . 0.0 110.832 -179.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.637 ' HG3' ' O ' ' A' ' 161' ' ' GLU . 42.3 mtp180 -61.58 -36.37 80.48 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.253 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.491 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 24.4 t90 -71.21 -50.32 34.24 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.948 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -51.94 -40.74 61.28 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.944 0.402 . . . . 0.0 110.39 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.41 ' HG2' ' HA ' ' A' ' 165' ' ' ARG . 8.4 pt-20 -74.28 -31.12 62.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.09 179.01 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -63.01 -31.17 72.25 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.301 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.43 HG23 ' CZ3' ' A' ' 166' ' ' TRP . 5.0 p -68.92 -52.02 33.78 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.259 179.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -67.04 -24.57 66.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.617 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.85 -39.53 76.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.872 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -58.98 -42.1 89.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.181 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 12.0 t -88.19 117.39 27.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.953 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.173 -0.918 . . . . 0.0 111.163 -179.995 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.582 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 N--CA 1.454 -0.266 0 CA-C-O 120.936 0.398 . . . . 0.0 110.874 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -152.27 95.5 2.06 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.866 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.463 ' HE3' ' CG2' ' A' ' 157' ' ' VAL . 18.0 ptp -47.43 166.95 0.18 Allowed Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.768 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.4 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.1 Cg_exo -65.91 -47.48 3.68 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.756 2.304 . . . . 0.0 112.857 -178.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.435 ' HB3' HG22 ' A' ' 160' ' ' VAL . . . -54.19 -51.04 65.65 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.522 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.569 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -69.68 -33.57 72.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.051 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -68.49 -48.12 65.29 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.251 0.548 . . . . 0.0 110.547 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -58.88 -54.72 43.89 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.851 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.734 HD12 ' N ' ' A' ' 139' ' ' ALA . 4.3 pp -62.62 -39.48 93.93 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.527 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.734 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -58.72 -39.62 81.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.886 0.374 . . . . 0.0 110.827 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.19 -29.76 57.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.783 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -81.85 -23.94 36.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.926 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.643 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.5 mt -90.56 -28.95 18.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.843 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.17 35.55 8.81 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.72 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.498 HD13 ' CG2' ' A' ' 149' ' ' VAL . 1.5 tt -116.39 142.32 30.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.781 0.324 . . . . 0.0 111.34 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.526 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 1.9 t0 -73.95 101.02 3.69 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.993 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -49.84 -28.03 5.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.277 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.73 -37.26 84.3 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.526 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -65.94 -21.14 66.41 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 177.349 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.498 ' CG2' HD13 ' A' ' 144' ' ' ILE . 21.7 t -89.93 88.12 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.455 179.106 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.7 ttmt -50.82 91.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.001 0.429 . . . . 0.0 111.206 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.502 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -70.18 133.76 24.48 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 121.015 -0.612 . . . . 0.0 113.198 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.421 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.4 OUTLIER -118.47 14.18 13.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.847 0.356 . . . . 0.0 110.766 179.563 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.458 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -73.18 155.34 50.43 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.709 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -44.37 106.5 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.097 2.531 . . . . 0.0 112.851 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.14 19.79 22.67 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.245 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.582 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 74.61 22.17 77.62 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.598 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.477 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.3 m -85.77 126.29 40.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 117.042 0.421 . . . . 0.0 111.067 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.993 HD13 ' HB1' ' A' ' 146' ' ' ALA . 19.1 pt -64.98 111.94 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.509 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 61.7 p -75.02 156.48 36.16 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.558 0.694 . . . . 0.0 111.657 -177.527 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.502 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -56.08 -39.91 61.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.715 -179.464 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.546 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 1.2 tp10 -65.82 -28.05 68.71 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.907 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.509 ' HB2' ' O ' ' A' ' 159' ' ' THR . 82.1 m-20 -68.49 -53.41 23.49 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.198 0.523 . . . . 0.0 110.225 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.726 ' CB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -65.64 -41.27 90.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.62 -179.729 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.55 -48.03 73.83 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 120.942 0.401 . . . . 0.0 111.465 -178.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.546 ' HG3' ' O ' ' A' ' 161' ' ' GLU . 21.6 mtt180 -60.63 -40.29 91.36 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.89 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' TRP . . . . . 0.473 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 27.5 t90 -70.65 -48.99 52.13 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.661 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -50.52 -39.02 47.68 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.968 0.413 . . . . 0.0 110.486 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.401 ' HG2' ' HA ' ' A' ' 165' ' ' ARG . 13.0 pt-20 -77.33 -31.3 54.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.356 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.953 0.406 . . . . 0.0 110.402 179.518 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.57 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 N--CA 1.455 -0.203 0 CA-C-O 120.917 0.389 . . . . 0.0 110.846 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -153.37 95.49 1.93 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.897 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.438 ' HE2' ' HB3' ' A' ' 134' ' ' ALA . 19.9 ptm -48.14 167.42 0.19 Allowed Pre-proline 0 CA--C 1.532 0.26 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.793 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.408 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.8 Cg_exo -65.54 -45.56 6.7 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.807 2.338 . . . . 0.0 112.918 -178.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.438 ' HB3' ' HE2' ' A' ' 132' ' ' MET . . . -54.29 -52.71 60.59 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.423 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.562 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -69.25 -33.3 73.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.165 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 12.1 mtm180 -67.99 -49.17 63.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.524 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -58.29 -54.33 48.2 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.893 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.721 HD11 ' CB ' ' A' ' 163' ' ' VAL . 4.4 pp -63.05 -38.92 93.1 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.417 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.712 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -58.31 -39.93 80.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.722 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -76.62 -29.81 56.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.726 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 -81.95 -20.02 39.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.059 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.654 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.3 mt -94.88 -28.85 15.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.927 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.64 35.98 8.2 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.812 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.493 ' CD1' ' CE3' ' A' ' 166' ' ' TRP . 1.5 tt -118.22 141.34 37.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.832 0.348 . . . . 0.0 111.183 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.518 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.6 OUTLIER -72.93 101.05 3.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.805 179.229 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 1.016 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -49.73 -28.71 6.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.641 0.257 . . . . 0.0 111.321 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.78 -36.98 85.06 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.518 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -66.52 -22.48 66.17 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.453 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.526 HG21 HG13 ' A' ' 163' ' ' VAL . 21.8 t -86.87 84.77 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.646 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 6.4 ttmt -50.73 90.82 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.976 0.417 . . . . 0.0 111.14 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.512 ' HA3' ' HA ' ' A' ' 158' ' ' ILE . . . -66.5 142.94 43.29 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.809 -0.632 . . . . 0.0 113.295 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.45 0.9 11.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.688 0.28 . . . . 0.0 110.885 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.438 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -65.99 151.96 51.93 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.747 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.543 ' O ' HG13 ' A' ' 157' ' ' VAL . 84.8 Cg_exo -42.04 120.67 1.58 Allowed 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.234 2.622 . . . . 0.0 113.182 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 89.55 -0.68 80.73 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.715 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.57 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 94.53 22.24 24.65 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.694 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.543 HG13 ' O ' ' A' ' 154' ' ' PRO . 1.2 m -83.49 126.38 40.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 117.017 0.408 . . . . 0.0 111.107 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 1.016 HD13 ' HB1' ' A' ' 146' ' ' ALA . 19.0 pt -65.89 111.82 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.187 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.518 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 44.0 p -75.3 156.53 35.5 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.575 0.702 . . . . 0.0 111.816 -177.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.504 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -56.01 -40.16 61.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.805 -179.431 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.49 ' O ' ' CG ' ' A' ' 165' ' ' ARG . 5.6 mt-10 -64.89 -27.61 68.98 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.834 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.518 ' HB2' ' O ' ' A' ' 159' ' ' THR . 88.1 m-20 -70.2 -53.97 14.85 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.522 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.721 ' CB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -65.16 -42.71 94.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.794 -179.37 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.9 mmtt -66.38 -52.11 50.16 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.953 0.406 . . . . 0.0 111.486 -178.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.49 ' CG ' ' O ' ' A' ' 161' ' ' GLU . 27.1 mtp180 -59.24 -35.88 74.47 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.035 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' TRP . . . . . 0.493 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 32.9 t90 -70.66 -50.05 40.77 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.791 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -50.66 -41.26 55.29 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-O 120.97 0.414 . . . . 0.0 110.411 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.422 ' HG2' ' HA ' ' A' ' 165' ' ' ARG . 7.6 pt-20 -74.04 -31.88 63.08 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.048 179.129 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 . . . . . 0 N--CA 1.456 -0.169 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.278 179.458 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.532 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 C--O 1.233 0.192 0 CA-C-O 120.846 0.355 . . . . 0.0 110.824 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -154.88 96.22 1.83 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.134 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.442 ' HE3' ' CG2' ' A' ' 157' ' ' VAL . 19.0 ptp -47.81 167.59 0.18 Allowed Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.57 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.405 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.4 Cg_exo -65.49 -47.12 4.52 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.778 2.319 . . . . 0.0 112.809 -179.058 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.465 ' HB3' HG22 ' A' ' 160' ' ' VAL . . . -54.27 -51.48 64.41 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.475 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.546 ' HA ' HD21 ' A' ' 138' ' ' LEU . . . -69.23 -33.36 73.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.277 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.69 -48.75 63.1 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.296 0.57 . . . . 0.0 110.371 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -57.77 -54.2 49.57 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.98 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.729 HD12 ' N ' ' A' ' 139' ' ' ALA . 4.3 pp -63.49 -41.23 98.57 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.553 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.729 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -58.47 -37.64 75.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.743 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.92 -29.81 55.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.754 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -83.36 -20.52 34.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.997 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.648 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.5 mt -94.22 -28.92 15.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.863 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.75 38.68 7.96 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.543 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.511 HD13 ' CG2' ' A' ' 149' ' ' VAL . 1.3 tt -118.4 140.39 42.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.742 0.306 . . . . 0.0 111.305 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.531 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 1.5 t0 -71.97 100.97 2.58 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.998 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -50.6 -28.84 9.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.681 0.277 . . . . 0.0 111.271 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.69 -36.97 85.15 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 178.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.531 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -64.97 -23.88 67.35 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 177.283 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.511 ' CG2' HD13 ' A' ' 144' ' ' ILE . 21.2 t -87.44 89.15 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.324 179.078 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.64 90.93 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.937 0.399 . . . . 0.0 111.14 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.512 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -68.55 130.03 25.63 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.837 -0.696 . . . . 0.0 113.104 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.479 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.1 OUTLIER -118.5 24.13 11.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.136 0.493 . . . . 0.0 110.495 179.658 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.429 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -84.63 157.16 32.44 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.758 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_exo -43.37 102.89 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.227 2.618 . . . . 0.0 112.993 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 99.3 23.52 11.18 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.212 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.532 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 71.23 22.18 78.52 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.601 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.442 ' CG2' ' HE3' ' A' ' 132' ' ' MET . 1.2 m -85.43 128.35 39.21 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.957 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.998 HD13 ' HB1' ' A' ' 146' ' ' ALA . 18.6 pt -66.65 112.11 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.079 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.504 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 55.7 p -75.14 156.35 36.05 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.532 0.682 . . . . 0.0 111.533 -177.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.521 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -56.41 -39.46 61.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.706 -179.582 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.565 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 6.1 mm-40 -65.67 -27.79 68.62 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.944 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.504 ' HB2' ' O ' ' A' ' 159' ' ' THR . 83.0 m-20 -69.31 -54.6 13.75 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.223 0.535 . . . . 0.0 110.322 179.445 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.715 ' CB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -64.09 -40.83 90.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.648 -179.612 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.61 -47.57 78.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.9 0.381 . . . . 0.0 111.445 -178.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.565 ' HG3' ' O ' ' A' ' 161' ' ' GLU . 65.2 mtt-85 -60.83 -42.0 96.87 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.05 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' TRP . . . . . 0.489 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 18.1 t90 -67.98 -50.18 57.23 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.915 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -50.94 -41.1 58.75 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.919 0.39 . . . . 0.0 110.725 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.416 ' HG2' ' HA ' ' A' ' 165' ' ' ARG . 11.9 pt-20 -74.9 -29.47 61.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.321 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.406 ' OE1' ' CD1' ' A' ' 166' ' ' TRP . 0.4 OUTLIER . . . . . 0 N--CA 1.454 -0.264 0 CA-C-O 121.224 0.535 . . . . 0.0 110.096 179.41 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.539 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 N--CA 1.456 -0.174 0 CA-C-O 120.931 0.396 . . . . 0.0 110.892 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.5 ' HB1' ' HG2' ' A' ' 136' ' ' ARG . . . -152.12 95.43 2.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.965 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.415 ' HG2' ' O ' ' A' ' 158' ' ' ILE . 14.0 ptp -46.91 167.74 0.15 Allowed Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.863 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.414 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.2 Cg_exo -65.76 -47.59 3.75 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.799 2.333 . . . . 0.0 112.822 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.462 ' HB3' HG22 ' A' ' 160' ' ' VAL . . . -54.3 -51.61 64.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.372 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.563 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -69.48 -34.21 74.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.911 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.5 ' HG2' ' HB1' ' A' ' 131' ' ' ALA . 9.0 mmm180 -66.53 -48.53 69.42 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.501 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.41 ' CZ ' ' HB2' ' A' ' 137' ' ' ARG . 26.4 ttm105 -59.93 -55.38 34.8 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.154 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.729 HD12 ' N ' ' A' ' 139' ' ' ALA . 4.3 pp -61.54 -41.03 96.75 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.716 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.729 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -58.11 -37.95 75.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.994 0.426 . . . . 0.0 110.809 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.3 tptt -76.48 -29.81 57.02 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.825 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -84.32 -19.38 33.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.12 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.614 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.4 mt -94.49 -28.89 15.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.719 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.72 38.28 8.19 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.505 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.481 ' CD1' ' CE3' ' A' ' 166' ' ' TRP . 1.4 tt -118.31 141.6 36.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.744 0.307 . . . . 0.0 111.248 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.529 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 1.9 t0 -72.94 101.02 3.08 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 1.004 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -50.45 -28.85 9.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.735 0.302 . . . . 0.0 111.182 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.92 -36.93 85.96 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 178.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.529 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -66.59 -23.37 66.18 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 177.666 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.536 HG21 HG13 ' A' ' 163' ' ' VAL . 20.1 t -86.7 84.15 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.625 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.74 91.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.911 0.386 . . . . 0.0 111.113 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.571 ' HA3' ' HA ' ' A' ' 158' ' ' ILE . . . -69.17 141.55 36.0 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.098 -0.572 . . . . 0.0 113.488 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.61 11.06 12.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.743 0.306 . . . . 0.0 110.786 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.448 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -73.4 152.21 46.17 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.842 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.417 ' O ' HG13 ' A' ' 157' ' ' VAL . 90.8 Cg_exo -43.83 112.29 0.31 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.092 2.528 . . . . 0.0 112.832 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 95.54 13.12 52.32 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.374 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.539 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 79.62 22.11 65.1 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.776 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.457 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.3 m -83.98 126.92 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 117.122 0.461 . . . . 0.0 111.06 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 1.004 HD13 ' HB1' ' A' ' 146' ' ' ALA . 17.7 pt -66.94 111.79 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.205 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.529 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 75.3 p -75.07 156.46 36.07 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.505 0.669 . . . . 0.0 111.735 -177.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.462 HG22 ' HB3' ' A' ' 134' ' ' ALA . 0.2 OUTLIER -55.58 -40.71 60.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.697 -179.56 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -64.29 -27.51 69.09 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.114 179.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.529 ' HB2' ' O ' ' A' ' 159' ' ' THR . 82.6 m-20 -71.45 -53.27 14.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.835 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.726 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -64.43 -45.77 94.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.687 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -61.47 -48.64 80.21 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.043 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.469 ' HG3' ' N ' ' A' ' 166' ' ' TRP . 0.8 OUTLIER -57.71 -39.75 77.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.903 -179.718 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 166' ' ' TRP . . . . . 0.481 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 23.9 t90 -72.39 -48.36 42.14 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.754 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -52.21 -38.37 57.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.975 0.417 . . . . 0.0 110.445 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -77.3 -33.15 55.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.243 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 . . . . . 0 C--N 1.331 -0.197 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.577 179.789 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.612 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 N--CA 1.455 -0.207 0 CA-C-O 121.022 0.439 . . . . 0.0 111.098 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -153.83 94.33 1.75 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.645 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.48 ' HE2' ' HB3' ' A' ' 134' ' ' ALA . 20.2 ptm -47.03 166.64 0.18 Allowed Pre-proline 0 CA--C 1.533 0.306 0 CA-C-O 120.582 0.23 . . . . 0.0 110.936 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -65.62 -44.85 7.64 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.868 2.379 . . . . 0.0 112.826 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.48 ' HB3' ' HE2' ' A' ' 132' ' ' MET . . . -54.21 -53.62 51.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.372 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.571 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -68.29 -33.88 75.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.024 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.65 -49.88 64.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.587 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -58.28 -55.58 33.16 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.133 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.721 HD12 ' N ' ' A' ' 139' ' ' ALA . 4.4 pp -60.98 -40.67 94.33 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.615 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.721 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -57.55 -37.71 73.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.853 0.358 . . . . 0.0 110.66 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.8 tptp -76.9 -30.07 56.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.771 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -83.32 -19.92 35.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.061 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.613 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.5 mt -94.5 -28.89 15.21 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.864 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.53 37.76 7.95 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.607 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.488 HD13 ' CG2' ' A' ' 149' ' ' VAL . 1.4 tt -118.36 143.07 30.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.809 0.337 . . . . 0.0 111.181 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.539 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.9 OUTLIER -74.63 101.12 4.14 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.372 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.975 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -49.78 -28.81 6.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.689 0.28 . . . . 0.0 111.099 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.42 -37.65 87.56 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.539 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -66.25 -22.23 66.31 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 177.578 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.488 ' CG2' HD13 ' A' ' 144' ' ' ILE . 21.3 t -88.37 85.58 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.623 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.5 ptmt -50.7 92.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.986 0.422 . . . . 0.0 111.149 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.512 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -68.02 136.29 30.71 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.064 -0.589 . . . . 0.0 113.339 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.52 10.71 12.7 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.738 0.304 . . . . 0.0 110.819 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.46 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -72.29 154.68 50.82 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.771 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -43.99 107.65 0.1 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.111 2.541 . . . . 0.0 112.886 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.51 18.38 28.36 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.364 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.612 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 75.58 22.27 75.54 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.634 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.486 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -84.6 124.21 39.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 117.069 0.434 . . . . 0.0 111.063 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.975 HD13 ' HB1' ' A' ' 146' ' ' ALA . 19.6 pt -63.59 111.59 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.334 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.539 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 48.9 p -75.4 156.53 35.28 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.555 0.693 . . . . 0.0 111.904 -177.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.479 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.54 -41.48 63.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.78 -179.524 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -64.26 -27.44 69.05 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.125 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.539 ' HB2' ' O ' ' A' ' 159' ' ' THR . 84.1 m-20 -70.61 -52.58 20.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.512 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.719 ' CB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -65.98 -45.77 90.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.579 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 10.5 mttm -62.71 -50.94 69.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.616 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.535 ' HG3' ' O ' ' A' ' 162' ' ' ASP . 1.8 ppt_? -57.83 -39.07 76.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.607 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' TRP . . . . . 0.487 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 26.6 t90 -71.49 -48.42 49.18 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.59 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -51.66 -38.3 54.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.52 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -77.24 -32.81 56.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.158 179.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.983 0.421 . . . . 0.0 110.35 179.462 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.579 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.977 0.418 . . . . 0.0 111.019 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -152.52 95.27 2.0 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.862 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 9.8 ptp -47.44 166.93 0.18 Allowed Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.842 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -65.67 -46.28 5.43 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.859 2.373 . . . . 0.0 112.943 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.44 ' HB3' HG22 ' A' ' 160' ' ' VAL . . . -54.28 -52.42 61.48 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.401 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.566 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -68.34 -34.19 75.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.124 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.74 -49.34 63.06 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.252 0.548 . . . . 0.0 110.585 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 7.5 tpt180 -57.37 -55.55 33.3 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.838 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.722 HD12 ' N ' ' A' ' 139' ' ' ALA . 4.3 pp -62.33 -41.14 98.32 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.562 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.722 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -56.45 -39.72 73.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.974 0.416 . . . . 0.0 110.956 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.65 -29.86 56.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.75 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -82.41 -19.04 39.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.083 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.603 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.4 mt -95.64 -28.86 14.61 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.866 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.05 37.08 7.95 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.661 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.49 HD13 ' CG2' ' A' ' 149' ' ' VAL . 1.8 tt -118.34 143.02 30.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.803 0.335 . . . . 0.0 111.232 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.565 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 1.9 t0 -74.47 101.1 4.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.803 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 1.013 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -49.6 -28.95 6.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.595 0.236 . . . . 0.0 111.294 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.08 -36.98 84.63 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.565 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -66.68 -21.44 66.09 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 177.46 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.504 HG21 HG13 ' A' ' 163' ' ' VAL . 21.4 t -89.16 86.02 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.497 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.71 93.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.965 0.412 . . . . 0.0 111.124 -179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.519 ' HA3' ' HA ' ' A' ' 158' ' ' ILE . . . -70.82 139.2 29.56 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 121.001 -0.619 . . . . 0.0 113.419 -179.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -118.56 10.38 12.56 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.721 0.296 . . . . 0.0 110.846 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.475 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -71.19 152.69 50.2 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.746 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.402 ' O ' HG13 ' A' ' 157' ' ' VAL . 82.4 Cg_exo -44.68 111.04 0.26 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.059 2.506 . . . . 0.0 112.722 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 96.43 14.22 45.25 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.289 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.579 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 79.41 22.11 65.6 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.674 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.475 HG22 ' HA3' ' A' ' 153' ' ' GLY . 1.2 m -85.22 125.66 40.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 117.121 0.461 . . . . 0.0 110.961 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 1.013 HD13 ' HB1' ' A' ' 146' ' ' ALA . 18.8 pt -65.33 111.74 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.222 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.532 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 55.0 p -75.15 156.43 35.94 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.523 0.678 . . . . 0.0 111.723 -177.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.467 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.33 -40.78 58.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.787 -179.503 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.416 ' O ' ' HG2' ' A' ' 165' ' ' ARG . 55.7 tt0 -64.62 -27.47 68.96 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.171 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.532 ' HB2' ' O ' ' A' ' 159' ' ' THR . 72.4 m-20 -70.74 -53.6 14.94 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.749 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.709 ' CB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -63.62 -48.15 88.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.406 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 16.9 mttp -60.24 -46.34 90.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.561 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.516 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 24.8 ptt180 -60.1 -39.23 85.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.779 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' TRP . . . . . 0.455 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 30.2 t90 -72.73 -48.15 41.03 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.843 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -52.47 -37.78 57.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.997 0.427 . . . . 0.0 110.476 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -77.26 -33.66 55.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.056 179.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.149 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.271 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.583 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 N--CA 1.453 -0.281 0 CA-C-O 121.11 0.481 . . . . 0.0 111.052 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.438 ' HB1' ' HG2' ' A' ' 136' ' ' ARG . . . -151.54 94.71 2.04 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.688 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.409 ' HE2' ' HB3' ' A' ' 134' ' ' ALA . 22.4 ptm -48.63 166.66 0.22 Allowed Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.005 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.402 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 21.7 Cg_exo -66.19 -45.25 5.84 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.878 2.385 . . . . 0.0 112.818 -178.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.409 ' HB3' ' HE2' ' A' ' 132' ' ' MET . . . -54.32 -52.2 62.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.268 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.533 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -70.28 -32.45 70.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.875 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.438 ' HG2' ' HB1' ' A' ' 131' ' ' ALA . 0.1 OUTLIER -68.02 -47.94 67.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.256 179.475 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -59.97 -54.81 41.67 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.033 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.725 HD11 ' CB ' ' A' ' 163' ' ' VAL . 4.3 pp -62.52 -40.8 97.93 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.589 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.712 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -57.08 -38.81 73.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.892 0.377 . . . . 0.0 110.683 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.97 -29.81 55.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.827 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -82.4 -21.21 35.91 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.069 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.622 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.6 mt -94.02 -28.91 15.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.925 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.75 38.39 8.11 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.461 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.521 HD13 ' CG2' ' A' ' 149' ' ' VAL . 0.6 OUTLIER -116.6 143.21 27.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.865 0.365 . . . . 0.0 111.19 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.468 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.9 OUTLIER -74.84 100.88 4.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.469 . . . . 0.0 109.852 179.185 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 1.035 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -53.27 -33.81 54.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.665 0.269 . . . . 0.0 111.109 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.9 -36.69 75.12 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.051 0.453 . . . . 0.0 109.805 179.058 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.512 ' HE2' ' CE2' ' A' ' 166' ' ' TRP . 0.0 OUTLIER -67.92 -30.45 69.78 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.846 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.521 ' CG2' HD13 ' A' ' 144' ' ' ILE . 8.1 t -78.2 81.79 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.379 179.051 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.47 ' O ' ' HG3' ' A' ' 150' ' ' LYS . 2.0 ptpp? -50.51 93.25 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.266 0.555 . . . . 0.0 111.105 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.552 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -63.1 139.04 44.18 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.605 -0.725 . . . . 0.0 113.492 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.55 13.66 13.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.752 0.311 . . . . 0.0 110.608 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.433 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -80.14 154.97 37.76 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.736 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_exo -43.23 108.79 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.161 2.574 . . . . 0.0 112.972 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 96.95 16.94 34.06 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.377 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.583 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 76.17 22.33 73.91 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.634 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.502 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -83.0 125.6 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.173 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 1.035 HD13 ' HB1' ' A' ' 146' ' ' ALA . 18.2 pt -64.4 111.23 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.292 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.493 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 25.7 p -75.29 156.32 35.75 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.639 0.733 . . . . 0.0 111.792 -177.436 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.537 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -56.59 -39.82 65.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.649 -179.643 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.576 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 0.4 OUTLIER -63.69 -29.75 70.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.921 179.413 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.493 ' HB2' ' O ' ' A' ' 159' ' ' THR . 91.8 m-20 -68.97 -54.07 17.31 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.9 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.725 ' CB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -63.98 -41.91 94.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.766 -178.762 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.533 ' CG ' ' HA ' ' A' ' 161' ' ' GLU . 0.0 OUTLIER -64.84 -48.83 72.92 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.024 0.44 . . . . 0.0 111.418 -178.64 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.576 ' HG3' ' O ' ' A' ' 161' ' ' GLU . 8.5 mtm105 -57.62 -43.33 84.72 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.981 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' TRP . . . . . 0.512 ' CE2' ' HE2' ' A' ' 148' ' ' LYS . 61.9 t90 -68.09 -49.86 58.57 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.606 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -50.58 -39.55 49.93 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.856 0.36 . . . . 0.0 110.746 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.429 ' HG2' ' HA ' ' A' ' 165' ' ' ARG . 11.1 pt-20 -77.17 -29.18 54.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.485 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.455 -0.195 0 CA-C-O 121.208 0.528 . . . . 0.0 109.985 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.575 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 N--CA 1.456 -0.159 0 CA-C-O 121.039 0.447 . . . . 0.0 110.973 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.422 ' HB1' ' HG2' ' A' ' 136' ' ' ARG . . . -155.11 95.21 1.71 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.801 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.667 ' HE2' ' HB3' ' A' ' 134' ' ' ALA . 19.2 ptm -47.35 168.65 0.13 Allowed Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.873 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.435 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.0 Cg_exo -66.07 -45.34 5.98 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.772 2.315 . . . . 0.0 112.949 -178.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.667 ' HB3' ' HE2' ' A' ' 132' ' ' MET . . . -54.24 -53.35 54.83 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.442 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.553 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -69.63 -32.03 70.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.823 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.422 ' HG2' ' HB1' ' A' ' 131' ' ' ALA . 0.0 OUTLIER -67.41 -48.74 66.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.434 179.371 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -59.97 -55.13 37.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.042 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.721 HD12 ' N ' ' A' ' 139' ' ' ALA . 4.3 pp -62.52 -41.11 98.63 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.83 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.721 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -55.99 -41.76 75.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.863 0.363 . . . . 0.0 110.939 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -75.42 -29.84 59.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.9 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -80.9 -22.74 39.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.075 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.607 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.6 mt -92.09 -28.91 16.83 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.879 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.46 37.48 8.12 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.439 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.496 HD13 ' CG2' ' A' ' 149' ' ' VAL . 1.4 tt -117.85 141.53 36.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.828 0.347 . . . . 0.0 111.188 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.513 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 1.2 t0 -72.94 101.05 3.1 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.978 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -49.64 -28.59 6.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.688 0.28 . . . . 0.0 111.241 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.9 -37.27 85.67 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.513 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -65.8 -22.64 66.58 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 177.399 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.515 HG21 HG13 ' A' ' 163' ' ' VAL . 20.7 t -88.22 87.94 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.404 179.098 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.75 91.02 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.015 0.436 . . . . 0.0 111.267 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.507 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -68.51 132.86 27.54 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.904 -0.665 . . . . 0.0 113.093 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.433 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.2 OUTLIER -118.49 16.75 13.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.952 0.406 . . . . 0.0 110.812 179.624 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.459 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -77.67 154.32 41.69 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.655 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -43.93 107.56 0.1 OUTLIER 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.087 2.524 . . . . 0.0 112.813 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.75 18.76 26.68 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.236 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.575 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 74.94 22.18 77.26 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.671 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.479 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -84.76 125.47 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 CA-C-N 117.027 0.414 . . . . 0.0 110.992 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.978 HD13 ' HB1' ' A' ' 146' ' ' ALA . 19.1 pt -65.4 112.34 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.263 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.525 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 60.8 p -75.33 156.5 35.46 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.533 0.682 . . . . 0.0 111.891 -177.458 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.496 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.91 -40.55 63.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.743 -179.492 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.407 ' O ' ' HG2' ' A' ' 165' ' ' ARG . 20.2 mm-40 -65.21 -27.43 68.67 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.199 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 159' ' ' THR . 81.6 m-20 -70.43 -53.98 14.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.608 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.712 ' CB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -63.39 -47.71 90.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.412 179.928 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 10.7 mttm -60.41 -48.66 80.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.502 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.512 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 10.4 ptt180 -57.8 -39.98 78.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.882 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' TRP . . . . . 0.483 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 23.7 t90 -72.04 -48.14 46.66 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.778 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -52.19 -38.4 57.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.947 0.404 . . . . 0.0 110.58 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -77.24 -33.53 56.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.262 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 . . . . . 0 C--N 1.332 -0.163 0 CA-C-O 120.974 0.416 . . . . 0.0 110.443 179.579 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.581 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 N--CA 1.453 -0.279 0 CA-C-O 120.937 0.399 . . . . 0.0 110.789 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.43 ' HB1' ' HG2' ' A' ' 136' ' ' ARG . . . -151.13 94.98 2.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.857 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.417 ' HB2' ' CD ' ' A' ' 133' ' ' PRO . 9.5 ptm -46.96 167.73 0.15 Allowed Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.98 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.417 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.8 Cg_exo -65.49 -45.58 6.77 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.794 2.329 . . . . 0.0 112.885 -178.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.2 -53.48 52.91 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.365 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.593 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -68.99 -32.13 71.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.919 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.43 ' HG2' ' HB1' ' A' ' 131' ' ' ALA . 0.0 OUTLIER -68.36 -48.69 64.13 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.486 179.418 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.2 ttp85 -59.04 -55.74 31.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.073 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.732 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.3 pp -61.36 -41.04 96.43 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.647 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.717 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -57.4 -38.15 73.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.864 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.98 -29.78 55.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.767 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -83.83 -18.15 38.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.981 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.613 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.3 mt -96.14 -28.81 14.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.828 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.36 37.66 8.09 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.555 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.482 ' CD1' ' CE3' ' A' ' 166' ' ' TRP . 1.4 tt -118.45 142.33 33.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.717 0.294 . . . . 0.0 111.28 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.525 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.3 OUTLIER -73.96 101.09 3.72 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.899 179.282 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 1.002 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -49.91 -29.0 7.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.64 0.257 . . . . 0.0 111.204 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 32.3 t -65.03 -37.09 86.46 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.525 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -66.73 -22.91 66.05 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 177.679 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.555 HG21 HG13 ' A' ' 163' ' ' VAL . 20.3 t -86.9 84.03 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.72 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.76 92.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.012 0.434 . . . . 0.0 111.066 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.537 ' HA3' ' HA ' ' A' ' 158' ' ' ILE . . . -68.59 142.1 38.02 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.795 -0.639 . . . . 0.0 113.571 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.6 10.78 12.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.73 0.3 . . . . 0.0 110.779 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.47 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -75.19 151.92 42.8 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.771 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.453 ' O ' HG13 ' A' ' 157' ' ' VAL . 93.5 Cg_exo -43.86 114.74 0.57 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.057 2.505 . . . . 0.0 112.928 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 94.03 9.06 59.86 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.542 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.581 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 84.36 22.26 54.64 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.825 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.47 HG22 ' HA3' ' A' ' 153' ' ' GLY . 1.2 m -84.3 126.08 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 CA-C-N 117.055 0.428 . . . . 0.0 111.084 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 1.002 HD13 ' HB1' ' A' ' 146' ' ' ALA . 16.9 pt -66.57 111.49 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.21 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.535 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 45.6 p -75.33 156.53 35.45 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.584 0.706 . . . . 0.0 111.773 -177.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.472 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.31 -40.76 58.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.895 -179.483 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -64.22 -27.41 69.04 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.139 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.535 ' HB2' ' O ' ' A' ' 159' ' ' THR . 77.2 m-20 -71.47 -53.02 15.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.775 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.732 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -64.61 -45.5 95.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.321 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.409 ' CG ' ' N ' ' A' ' 165' ' ' ARG . 7.7 pttt -61.58 -49.08 78.08 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.209 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.493 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 4.2 ptm180 -57.96 -39.72 78.81 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.866 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' TRP . . . . . 0.482 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 23.2 t90 -72.16 -48.12 45.76 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.818 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -52.47 -38.3 59.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.035 0.445 . . . . 0.0 110.396 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -77.27 -32.38 55.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.12 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.456 -0.167 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.321 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.57 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 N--CA 1.455 -0.182 0 CA-C-O 120.916 0.389 . . . . 0.0 110.931 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.465 ' O ' ' HG3' ' A' ' 136' ' ' ARG . . . -151.61 96.3 2.23 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.859 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.434 ' HE3' ' CG2' ' A' ' 157' ' ' VAL . 15.3 ptp -47.88 167.94 0.17 Allowed Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.718 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.409 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.0 Cg_exo -65.79 -47.29 3.99 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.81 2.34 . . . . 0.0 112.965 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.433 ' HB3' HG22 ' A' ' 160' ' ' VAL . . . -54.28 -50.76 66.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.43 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.548 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -69.2 -34.7 75.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.236 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 131' ' ' ALA . 0.9 OUTLIER -67.6 -48.54 66.52 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.265 0.555 . . . . 0.0 110.397 179.484 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 66.2 ttt180 -57.59 -54.42 47.08 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.931 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.738 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.3 pp -64.15 -40.85 97.03 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.51 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.731 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -58.92 -37.98 77.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.92 0.39 . . . . 0.0 110.803 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.02 -29.77 55.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.662 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -81.59 -24.92 36.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.966 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.661 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.7 mt -90.88 -28.93 17.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.068 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.36 38.91 7.5 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.846 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.494 HD13 ' CG2' ' A' ' 149' ' ' VAL . 1.2 tt -118.62 140.74 41.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.735 0.302 . . . . 0.0 111.229 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.569 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.6 OUTLIER -71.57 100.89 2.36 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.299 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 1.029 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -50.51 -31.12 14.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.44 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 29.5 m -64.6 -36.1 83.16 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.569 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -65.44 -25.15 67.39 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 177.31 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.541 HG21 HG13 ' A' ' 163' ' ' VAL . 21.9 t -84.2 85.99 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.449 178.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.73 90.75 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.111 0.481 . . . . 0.0 111.224 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' ' 158' ' ' ILE . . . -66.06 141.28 41.2 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.82 -0.627 . . . . 0.0 113.247 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.46 10.95 12.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.707 0.289 . . . . 0.0 110.739 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.422 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -77.42 151.91 38.85 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.569 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.554 ' O ' HG13 ' A' ' 157' ' ' VAL . 82.2 Cg_exo -41.43 122.05 1.69 Allowed 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.244 2.629 . . . . 0.0 113.244 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 88.31 -2.93 85.42 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.773 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.57 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 96.79 22.21 18.92 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.674 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.554 HG13 ' O ' ' A' ' 154' ' ' PRO . 1.2 m -83.5 127.37 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.156 0 CA-C-N 117.092 0.446 . . . . 0.0 111.221 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 1.029 HD13 ' HB1' ' A' ' 146' ' ' ALA . 15.1 pt -67.85 111.87 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 178.078 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.527 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 62.9 p -75.08 156.49 36.03 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.625 0.726 . . . . 0.0 111.693 -177.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.472 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.59 -41.0 62.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.917 -179.407 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.523 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 0.9 OUTLIER -64.0 -27.73 69.32 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.919 179.387 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.527 ' HB2' ' O ' ' A' ' 159' ' ' THR . 87.3 m-20 -69.98 -54.37 13.58 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.318 0.58 . . . . 0.0 110.495 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.738 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -65.19 -40.81 89.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.725 -179.59 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -65.61 -46.66 78.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.903 0.382 . . . . 0.0 111.428 -178.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.523 ' HG3' ' O ' ' A' ' 161' ' ' GLU . 26.8 mtp180 -62.6 -38.57 90.68 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.885 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' TRP . . . . . 0.478 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 19.6 t90 -71.4 -50.12 35.17 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.71 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -51.93 -38.36 56.09 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.002 0.43 . . . . 0.0 110.571 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.456 ' HG2' ' HA ' ' A' ' 165' ' ' ARG . 8.4 pt-20 -76.78 -31.35 56.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.254 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 . . . . . 0 N--CA 1.456 -0.143 0 CA-C-O 120.957 0.408 . . . . 0.0 110.535 179.524 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.575 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 N--CA 1.454 -0.234 0 CA-C-O 120.866 0.365 . . . . 0.0 110.762 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -151.44 95.79 2.19 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.983 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.736 ' HE2' ' HB3' ' A' ' 134' ' ' ALA . 18.3 ptm -47.88 167.76 0.17 Allowed Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.664 -0.244 . . . . 0.0 110.805 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.417 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.4 Cg_exo -65.75 -46.26 5.31 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.776 2.317 . . . . 0.0 112.963 -178.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.736 ' HB3' ' HE2' ' A' ' 132' ' ' MET . . . -54.28 -52.41 61.52 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.449 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.59 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -68.78 -33.56 74.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.019 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.7 mtp180 -68.37 -48.89 63.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.553 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.2 tpt85 -57.78 -55.73 31.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.734 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.716 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.4 pp -61.65 -38.71 88.74 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.329 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.704 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -58.98 -39.47 81.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.807 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.19 -29.82 57.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.757 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -81.54 -24.35 36.65 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.993 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.658 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.5 mt -90.27 -28.89 18.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.018 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.05 37.37 7.82 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.836 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.478 HD13 ' CG2' ' A' ' 149' ' ' VAL . 1.4 tt -119.07 142.47 34.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.788 0.328 . . . . 0.0 111.213 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.558 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.6 OUTLIER -73.78 101.06 3.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.871 179.394 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 1.019 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -49.49 -30.56 8.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.735 0.302 . . . . 0.0 111.303 -179.361 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 20.4 m -65.11 -36.46 84.37 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.558 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -66.27 -23.79 66.46 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.415 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.539 HG21 HG13 ' A' ' 163' ' ' VAL . 22.0 t -85.27 85.01 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.478 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.65 90.99 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.096 0.474 . . . . 0.0 111.175 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.502 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -66.27 142.67 43.19 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.798 -0.637 . . . . 0.0 113.394 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.46 1.27 11.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.692 0.282 . . . . 0.0 110.838 179.458 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.432 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -66.56 152.25 52.37 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.551 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.534 ' O ' HG13 ' A' ' 157' ' ' VAL . 86.6 Cg_exo -42.32 120.09 1.52 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.179 2.586 . . . . 0.0 113.126 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 90.12 -0.24 78.4 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.682 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.575 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 93.89 22.25 26.15 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.697 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 154' ' ' PRO . 1.2 m -83.51 126.09 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 CA-C-N 117.038 0.419 . . . . 0.0 111.214 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 1.019 HD13 ' HB1' ' A' ' 146' ' ' ALA . 16.4 pt -65.69 111.31 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 178.283 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.554 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 55.4 p -75.22 156.5 35.7 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.487 0.66 . . . . 0.0 111.909 -177.574 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.461 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.73 -41.86 58.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.888 -179.425 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.4 ' O ' ' CG ' ' A' ' 165' ' ' ARG . 21.7 tt0 -63.99 -27.48 69.15 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.069 179.182 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.565 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 83.9 m-20 -70.75 -52.16 22.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.648 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.716 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -65.95 -46.76 87.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.489 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.2 mtmp? -61.3 -51.22 69.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.468 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.565 ' HG3' ' O ' ' A' ' 162' ' ' ASP . 0.1 OUTLIER -57.74 -38.8 75.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.895 -179.787 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 166' ' ' TRP . . . . . 0.477 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 27.3 t90 -71.53 -48.2 50.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.784 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -52.22 -37.91 56.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.976 0.417 . . . . 0.0 110.559 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -77.2 -32.3 55.88 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.083 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 . . . . . 0 C--N 1.333 -0.146 0 CA-C-O 120.956 0.408 . . . . 0.0 110.383 179.487 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.608 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 N--CA 1.454 -0.244 0 CA-C-O 120.949 0.404 . . . . 0.0 110.852 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.447 ' HB1' ' HG2' ' A' ' 136' ' ' ARG . . . -147.83 94.67 2.38 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.848 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.488 ' HE3' ' CG2' ' A' ' 157' ' ' VAL . 17.9 ptp -47.3 166.56 0.19 Allowed Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.064 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.406 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 21.8 Cg_exo -65.74 -46.57 4.9 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.883 2.389 . . . . 0.0 112.867 -179.136 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.418 ' HB3' HG22 ' A' ' 160' ' ' VAL . . . -54.29 -50.84 66.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.259 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.594 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -70.49 -36.08 73.61 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.018 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.447 ' HG2' ' HB1' ' A' ' 131' ' ' ALA . 0.2 OUTLIER -64.87 -46.83 80.17 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.359 0.6 . . . . 0.0 110.135 179.357 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.55 -58.71 7.42 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.031 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.83 HD11 ' HB ' ' A' ' 163' ' ' VAL . 3.9 pp -59.91 -43.93 94.57 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.516 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.694 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -53.5 -41.12 65.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.982 0.42 . . . . 0.0 110.828 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -73.02 -32.55 65.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.898 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -73.88 -46.51 44.2 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.001 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.559 HD13 ' O ' ' A' ' 138' ' ' LEU . 8.9 mp -72.21 -29.03 63.57 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.082 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.83 37.71 7.22 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.772 -0.728 . . . . 0.0 113.104 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.491 ' CD1' ' CE3' ' A' ' 166' ' ' TRP . 1.5 tt -114.5 141.94 29.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.736 0.303 . . . . 0.0 111.084 179.637 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.498 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 1.2 t0 -72.47 101.25 2.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.06 179.415 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.968 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -49.31 -28.29 4.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.764 0.316 . . . . 0.0 111.353 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 37.1 t -66.42 -37.77 85.94 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.498 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -66.13 -21.04 66.33 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.4 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.61 HG21 HG13 ' A' ' 163' ' ' VAL . 21.3 t -89.48 88.29 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.565 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 6.5 ttpt -50.62 93.66 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.009 0.433 . . . . 0.0 111.17 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.523 ' HA3' HG22 ' A' ' 158' ' ' ILE . . . -72.74 130.25 14.45 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.146 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.431 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.2 OUTLIER -118.48 20.15 13.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.024 0.44 . . . . 0.0 110.702 179.585 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.451 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -78.59 156.92 43.39 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.741 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -43.82 103.95 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.086 2.524 . . . . 0.0 112.992 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.73 22.17 14.55 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.2 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.608 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 72.99 22.15 79.34 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.637 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.488 ' CG2' ' HE3' ' A' ' 132' ' ' MET . 1.2 m -85.45 125.82 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 CA-C-N 117.031 0.415 . . . . 0.0 111.191 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.968 HD13 ' HB1' ' A' ' 146' ' ' ALA . 17.6 pt -65.49 110.67 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.344 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.513 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 71.8 p -75.12 156.37 36.08 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.491 0.663 . . . . 0.0 111.62 -177.56 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.49 HG13 HD23 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -56.5 -39.66 63.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.511 -179.724 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.602 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 0.5 OUTLIER -63.25 -28.51 70.08 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.768 179.1 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.513 ' HB2' ' O ' ' A' ' 159' ' ' THR . 91.1 m-20 -71.35 -52.56 18.06 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.826 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.83 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -67.21 -37.16 78.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.872 -179.183 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.485 ' HG3' ' N ' ' A' ' 165' ' ' ARG . 5.3 ptpt -70.9 -51.37 26.6 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.192 0.52 . . . . 0.0 111.14 -179.289 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.602 ' HG3' ' O ' ' A' ' 161' ' ' GLU . 49.3 mtm180 -57.81 -37.62 74.09 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.005 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' TRP . . . . . 0.491 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 46.8 t90 -68.9 -50.04 53.0 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.716 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -50.41 -43.11 54.63 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.507 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.433 ' HG2' ' HA ' ' A' ' 165' ' ' ARG . 7.2 pt-20 -71.26 -32.37 68.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.897 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 . . . . . 0 N--CA 1.456 -0.156 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.231 179.279 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.569 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 N--CA 1.455 -0.192 0 CA-C-O 120.855 0.36 . . . . 0.0 110.682 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.42 ' HB1' ' HG2' ' A' ' 136' ' ' ARG . . . -154.62 95.42 1.78 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.045 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.671 ' HB2' ' HD2' ' A' ' 133' ' ' PRO . 19.5 ptm -46.46 167.76 0.14 Allowed Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.558 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.671 ' HD2' ' HB2' ' A' ' 132' ' ' MET . 50.4 Cg_endo -71.88 -34.35 8.79 Favored 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 122.122 1.882 . . . . 0.0 112.5 -178.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.45 ' HB3' ' CE ' ' A' ' 132' ' ' MET . . . -59.71 -54.47 45.98 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.242 0.544 . . . . 0.0 110.649 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.635 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -69.53 -33.26 72.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.507 179.497 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.42 ' HG2' ' HB1' ' A' ' 131' ' ' ALA . 16.6 mmm-85 -66.49 -47.76 71.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.383 179.409 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.02 -55.89 28.43 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.9 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.735 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.4 pp -61.04 -40.19 92.68 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.536 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.721 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -57.87 -38.44 75.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.974 0.416 . . . . 0.0 110.791 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.52 -30.05 57.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.713 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -83.08 -19.85 36.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.953 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.628 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.3 mt -94.02 -28.88 15.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.886 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.71 37.36 8.03 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.746 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.479 ' CD1' ' CE3' ' A' ' 166' ' ' TRP . 1.6 tt -118.67 143.48 29.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.788 0.327 . . . . 0.0 111.306 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.547 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 1.3 t0 -74.39 101.04 3.96 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.241 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 1.033 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -50.2 -28.57 7.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.662 0.268 . . . . 0.0 111.37 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.19 -36.92 84.35 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.547 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -66.54 -21.91 66.16 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 177.524 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.509 HG21 HG13 ' A' ' 163' ' ' VAL . 21.7 t -88.0 85.76 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.61 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -50.7 92.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.988 0.423 . . . . 0.0 111.304 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.547 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -69.47 138.14 30.1 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.809 -0.632 . . . . 0.0 113.525 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.54 12.02 13.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.795 0.331 . . . . 0.0 110.788 179.267 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.45 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -74.5 154.76 47.78 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.786 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -43.85 108.23 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.034 2.489 . . . . 0.0 112.878 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.16 18.79 27.95 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.296 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.569 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 74.62 22.18 77.59 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.801 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.481 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -83.68 126.09 40.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 117.069 0.435 . . . . 0.0 111.192 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 1.033 HD13 ' HB1' ' A' ' 146' ' ' ALA . 19.0 pt -64.79 111.52 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 178.369 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.544 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 36.9 p -75.36 156.52 35.37 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.565 0.697 . . . . 0.0 111.813 -177.563 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.474 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.03 -41.27 58.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.719 -179.429 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -63.94 -27.51 69.19 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.183 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.544 ' HB2' ' O ' ' A' ' 159' ' ' THR . 83.1 m-20 -71.35 -51.59 23.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.731 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.735 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -66.9 -45.3 87.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.512 -179.884 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.423 ' CG ' ' N ' ' A' ' 165' ' ' ARG . 2.0 pttt -62.85 -50.34 71.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.385 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.537 ' HG3' ' O ' ' A' ' 162' ' ' ASP . 6.8 ppt_? -58.54 -40.01 81.81 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.895 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' TRP . . . . . 0.479 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 29.4 t90 -70.08 -48.55 57.27 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.85 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -51.99 -38.81 58.04 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.937 0.399 . . . . 0.0 110.68 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -76.48 -31.43 57.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.027 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 . . . . . 0 N--CA 1.455 -0.213 0 CA-C-O 120.926 0.393 . . . . 0.0 110.364 179.398 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.627 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 N--CA 1.454 -0.229 0 CA-C-O 121.061 0.457 . . . . 0.0 111.085 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -147.83 94.2 2.31 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.712 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.446 ' HG2' ' O ' ' A' ' 158' ' ' ILE . 14.8 ptp -47.41 166.04 0.2 Allowed Pre-proline 0 CA--C 1.532 0.252 0 CA-C-O 120.665 0.269 . . . . 0.0 110.991 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -66.21 -47.97 2.95 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.883 2.389 . . . . 0.0 113.069 -178.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.26 -48.38 71.25 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.666 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.584 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -71.16 -35.13 71.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.855 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 28.8 mtt180 -68.0 -45.76 73.16 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.155 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.3 tpt180 -59.12 -56.98 15.28 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.853 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.78 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -61.1 -41.49 96.77 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.624 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.729 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -56.47 -38.37 71.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.925 0.393 . . . . 0.0 110.907 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 9.6 ttmm -77.02 -30.73 55.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.799 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 51.5 tp10 -83.23 -16.18 47.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.185 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.565 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.1 mt -98.45 -28.92 13.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.915 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.72 35.35 8.48 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.672 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.487 HD13 ' CG2' ' A' ' 149' ' ' VAL . 1.5 tt -116.56 143.53 26.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.834 0.35 . . . . 0.0 111.241 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.504 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 1.9 t0 -76.07 101.47 5.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.917 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.944 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -49.4 -28.25 4.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.673 0.273 . . . . 0.0 111.075 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.4 p -65.96 -37.76 86.83 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.504 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -66.4 -21.24 66.22 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 177.573 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.564 HG21 HG13 ' A' ' 163' ' ' VAL . 20.4 t -89.69 86.45 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.696 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.2 ptmm? -50.67 93.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.934 0.397 . . . . 0.0 110.98 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.518 ' CA ' HG22 ' A' ' 158' ' ' ILE . . . -69.56 133.39 25.5 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.969 -0.634 . . . . 0.0 113.192 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.421 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.4 OUTLIER -118.46 15.56 13.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.963 0.411 . . . . 0.0 110.739 179.545 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.466 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -74.9 155.61 48.23 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.717 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -44.74 105.84 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.138 2.559 . . . . 0.0 112.824 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.35 20.16 21.04 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.209 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.627 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 74.81 22.07 77.57 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.674 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.469 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.1 m -85.91 125.08 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-N 117.08 0.44 . . . . 0.0 111.183 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.944 HD13 ' HB1' ' A' ' 146' ' ' ALA . 15.2 pt -64.69 110.31 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.292 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.533 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 67.0 p -75.16 156.58 35.76 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.611 0.719 . . . . 0.0 111.812 -177.387 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.471 HG13 HD23 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.97 -41.34 67.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.67 -179.656 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -63.78 -27.44 69.19 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.056 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.533 ' HB2' ' O ' ' A' ' 159' ' ' THR . 85.1 m-20 -71.49 -53.0 15.36 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.673 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.78 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -65.49 -45.23 93.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.364 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.41 ' CG ' ' N ' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -61.6 -49.1 77.96 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.11 -179.787 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.514 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 11.5 ptm180 -57.71 -40.4 79.45 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.755 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' TRP . . . . . 0.485 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 26.2 t90 -71.05 -48.83 50.49 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.747 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -51.55 -38.34 53.8 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.9 0.381 . . . . 0.0 110.592 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -77.21 -32.28 55.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.094 179.206 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 . . . . . 0 N--CA 1.456 -0.16 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.227 179.386 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.564 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 N--CA 1.454 -0.232 0 CA-C-O 120.895 0.379 . . . . 0.0 110.957 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.456 ' HB1' ' HG2' ' A' ' 136' ' ' ARG . . . -151.41 94.91 2.08 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.874 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.417 ' HB2' ' CD ' ' A' ' 133' ' ' PRO . 9.5 ptm -48.09 167.5 0.19 Allowed Pre-proline 0 CA--C 1.531 0.226 0 CA-C-O 120.61 0.243 . . . . 0.0 110.941 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.417 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.3 Cg_exo -65.9 -45.55 6.03 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.879 2.386 . . . . 0.0 112.864 -179.01 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.28 -53.1 58.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.397 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.577 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -69.55 -32.62 71.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.865 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.456 ' HG2' ' HB1' ' A' ' 131' ' ' ALA . 14.9 mmm-85 -67.82 -48.03 67.36 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.376 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 13.8 ttt85 -59.85 -55.39 34.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.083 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.732 HD12 ' N ' ' A' ' 139' ' ' ALA . 4.3 pp -61.67 -41.13 97.13 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.678 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.732 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -56.49 -40.88 75.69 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.954 0.407 . . . . 0.0 110.998 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.3 mtmm -75.9 -29.74 58.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.97 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -82.3 -19.83 38.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.163 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.621 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.4 mt -95.0 -28.82 14.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.87 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.75 37.91 7.75 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.484 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.538 HD13 ' CG2' ' A' ' 149' ' ' VAL . 0.6 OUTLIER -117.86 143.85 27.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.738 0.304 . . . . 0.0 111.201 -179.956 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.474 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.5 OUTLIER -76.11 100.97 5.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.013 179.415 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 1.003 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -51.85 -34.83 42.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.644 0.259 . . . . 0.0 111.252 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.16 -36.59 75.56 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.248 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.524 ' HE2' ' CD1' ' A' ' 166' ' ' TRP . 0.0 OUTLIER -67.61 -30.5 70.11 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 177.666 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.538 ' CG2' HD13 ' A' ' 144' ' ' ILE . 10.7 t -78.0 83.28 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.384 178.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.53 94.39 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.142 0.496 . . . . 0.0 111.115 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.537 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -68.18 137.38 31.4 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.695 -0.684 . . . . 0.0 113.36 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.54 13.21 13.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.767 0.318 . . . . 0.0 110.748 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.45 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -76.13 155.75 46.33 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.679 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_exo -43.26 106.41 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.133 2.555 . . . . 0.0 112.92 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.81 20.15 22.44 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.362 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.564 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 73.94 22.21 78.28 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.7 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.487 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -84.01 125.58 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 117.016 0.408 . . . . 0.0 111.031 -179.372 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 1.003 HD13 ' HB1' ' A' ' 146' ' ' ALA . 19.9 pt -64.57 111.35 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.293 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.54 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 38.6 p -75.33 156.43 35.53 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.559 0.695 . . . . 0.0 111.689 -177.523 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.477 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.76 -41.06 64.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.887 -179.4 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -64.58 -27.56 69.03 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.124 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.54 ' HB2' ' O ' ' A' ' 159' ' ' THR . 89.7 m-20 -69.47 -55.34 10.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.372 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.719 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -63.25 -44.19 99.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.683 -179.917 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 160' ' ' VAL . 11.8 mttp -64.0 -40.89 97.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.391 -179.27 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.545 ' HG3' ' N ' ' A' ' 166' ' ' TRP . 0.0 OUTLIER -64.24 -38.48 91.2 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.83 -179.801 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 166' ' ' TRP . . . . . 0.545 ' N ' ' HG3' ' A' ' 165' ' ' ARG . 62.8 t90 -73.88 -47.77 35.7 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.659 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -54.14 -37.08 64.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.919 0.39 . . . . 0.0 110.443 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.415 ' HG2' ' HA ' ' A' ' 165' ' ' ARG . 8.3 pt-20 -77.25 -33.34 56.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.074 179.174 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.165 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.443 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.587 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 N--CA 1.456 -0.162 0 CA-C-O 121.063 0.458 . . . . 0.0 110.788 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -153.99 95.52 1.86 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.841 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.696 ' HE2' ' HB3' ' A' ' 134' ' ' ALA . 16.7 ptm -47.22 168.02 0.15 Allowed Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.673 -0.239 . . . . 0.0 110.865 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.42 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 23.3 Cg_exo -65.41 -44.84 8.11 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.669 2.246 . . . . 0.0 112.922 -178.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.696 ' HB3' ' HE2' ' A' ' 132' ' ' MET . . . -54.32 -52.9 60.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.367 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.577 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -69.09 -33.2 73.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.052 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.36 -48.54 67.16 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.274 0.559 . . . . 0.0 110.322 179.338 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 18.2 ttp180 -58.63 -54.23 49.36 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.188 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.75 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -64.08 -41.64 97.24 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.804 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.744 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -58.08 -38.82 77.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.925 0.393 . . . . 0.0 110.985 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.97 -29.86 55.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.671 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -83.28 -17.92 40.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.124 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.649 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.4 mt -96.88 -28.89 14.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.872 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.69 37.7 7.88 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.455 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.51 HD13 ' CG2' ' A' ' 149' ' ' VAL . 1.4 tt -117.85 141.02 38.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.831 0.348 . . . . 0.0 111.288 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.52 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.6 OUTLIER -73.09 101.06 3.18 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.159 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 1.007 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -50.16 -28.63 7.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.307 -179.357 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.98 -37.04 84.96 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.52 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -65.09 -23.27 67.11 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 177.237 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.51 ' CG2' HD13 ' A' ' 144' ' ' ILE . 19.0 t -88.54 90.22 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.328 179.049 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.62 91.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.085 0.469 . . . . 0.0 111.125 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.567 ' HA3' HG22 ' A' ' 158' ' ' ILE . . . -69.36 125.88 18.46 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.934 -0.65 . . . . 0.0 113.047 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.439 ' OG1' ' O ' ' A' ' 152' ' ' THR . 0.1 OUTLIER -118.56 31.87 6.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.159 0.504 . . . . 0.0 110.292 179.708 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.45 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -91.47 156.76 24.25 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.679 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_exo -43.46 101.1 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 123.065 2.51 . . . . 0.0 113.022 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 99.83 25.77 8.91 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.315 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.587 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 70.16 22.1 77.28 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.602 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.47 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -86.27 126.46 40.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.017 -179.465 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 1.007 HD13 ' HB1' ' A' ' 146' ' ' ALA . 18.9 pt -66.06 112.01 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.34 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.518 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 47.4 p -75.33 156.43 35.54 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.485 0.66 . . . . 0.0 111.668 -177.636 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.509 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -56.98 -40.31 71.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.681 -179.721 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.539 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 2.1 tt0 -62.76 -27.73 69.49 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.863 179.287 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.518 ' HB2' ' O ' ' A' ' 159' ' ' THR . 91.2 m-20 -71.45 -53.9 12.44 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.342 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.75 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -67.08 -34.48 69.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.413 -179.479 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.434 ' HB3' ' O ' ' A' ' 160' ' ' VAL . 0.0 OUTLIER -69.28 -47.84 63.42 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-O 121.047 0.451 . . . . 0.0 110.892 -179.387 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.539 ' HG3' ' O ' ' A' ' 161' ' ' GLU . 15.1 mtp180 -60.39 -41.53 94.02 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.176 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' TRP . . . . . 0.478 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 13.4 t90 -70.67 -50.16 39.66 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.826 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -50.56 -38.69 46.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.002 0.429 . . . . 0.0 110.682 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -77.28 -32.54 55.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.555 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 . . . . . 0 C--N 1.333 -0.117 0 CA-C-O 120.933 0.397 . . . . 0.0 110.564 179.714 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.584 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 N--CA 1.454 -0.252 0 CA-C-O 120.964 0.411 . . . . 0.0 111.114 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.427 ' O ' ' HG3' ' A' ' 136' ' ' ARG . . . -151.23 95.79 2.21 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.693 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.41 ' HB2' ' CD ' ' A' ' 133' ' ' PRO . 16.0 ptp -47.02 167.74 0.15 Allowed Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.917 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.41 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.1 Cg_exo -65.86 -47.66 3.58 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.811 2.341 . . . . 0.0 112.746 -179.003 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.478 ' HB3' HG22 ' A' ' 160' ' ' VAL . . . -54.28 -50.38 67.41 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.347 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.572 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -69.9 -33.87 72.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.013 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.427 ' HG3' ' O ' ' A' ' 131' ' ' ALA . 0.2 OUTLIER -67.75 -47.71 68.46 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.324 0.583 . . . . 0.0 110.329 179.339 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.15 -54.42 47.2 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.217 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.746 HD12 ' N ' ' A' ' 139' ' ' ALA . 4.3 pp -63.59 -42.08 98.31 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.784 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.746 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -58.59 -37.25 75.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.865 0.364 . . . . 0.0 110.791 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -77.0 -29.75 55.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.781 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -81.97 -24.78 35.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.038 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.643 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.9 mt -90.99 -28.85 17.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.876 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.53 36.62 8.57 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.545 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.5 HD13 ' CG2' ' A' ' 149' ' ' VAL . 1.4 tt -114.87 142.37 27.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.875 0.369 . . . . 0.0 111.243 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.514 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 1.9 t0 -74.45 101.03 4.0 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.151 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 1.005 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -50.22 -28.44 7.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.703 0.287 . . . . 0.0 111.301 -179.396 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.54 -37.27 86.22 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.629 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.514 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -65.85 -22.63 66.55 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.514 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.534 HG21 HG13 ' A' ' 163' ' ' VAL . 20.1 t -88.41 86.48 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.589 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.5 tppt? -50.78 92.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.033 0.444 . . . . 0.0 110.976 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.521 ' HA3' ' HA ' ' A' ' 158' ' ' ILE . . . -70.01 140.52 32.91 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 115.876 -0.602 . . . . 0.0 113.122 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.46 9.46 12.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.677 0.275 . . . . 0.0 110.881 179.446 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.462 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -70.89 150.36 47.65 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.613 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.569 ' O ' HG13 ' A' ' 157' ' ' VAL . 94.3 Cg_exo -42.77 123.86 3.2 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.137 2.558 . . . . 0.0 113.081 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 87.82 -5.86 84.3 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.601 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.584 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 100.74 22.25 11.34 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.705 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.569 HG13 ' O ' ' A' ' 154' ' ' PRO . 1.2 m -86.09 127.13 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 CA-C-N 117.087 0.443 . . . . 0.0 111.198 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 1.005 HD13 ' HB1' ' A' ' 146' ' ' ALA . 14.5 pt -67.35 111.96 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 177.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.525 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 76.1 p -75.1 156.54 35.92 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.54 0.686 . . . . 0.0 111.536 -177.423 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.513 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -56.37 -40.72 68.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.873 -179.348 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.535 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 0.1 OUTLIER -62.81 -29.15 70.5 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.748 179.364 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 159' ' ' THR . 87.3 m-20 -69.36 -54.38 14.77 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.371 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.746 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -65.79 -34.62 71.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.0 -179.584 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.414 ' HB3' ' O ' ' A' ' 160' ' ' VAL . 0.2 OUTLIER -67.23 -47.67 70.12 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 121.014 0.435 . . . . 0.0 110.735 -179.64 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.535 ' HG3' ' O ' ' A' ' 161' ' ' GLU . 68.6 mtt-85 -59.26 -44.48 92.41 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.043 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' TRP . . . . . 0.484 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 10.4 t90 -70.06 -50.1 44.5 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.959 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -50.53 -38.43 44.66 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.937 0.399 . . . . 0.0 110.627 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -77.31 -31.69 54.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.503 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.902 0.382 . . . . 0.0 110.593 179.698 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.556 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 CA--C 1.522 -0.126 0 CA-C-O 120.882 0.373 . . . . 0.0 110.567 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -153.07 96.64 2.1 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.206 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.679 ' HB2' ' HD2' ' A' ' 133' ' ' PRO . 14.9 ptp -45.64 168.34 0.1 Allowed Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.546 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.679 ' HD2' ' HB2' ' A' ' 132' ' ' MET . 50.0 Cg_endo -71.44 -35.64 7.92 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.062 1.841 . . . . 0.0 112.363 -179.064 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.79 -52.45 65.01 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.759 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.639 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -70.43 -32.73 70.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.672 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 2.3 mmt85 -68.3 -46.11 71.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.079 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.63 -55.66 31.6 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.831 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.752 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -62.59 -42.08 99.34 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.641 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.737 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -57.99 -36.75 73.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.92 0.391 . . . . 0.0 110.778 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 3.8 mtmt -77.02 -30.76 55.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.555 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -82.93 -18.5 39.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.1 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.621 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.5 mt -96.66 -28.83 14.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.91 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.56 38.8 8.01 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.521 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.486 HD13 ' CG2' ' A' ' 149' ' ' VAL . 1.3 tt -118.43 141.72 36.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.696 0.284 . . . . 0.0 111.33 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.559 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.7 OUTLIER -73.18 100.97 3.21 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.181 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 1.006 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -50.45 -30.46 12.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.47 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 15.8 m -64.61 -36.16 83.34 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.559 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -66.05 -24.9 66.83 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 177.417 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.595 HG21 HG13 ' A' ' 163' ' ' VAL . 20.6 t -84.46 85.2 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.458 179.119 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.6 91.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.045 0.45 . . . . 0.0 111.124 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.575 ' HA3' ' HA ' ' A' ' 158' ' ' ILE . . . -70.03 143.09 37.3 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.808 -0.633 . . . . 0.0 113.415 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.56 9.1 12.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.714 0.292 . . . . 0.0 110.793 179.292 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.428 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -72.84 151.29 45.76 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.698 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.596 ' O ' HG13 ' A' ' 157' ' ' VAL . 86.5 Cg_exo -41.57 124.59 2.54 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.2 2.6 . . . . 0.0 113.197 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 86.48 -5.66 84.07 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.631 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.556 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 100.0 22.24 12.38 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.719 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.596 HG13 ' O ' ' A' ' 154' ' ' PRO . 1.2 m -84.47 128.84 38.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 117.096 0.448 . . . . 0.0 111.236 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 1.006 HD13 ' HB1' ' A' ' 146' ' ' ALA . 14.5 pt -68.61 111.75 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 177.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.53 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 72.2 p -75.0 156.45 36.25 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.495 0.664 . . . . 0.0 111.637 -177.672 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.494 HG13 HD23 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.55 -40.69 60.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.877 -179.467 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.533 ' O ' ' CG ' ' A' ' 165' ' ' ARG . 0.6 OUTLIER -63.6 -27.8 69.49 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.835 179.434 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.53 ' HB2' ' O ' ' A' ' 159' ' ' THR . 86.6 m-20 -70.99 -53.71 13.87 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.593 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.752 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -65.36 -37.87 81.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.155 -179.585 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.9 pttt -65.61 -47.35 75.97 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.977 0.418 . . . . 0.0 110.793 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.533 ' CG ' ' O ' ' A' ' 161' ' ' GLU . 4.9 mmt180 -59.61 -42.54 92.85 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.089 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' TRP . . . . . 0.477 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 13.1 t90 -69.83 -50.12 45.9 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.599 -0.441 . . . . 0.0 110.952 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -50.64 -38.84 48.41 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.843 0.354 . . . . 0.0 110.614 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -77.3 -31.61 54.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.37 179.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.953 0.406 . . . . 0.0 110.435 179.577 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.616 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 C--O 1.232 0.142 0 CA-C-O 121.109 0.48 . . . . 0.0 111.157 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.412 ' O ' ' HG3' ' A' ' 136' ' ' ARG . . . -151.36 95.28 2.13 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.801 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.439 ' HG2' ' O ' ' A' ' 158' ' ' ILE . 18.1 ptp -47.47 166.54 0.19 Allowed Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.985 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -66.24 -47.31 3.41 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.814 2.342 . . . . 0.0 112.978 -178.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.511 ' HB3' HG22 ' A' ' 160' ' ' VAL . . . -54.1 -50.62 66.43 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.456 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.555 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -69.29 -34.9 75.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.22 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.412 ' HG3' ' O ' ' A' ' 131' ' ' ALA . 0.2 OUTLIER -67.93 -48.49 65.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.156 0.503 . . . . 0.0 110.453 179.495 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.8 ttp-105 -57.53 -55.2 37.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.971 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.73 HD12 ' N ' ' A' ' 139' ' ' ALA . 4.4 pp -61.93 -41.14 97.62 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.486 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.73 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -57.9 -38.04 75.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.965 0.412 . . . . 0.0 110.868 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -76.85 -29.68 55.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.784 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -83.58 -20.08 34.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.033 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.635 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.4 mt -94.5 -28.95 15.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.851 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.98 35.67 8.88 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.645 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.538 HD13 ' CG2' ' A' ' 149' ' ' VAL . 1.9 tt -115.77 142.75 27.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.792 0.33 . . . . 0.0 111.3 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.566 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.9 OUTLIER -75.22 101.11 4.52 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.2 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 1.01 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -49.15 -29.04 4.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.672 0.272 . . . . 0.0 111.301 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.29 -37.43 85.43 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.639 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.566 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -65.78 -21.07 66.47 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 177.269 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.538 ' CG2' HD13 ' A' ' 144' ' ' ILE . 19.6 t -91.17 90.15 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.403 179.113 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.54 93.91 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.036 0.446 . . . . 0.0 111.015 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.601 ' HA3' HG22 ' A' ' 158' ' ' ILE . . . -72.79 126.34 10.64 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.815 -0.629 . . . . 0.0 113.035 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.447 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -118.49 31.62 6.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.153 0.501 . . . . 0.0 110.42 179.707 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.434 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -89.15 158.07 27.59 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.571 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -43.82 102.06 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.043 2.496 . . . . 0.0 112.945 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.78 24.58 10.6 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.382 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.616 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 71.71 22.17 78.74 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.748 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.48 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -87.03 126.99 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 CA-C-N 117.06 0.43 . . . . 0.0 111.328 -179.338 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 1.01 HD13 ' HB1' ' A' ' 146' ' ' ALA . 19.7 pt -65.77 111.9 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 177.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.516 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 70.2 p -75.07 156.32 36.23 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.612 0.72 . . . . 0.0 111.595 -177.41 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.519 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -56.24 -40.06 63.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.876 -179.561 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.587 ' O ' ' CG ' ' A' ' 165' ' ' ARG . 1.2 tp10 -65.28 -30.22 71.06 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.781 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.516 ' HB2' ' O ' ' A' ' 159' ' ' THR . 80.5 m-20 -65.7 -56.05 14.15 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.308 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.715 ' CB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -62.14 -41.39 91.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.165 -179.988 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -65.19 -41.72 94.28 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.555 -179.003 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.587 ' CG ' ' O ' ' A' ' 161' ' ' GLU . 0.1 OUTLIER -62.46 -44.59 96.04 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.661 179.916 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 166' ' ' TRP . . . . . 0.446 ' CZ2' ' HD2' ' A' ' 148' ' ' LYS . 18.5 t90 -68.32 -50.18 55.23 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.856 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -51.19 -39.4 56.39 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.887 0.375 . . . . 0.0 110.684 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.401 ' HG2' ' HA ' ' A' ' 165' ' ' ARG . 8.8 pt-20 -76.27 -29.13 57.32 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.277 179.287 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.401 ' OE1' ' CD1' ' A' ' 166' ' ' TRP . 0.5 OUTLIER . . . . . 0 N--CA 1.455 -0.217 0 CA-C-O 121.194 0.521 . . . . 0.0 110.048 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.554 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 N--CA 1.456 -0.145 0 CA-C-O 120.864 0.364 . . . . 0.0 110.72 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.441 ' O ' ' HG3' ' A' ' 136' ' ' ARG . . . -153.98 96.32 1.95 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.098 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.427 ' HB2' ' CD ' ' A' ' 133' ' ' PRO . 16.6 ptp -47.24 168.52 0.13 Allowed Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.725 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.427 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.7 Cg_exo -65.54 -47.6 3.99 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.687 2.258 . . . . 0.0 112.806 -178.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.451 ' HB3' HG22 ' A' ' 160' ' ' VAL . . . -54.18 -50.78 66.25 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.398 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.57 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -69.71 -34.52 74.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.084 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.441 ' HG3' ' O ' ' A' ' 131' ' ' ALA . 0.9 OUTLIER -66.48 -47.96 71.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.314 0.578 . . . . 0.0 110.296 179.367 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 11.4 ttt-85 -59.48 -55.24 37.16 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.259 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.763 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -62.58 -42.16 99.38 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.799 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.738 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -57.8 -36.68 72.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.912 0.387 . . . . 0.0 110.726 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.07 -30.76 55.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.705 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -84.45 -15.93 44.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.203 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.589 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.1 mt -98.12 -28.85 13.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.799 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.58 36.53 8.6 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.66 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.496 HD13 ' CG2' ' A' ' 149' ' ' VAL . 1.3 tt -118.31 140.25 42.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.739 0.304 . . . . 0.0 111.258 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.567 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.6 OUTLIER -71.47 100.93 2.32 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.293 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 1.006 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -50.02 -30.36 10.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.764 0.316 . . . . 0.0 111.441 -179.402 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 17.0 m -65.14 -36.69 85.05 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.567 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -65.76 -23.82 66.81 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.408 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.601 HG21 HG13 ' A' ' 163' ' ' VAL . 21.9 t -84.9 85.6 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.458 179.117 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 5.0 ttpp -50.66 90.61 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.971 0.415 . . . . 0.0 111.29 -179.458 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.56 ' HA3' ' HA ' ' A' ' 158' ' ' ILE . . . -69.91 139.76 31.83 Favored Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 115.777 -0.647 . . . . 0.0 113.383 -179.587 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.48 13.53 13.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.764 0.316 . . . . 0.0 110.638 179.366 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.424 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -76.08 153.45 43.42 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.799 -179.692 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.406 ' O ' HG13 ' A' ' 157' ' ' VAL . 92.6 Cg_exo -43.59 109.73 0.16 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.129 2.553 . . . . 0.0 112.873 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 96.59 16.47 36.68 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.294 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.554 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 76.2 22.21 74.11 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.72 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.424 HG22 ' HA3' ' A' ' 153' ' ' GLY . 1.3 m -83.59 126.67 40.16 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 CA-C-N 117.031 0.416 . . . . 0.0 111.025 -179.515 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 1.006 HD13 ' HB1' ' A' ' 146' ' ' ALA . 17.3 pt -66.55 111.51 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.195 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.513 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 70.6 p -75.14 156.39 36.0 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.4 0.619 . . . . 0.0 111.261 -177.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.494 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -56.18 -39.53 59.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.583 -179.664 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.624 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 27.3 tt0 -63.6 -27.91 69.56 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.814 179.174 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.513 ' HB2' ' O ' ' A' ' 159' ' ' THR . 88.7 m-20 -71.92 -52.59 16.48 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.711 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.763 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -67.68 -35.89 74.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.636 -179.378 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -69.52 -49.27 56.05 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.075 0.464 . . . . 0.0 110.832 -179.323 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.624 ' HG3' ' O ' ' A' ' 161' ' ' GLU . 42.3 mtp180 -61.58 -36.37 80.48 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.253 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' TRP . . . . . 0.491 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 24.4 t90 -71.21 -50.32 34.24 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.948 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -51.94 -40.74 61.28 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.944 0.402 . . . . 0.0 110.39 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.43 ' HG2' ' HA ' ' A' ' 165' ' ' ARG . 8.4 pt-20 -74.28 -31.12 62.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.09 179.01 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 . . . . . 0 N--CA 1.456 -0.128 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.301 179.517 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -87.28 -18.82 29.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.615 0.245 . . . . 0.0 111.188 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 7.0 mtp180 -96.47 31.97 2.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.856 0.36 . . . . 0.0 111.066 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -152.93 137.28 16.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.886 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.1 t -93.04 126.57 45.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.917 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.582 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -96.27 154.25 17.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.936 0.398 . . . . 0.0 110.874 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -152.27 95.5 2.06 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.866 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.463 ' HE3' ' CG2' ' A' ' 157' ' ' VAL . 18.0 ptp -47.43 166.95 0.18 Allowed Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.768 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.4 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.1 Cg_exo -65.91 -47.48 3.68 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.756 2.304 . . . . 0.0 112.857 -178.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.435 ' HB3' HG22 ' A' ' 160' ' ' VAL . . . -54.19 -51.04 65.65 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.522 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.569 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -69.68 -33.57 72.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.051 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -68.49 -48.12 65.29 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.251 0.548 . . . . 0.0 110.547 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -58.88 -54.72 43.89 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.851 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.734 HD12 ' N ' ' A' ' 139' ' ' ALA . 4.3 pp -62.62 -39.48 93.93 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.527 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.734 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -58.72 -39.62 81.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.886 0.374 . . . . 0.0 110.827 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.19 -29.76 57.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.783 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -81.85 -23.94 36.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.926 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.643 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.5 mt -90.56 -28.95 18.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.843 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.17 35.55 8.81 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.72 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.498 HD13 ' CG2' ' A' ' 149' ' ' VAL . 1.5 tt -116.39 142.32 30.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.781 0.324 . . . . 0.0 111.34 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.526 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 1.9 t0 -73.95 101.02 3.69 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.993 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -49.84 -28.03 5.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.277 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.73 -37.26 84.3 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.526 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -65.94 -21.14 66.41 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 177.349 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.498 ' CG2' HD13 ' A' ' 144' ' ' ILE . 21.7 t -89.93 88.12 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.455 179.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.7 ttmt -50.82 91.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.001 0.429 . . . . 0.0 111.206 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.502 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -70.18 133.76 24.48 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 121.015 -0.612 . . . . 0.0 113.198 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.421 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.4 OUTLIER -118.47 14.18 13.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.847 0.356 . . . . 0.0 110.766 179.563 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.458 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -73.18 155.34 50.43 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.709 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -44.37 106.5 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.097 2.531 . . . . 0.0 112.851 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.14 19.79 22.67 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.245 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.582 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 74.61 22.17 77.62 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.598 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.477 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.3 m -85.77 126.29 40.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 117.042 0.421 . . . . 0.0 111.067 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.993 HD13 ' HB1' ' A' ' 146' ' ' ALA . 19.1 pt -64.98 111.94 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.509 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 61.7 p -75.02 156.48 36.16 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.558 0.694 . . . . 0.0 111.657 -177.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.502 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -56.08 -39.91 61.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.715 -179.464 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.546 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 1.2 tp10 -65.82 -28.05 68.71 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.907 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.509 ' HB2' ' O ' ' A' ' 159' ' ' THR . 82.1 m-20 -68.49 -53.41 23.49 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.198 0.523 . . . . 0.0 110.225 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.726 ' CB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -65.64 -41.27 90.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.62 -179.729 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.55 -48.03 73.83 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 120.942 0.401 . . . . 0.0 111.465 -178.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.546 ' HG3' ' O ' ' A' ' 161' ' ' GLU . 21.6 mtt180 -60.63 -40.29 91.36 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.89 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.528 ' CZ3' HG21 ' A' ' 170' ' ' THR . 27.5 t90 -70.65 -48.99 52.13 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.661 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -50.52 -39.02 47.68 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.968 0.413 . . . . 0.0 110.486 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.401 ' HG2' ' HA ' ' A' ' 165' ' ' ARG . 13.0 pt-20 -77.33 -31.3 54.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.356 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -59.58 -30.06 68.39 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 120.953 0.406 . . . . 0.0 110.402 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.528 HG21 ' CZ3' ' A' ' 166' ' ' TRP . 19.0 p -75.36 -50.74 15.01 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.351 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -66.61 -31.17 71.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.388 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 7.3 mttm -61.04 -32.78 72.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.477 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.94 116.12 9.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.012 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -87.61 -66.98 0.86 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.893 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.274 -0.869 . . . . 0.0 111.131 179.968 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 112.439 -0.264 . . . . 0.0 112.439 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 9.0 p -87.83 -55.54 3.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.786 0.327 . . . . 0.0 110.912 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.14 -66.17 1.1 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.924 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 62.58 148.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.947 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.6 t -115.12 134.94 56.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.043 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.57 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -104.21 154.69 19.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.917 0.389 . . . . 0.0 110.846 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -153.37 95.49 1.93 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.897 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.438 ' HE2' ' HB3' ' A' ' 134' ' ' ALA . 19.9 ptm -48.14 167.42 0.19 Allowed Pre-proline 0 CA--C 1.532 0.26 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.793 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.408 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.8 Cg_exo -65.54 -45.56 6.7 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.807 2.338 . . . . 0.0 112.918 -178.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.438 ' HB3' ' HE2' ' A' ' 132' ' ' MET . . . -54.29 -52.71 60.59 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.423 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.562 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -69.25 -33.3 73.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.165 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 12.1 mtm180 -67.99 -49.17 63.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.524 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -58.29 -54.33 48.2 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.893 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.721 HD11 ' CB ' ' A' ' 163' ' ' VAL . 4.4 pp -63.05 -38.92 93.1 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.417 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.712 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -58.31 -39.93 80.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.722 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -76.62 -29.81 56.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.726 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 -81.95 -20.02 39.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.059 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.654 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.3 mt -94.88 -28.85 15.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.927 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.64 35.98 8.2 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.812 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.493 ' CD1' ' CE3' ' A' ' 166' ' ' TRP . 1.5 tt -118.22 141.34 37.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.832 0.348 . . . . 0.0 111.183 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.518 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.6 OUTLIER -72.93 101.05 3.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.805 179.229 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 1.016 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -49.73 -28.71 6.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.641 0.257 . . . . 0.0 111.321 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.78 -36.98 85.06 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.518 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -66.52 -22.48 66.17 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.453 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.526 HG21 HG13 ' A' ' 163' ' ' VAL . 21.8 t -86.87 84.77 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.646 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 6.4 ttmt -50.73 90.82 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.976 0.417 . . . . 0.0 111.14 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.512 ' HA3' ' HA ' ' A' ' 158' ' ' ILE . . . -66.5 142.94 43.29 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.809 -0.632 . . . . 0.0 113.295 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.45 0.9 11.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.688 0.28 . . . . 0.0 110.885 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.438 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -65.99 151.96 51.93 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.747 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.543 ' O ' HG13 ' A' ' 157' ' ' VAL . 84.8 Cg_exo -42.04 120.67 1.58 Allowed 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.234 2.622 . . . . 0.0 113.182 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 89.55 -0.68 80.73 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.715 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.57 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 94.53 22.24 24.65 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.694 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.543 HG13 ' O ' ' A' ' 154' ' ' PRO . 1.2 m -83.49 126.38 40.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 117.017 0.408 . . . . 0.0 111.107 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 1.016 HD13 ' HB1' ' A' ' 146' ' ' ALA . 19.0 pt -65.89 111.82 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.187 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.518 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 44.0 p -75.3 156.53 35.5 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.575 0.702 . . . . 0.0 111.816 -177.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.504 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -56.01 -40.16 61.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.805 -179.431 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.49 ' O ' ' CG ' ' A' ' 165' ' ' ARG . 5.6 mt-10 -64.89 -27.61 68.98 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.834 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.518 ' HB2' ' O ' ' A' ' 159' ' ' THR . 88.1 m-20 -70.2 -53.97 14.85 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.522 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.721 ' CB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -65.16 -42.71 94.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.794 -179.37 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.9 mmtt -66.38 -52.11 50.16 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.953 0.406 . . . . 0.0 111.486 -178.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.49 ' CG ' ' O ' ' A' ' 161' ' ' GLU . 27.1 mtp180 -59.24 -35.88 74.47 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.035 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.532 ' O ' HG23 ' A' ' 170' ' ' THR . 32.9 t90 -70.66 -50.05 40.77 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.791 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -50.66 -41.26 55.29 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-O 120.97 0.414 . . . . 0.0 110.411 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.422 ' HG2' ' HA ' ' A' ' 165' ' ' ARG . 7.6 pt-20 -74.04 -31.88 63.08 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.048 179.129 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -61.45 -29.46 69.97 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.278 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.532 HG23 ' O ' ' A' ' 166' ' ' TRP . 3.6 p -71.5 -52.24 19.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.263 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -70.09 -26.2 63.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.594 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -69.79 -36.33 75.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.768 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -74.45 135.19 42.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.145 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 6.6 t -107.38 -31.52 8.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.861 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.109 179.991 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.214 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.27 -53.02 2.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.801 0.334 . . . . 0.0 110.844 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 27.8 mtt180 -126.57 -64.58 1.02 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.857 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -66.64 -178.44 0.71 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.884 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.1 t -83.06 145.26 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.936 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.532 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -85.91 159.06 19.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.846 0.355 . . . . 0.0 110.824 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -154.88 96.22 1.83 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.134 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.442 ' HE3' ' CG2' ' A' ' 157' ' ' VAL . 19.0 ptp -47.81 167.59 0.18 Allowed Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.57 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.405 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.4 Cg_exo -65.49 -47.12 4.52 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.778 2.319 . . . . 0.0 112.809 -179.058 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.465 ' HB3' HG22 ' A' ' 160' ' ' VAL . . . -54.27 -51.48 64.41 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.475 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.546 ' HA ' HD21 ' A' ' 138' ' ' LEU . . . -69.23 -33.36 73.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.277 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.69 -48.75 63.1 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.296 0.57 . . . . 0.0 110.371 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -57.77 -54.2 49.57 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.98 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.729 HD12 ' N ' ' A' ' 139' ' ' ALA . 4.3 pp -63.49 -41.23 98.57 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.553 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.729 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -58.47 -37.64 75.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.743 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.92 -29.81 55.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.754 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -83.36 -20.52 34.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.997 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.648 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.5 mt -94.22 -28.92 15.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.863 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.75 38.68 7.96 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.543 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.511 HD13 ' CG2' ' A' ' 149' ' ' VAL . 1.3 tt -118.4 140.39 42.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.742 0.306 . . . . 0.0 111.305 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.531 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 1.5 t0 -71.97 100.97 2.58 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.998 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -50.6 -28.84 9.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.681 0.277 . . . . 0.0 111.271 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.69 -36.97 85.15 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 178.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.531 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -64.97 -23.88 67.35 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 177.283 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.511 ' CG2' HD13 ' A' ' 144' ' ' ILE . 21.2 t -87.44 89.15 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.324 179.078 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.64 90.93 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.937 0.399 . . . . 0.0 111.14 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.512 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -68.55 130.03 25.63 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.837 -0.696 . . . . 0.0 113.104 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.479 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.1 OUTLIER -118.5 24.13 11.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.136 0.493 . . . . 0.0 110.495 179.658 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.429 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -84.63 157.16 32.44 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.758 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_exo -43.37 102.89 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.227 2.618 . . . . 0.0 112.993 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 99.3 23.52 11.18 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.212 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.532 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 71.23 22.18 78.52 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.601 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.442 ' CG2' ' HE3' ' A' ' 132' ' ' MET . 1.2 m -85.43 128.35 39.21 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.957 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.998 HD13 ' HB1' ' A' ' 146' ' ' ALA . 18.6 pt -66.65 112.11 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.079 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.504 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 55.7 p -75.14 156.35 36.05 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.532 0.682 . . . . 0.0 111.533 -177.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.521 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -56.41 -39.46 61.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.706 -179.582 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.565 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 6.1 mm-40 -65.67 -27.79 68.62 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.944 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.504 ' HB2' ' O ' ' A' ' 159' ' ' THR . 83.0 m-20 -69.31 -54.6 13.75 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.223 0.535 . . . . 0.0 110.322 179.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.715 ' CB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -64.09 -40.83 90.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.648 -179.612 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.61 -47.57 78.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.9 0.381 . . . . 0.0 111.445 -178.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.565 ' HG3' ' O ' ' A' ' 161' ' ' GLU . 65.2 mtt-85 -60.83 -42.0 96.87 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.05 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.489 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 18.1 t90 -67.98 -50.18 57.23 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.915 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -50.94 -41.1 58.75 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.919 0.39 . . . . 0.0 110.725 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.416 ' HG2' ' HA ' ' A' ' 165' ' ' ARG . 11.9 pt-20 -74.9 -29.47 61.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.321 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.406 ' OE1' ' CD1' ' A' ' 166' ' ' TRP . 0.4 OUTLIER -61.16 -43.62 98.6 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 121.224 0.535 . . . . 0.0 110.096 179.41 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.466 HG23 ' O ' ' A' ' 166' ' ' TRP . 8.2 p -59.47 -52.24 66.43 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.404 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -66.65 -21.64 66.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.365 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.1 -36.65 64.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.811 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.04 134.63 35.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.17 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 64.8 p -122.9 157.1 33.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.891 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.232 -0.89 . . . . 0.0 111.122 -179.969 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.183 0 N-CA-C 112.537 -0.225 . . . . 0.0 112.537 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 70.0 m -118.76 145.32 45.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.821 0.343 . . . . 0.0 110.949 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -69.29 -38.62 78.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.962 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -158.83 154.51 26.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.935 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.3 t -101.95 137.76 28.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.9 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.539 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -96.34 155.2 16.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.892 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.5 ' HB1' ' HG2' ' A' ' 136' ' ' ARG . . . -152.12 95.43 2.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.965 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.415 ' HG2' ' O ' ' A' ' 158' ' ' ILE . 14.0 ptp -46.91 167.74 0.15 Allowed Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.863 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.414 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.2 Cg_exo -65.76 -47.59 3.75 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.799 2.333 . . . . 0.0 112.822 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.462 ' HB3' HG22 ' A' ' 160' ' ' VAL . . . -54.3 -51.61 64.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.372 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.563 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -69.48 -34.21 74.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.911 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.5 ' HG2' ' HB1' ' A' ' 131' ' ' ALA . 9.0 mmm180 -66.53 -48.53 69.42 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.501 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.41 ' CZ ' ' HB2' ' A' ' 137' ' ' ARG . 26.4 ttm105 -59.93 -55.38 34.8 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.154 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.729 HD12 ' N ' ' A' ' 139' ' ' ALA . 4.3 pp -61.54 -41.03 96.75 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.716 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.729 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -58.11 -37.95 75.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.994 0.426 . . . . 0.0 110.809 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.3 tptt -76.48 -29.81 57.02 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.825 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -84.32 -19.38 33.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.12 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.614 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.4 mt -94.49 -28.89 15.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.719 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.72 38.28 8.19 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.505 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.481 ' CD1' ' CE3' ' A' ' 166' ' ' TRP . 1.4 tt -118.31 141.6 36.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.744 0.307 . . . . 0.0 111.248 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.529 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 1.9 t0 -72.94 101.02 3.08 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 1.004 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -50.45 -28.85 9.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.735 0.302 . . . . 0.0 111.182 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.92 -36.93 85.96 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 178.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.529 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -66.59 -23.37 66.18 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 177.666 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.536 HG21 HG13 ' A' ' 163' ' ' VAL . 20.1 t -86.7 84.15 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.625 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.74 91.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.911 0.386 . . . . 0.0 111.113 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.571 ' HA3' ' HA ' ' A' ' 158' ' ' ILE . . . -69.17 141.55 36.0 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.098 -0.572 . . . . 0.0 113.488 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.61 11.06 12.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.743 0.306 . . . . 0.0 110.786 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.448 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -73.4 152.21 46.17 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.842 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.417 ' O ' HG13 ' A' ' 157' ' ' VAL . 90.8 Cg_exo -43.83 112.29 0.31 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.092 2.528 . . . . 0.0 112.832 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 95.54 13.12 52.32 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.374 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.539 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 79.62 22.11 65.1 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.776 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.457 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.3 m -83.98 126.92 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 117.122 0.461 . . . . 0.0 111.06 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 1.004 HD13 ' HB1' ' A' ' 146' ' ' ALA . 17.7 pt -66.94 111.79 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.529 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 75.3 p -75.07 156.46 36.07 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.505 0.669 . . . . 0.0 111.735 -177.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.462 HG22 ' HB3' ' A' ' 134' ' ' ALA . 0.2 OUTLIER -55.58 -40.71 60.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.697 -179.56 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -64.29 -27.51 69.09 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.114 179.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.529 ' HB2' ' O ' ' A' ' 159' ' ' THR . 82.6 m-20 -71.45 -53.27 14.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.835 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.726 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -64.43 -45.77 94.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.687 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -61.47 -48.64 80.21 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.043 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.469 ' HG3' ' N ' ' A' ' 166' ' ' TRP . 0.8 OUTLIER -57.71 -39.75 77.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.903 -179.718 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.677 ' O ' HG23 ' A' ' 170' ' ' THR . 23.9 t90 -72.39 -48.36 42.14 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.754 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -52.21 -38.37 57.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.975 0.417 . . . . 0.0 110.445 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -77.3 -33.15 55.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.243 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -63.49 -27.61 69.39 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.577 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.677 HG23 ' O ' ' A' ' 166' ' ' TRP . 18.0 p -74.06 -52.06 13.84 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.555 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -73.14 -26.75 61.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.696 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -66.06 -34.88 79.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.79 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -67.51 -62.78 1.25 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.088 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 44.2 p -63.69 142.15 58.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.949 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.226 -0.892 . . . . 0.0 111.056 -179.989 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.193 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 11.4 p -99.14 31.76 2.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.811 0.338 . . . . 0.0 110.87 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.67 82.25 1.46 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.854 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -150.22 138.46 20.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.889 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.1 t -96.94 117.11 40.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.861 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.612 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -96.82 151.45 19.65 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.022 0.439 . . . . 0.0 111.098 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -153.83 94.33 1.75 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.645 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.48 ' HE2' ' HB3' ' A' ' 134' ' ' ALA . 20.2 ptm -47.03 166.64 0.18 Allowed Pre-proline 0 CA--C 1.533 0.306 0 CA-C-O 120.582 0.23 . . . . 0.0 110.936 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -65.62 -44.85 7.64 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.868 2.379 . . . . 0.0 112.826 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.48 ' HB3' ' HE2' ' A' ' 132' ' ' MET . . . -54.21 -53.62 51.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.372 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.571 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -68.29 -33.88 75.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.024 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.65 -49.88 64.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.587 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -58.28 -55.58 33.16 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.133 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.721 HD12 ' N ' ' A' ' 139' ' ' ALA . 4.4 pp -60.98 -40.67 94.33 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.615 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.721 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -57.55 -37.71 73.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.853 0.358 . . . . 0.0 110.66 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.8 tptp -76.9 -30.07 56.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.771 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -83.32 -19.92 35.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.061 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.613 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.5 mt -94.5 -28.89 15.21 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.864 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.53 37.76 7.95 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.607 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.488 HD13 ' CG2' ' A' ' 149' ' ' VAL . 1.4 tt -118.36 143.07 30.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.809 0.337 . . . . 0.0 111.181 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.539 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.9 OUTLIER -74.63 101.12 4.14 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.372 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.975 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -49.78 -28.81 6.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.689 0.28 . . . . 0.0 111.099 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.42 -37.65 87.56 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.539 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -66.25 -22.23 66.31 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 177.578 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.488 ' CG2' HD13 ' A' ' 144' ' ' ILE . 21.3 t -88.37 85.58 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.623 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.5 ptmt -50.7 92.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.986 0.422 . . . . 0.0 111.149 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.512 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -68.02 136.29 30.71 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.064 -0.589 . . . . 0.0 113.339 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.52 10.71 12.7 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.738 0.304 . . . . 0.0 110.819 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.46 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -72.29 154.68 50.82 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.771 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -43.99 107.65 0.1 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.111 2.541 . . . . 0.0 112.886 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.51 18.38 28.36 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.364 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.612 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 75.58 22.27 75.54 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.634 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.486 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -84.6 124.21 39.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 117.069 0.434 . . . . 0.0 111.063 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.975 HD13 ' HB1' ' A' ' 146' ' ' ALA . 19.6 pt -63.59 111.59 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.539 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 48.9 p -75.4 156.53 35.28 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.555 0.693 . . . . 0.0 111.904 -177.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.479 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.54 -41.48 63.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.78 -179.524 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -64.26 -27.44 69.05 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.125 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.539 ' HB2' ' O ' ' A' ' 159' ' ' THR . 84.1 m-20 -70.61 -52.58 20.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.512 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.719 ' CB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -65.98 -45.77 90.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.579 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 10.5 mttm -62.71 -50.94 69.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.616 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.535 ' HG3' ' O ' ' A' ' 162' ' ' ASP . 1.8 ppt_? -57.83 -39.07 76.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.607 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.556 ' O ' HG23 ' A' ' 170' ' ' THR . 26.6 t90 -71.49 -48.42 49.18 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.59 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -51.66 -38.3 54.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.52 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -77.24 -32.81 56.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.158 179.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -59.61 -28.55 67.29 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.983 0.421 . . . . 0.0 110.35 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.556 HG23 ' O ' ' A' ' 166' ' ' TRP . 4.0 p -75.16 -51.44 13.39 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.352 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -65.4 -30.03 70.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.517 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -63.29 -30.87 71.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.654 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -69.46 -55.83 9.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.171 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 8.8 t -59.86 -28.64 67.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.031 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.254 -0.879 . . . . 0.0 111.138 179.994 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.184 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 19.4 m -160.15 177.0 11.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.798 0.333 . . . . 0.0 110.891 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 5.9 ttt85 -147.58 89.56 1.78 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.916 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -83.31 172.04 12.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.939 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.2 t -83.75 129.3 37.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.976 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.579 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -91.61 153.4 19.74 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.977 0.418 . . . . 0.0 111.019 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -152.52 95.27 2.0 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.862 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 9.8 ptp -47.44 166.93 0.18 Allowed Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.842 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -65.67 -46.28 5.43 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.859 2.373 . . . . 0.0 112.943 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.44 ' HB3' HG22 ' A' ' 160' ' ' VAL . . . -54.28 -52.42 61.48 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.401 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.566 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -68.34 -34.19 75.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.124 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.74 -49.34 63.06 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.252 0.548 . . . . 0.0 110.585 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 7.5 tpt180 -57.37 -55.55 33.3 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.838 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.722 HD12 ' N ' ' A' ' 139' ' ' ALA . 4.3 pp -62.33 -41.14 98.32 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.562 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.722 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -56.45 -39.72 73.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.974 0.416 . . . . 0.0 110.956 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.65 -29.86 56.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.75 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -82.41 -19.04 39.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.083 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.603 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.4 mt -95.64 -28.86 14.61 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.866 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.05 37.08 7.95 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.661 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.49 HD13 ' CG2' ' A' ' 149' ' ' VAL . 1.8 tt -118.34 143.02 30.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.803 0.335 . . . . 0.0 111.232 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.565 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 1.9 t0 -74.47 101.1 4.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.803 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 1.013 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -49.6 -28.95 6.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.595 0.236 . . . . 0.0 111.294 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.08 -36.98 84.63 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.565 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -66.68 -21.44 66.09 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 177.46 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.504 HG21 HG13 ' A' ' 163' ' ' VAL . 21.4 t -89.16 86.02 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.497 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.71 93.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.965 0.412 . . . . 0.0 111.124 -179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.519 ' HA3' ' HA ' ' A' ' 158' ' ' ILE . . . -70.82 139.2 29.56 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 121.001 -0.619 . . . . 0.0 113.419 -179.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -118.56 10.38 12.56 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.721 0.296 . . . . 0.0 110.846 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.475 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -71.19 152.69 50.2 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.746 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.402 ' O ' HG13 ' A' ' 157' ' ' VAL . 82.4 Cg_exo -44.68 111.04 0.26 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.059 2.506 . . . . 0.0 112.722 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 96.43 14.22 45.25 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.289 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.579 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 79.41 22.11 65.6 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.674 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.475 HG22 ' HA3' ' A' ' 153' ' ' GLY . 1.2 m -85.22 125.66 40.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 117.121 0.461 . . . . 0.0 110.961 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 1.013 HD13 ' HB1' ' A' ' 146' ' ' ALA . 18.8 pt -65.33 111.74 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.222 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.532 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 55.0 p -75.15 156.43 35.94 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.523 0.678 . . . . 0.0 111.723 -177.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.467 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.33 -40.78 58.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.787 -179.503 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.416 ' O ' ' HG2' ' A' ' 165' ' ' ARG . 55.7 tt0 -64.62 -27.47 68.96 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.171 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.532 ' HB2' ' O ' ' A' ' 159' ' ' THR . 72.4 m-20 -70.74 -53.6 14.94 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.749 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.709 ' CB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -63.62 -48.15 88.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.406 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 16.9 mttp -60.24 -46.34 90.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.561 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.516 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 24.8 ptt180 -60.1 -39.23 85.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.779 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.59 ' O ' HG23 ' A' ' 170' ' ' THR . 30.2 t90 -72.73 -48.15 41.03 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.843 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -52.47 -37.78 57.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.997 0.427 . . . . 0.0 110.476 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -77.26 -33.66 55.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.056 179.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.04 -31.35 69.89 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.271 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.59 HG23 ' O ' ' A' ' 166' ' ' TRP . 11.9 p -70.07 -52.04 27.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.183 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.37 -26.5 64.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.685 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.28 -32.15 71.13 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.733 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -54.39 -29.02 47.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.302 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 9.6 t -112.34 31.84 6.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.825 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.24 -0.886 . . . . 0.0 111.105 179.951 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.184 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 33.1 t -92.49 140.61 29.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.833 0.349 . . . . 0.0 110.894 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -126.37 -68.29 0.82 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.779 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.51 146.29 52.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.809 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.9 t -85.55 111.22 20.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.964 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.583 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -103.08 151.28 22.73 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.11 0.481 . . . . 0.0 111.052 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.438 ' HB1' ' HG2' ' A' ' 136' ' ' ARG . . . -151.54 94.71 2.04 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.688 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.409 ' HE2' ' HB3' ' A' ' 134' ' ' ALA . 22.4 ptm -48.63 166.66 0.22 Allowed Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.005 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.402 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 21.7 Cg_exo -66.19 -45.25 5.84 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.878 2.385 . . . . 0.0 112.818 -178.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.409 ' HB3' ' HE2' ' A' ' 132' ' ' MET . . . -54.32 -52.2 62.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.268 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.533 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -70.28 -32.45 70.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.875 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.438 ' HG2' ' HB1' ' A' ' 131' ' ' ALA . 0.1 OUTLIER -68.02 -47.94 67.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.256 179.475 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -59.97 -54.81 41.67 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.033 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.725 HD11 ' CB ' ' A' ' 163' ' ' VAL . 4.3 pp -62.52 -40.8 97.93 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.589 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.712 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -57.08 -38.81 73.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.892 0.377 . . . . 0.0 110.683 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.97 -29.81 55.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.827 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -82.4 -21.21 35.91 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.069 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.622 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.6 mt -94.02 -28.91 15.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.925 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.75 38.39 8.11 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.461 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.521 HD13 ' CG2' ' A' ' 149' ' ' VAL . 0.6 OUTLIER -116.6 143.21 27.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.865 0.365 . . . . 0.0 111.19 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.468 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.9 OUTLIER -74.84 100.88 4.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.469 . . . . 0.0 109.852 179.185 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 1.035 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -53.27 -33.81 54.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.665 0.269 . . . . 0.0 111.109 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.9 -36.69 75.12 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.051 0.453 . . . . 0.0 109.805 179.058 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.512 ' HE2' ' CE2' ' A' ' 166' ' ' TRP . 0.0 OUTLIER -67.92 -30.45 69.78 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.846 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.521 ' CG2' HD13 ' A' ' 144' ' ' ILE . 8.1 t -78.2 81.79 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.379 179.051 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.47 ' O ' ' HG3' ' A' ' 150' ' ' LYS . 2.0 ptpp? -50.51 93.25 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.266 0.555 . . . . 0.0 111.105 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.552 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -63.1 139.04 44.18 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.605 -0.725 . . . . 0.0 113.492 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.55 13.66 13.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.752 0.311 . . . . 0.0 110.608 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.433 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -80.14 154.97 37.76 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.736 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_exo -43.23 108.79 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.161 2.574 . . . . 0.0 112.972 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 96.95 16.94 34.06 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.377 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.583 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 76.17 22.33 73.91 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.634 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.502 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -83.0 125.6 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.173 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 1.035 HD13 ' HB1' ' A' ' 146' ' ' ALA . 18.2 pt -64.4 111.23 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.292 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.493 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 25.7 p -75.29 156.32 35.75 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.639 0.733 . . . . 0.0 111.792 -177.436 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.537 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -56.59 -39.82 65.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.649 -179.643 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.576 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 0.4 OUTLIER -63.69 -29.75 70.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.921 179.413 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.493 ' HB2' ' O ' ' A' ' 159' ' ' THR . 91.8 m-20 -68.97 -54.07 17.31 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.9 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.725 ' CB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -63.98 -41.91 94.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.766 -178.762 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.533 ' CG ' ' HA ' ' A' ' 161' ' ' GLU . 0.0 OUTLIER -64.84 -48.83 72.92 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.024 0.44 . . . . 0.0 111.418 -178.64 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.576 ' HG3' ' O ' ' A' ' 161' ' ' GLU . 8.5 mtm105 -57.62 -43.33 84.72 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.981 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.623 ' CZ3' HG21 ' A' ' 170' ' ' THR . 61.9 t90 -68.09 -49.86 58.57 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.606 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -50.58 -39.55 49.93 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.856 0.36 . . . . 0.0 110.746 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.429 ' HG2' ' HA ' ' A' ' 165' ' ' ARG . 11.1 pt-20 -77.17 -29.18 54.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.485 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.27 -41.95 94.37 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.208 0.528 . . . . 0.0 109.985 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.623 HG21 ' CZ3' ' A' ' 166' ' ' TRP . 6.6 p -63.08 -52.2 63.63 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.413 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -70.91 -17.32 62.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.428 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -77.05 -32.45 56.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.608 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -63.72 -48.8 75.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.236 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 7.5 p 56.8 31.34 19.34 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.968 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.257 -0.878 . . . . 0.0 111.095 -179.977 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.185 0 N-CA-C 112.565 -0.214 . . . . 0.0 112.565 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -169.06 138.52 2.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.78 0.324 . . . . 0.0 110.946 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -119.31 97.09 5.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.803 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.33 168.9 10.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.854 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.2 t -79.99 131.52 33.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.992 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.575 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -95.86 154.67 17.11 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.039 0.447 . . . . 0.0 110.973 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.422 ' HB1' ' HG2' ' A' ' 136' ' ' ARG . . . -155.11 95.21 1.71 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.801 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.667 ' HE2' ' HB3' ' A' ' 134' ' ' ALA . 19.2 ptm -47.35 168.65 0.13 Allowed Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.873 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.435 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.0 Cg_exo -66.07 -45.34 5.98 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.772 2.315 . . . . 0.0 112.949 -178.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.667 ' HB3' ' HE2' ' A' ' 132' ' ' MET . . . -54.24 -53.35 54.83 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.442 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.553 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -69.63 -32.03 70.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.823 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.422 ' HG2' ' HB1' ' A' ' 131' ' ' ALA . 0.0 OUTLIER -67.41 -48.74 66.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.434 179.371 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -59.97 -55.13 37.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.042 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.721 HD12 ' N ' ' A' ' 139' ' ' ALA . 4.3 pp -62.52 -41.11 98.63 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.83 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.721 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -55.99 -41.76 75.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.863 0.363 . . . . 0.0 110.939 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -75.42 -29.84 59.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.9 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -80.9 -22.74 39.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.075 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.607 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.6 mt -92.09 -28.91 16.83 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.879 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.46 37.48 8.12 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.439 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.496 HD13 ' CG2' ' A' ' 149' ' ' VAL . 1.4 tt -117.85 141.53 36.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.828 0.347 . . . . 0.0 111.188 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.513 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 1.2 t0 -72.94 101.05 3.1 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.978 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -49.64 -28.59 6.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.688 0.28 . . . . 0.0 111.241 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.9 -37.27 85.67 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.513 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -65.8 -22.64 66.58 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 177.399 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.515 HG21 HG13 ' A' ' 163' ' ' VAL . 20.7 t -88.22 87.94 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.404 179.098 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.75 91.02 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.015 0.436 . . . . 0.0 111.267 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.507 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -68.51 132.86 27.54 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.904 -0.665 . . . . 0.0 113.093 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.433 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.2 OUTLIER -118.49 16.75 13.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.952 0.406 . . . . 0.0 110.812 179.624 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.459 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -77.67 154.32 41.69 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.655 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -43.93 107.56 0.1 OUTLIER 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.087 2.524 . . . . 0.0 112.813 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.75 18.76 26.68 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.236 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.575 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 74.94 22.18 77.26 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.671 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.479 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -84.76 125.47 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 CA-C-N 117.027 0.414 . . . . 0.0 110.992 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.978 HD13 ' HB1' ' A' ' 146' ' ' ALA . 19.1 pt -65.4 112.34 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.525 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 60.8 p -75.33 156.5 35.46 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.533 0.682 . . . . 0.0 111.891 -177.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.496 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.91 -40.55 63.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.743 -179.492 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.407 ' O ' ' HG2' ' A' ' 165' ' ' ARG . 20.2 mm-40 -65.21 -27.43 68.67 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.199 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 159' ' ' THR . 81.6 m-20 -70.43 -53.98 14.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.608 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.712 ' CB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -63.39 -47.71 90.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.412 179.928 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 10.7 mttm -60.41 -48.66 80.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.502 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.512 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 10.4 ptt180 -57.8 -39.98 78.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.882 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.658 ' O ' HG23 ' A' ' 170' ' ' THR . 23.7 t90 -72.04 -48.14 46.66 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.778 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -52.19 -38.4 57.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.947 0.404 . . . . 0.0 110.58 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -77.24 -33.53 56.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.262 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -61.73 -29.53 70.17 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.974 0.416 . . . . 0.0 110.443 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.658 HG23 ' O ' ' A' ' 166' ' ' TRP . 12.0 p -72.07 -52.08 18.53 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.423 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.59 -22.92 61.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.739 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 9.9 mttp -73.65 -38.76 64.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.919 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -62.89 -43.22 99.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.14 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 32.4 p -59.27 175.11 0.34 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.93 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.195 -0.907 . . . . 0.0 111.072 179.992 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 112.441 -0.264 . . . . 0.0 112.441 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 12.3 p -110.58 77.99 1.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.856 0.36 . . . . 0.0 110.796 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.5 mtm105 -141.9 103.31 4.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.863 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -130.33 -45.12 1.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.922 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.1 t -90.74 111.71 23.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.061 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.581 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -92.2 151.22 20.47 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.937 0.399 . . . . 0.0 110.789 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.43 ' HB1' ' HG2' ' A' ' 136' ' ' ARG . . . -151.13 94.98 2.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.857 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.417 ' HB2' ' CD ' ' A' ' 133' ' ' PRO . 9.5 ptm -46.96 167.73 0.15 Allowed Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.98 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.417 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.8 Cg_exo -65.49 -45.58 6.77 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.794 2.329 . . . . 0.0 112.885 -178.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.2 -53.48 52.91 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.365 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.593 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -68.99 -32.13 71.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.919 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.43 ' HG2' ' HB1' ' A' ' 131' ' ' ALA . 0.0 OUTLIER -68.36 -48.69 64.13 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.486 179.418 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.2 ttp85 -59.04 -55.74 31.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.073 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.732 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.3 pp -61.36 -41.04 96.43 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.647 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.717 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -57.4 -38.15 73.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.864 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.98 -29.78 55.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.767 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -83.83 -18.15 38.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.981 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.613 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.3 mt -96.14 -28.81 14.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.828 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.36 37.66 8.09 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.555 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.482 ' CD1' ' CE3' ' A' ' 166' ' ' TRP . 1.4 tt -118.45 142.33 33.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.717 0.294 . . . . 0.0 111.28 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.525 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.3 OUTLIER -73.96 101.09 3.72 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.899 179.282 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 1.002 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -49.91 -29.0 7.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.64 0.257 . . . . 0.0 111.204 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 32.3 t -65.03 -37.09 86.46 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.525 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -66.73 -22.91 66.05 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 177.679 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.555 HG21 HG13 ' A' ' 163' ' ' VAL . 20.3 t -86.9 84.03 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.72 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.76 92.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.012 0.434 . . . . 0.0 111.066 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.537 ' HA3' ' HA ' ' A' ' 158' ' ' ILE . . . -68.59 142.1 38.02 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.795 -0.639 . . . . 0.0 113.571 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.6 10.78 12.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.73 0.3 . . . . 0.0 110.779 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.47 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -75.19 151.92 42.8 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.771 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.453 ' O ' HG13 ' A' ' 157' ' ' VAL . 93.5 Cg_exo -43.86 114.74 0.57 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.057 2.505 . . . . 0.0 112.928 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 94.03 9.06 59.86 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.542 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.581 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 84.36 22.26 54.64 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.825 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.47 HG22 ' HA3' ' A' ' 153' ' ' GLY . 1.2 m -84.3 126.08 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 CA-C-N 117.055 0.428 . . . . 0.0 111.084 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 1.002 HD13 ' HB1' ' A' ' 146' ' ' ALA . 16.9 pt -66.57 111.49 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.21 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.535 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 45.6 p -75.33 156.53 35.45 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.584 0.706 . . . . 0.0 111.773 -177.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.472 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.31 -40.76 58.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.895 -179.483 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -64.22 -27.41 69.04 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.139 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.535 ' HB2' ' O ' ' A' ' 159' ' ' THR . 77.2 m-20 -71.47 -53.02 15.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.775 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.732 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -64.61 -45.5 95.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.321 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.409 ' CG ' ' N ' ' A' ' 165' ' ' ARG . 7.7 pttt -61.58 -49.08 78.08 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.209 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.493 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 4.2 ptm180 -57.96 -39.72 78.81 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.866 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.594 ' O ' HG23 ' A' ' 170' ' ' THR . 23.2 t90 -72.16 -48.12 45.76 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.818 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -52.47 -38.3 59.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.035 0.445 . . . . 0.0 110.396 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -77.27 -32.38 55.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.12 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.81 -31.12 70.53 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.321 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.594 HG23 ' O ' ' A' ' 166' ' ' TRP . 6.4 p -71.64 -51.92 20.66 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.33 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -68.82 -30.11 68.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.464 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.25 -22.62 66.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.867 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -87.68 10.15 19.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.67 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 51.43 30.09 5.88 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.827 0.346 . . . . 0.0 111.093 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.309 -0.853 . . . . 0.0 111.117 179.951 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.218 0 N-CA-C 112.459 -0.256 . . . . 0.0 112.459 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -155.18 -45.75 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.802 0.334 . . . . 0.0 110.916 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -101.7 79.8 1.97 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.042 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 61.66 168.33 0.11 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.97 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.3 t -81.57 128.33 38.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.952 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.57 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -90.17 153.52 20.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.916 0.389 . . . . 0.0 110.931 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.465 ' O ' ' HG3' ' A' ' 136' ' ' ARG . . . -151.61 96.3 2.23 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.859 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.434 ' HE3' ' CG2' ' A' ' 157' ' ' VAL . 15.3 ptp -47.88 167.94 0.17 Allowed Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.718 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.409 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.0 Cg_exo -65.79 -47.29 3.99 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.81 2.34 . . . . 0.0 112.965 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.433 ' HB3' HG22 ' A' ' 160' ' ' VAL . . . -54.28 -50.76 66.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.43 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.548 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -69.2 -34.7 75.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.236 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 131' ' ' ALA . 0.9 OUTLIER -67.6 -48.54 66.52 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.265 0.555 . . . . 0.0 110.397 179.484 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 66.2 ttt180 -57.59 -54.42 47.08 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.931 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.738 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.3 pp -64.15 -40.85 97.03 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.51 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.731 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -58.92 -37.98 77.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.92 0.39 . . . . 0.0 110.803 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.02 -29.77 55.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.662 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -81.59 -24.92 36.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.966 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.661 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.7 mt -90.88 -28.93 17.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.068 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.36 38.91 7.5 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.846 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.494 HD13 ' CG2' ' A' ' 149' ' ' VAL . 1.2 tt -118.62 140.74 41.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.735 0.302 . . . . 0.0 111.229 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.569 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.6 OUTLIER -71.57 100.89 2.36 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.299 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 1.029 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -50.51 -31.12 14.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.44 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 29.5 m -64.6 -36.1 83.16 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.569 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -65.44 -25.15 67.39 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 177.31 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.541 HG21 HG13 ' A' ' 163' ' ' VAL . 21.9 t -84.2 85.99 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.449 178.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.73 90.75 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.111 0.481 . . . . 0.0 111.224 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' ' 158' ' ' ILE . . . -66.06 141.28 41.2 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.82 -0.627 . . . . 0.0 113.247 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.46 10.95 12.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.707 0.289 . . . . 0.0 110.739 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.422 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -77.42 151.91 38.85 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.569 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.554 ' O ' HG13 ' A' ' 157' ' ' VAL . 82.2 Cg_exo -41.43 122.05 1.69 Allowed 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.244 2.629 . . . . 0.0 113.244 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 88.31 -2.93 85.42 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.773 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.57 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 96.79 22.21 18.92 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.674 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.554 HG13 ' O ' ' A' ' 154' ' ' PRO . 1.2 m -83.5 127.37 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.156 0 CA-C-N 117.092 0.446 . . . . 0.0 111.221 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 1.029 HD13 ' HB1' ' A' ' 146' ' ' ALA . 15.1 pt -67.85 111.87 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 178.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.527 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 62.9 p -75.08 156.49 36.03 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.625 0.726 . . . . 0.0 111.693 -177.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.472 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.59 -41.0 62.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.917 -179.407 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.523 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 0.9 OUTLIER -64.0 -27.73 69.32 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.919 179.387 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.527 ' HB2' ' O ' ' A' ' 159' ' ' THR . 87.3 m-20 -69.98 -54.37 13.58 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.318 0.58 . . . . 0.0 110.495 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.738 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -65.19 -40.81 89.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.725 -179.59 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -65.61 -46.66 78.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.903 0.382 . . . . 0.0 111.428 -178.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.523 ' HG3' ' O ' ' A' ' 161' ' ' GLU . 26.8 mtp180 -62.6 -38.57 90.68 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.885 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.522 ' O ' HG23 ' A' ' 170' ' ' THR . 19.6 t90 -71.4 -50.12 35.17 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.71 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -51.93 -38.36 56.09 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.002 0.43 . . . . 0.0 110.571 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.456 ' HG2' ' HA ' ' A' ' 165' ' ' ARG . 8.4 pt-20 -76.78 -31.35 56.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.254 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -61.45 -26.88 68.17 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 120.957 0.408 . . . . 0.0 110.535 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.522 HG23 ' O ' ' A' ' 166' ' ' TRP . 3.7 p -75.95 -51.61 12.05 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.531 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -73.67 -28.04 61.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.772 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.59 -30.61 71.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.759 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -70.96 64.61 0.33 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.173 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 15.9 p 54.08 175.18 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.126 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.211 -0.9 . . . . 0.0 111.077 179.922 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 112.481 -0.247 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.7 -47.29 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.857 0.361 . . . . 0.0 110.894 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 5.9 mmt85 -105.12 131.17 52.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.933 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.51 136.57 40.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.917 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.1 t -98.96 114.7 37.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.129 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.575 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -91.47 152.32 20.41 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.866 0.365 . . . . 0.0 110.762 179.406 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -151.44 95.79 2.19 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.983 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.736 ' HE2' ' HB3' ' A' ' 134' ' ' ALA . 18.3 ptm -47.88 167.76 0.17 Allowed Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.664 -0.244 . . . . 0.0 110.805 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.417 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.4 Cg_exo -65.75 -46.26 5.31 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.776 2.317 . . . . 0.0 112.963 -178.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.736 ' HB3' ' HE2' ' A' ' 132' ' ' MET . . . -54.28 -52.41 61.52 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.449 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.59 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -68.78 -33.56 74.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.019 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.7 mtp180 -68.37 -48.89 63.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.553 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.2 tpt85 -57.78 -55.73 31.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.734 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.716 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.4 pp -61.65 -38.71 88.74 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.329 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.704 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -58.98 -39.47 81.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.807 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.19 -29.82 57.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.757 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -81.54 -24.35 36.65 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.993 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.658 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.5 mt -90.27 -28.89 18.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.018 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.05 37.37 7.82 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.836 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.478 HD13 ' CG2' ' A' ' 149' ' ' VAL . 1.4 tt -119.07 142.47 34.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.788 0.328 . . . . 0.0 111.213 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.558 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.6 OUTLIER -73.78 101.06 3.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.871 179.394 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 1.019 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -49.49 -30.56 8.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.735 0.302 . . . . 0.0 111.303 -179.361 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 20.4 m -65.11 -36.46 84.37 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.558 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -66.27 -23.79 66.46 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.415 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.539 HG21 HG13 ' A' ' 163' ' ' VAL . 22.0 t -85.27 85.01 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.478 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.65 90.99 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.096 0.474 . . . . 0.0 111.175 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.502 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -66.27 142.67 43.19 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.798 -0.637 . . . . 0.0 113.394 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.46 1.27 11.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.692 0.282 . . . . 0.0 110.838 179.458 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.432 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -66.56 152.25 52.37 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.551 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.534 ' O ' HG13 ' A' ' 157' ' ' VAL . 86.6 Cg_exo -42.32 120.09 1.52 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.179 2.586 . . . . 0.0 113.126 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 90.12 -0.24 78.4 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.682 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.575 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 93.89 22.25 26.15 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.697 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 154' ' ' PRO . 1.2 m -83.51 126.09 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 CA-C-N 117.038 0.419 . . . . 0.0 111.214 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 1.019 HD13 ' HB1' ' A' ' 146' ' ' ALA . 16.4 pt -65.69 111.31 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 178.283 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.554 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 55.4 p -75.22 156.5 35.7 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.487 0.66 . . . . 0.0 111.909 -177.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.461 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.73 -41.86 58.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.888 -179.425 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.4 ' O ' ' CG ' ' A' ' 165' ' ' ARG . 21.7 tt0 -63.99 -27.48 69.15 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.069 179.182 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.565 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 83.9 m-20 -70.75 -52.16 22.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.648 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.716 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -65.95 -46.76 87.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.489 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.2 mtmp? -61.3 -51.22 69.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.468 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.565 ' HG3' ' O ' ' A' ' 162' ' ' ASP . 0.1 OUTLIER -57.74 -38.8 75.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.895 -179.787 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.542 ' O ' HG23 ' A' ' 170' ' ' THR . 27.3 t90 -71.53 -48.2 50.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.784 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -52.22 -37.91 56.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.976 0.417 . . . . 0.0 110.559 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -77.2 -32.3 55.88 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.083 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -60.05 -29.91 68.84 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.956 0.408 . . . . 0.0 110.383 179.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.542 HG23 ' O ' ' A' ' 166' ' ' TRP . 4.4 p -73.11 -52.04 15.74 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.324 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.11 -28.75 66.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.528 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.16 -26.86 67.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.808 179.645 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -94.19 43.15 1.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.087 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 7.6 p 55.86 -177.94 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.937 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.148 -179.963 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.182 0 N-CA-C 112.54 -0.224 . . . . 0.0 112.54 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.7 -42.98 2.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.821 0.343 . . . . 0.0 110.819 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -96.05 -27.43 15.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.982 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 69.25 -68.17 0.2 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.003 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.0 t -95.71 88.25 2.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.022 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.608 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -85.21 148.78 25.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.949 0.404 . . . . 0.0 110.852 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.447 ' HB1' ' HG2' ' A' ' 136' ' ' ARG . . . -147.83 94.67 2.38 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.848 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.488 ' HE3' ' CG2' ' A' ' 157' ' ' VAL . 17.9 ptp -47.3 166.56 0.19 Allowed Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.064 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.406 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 21.8 Cg_exo -65.74 -46.57 4.9 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.883 2.389 . . . . 0.0 112.867 -179.136 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.418 ' HB3' HG22 ' A' ' 160' ' ' VAL . . . -54.29 -50.84 66.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.259 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.594 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -70.49 -36.08 73.61 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.018 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.447 ' HG2' ' HB1' ' A' ' 131' ' ' ALA . 0.2 OUTLIER -64.87 -46.83 80.17 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.359 0.6 . . . . 0.0 110.135 179.357 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.55 -58.71 7.42 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.031 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.83 HD11 ' HB ' ' A' ' 163' ' ' VAL . 3.9 pp -59.91 -43.93 94.57 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.516 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.694 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -53.5 -41.12 65.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.982 0.42 . . . . 0.0 110.828 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -73.02 -32.55 65.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.898 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -73.88 -46.51 44.2 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.001 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.559 HD13 ' O ' ' A' ' 138' ' ' LEU . 8.9 mp -72.21 -29.03 63.57 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.082 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.83 37.71 7.22 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.772 -0.728 . . . . 0.0 113.104 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.491 ' CD1' ' CE3' ' A' ' 166' ' ' TRP . 1.5 tt -114.5 141.94 29.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.736 0.303 . . . . 0.0 111.084 179.637 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.498 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 1.2 t0 -72.47 101.25 2.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.06 179.415 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.968 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -49.31 -28.29 4.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.764 0.316 . . . . 0.0 111.353 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 37.1 t -66.42 -37.77 85.94 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.498 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -66.13 -21.04 66.33 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.4 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.61 HG21 HG13 ' A' ' 163' ' ' VAL . 21.3 t -89.48 88.29 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.565 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 6.5 ttpt -50.62 93.66 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.009 0.433 . . . . 0.0 111.17 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.523 ' HA3' HG22 ' A' ' 158' ' ' ILE . . . -72.74 130.25 14.45 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.146 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.431 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.2 OUTLIER -118.48 20.15 13.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.024 0.44 . . . . 0.0 110.702 179.585 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.451 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -78.59 156.92 43.39 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.741 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -43.82 103.95 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.086 2.524 . . . . 0.0 112.992 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.73 22.17 14.55 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.2 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.608 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 72.99 22.15 79.34 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.637 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.488 ' CG2' ' HE3' ' A' ' 132' ' ' MET . 1.2 m -85.45 125.82 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 CA-C-N 117.031 0.415 . . . . 0.0 111.191 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.968 HD13 ' HB1' ' A' ' 146' ' ' ALA . 17.6 pt -65.49 110.67 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.344 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.513 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 71.8 p -75.12 156.37 36.08 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.491 0.663 . . . . 0.0 111.62 -177.56 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.49 HG13 HD23 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -56.5 -39.66 63.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.511 -179.724 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.602 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 0.5 OUTLIER -63.25 -28.51 70.08 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.768 179.1 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.513 ' HB2' ' O ' ' A' ' 159' ' ' THR . 91.1 m-20 -71.35 -52.56 18.06 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.826 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.83 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -67.21 -37.16 78.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.872 -179.183 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.485 ' HG3' ' N ' ' A' ' 165' ' ' ARG . 5.3 ptpt -70.9 -51.37 26.6 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.192 0.52 . . . . 0.0 111.14 -179.289 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.602 ' HG3' ' O ' ' A' ' 161' ' ' GLU . 49.3 mtm180 -57.81 -37.62 74.09 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.005 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.505 ' O ' HG23 ' A' ' 170' ' ' THR . 46.8 t90 -68.9 -50.04 53.0 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.716 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -50.41 -43.11 54.63 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.507 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.433 ' HG2' ' HA ' ' A' ' 165' ' ' ARG . 7.2 pt-20 -71.26 -32.37 68.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.897 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -62.31 -27.04 68.76 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.231 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.505 HG23 ' O ' ' A' ' 166' ' ' TRP . 2.5 p -71.17 -52.14 20.88 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.367 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -68.65 -23.3 64.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.693 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.42 -35.49 63.41 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.922 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -58.32 -55.5 34.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.164 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 34.0 p -74.39 73.6 1.87 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.845 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.258 -0.877 . . . . 0.0 111.166 -179.973 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.182 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.9 t -105.01 94.14 5.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.843 0.354 . . . . 0.0 110.925 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -95.56 171.5 8.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.794 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -154.71 -45.68 0.09 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.987 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.1 t -96.9 134.69 33.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.037 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.569 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -107.83 156.19 19.42 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.682 179.208 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.42 ' HB1' ' HG2' ' A' ' 136' ' ' ARG . . . -154.62 95.42 1.78 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.045 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.671 ' HB2' ' HD2' ' A' ' 133' ' ' PRO . 19.5 ptm -46.46 167.76 0.14 Allowed Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.558 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.671 ' HD2' ' HB2' ' A' ' 132' ' ' MET . 50.4 Cg_endo -71.88 -34.35 8.79 Favored 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 122.122 1.882 . . . . 0.0 112.5 -178.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.45 ' HB3' ' CE ' ' A' ' 132' ' ' MET . . . -59.71 -54.47 45.98 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.242 0.544 . . . . 0.0 110.649 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.635 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -69.53 -33.26 72.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.507 179.497 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.42 ' HG2' ' HB1' ' A' ' 131' ' ' ALA . 16.6 mmm-85 -66.49 -47.76 71.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.383 179.409 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.02 -55.89 28.43 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.9 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.735 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.4 pp -61.04 -40.19 92.68 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.536 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.721 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -57.87 -38.44 75.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.974 0.416 . . . . 0.0 110.791 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.52 -30.05 57.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.713 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -83.08 -19.85 36.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.953 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.628 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.3 mt -94.02 -28.88 15.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.886 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.71 37.36 8.03 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.746 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.479 ' CD1' ' CE3' ' A' ' 166' ' ' TRP . 1.6 tt -118.67 143.48 29.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.788 0.327 . . . . 0.0 111.306 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.547 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 1.3 t0 -74.39 101.04 3.96 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.241 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 1.033 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -50.2 -28.57 7.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.662 0.268 . . . . 0.0 111.37 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.19 -36.92 84.35 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.547 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -66.54 -21.91 66.16 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 177.524 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.509 HG21 HG13 ' A' ' 163' ' ' VAL . 21.7 t -88.0 85.76 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.61 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -50.7 92.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.988 0.423 . . . . 0.0 111.304 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.547 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -69.47 138.14 30.1 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.809 -0.632 . . . . 0.0 113.525 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.54 12.02 13.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.795 0.331 . . . . 0.0 110.788 179.267 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.45 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -74.5 154.76 47.78 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.786 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -43.85 108.23 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.034 2.489 . . . . 0.0 112.878 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.16 18.79 27.95 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.296 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.569 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 74.62 22.18 77.59 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.801 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.481 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -83.68 126.09 40.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 117.069 0.435 . . . . 0.0 111.192 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 1.033 HD13 ' HB1' ' A' ' 146' ' ' ALA . 19.0 pt -64.79 111.52 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 178.369 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.544 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 36.9 p -75.36 156.52 35.37 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.565 0.697 . . . . 0.0 111.813 -177.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.474 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.03 -41.27 58.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.719 -179.429 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -63.94 -27.51 69.19 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.183 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.544 ' HB2' ' O ' ' A' ' 159' ' ' THR . 83.1 m-20 -71.35 -51.59 23.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.731 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.735 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -66.9 -45.3 87.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.512 -179.884 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.423 ' CG ' ' N ' ' A' ' 165' ' ' ARG . 2.0 pttt -62.85 -50.34 71.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.385 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.537 ' HG3' ' O ' ' A' ' 162' ' ' ASP . 6.8 ppt_? -58.54 -40.01 81.81 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.895 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.539 ' O ' HG23 ' A' ' 170' ' ' THR . 29.4 t90 -70.08 -48.55 57.27 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.85 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -51.99 -38.81 58.04 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.937 0.399 . . . . 0.0 110.68 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -76.48 -31.43 57.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.027 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -61.72 -27.64 68.85 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 120.926 0.393 . . . . 0.0 110.364 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.539 HG23 ' O ' ' A' ' 166' ' ' TRP . 4.6 p -74.37 -52.07 13.22 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.373 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -73.98 -19.19 60.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.84 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 13.2 ttpt -78.11 -32.04 50.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.835 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -75.58 -77.5 0.13 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.234 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 9.7 t -96.41 41.16 1.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.014 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.256 -0.878 . . . . 0.0 111.142 179.959 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.183 0 N-CA-C 112.481 -0.247 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.02 -30.7 44.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.866 0.365 . . . . 0.0 110.915 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.9 90.64 6.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.954 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -93.93 154.79 17.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.858 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.0 t -81.43 83.58 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.919 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.627 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -85.95 146.82 26.52 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.061 0.457 . . . . 0.0 111.085 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -147.83 94.2 2.31 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.712 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.446 ' HG2' ' O ' ' A' ' 158' ' ' ILE . 14.8 ptp -47.41 166.04 0.2 Allowed Pre-proline 0 CA--C 1.532 0.252 0 CA-C-O 120.665 0.269 . . . . 0.0 110.991 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -66.21 -47.97 2.95 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.883 2.389 . . . . 0.0 113.069 -178.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.26 -48.38 71.25 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.666 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.584 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -71.16 -35.13 71.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.855 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 28.8 mtt180 -68.0 -45.76 73.16 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.155 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.3 tpt180 -59.12 -56.98 15.28 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.853 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.78 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -61.1 -41.49 96.77 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.624 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.729 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -56.47 -38.37 71.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.925 0.393 . . . . 0.0 110.907 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 9.6 ttmm -77.02 -30.73 55.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.799 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 51.5 tp10 -83.23 -16.18 47.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.185 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.565 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.1 mt -98.45 -28.92 13.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.915 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.72 35.35 8.48 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.672 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.487 HD13 ' CG2' ' A' ' 149' ' ' VAL . 1.5 tt -116.56 143.53 26.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.834 0.35 . . . . 0.0 111.241 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.504 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 1.9 t0 -76.07 101.47 5.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.917 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.944 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -49.4 -28.25 4.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.673 0.273 . . . . 0.0 111.075 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.4 p -65.96 -37.76 86.83 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.504 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -66.4 -21.24 66.22 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 177.573 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.564 HG21 HG13 ' A' ' 163' ' ' VAL . 20.4 t -89.69 86.45 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.696 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.2 ptmm? -50.67 93.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.934 0.397 . . . . 0.0 110.98 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.518 ' CA ' HG22 ' A' ' 158' ' ' ILE . . . -69.56 133.39 25.5 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.969 -0.634 . . . . 0.0 113.192 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.421 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.4 OUTLIER -118.46 15.56 13.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.963 0.411 . . . . 0.0 110.739 179.545 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.466 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -74.9 155.61 48.23 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.717 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -44.74 105.84 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.138 2.559 . . . . 0.0 112.824 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.35 20.16 21.04 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.209 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.627 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 74.81 22.07 77.57 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.674 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.469 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.1 m -85.91 125.08 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-N 117.08 0.44 . . . . 0.0 111.183 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.944 HD13 ' HB1' ' A' ' 146' ' ' ALA . 15.2 pt -64.69 110.31 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.292 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.533 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 67.0 p -75.16 156.58 35.76 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.611 0.719 . . . . 0.0 111.812 -177.387 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.471 HG13 HD23 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.97 -41.34 67.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.67 -179.656 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -63.78 -27.44 69.19 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.056 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.533 ' HB2' ' O ' ' A' ' 159' ' ' THR . 85.1 m-20 -71.49 -53.0 15.36 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.673 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.78 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -65.49 -45.23 93.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.364 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.41 ' CG ' ' N ' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -61.6 -49.1 77.96 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.11 -179.787 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.514 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 11.5 ptm180 -57.71 -40.4 79.45 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.755 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.547 ' O ' HG23 ' A' ' 170' ' ' THR . 26.2 t90 -71.05 -48.83 50.49 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.747 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -51.55 -38.34 53.8 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.9 0.381 . . . . 0.0 110.592 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -77.21 -32.28 55.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.094 179.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -60.31 -30.13 69.3 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.227 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.547 HG23 ' O ' ' A' ' 166' ' ' TRP . 4.2 p -72.35 -52.12 17.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.304 179.529 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -67.61 -26.56 66.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.601 179.409 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -68.77 -36.92 78.93 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.777 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -79.96 -52.8 7.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.148 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 17.2 p -106.71 107.77 18.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.902 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.236 -0.888 . . . . 0.0 111.094 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.227 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 56.9 m -84.51 -71.08 0.53 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.839 0.352 . . . . 0.0 110.914 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 5.3 mmt85 -111.98 -48.84 3.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.937 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -177.47 -38.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.02 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.1 t -77.83 125.1 37.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.989 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.564 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -106.34 153.47 22.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.957 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.456 ' HB1' ' HG2' ' A' ' 136' ' ' ARG . . . -151.41 94.91 2.08 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.874 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.417 ' HB2' ' CD ' ' A' ' 133' ' ' PRO . 9.5 ptm -48.09 167.5 0.19 Allowed Pre-proline 0 CA--C 1.531 0.226 0 CA-C-O 120.61 0.243 . . . . 0.0 110.941 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.417 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.3 Cg_exo -65.9 -45.55 6.03 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.879 2.386 . . . . 0.0 112.864 -179.01 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.28 -53.1 58.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.397 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.577 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -69.55 -32.62 71.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.865 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.456 ' HG2' ' HB1' ' A' ' 131' ' ' ALA . 14.9 mmm-85 -67.82 -48.03 67.36 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.376 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 13.8 ttt85 -59.85 -55.39 34.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.083 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.732 HD12 ' N ' ' A' ' 139' ' ' ALA . 4.3 pp -61.67 -41.13 97.13 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.678 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.732 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -56.49 -40.88 75.69 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.954 0.407 . . . . 0.0 110.998 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.3 mtmm -75.9 -29.74 58.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.97 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -82.3 -19.83 38.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.163 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.621 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.4 mt -95.0 -28.82 14.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.87 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.75 37.91 7.75 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.484 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.538 HD13 ' CG2' ' A' ' 149' ' ' VAL . 0.6 OUTLIER -117.86 143.85 27.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.738 0.304 . . . . 0.0 111.201 -179.956 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.474 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.5 OUTLIER -76.11 100.97 5.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.013 179.415 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 1.003 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -51.85 -34.83 42.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.644 0.259 . . . . 0.0 111.252 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.16 -36.59 75.56 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.248 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.524 ' HE2' ' CD1' ' A' ' 166' ' ' TRP . 0.0 OUTLIER -67.61 -30.5 70.11 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 177.666 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.538 ' CG2' HD13 ' A' ' 144' ' ' ILE . 10.7 t -78.0 83.28 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.384 178.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.53 94.39 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.142 0.496 . . . . 0.0 111.115 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.537 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -68.18 137.38 31.4 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.695 -0.684 . . . . 0.0 113.36 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.54 13.21 13.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.767 0.318 . . . . 0.0 110.748 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.45 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -76.13 155.75 46.33 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.679 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_exo -43.26 106.41 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.133 2.555 . . . . 0.0 112.92 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.81 20.15 22.44 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.362 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.564 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 73.94 22.21 78.28 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.7 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.487 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -84.01 125.58 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 117.016 0.408 . . . . 0.0 111.031 -179.372 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 1.003 HD13 ' HB1' ' A' ' 146' ' ' ALA . 19.9 pt -64.57 111.35 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.293 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.54 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 38.6 p -75.33 156.43 35.53 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.559 0.695 . . . . 0.0 111.689 -177.523 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.477 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.76 -41.06 64.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.887 -179.4 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -64.58 -27.56 69.03 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.124 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.54 ' HB2' ' O ' ' A' ' 159' ' ' THR . 89.7 m-20 -69.47 -55.34 10.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.372 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.719 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -63.25 -44.19 99.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.683 -179.917 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 160' ' ' VAL . 11.8 mttp -64.0 -40.89 97.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.391 -179.27 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.545 ' HG3' ' N ' ' A' ' 166' ' ' TRP . 0.0 OUTLIER -64.24 -38.48 91.2 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.83 -179.801 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.654 ' O ' HG23 ' A' ' 170' ' ' THR . 62.8 t90 -73.88 -47.77 35.7 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.659 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -54.14 -37.08 64.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.919 0.39 . . . . 0.0 110.443 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.415 ' HG2' ' HA ' ' A' ' 165' ' ' ARG . 8.3 pt-20 -77.25 -33.34 56.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.074 179.174 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.12 -26.98 68.61 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.443 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.654 HG23 ' O ' ' A' ' 166' ' ' TRP . 6.3 p -73.81 -52.12 14.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.556 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.52 -24.68 59.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.728 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.93 -29.87 66.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.809 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -55.58 107.18 0.31 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.217 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 10.1 t -148.82 138.38 21.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.887 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.24 -0.886 . . . . 0.0 111.137 179.952 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.195 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 44.8 p -153.04 36.63 0.48 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.843 0.354 . . . . 0.0 110.898 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 5.3 ttm-85 -100.16 48.19 0.93 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.907 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -61.81 -24.25 66.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.147 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.5 t -70.25 130.04 34.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.924 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.587 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -95.96 154.32 17.3 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.063 0.458 . . . . 0.0 110.788 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -153.99 95.52 1.86 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.841 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.696 ' HE2' ' HB3' ' A' ' 134' ' ' ALA . 16.7 ptm -47.22 168.02 0.15 Allowed Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.673 -0.239 . . . . 0.0 110.865 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.42 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 23.3 Cg_exo -65.41 -44.84 8.11 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.669 2.246 . . . . 0.0 112.922 -178.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.696 ' HB3' ' HE2' ' A' ' 132' ' ' MET . . . -54.32 -52.9 60.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.367 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.577 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -69.09 -33.2 73.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.052 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.36 -48.54 67.16 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.274 0.559 . . . . 0.0 110.322 179.338 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 18.2 ttp180 -58.63 -54.23 49.36 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.188 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.75 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -64.08 -41.64 97.24 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.804 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.744 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -58.08 -38.82 77.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.925 0.393 . . . . 0.0 110.985 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.97 -29.86 55.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.671 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -83.28 -17.92 40.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.124 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.649 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.4 mt -96.88 -28.89 14.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.872 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.69 37.7 7.88 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.455 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.51 HD13 ' CG2' ' A' ' 149' ' ' VAL . 1.4 tt -117.85 141.02 38.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.831 0.348 . . . . 0.0 111.288 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.52 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.6 OUTLIER -73.09 101.06 3.18 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.159 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 1.007 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -50.16 -28.63 7.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.307 -179.357 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.98 -37.04 84.96 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.52 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -65.09 -23.27 67.11 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 177.237 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.51 ' CG2' HD13 ' A' ' 144' ' ' ILE . 19.0 t -88.54 90.22 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.328 179.049 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.62 91.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.085 0.469 . . . . 0.0 111.125 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.567 ' HA3' HG22 ' A' ' 158' ' ' ILE . . . -69.36 125.88 18.46 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.934 -0.65 . . . . 0.0 113.047 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.439 ' OG1' ' O ' ' A' ' 152' ' ' THR . 0.1 OUTLIER -118.56 31.87 6.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.159 0.504 . . . . 0.0 110.292 179.708 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.45 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -91.47 156.76 24.25 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.679 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_exo -43.46 101.1 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 123.065 2.51 . . . . 0.0 113.022 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 99.83 25.77 8.91 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.315 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.587 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 70.16 22.1 77.28 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.602 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.47 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -86.27 126.46 40.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.017 -179.465 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 1.007 HD13 ' HB1' ' A' ' 146' ' ' ALA . 18.9 pt -66.06 112.01 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.34 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.518 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 47.4 p -75.33 156.43 35.54 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.485 0.66 . . . . 0.0 111.668 -177.636 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.509 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -56.98 -40.31 71.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.681 -179.721 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.539 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 2.1 tt0 -62.76 -27.73 69.49 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.863 179.287 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.518 ' HB2' ' O ' ' A' ' 159' ' ' THR . 91.2 m-20 -71.45 -53.9 12.44 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.342 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.75 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -67.08 -34.48 69.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.413 -179.479 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.434 ' HB3' ' O ' ' A' ' 160' ' ' VAL . 0.0 OUTLIER -69.28 -47.84 63.42 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-O 121.047 0.451 . . . . 0.0 110.892 -179.387 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.539 ' HG3' ' O ' ' A' ' 161' ' ' GLU . 15.1 mtp180 -60.39 -41.53 94.02 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.176 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.496 ' O ' HG23 ' A' ' 170' ' ' THR . 13.4 t90 -70.67 -50.16 39.66 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.826 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -50.56 -38.69 46.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.002 0.429 . . . . 0.0 110.682 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -77.28 -32.54 55.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.555 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -59.63 -28.22 67.03 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.933 0.397 . . . . 0.0 110.564 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.496 HG23 ' O ' ' A' ' 166' ' ' TRP . 7.2 p -77.16 -50.32 13.25 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.395 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.754 ' O ' HG23 ' A' ' 174' ' ' THR . . . -67.81 -30.07 69.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.447 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 11.7 mttp -64.19 -30.21 71.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.635 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -79.28 61.23 3.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.992 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.754 HG23 ' O ' ' A' ' 171' ' ' ALA . 9.7 p -101.96 125.21 48.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.98 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.114 179.964 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.248 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.74 134.38 33.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.802 0.334 . . . . 0.0 110.896 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.95 -50.99 2.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.966 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -96.16 -36.96 10.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.967 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.1 t -90.73 128.01 42.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.901 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.584 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -100.85 153.47 19.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.964 0.411 . . . . 0.0 111.114 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.427 ' O ' ' HG3' ' A' ' 136' ' ' ARG . . . -151.23 95.79 2.21 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.693 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.41 ' HB2' ' CD ' ' A' ' 133' ' ' PRO . 16.0 ptp -47.02 167.74 0.15 Allowed Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.917 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.41 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.1 Cg_exo -65.86 -47.66 3.58 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.811 2.341 . . . . 0.0 112.746 -179.003 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.478 ' HB3' HG22 ' A' ' 160' ' ' VAL . . . -54.28 -50.38 67.41 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.347 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.572 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -69.9 -33.87 72.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.013 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.427 ' HG3' ' O ' ' A' ' 131' ' ' ALA . 0.2 OUTLIER -67.75 -47.71 68.46 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.324 0.583 . . . . 0.0 110.329 179.339 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.15 -54.42 47.2 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.217 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.746 HD12 ' N ' ' A' ' 139' ' ' ALA . 4.3 pp -63.59 -42.08 98.31 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.784 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.746 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -58.59 -37.25 75.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.865 0.364 . . . . 0.0 110.791 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -77.0 -29.75 55.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.781 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -81.97 -24.78 35.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.038 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.643 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.9 mt -90.99 -28.85 17.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.876 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.53 36.62 8.57 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.545 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.5 HD13 ' CG2' ' A' ' 149' ' ' VAL . 1.4 tt -114.87 142.37 27.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.875 0.369 . . . . 0.0 111.243 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.514 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 1.9 t0 -74.45 101.03 4.0 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.151 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 1.005 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -50.22 -28.44 7.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.703 0.287 . . . . 0.0 111.301 -179.396 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.54 -37.27 86.22 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.514 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -65.85 -22.63 66.55 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.514 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.534 HG21 HG13 ' A' ' 163' ' ' VAL . 20.1 t -88.41 86.48 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.589 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.5 tppt? -50.78 92.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.033 0.444 . . . . 0.0 110.976 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.521 ' HA3' ' HA ' ' A' ' 158' ' ' ILE . . . -70.01 140.52 32.91 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 115.876 -0.602 . . . . 0.0 113.122 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.46 9.46 12.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.677 0.275 . . . . 0.0 110.881 179.446 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.462 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -70.89 150.36 47.65 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.613 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.569 ' O ' HG13 ' A' ' 157' ' ' VAL . 94.3 Cg_exo -42.77 123.86 3.2 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.137 2.558 . . . . 0.0 113.081 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 87.82 -5.86 84.3 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.601 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.584 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 100.74 22.25 11.34 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.705 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.569 HG13 ' O ' ' A' ' 154' ' ' PRO . 1.2 m -86.09 127.13 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 CA-C-N 117.087 0.443 . . . . 0.0 111.198 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 1.005 HD13 ' HB1' ' A' ' 146' ' ' ALA . 14.5 pt -67.35 111.96 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 177.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.525 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 76.1 p -75.1 156.54 35.92 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.54 0.686 . . . . 0.0 111.536 -177.423 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.513 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -56.37 -40.72 68.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.873 -179.348 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.535 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 0.1 OUTLIER -62.81 -29.15 70.5 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.748 179.364 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 159' ' ' THR . 87.3 m-20 -69.36 -54.38 14.77 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.371 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.746 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -65.79 -34.62 71.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.0 -179.584 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.414 ' HB3' ' O ' ' A' ' 160' ' ' VAL . 0.2 OUTLIER -67.23 -47.67 70.12 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 121.014 0.435 . . . . 0.0 110.735 -179.64 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.535 ' HG3' ' O ' ' A' ' 161' ' ' GLU . 68.6 mtt-85 -59.26 -44.48 92.41 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.043 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.484 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 10.4 t90 -70.06 -50.1 44.5 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.959 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -50.53 -38.43 44.66 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.937 0.399 . . . . 0.0 110.627 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -77.31 -31.69 54.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.503 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -60.1 -28.07 67.54 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.902 0.382 . . . . 0.0 110.593 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.449 HG23 ' O ' ' A' ' 166' ' ' TRP . 8.0 p -77.6 -50.21 13.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.439 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.27 -28.41 66.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.427 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 10.3 mtpt -66.83 -32.61 74.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.77 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -84.67 -48.87 9.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.011 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 8.9 t -129.08 146.94 50.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.842 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.231 -0.89 . . . . 0.0 111.163 179.999 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.216 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.57 -67.55 0.79 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.809 0.338 . . . . 0.0 110.853 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.62 79.78 1.89 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.888 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -76.42 133.88 39.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.873 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.1 t -99.23 136.21 31.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.999 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.556 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -87.64 157.17 19.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.882 0.373 . . . . 0.0 110.567 179.303 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -153.07 96.64 2.1 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.206 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.679 ' HB2' ' HD2' ' A' ' 133' ' ' PRO . 14.9 ptp -45.64 168.34 0.1 Allowed Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.546 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.679 ' HD2' ' HB2' ' A' ' 132' ' ' MET . 50.0 Cg_endo -71.44 -35.64 7.92 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.062 1.841 . . . . 0.0 112.363 -179.064 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.79 -52.45 65.01 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.759 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.639 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -70.43 -32.73 70.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.672 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 2.3 mmt85 -68.3 -46.11 71.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.079 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.63 -55.66 31.6 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.831 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.752 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -62.59 -42.08 99.34 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.641 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.737 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -57.99 -36.75 73.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.92 0.391 . . . . 0.0 110.778 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 3.8 mtmt -77.02 -30.76 55.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.555 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -82.93 -18.5 39.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.1 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.621 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.5 mt -96.66 -28.83 14.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.91 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.56 38.8 8.01 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.521 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.486 HD13 ' CG2' ' A' ' 149' ' ' VAL . 1.3 tt -118.43 141.72 36.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.696 0.284 . . . . 0.0 111.33 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.559 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.7 OUTLIER -73.18 100.97 3.21 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.181 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 1.006 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -50.45 -30.46 12.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.47 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 15.8 m -64.61 -36.16 83.34 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.559 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -66.05 -24.9 66.83 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 177.417 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.595 HG21 HG13 ' A' ' 163' ' ' VAL . 20.6 t -84.46 85.2 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.458 179.119 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.6 91.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.045 0.45 . . . . 0.0 111.124 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.575 ' HA3' ' HA ' ' A' ' 158' ' ' ILE . . . -70.03 143.09 37.3 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.808 -0.633 . . . . 0.0 113.415 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.56 9.1 12.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.714 0.292 . . . . 0.0 110.793 179.292 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.428 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -72.84 151.29 45.76 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.698 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.596 ' O ' HG13 ' A' ' 157' ' ' VAL . 86.5 Cg_exo -41.57 124.59 2.54 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.2 2.6 . . . . 0.0 113.197 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 86.48 -5.66 84.07 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.631 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.556 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 100.0 22.24 12.38 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.719 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.596 HG13 ' O ' ' A' ' 154' ' ' PRO . 1.2 m -84.47 128.84 38.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 117.096 0.448 . . . . 0.0 111.236 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 1.006 HD13 ' HB1' ' A' ' 146' ' ' ALA . 14.5 pt -68.61 111.75 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 177.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.53 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 72.2 p -75.0 156.45 36.25 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.495 0.664 . . . . 0.0 111.637 -177.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.494 HG13 HD23 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.55 -40.69 60.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.877 -179.467 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.533 ' O ' ' CG ' ' A' ' 165' ' ' ARG . 0.6 OUTLIER -63.6 -27.8 69.49 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.835 179.434 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.53 ' HB2' ' O ' ' A' ' 159' ' ' THR . 86.6 m-20 -70.99 -53.71 13.87 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.593 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.752 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -65.36 -37.87 81.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.155 -179.585 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.9 pttt -65.61 -47.35 75.97 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.977 0.418 . . . . 0.0 110.793 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.533 ' CG ' ' O ' ' A' ' 161' ' ' GLU . 4.9 mmt180 -59.61 -42.54 92.85 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.089 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.477 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 13.1 t90 -69.83 -50.12 45.9 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.599 -0.441 . . . . 0.0 110.952 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -50.64 -38.84 48.41 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.843 0.354 . . . . 0.0 110.614 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -77.3 -31.61 54.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.37 179.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -60.15 -29.99 69.02 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.953 0.406 . . . . 0.0 110.435 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 166' ' ' TRP . 20.7 p -74.56 -51.34 14.9 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.305 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -67.1 -28.21 67.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.472 179.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.6 -34.39 76.91 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.664 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -84.66 103.46 13.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.233 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 2.9 p -145.98 80.55 1.58 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.883 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.127 179.987 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.267 0 N-CA-C 112.506 -0.238 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.2 p -98.84 38.51 1.37 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.883 0.373 . . . . 0.0 110.897 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -90.05 149.8 22.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.956 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -99.34 -167.49 1.48 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.694 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.4 t -71.57 117.64 15.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.766 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.616 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -89.63 151.37 21.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.109 0.48 . . . . 0.0 111.157 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.412 ' O ' ' HG3' ' A' ' 136' ' ' ARG . . . -151.36 95.28 2.13 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.801 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.439 ' HG2' ' O ' ' A' ' 158' ' ' ILE . 18.1 ptp -47.47 166.54 0.19 Allowed Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.985 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -66.24 -47.31 3.41 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.814 2.342 . . . . 0.0 112.978 -178.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.511 ' HB3' HG22 ' A' ' 160' ' ' VAL . . . -54.1 -50.62 66.43 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.456 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.555 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -69.29 -34.9 75.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.22 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.412 ' HG3' ' O ' ' A' ' 131' ' ' ALA . 0.2 OUTLIER -67.93 -48.49 65.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.156 0.503 . . . . 0.0 110.453 179.495 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.8 ttp-105 -57.53 -55.2 37.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.971 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.73 HD12 ' N ' ' A' ' 139' ' ' ALA . 4.4 pp -61.93 -41.14 97.62 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.486 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.73 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -57.9 -38.04 75.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.965 0.412 . . . . 0.0 110.868 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -76.85 -29.68 55.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.784 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -83.58 -20.08 34.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.033 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.635 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.4 mt -94.5 -28.95 15.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.851 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.98 35.67 8.88 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.645 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.538 HD13 ' CG2' ' A' ' 149' ' ' VAL . 1.9 tt -115.77 142.75 27.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.792 0.33 . . . . 0.0 111.3 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.566 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.9 OUTLIER -75.22 101.11 4.52 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.2 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 1.01 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -49.15 -29.04 4.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.672 0.272 . . . . 0.0 111.301 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.29 -37.43 85.43 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.639 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.566 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -65.78 -21.07 66.47 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 177.269 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.538 ' CG2' HD13 ' A' ' 144' ' ' ILE . 19.6 t -91.17 90.15 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.403 179.113 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.54 93.91 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.036 0.446 . . . . 0.0 111.015 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.601 ' HA3' HG22 ' A' ' 158' ' ' ILE . . . -72.79 126.34 10.64 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.815 -0.629 . . . . 0.0 113.035 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.447 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -118.49 31.62 6.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.153 0.501 . . . . 0.0 110.42 179.707 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.434 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -89.15 158.07 27.59 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.571 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -43.82 102.06 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.043 2.496 . . . . 0.0 112.945 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.78 24.58 10.6 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.382 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.616 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 71.71 22.17 78.74 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.748 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.48 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -87.03 126.99 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 CA-C-N 117.06 0.43 . . . . 0.0 111.328 -179.338 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 1.01 HD13 ' HB1' ' A' ' 146' ' ' ALA . 19.7 pt -65.77 111.9 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 177.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.516 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 70.2 p -75.07 156.32 36.23 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.612 0.72 . . . . 0.0 111.595 -177.41 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.519 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -56.24 -40.06 63.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.876 -179.561 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.587 ' O ' ' CG ' ' A' ' 165' ' ' ARG . 1.2 tp10 -65.28 -30.22 71.06 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.781 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.516 ' HB2' ' O ' ' A' ' 159' ' ' THR . 80.5 m-20 -65.7 -56.05 14.15 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.308 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.715 ' CB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -62.14 -41.39 91.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.165 -179.988 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -65.19 -41.72 94.28 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.555 -179.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.587 ' CG ' ' O ' ' A' ' 161' ' ' GLU . 0.1 OUTLIER -62.46 -44.59 96.04 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.661 179.916 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.446 ' CZ2' ' HD2' ' A' ' 148' ' ' LYS . 18.5 t90 -68.32 -50.18 55.23 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.856 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -51.19 -39.4 56.39 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.887 0.375 . . . . 0.0 110.684 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.401 ' HG2' ' HA ' ' A' ' 165' ' ' ARG . 8.8 pt-20 -76.27 -29.13 57.32 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.277 179.287 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.401 ' OE1' ' CD1' ' A' ' 166' ' ' TRP . 0.5 OUTLIER -61.21 -42.52 98.74 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 121.194 0.521 . . . . 0.0 110.048 179.302 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.444 HG23 ' O ' ' A' ' 166' ' ' TRP . 7.4 p -60.91 -52.27 65.74 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.447 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.25 -22.27 62.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.356 179.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -71.47 -31.45 67.17 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.669 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -57.59 -34.97 69.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.196 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 7.5 t -150.69 140.1 21.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.946 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.199 -0.905 . . . . 0.0 111.121 179.989 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.184 0 N-CA-C 112.539 -0.224 . . . . 0.0 112.539 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.4 m -60.25 175.21 0.44 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.885 0.374 . . . . 0.0 110.817 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.09 -51.73 4.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.864 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -142.24 130.35 22.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.953 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.2 t -101.11 138.55 24.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.886 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.554 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -82.62 157.04 23.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.864 0.364 . . . . 0.0 110.72 179.412 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.441 ' O ' ' HG3' ' A' ' 136' ' ' ARG . . . -153.98 96.32 1.95 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.098 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.427 ' HB2' ' CD ' ' A' ' 133' ' ' PRO . 16.6 ptp -47.24 168.52 0.13 Allowed Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.725 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.427 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.7 Cg_exo -65.54 -47.6 3.99 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.687 2.258 . . . . 0.0 112.806 -178.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.451 ' HB3' HG22 ' A' ' 160' ' ' VAL . . . -54.18 -50.78 66.25 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.398 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.57 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -69.71 -34.52 74.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.084 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.441 ' HG3' ' O ' ' A' ' 131' ' ' ALA . 0.9 OUTLIER -66.48 -47.96 71.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.314 0.578 . . . . 0.0 110.296 179.367 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 11.4 ttt-85 -59.48 -55.24 37.16 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.259 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.763 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -62.58 -42.16 99.38 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.799 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.738 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -57.8 -36.68 72.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.912 0.387 . . . . 0.0 110.726 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.07 -30.76 55.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.705 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -84.45 -15.93 44.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.203 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.589 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.1 mt -98.12 -28.85 13.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.799 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.58 36.53 8.6 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.66 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.496 HD13 ' CG2' ' A' ' 149' ' ' VAL . 1.3 tt -118.31 140.25 42.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.739 0.304 . . . . 0.0 111.258 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.567 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.6 OUTLIER -71.47 100.93 2.32 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.293 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 1.006 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -50.02 -30.36 10.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.764 0.316 . . . . 0.0 111.441 -179.402 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 17.0 m -65.14 -36.69 85.05 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.567 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -65.76 -23.82 66.81 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.408 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.601 HG21 HG13 ' A' ' 163' ' ' VAL . 21.9 t -84.9 85.6 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.458 179.117 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 5.0 ttpp -50.66 90.61 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.971 0.415 . . . . 0.0 111.29 -179.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.56 ' HA3' ' HA ' ' A' ' 158' ' ' ILE . . . -69.91 139.76 31.83 Favored Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 115.777 -0.647 . . . . 0.0 113.383 -179.587 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.48 13.53 13.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.764 0.316 . . . . 0.0 110.638 179.366 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.424 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -76.08 153.45 43.42 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.799 -179.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.406 ' O ' HG13 ' A' ' 157' ' ' VAL . 92.6 Cg_exo -43.59 109.73 0.16 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.129 2.553 . . . . 0.0 112.873 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 96.59 16.47 36.68 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.294 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.554 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 76.2 22.21 74.11 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.72 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.424 HG22 ' HA3' ' A' ' 153' ' ' GLY . 1.3 m -83.59 126.67 40.16 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 CA-C-N 117.031 0.416 . . . . 0.0 111.025 -179.515 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 1.006 HD13 ' HB1' ' A' ' 146' ' ' ALA . 17.3 pt -66.55 111.51 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.195 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.513 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 70.6 p -75.14 156.39 36.0 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.4 0.619 . . . . 0.0 111.261 -177.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.494 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -56.18 -39.53 59.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.583 -179.664 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.624 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 27.3 tt0 -63.6 -27.91 69.56 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.814 179.174 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.513 ' HB2' ' O ' ' A' ' 159' ' ' THR . 88.7 m-20 -71.92 -52.59 16.48 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.711 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.763 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -67.68 -35.89 74.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.636 -179.378 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -69.52 -49.27 56.05 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.075 0.464 . . . . 0.0 110.832 -179.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.624 ' HG3' ' O ' ' A' ' 161' ' ' GLU . 42.3 mtp180 -61.58 -36.37 80.48 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.253 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.581 ' O ' HG23 ' A' ' 170' ' ' THR . 24.4 t90 -71.21 -50.32 34.24 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.948 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -51.94 -40.74 61.28 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.944 0.402 . . . . 0.0 110.39 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.43 ' HG2' ' HA ' ' A' ' 165' ' ' ARG . 8.4 pt-20 -74.28 -31.12 62.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.09 179.01 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -63.01 -31.17 72.25 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.301 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.581 HG23 ' O ' ' A' ' 166' ' ' TRP . 5.0 p -68.92 -52.02 33.78 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.259 179.538 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -67.04 -24.57 66.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.617 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.85 -39.53 76.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.872 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -58.98 -42.1 89.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.181 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.449 ' O ' HG23 ' A' ' 174' ' ' THR . 12.0 t -88.19 117.39 27.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.953 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.173 -0.918 . . . . 0.0 111.163 -179.995 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.582 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 N--CA 1.454 -0.266 0 CA-C-O 120.936 0.398 . . . . 0.0 110.874 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -152.27 95.5 2.06 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.866 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.463 ' HE3' ' CG2' ' A' ' 157' ' ' VAL . 18.0 ptp -47.43 166.95 0.18 Allowed Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.768 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.4 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.1 Cg_exo -65.91 -47.48 3.68 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.756 2.304 . . . . 0.0 112.857 -178.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.435 ' HB3' HG22 ' A' ' 160' ' ' VAL . . . -54.19 -51.04 65.65 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.522 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.569 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -69.68 -33.57 72.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.051 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -68.49 -48.12 65.29 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.251 0.548 . . . . 0.0 110.547 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -58.88 -54.72 43.89 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.851 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.734 HD12 ' N ' ' A' ' 139' ' ' ALA . 4.3 pp -62.62 -39.48 93.93 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.527 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.734 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -58.72 -39.62 81.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.886 0.374 . . . . 0.0 110.827 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.19 -29.76 57.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.783 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -81.85 -23.94 36.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.926 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.643 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.5 mt -90.56 -28.95 18.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.843 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.17 35.55 8.81 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.72 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.498 HD13 ' CG2' ' A' ' 149' ' ' VAL . 1.5 tt -116.39 142.32 30.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.781 0.324 . . . . 0.0 111.34 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.526 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 1.9 t0 -73.95 101.02 3.69 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.993 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -49.84 -28.03 5.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.277 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.73 -37.26 84.3 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.526 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -65.94 -21.14 66.41 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 177.349 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.498 ' CG2' HD13 ' A' ' 144' ' ' ILE . 21.7 t -89.93 88.12 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.455 179.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.7 ttmt -50.82 91.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.001 0.429 . . . . 0.0 111.206 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.502 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -70.18 133.76 24.48 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 121.015 -0.612 . . . . 0.0 113.198 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.421 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.4 OUTLIER -118.47 14.18 13.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.847 0.356 . . . . 0.0 110.766 179.563 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.458 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -73.18 155.34 50.43 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.709 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -44.37 106.5 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.097 2.531 . . . . 0.0 112.851 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.14 19.79 22.67 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.245 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.582 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 74.61 22.17 77.62 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.598 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.477 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.3 m -85.77 126.29 40.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 117.042 0.421 . . . . 0.0 111.067 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.993 HD13 ' HB1' ' A' ' 146' ' ' ALA . 19.1 pt -64.98 111.94 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.509 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 61.7 p -75.02 156.48 36.16 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.558 0.694 . . . . 0.0 111.657 -177.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.502 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -56.08 -39.91 61.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.715 -179.464 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.546 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 1.2 tp10 -65.82 -28.05 68.71 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.907 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.509 ' HB2' ' O ' ' A' ' 159' ' ' THR . 82.1 m-20 -68.49 -53.41 23.49 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.198 0.523 . . . . 0.0 110.225 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.726 ' CB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -65.64 -41.27 90.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.62 -179.729 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.55 -48.03 73.83 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 120.942 0.401 . . . . 0.0 111.465 -178.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.546 ' HG3' ' O ' ' A' ' 161' ' ' GLU . 21.6 mtt180 -60.63 -40.29 91.36 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.89 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . 0.473 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 27.5 t90 -70.65 -48.99 52.13 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.661 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -50.52 -39.02 47.68 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.968 0.413 . . . . 0.0 110.486 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.401 ' HG2' ' HA ' ' A' ' 165' ' ' ARG . 13.0 pt-20 -77.33 -31.3 54.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.356 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.953 0.406 . . . . 0.0 110.402 179.518 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.57 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 N--CA 1.455 -0.203 0 CA-C-O 120.917 0.389 . . . . 0.0 110.846 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -153.37 95.49 1.93 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.897 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.438 ' HE2' ' HB3' ' A' ' 134' ' ' ALA . 19.9 ptm -48.14 167.42 0.19 Allowed Pre-proline 0 CA--C 1.532 0.26 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.793 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.408 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.8 Cg_exo -65.54 -45.56 6.7 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.807 2.338 . . . . 0.0 112.918 -178.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.438 ' HB3' ' HE2' ' A' ' 132' ' ' MET . . . -54.29 -52.71 60.59 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.423 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.562 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -69.25 -33.3 73.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.165 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 12.1 mtm180 -67.99 -49.17 63.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.524 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -58.29 -54.33 48.2 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.893 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.721 HD11 ' CB ' ' A' ' 163' ' ' VAL . 4.4 pp -63.05 -38.92 93.1 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.417 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.712 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -58.31 -39.93 80.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.722 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -76.62 -29.81 56.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.726 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 -81.95 -20.02 39.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.059 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.654 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.3 mt -94.88 -28.85 15.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.927 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.64 35.98 8.2 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.812 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.493 ' CD1' ' CE3' ' A' ' 166' ' ' TRP . 1.5 tt -118.22 141.34 37.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.832 0.348 . . . . 0.0 111.183 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.518 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.6 OUTLIER -72.93 101.05 3.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.805 179.229 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 1.016 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -49.73 -28.71 6.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.641 0.257 . . . . 0.0 111.321 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.78 -36.98 85.06 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.518 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -66.52 -22.48 66.17 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.453 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.526 HG21 HG13 ' A' ' 163' ' ' VAL . 21.8 t -86.87 84.77 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.646 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 6.4 ttmt -50.73 90.82 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.976 0.417 . . . . 0.0 111.14 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.512 ' HA3' ' HA ' ' A' ' 158' ' ' ILE . . . -66.5 142.94 43.29 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.809 -0.632 . . . . 0.0 113.295 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.45 0.9 11.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.688 0.28 . . . . 0.0 110.885 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.438 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -65.99 151.96 51.93 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.747 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.543 ' O ' HG13 ' A' ' 157' ' ' VAL . 84.8 Cg_exo -42.04 120.67 1.58 Allowed 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.234 2.622 . . . . 0.0 113.182 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 89.55 -0.68 80.73 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.715 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.57 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 94.53 22.24 24.65 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.694 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.543 HG13 ' O ' ' A' ' 154' ' ' PRO . 1.2 m -83.49 126.38 40.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 117.017 0.408 . . . . 0.0 111.107 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 1.016 HD13 ' HB1' ' A' ' 146' ' ' ALA . 19.0 pt -65.89 111.82 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.518 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 44.0 p -75.3 156.53 35.5 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.575 0.702 . . . . 0.0 111.816 -177.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.504 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -56.01 -40.16 61.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.805 -179.431 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.49 ' O ' ' CG ' ' A' ' 165' ' ' ARG . 5.6 mt-10 -64.89 -27.61 68.98 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.834 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.518 ' HB2' ' O ' ' A' ' 159' ' ' THR . 88.1 m-20 -70.2 -53.97 14.85 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.522 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.721 ' CB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -65.16 -42.71 94.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.794 -179.37 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.9 mmtt -66.38 -52.11 50.16 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.953 0.406 . . . . 0.0 111.486 -178.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.49 ' CG ' ' O ' ' A' ' 161' ' ' GLU . 27.1 mtp180 -59.24 -35.88 74.47 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.035 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . 0.493 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 32.9 t90 -70.66 -50.05 40.77 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.791 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -50.66 -41.26 55.29 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-O 120.97 0.414 . . . . 0.0 110.411 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.422 ' HG2' ' HA ' ' A' ' 165' ' ' ARG . 7.6 pt-20 -74.04 -31.88 63.08 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.048 179.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 . . . . . 0 N--CA 1.456 -0.169 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.278 179.458 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.532 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 C--O 1.233 0.192 0 CA-C-O 120.846 0.355 . . . . 0.0 110.824 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -154.88 96.22 1.83 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.134 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.442 ' HE3' ' CG2' ' A' ' 157' ' ' VAL . 19.0 ptp -47.81 167.59 0.18 Allowed Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.57 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.405 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.4 Cg_exo -65.49 -47.12 4.52 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.778 2.319 . . . . 0.0 112.809 -179.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.465 ' HB3' HG22 ' A' ' 160' ' ' VAL . . . -54.27 -51.48 64.41 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.475 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.546 ' HA ' HD21 ' A' ' 138' ' ' LEU . . . -69.23 -33.36 73.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.277 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.69 -48.75 63.1 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.296 0.57 . . . . 0.0 110.371 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -57.77 -54.2 49.57 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.98 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.729 HD12 ' N ' ' A' ' 139' ' ' ALA . 4.3 pp -63.49 -41.23 98.57 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.553 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.729 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -58.47 -37.64 75.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.743 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.92 -29.81 55.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.754 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -83.36 -20.52 34.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.997 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.648 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.5 mt -94.22 -28.92 15.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.863 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.75 38.68 7.96 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.543 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.511 HD13 ' CG2' ' A' ' 149' ' ' VAL . 1.3 tt -118.4 140.39 42.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.742 0.306 . . . . 0.0 111.305 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.531 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 1.5 t0 -71.97 100.97 2.58 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.998 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -50.6 -28.84 9.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.681 0.277 . . . . 0.0 111.271 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.69 -36.97 85.15 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 178.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.531 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -64.97 -23.88 67.35 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 177.283 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.511 ' CG2' HD13 ' A' ' 144' ' ' ILE . 21.2 t -87.44 89.15 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.324 179.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.64 90.93 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.937 0.399 . . . . 0.0 111.14 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.512 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -68.55 130.03 25.63 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.837 -0.696 . . . . 0.0 113.104 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.479 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.1 OUTLIER -118.5 24.13 11.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.136 0.493 . . . . 0.0 110.495 179.658 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.429 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -84.63 157.16 32.44 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.758 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_exo -43.37 102.89 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.227 2.618 . . . . 0.0 112.993 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 99.3 23.52 11.18 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.212 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.532 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 71.23 22.18 78.52 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.601 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.442 ' CG2' ' HE3' ' A' ' 132' ' ' MET . 1.2 m -85.43 128.35 39.21 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.957 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.998 HD13 ' HB1' ' A' ' 146' ' ' ALA . 18.6 pt -66.65 112.11 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.504 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 55.7 p -75.14 156.35 36.05 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.532 0.682 . . . . 0.0 111.533 -177.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.521 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -56.41 -39.46 61.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.706 -179.582 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.565 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 6.1 mm-40 -65.67 -27.79 68.62 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.944 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.504 ' HB2' ' O ' ' A' ' 159' ' ' THR . 83.0 m-20 -69.31 -54.6 13.75 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.223 0.535 . . . . 0.0 110.322 179.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.715 ' CB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -64.09 -40.83 90.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.648 -179.612 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.61 -47.57 78.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.9 0.381 . . . . 0.0 111.445 -178.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.565 ' HG3' ' O ' ' A' ' 161' ' ' GLU . 65.2 mtt-85 -60.83 -42.0 96.87 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.05 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . 0.489 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 18.1 t90 -67.98 -50.18 57.23 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.915 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -50.94 -41.1 58.75 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.919 0.39 . . . . 0.0 110.725 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.416 ' HG2' ' HA ' ' A' ' 165' ' ' ARG . 11.9 pt-20 -74.9 -29.47 61.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.321 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.406 ' OE1' ' CD1' ' A' ' 166' ' ' TRP . 0.4 OUTLIER . . . . . 0 N--CA 1.454 -0.264 0 CA-C-O 121.224 0.535 . . . . 0.0 110.096 179.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.539 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 N--CA 1.456 -0.174 0 CA-C-O 120.931 0.396 . . . . 0.0 110.892 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.5 ' HB1' ' HG2' ' A' ' 136' ' ' ARG . . . -152.12 95.43 2.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.965 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.415 ' HG2' ' O ' ' A' ' 158' ' ' ILE . 14.0 ptp -46.91 167.74 0.15 Allowed Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.863 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.414 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.2 Cg_exo -65.76 -47.59 3.75 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.799 2.333 . . . . 0.0 112.822 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.462 ' HB3' HG22 ' A' ' 160' ' ' VAL . . . -54.3 -51.61 64.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.372 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.563 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -69.48 -34.21 74.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.911 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.5 ' HG2' ' HB1' ' A' ' 131' ' ' ALA . 9.0 mmm180 -66.53 -48.53 69.42 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.501 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.41 ' CZ ' ' HB2' ' A' ' 137' ' ' ARG . 26.4 ttm105 -59.93 -55.38 34.8 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.154 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.729 HD12 ' N ' ' A' ' 139' ' ' ALA . 4.3 pp -61.54 -41.03 96.75 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.716 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.729 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -58.11 -37.95 75.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.994 0.426 . . . . 0.0 110.809 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.3 tptt -76.48 -29.81 57.02 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.825 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -84.32 -19.38 33.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.12 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.614 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.4 mt -94.49 -28.89 15.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.719 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.72 38.28 8.19 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.505 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.481 ' CD1' ' CE3' ' A' ' 166' ' ' TRP . 1.4 tt -118.31 141.6 36.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.744 0.307 . . . . 0.0 111.248 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.529 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 1.9 t0 -72.94 101.02 3.08 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 1.004 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -50.45 -28.85 9.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.735 0.302 . . . . 0.0 111.182 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.92 -36.93 85.96 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 178.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.529 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -66.59 -23.37 66.18 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 177.666 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.536 HG21 HG13 ' A' ' 163' ' ' VAL . 20.1 t -86.7 84.15 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.625 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.74 91.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.911 0.386 . . . . 0.0 111.113 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.571 ' HA3' ' HA ' ' A' ' 158' ' ' ILE . . . -69.17 141.55 36.0 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.098 -0.572 . . . . 0.0 113.488 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.61 11.06 12.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.743 0.306 . . . . 0.0 110.786 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.448 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -73.4 152.21 46.17 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.842 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.417 ' O ' HG13 ' A' ' 157' ' ' VAL . 90.8 Cg_exo -43.83 112.29 0.31 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.092 2.528 . . . . 0.0 112.832 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 95.54 13.12 52.32 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.374 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.539 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 79.62 22.11 65.1 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.776 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.457 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.3 m -83.98 126.92 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 117.122 0.461 . . . . 0.0 111.06 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 1.004 HD13 ' HB1' ' A' ' 146' ' ' ALA . 17.7 pt -66.94 111.79 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.529 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 75.3 p -75.07 156.46 36.07 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.505 0.669 . . . . 0.0 111.735 -177.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.462 HG22 ' HB3' ' A' ' 134' ' ' ALA . 0.2 OUTLIER -55.58 -40.71 60.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.697 -179.56 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -64.29 -27.51 69.09 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.114 179.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.529 ' HB2' ' O ' ' A' ' 159' ' ' THR . 82.6 m-20 -71.45 -53.27 14.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.835 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.726 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -64.43 -45.77 94.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.687 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -61.47 -48.64 80.21 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.043 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.469 ' HG3' ' N ' ' A' ' 166' ' ' TRP . 0.8 OUTLIER -57.71 -39.75 77.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.903 -179.718 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . 0.481 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 23.9 t90 -72.39 -48.36 42.14 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.754 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -52.21 -38.37 57.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.975 0.417 . . . . 0.0 110.445 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -77.3 -33.15 55.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.243 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 . . . . . 0 C--N 1.331 -0.197 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.577 179.789 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.612 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 N--CA 1.455 -0.207 0 CA-C-O 121.022 0.439 . . . . 0.0 111.098 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -153.83 94.33 1.75 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.645 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.48 ' HE2' ' HB3' ' A' ' 134' ' ' ALA . 20.2 ptm -47.03 166.64 0.18 Allowed Pre-proline 0 CA--C 1.533 0.306 0 CA-C-O 120.582 0.23 . . . . 0.0 110.936 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -65.62 -44.85 7.64 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.868 2.379 . . . . 0.0 112.826 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.48 ' HB3' ' HE2' ' A' ' 132' ' ' MET . . . -54.21 -53.62 51.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.372 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.571 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -68.29 -33.88 75.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.024 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.65 -49.88 64.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.587 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -58.28 -55.58 33.16 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.133 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.721 HD12 ' N ' ' A' ' 139' ' ' ALA . 4.4 pp -60.98 -40.67 94.33 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.615 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.721 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -57.55 -37.71 73.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.853 0.358 . . . . 0.0 110.66 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.8 tptp -76.9 -30.07 56.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.771 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -83.32 -19.92 35.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.061 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.613 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.5 mt -94.5 -28.89 15.21 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.864 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.53 37.76 7.95 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.607 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.488 HD13 ' CG2' ' A' ' 149' ' ' VAL . 1.4 tt -118.36 143.07 30.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.809 0.337 . . . . 0.0 111.181 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.539 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.9 OUTLIER -74.63 101.12 4.14 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.372 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.975 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -49.78 -28.81 6.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.689 0.28 . . . . 0.0 111.099 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.42 -37.65 87.56 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.539 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -66.25 -22.23 66.31 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 177.578 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.488 ' CG2' HD13 ' A' ' 144' ' ' ILE . 21.3 t -88.37 85.58 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.623 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.5 ptmt -50.7 92.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.986 0.422 . . . . 0.0 111.149 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.512 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -68.02 136.29 30.71 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.064 -0.589 . . . . 0.0 113.339 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.52 10.71 12.7 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.738 0.304 . . . . 0.0 110.819 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.46 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -72.29 154.68 50.82 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.771 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -43.99 107.65 0.1 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.111 2.541 . . . . 0.0 112.886 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.51 18.38 28.36 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.364 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.612 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 75.58 22.27 75.54 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.634 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.486 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -84.6 124.21 39.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 117.069 0.434 . . . . 0.0 111.063 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.975 HD13 ' HB1' ' A' ' 146' ' ' ALA . 19.6 pt -63.59 111.59 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.539 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 48.9 p -75.4 156.53 35.28 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.555 0.693 . . . . 0.0 111.904 -177.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.479 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.54 -41.48 63.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.78 -179.524 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -64.26 -27.44 69.05 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.125 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.539 ' HB2' ' O ' ' A' ' 159' ' ' THR . 84.1 m-20 -70.61 -52.58 20.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.512 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.719 ' CB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -65.98 -45.77 90.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.579 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 10.5 mttm -62.71 -50.94 69.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.616 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.535 ' HG3' ' O ' ' A' ' 162' ' ' ASP . 1.8 ppt_? -57.83 -39.07 76.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.607 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . 0.487 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 26.6 t90 -71.49 -48.42 49.18 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.59 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -51.66 -38.3 54.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.52 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -77.24 -32.81 56.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.158 179.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.983 0.421 . . . . 0.0 110.35 179.462 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.579 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.977 0.418 . . . . 0.0 111.019 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -152.52 95.27 2.0 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.862 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 9.8 ptp -47.44 166.93 0.18 Allowed Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.842 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -65.67 -46.28 5.43 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.859 2.373 . . . . 0.0 112.943 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.44 ' HB3' HG22 ' A' ' 160' ' ' VAL . . . -54.28 -52.42 61.48 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.401 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.566 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -68.34 -34.19 75.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.124 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.74 -49.34 63.06 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.252 0.548 . . . . 0.0 110.585 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 7.5 tpt180 -57.37 -55.55 33.3 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.838 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.722 HD12 ' N ' ' A' ' 139' ' ' ALA . 4.3 pp -62.33 -41.14 98.32 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.562 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.722 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -56.45 -39.72 73.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.974 0.416 . . . . 0.0 110.956 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.65 -29.86 56.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.75 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -82.41 -19.04 39.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.083 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.603 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.4 mt -95.64 -28.86 14.61 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.866 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.05 37.08 7.95 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.661 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.49 HD13 ' CG2' ' A' ' 149' ' ' VAL . 1.8 tt -118.34 143.02 30.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.803 0.335 . . . . 0.0 111.232 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.565 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 1.9 t0 -74.47 101.1 4.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.803 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 1.013 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -49.6 -28.95 6.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.595 0.236 . . . . 0.0 111.294 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.08 -36.98 84.63 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.565 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -66.68 -21.44 66.09 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 177.46 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.504 HG21 HG13 ' A' ' 163' ' ' VAL . 21.4 t -89.16 86.02 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.497 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.71 93.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.965 0.412 . . . . 0.0 111.124 -179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.519 ' HA3' ' HA ' ' A' ' 158' ' ' ILE . . . -70.82 139.2 29.56 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 121.001 -0.619 . . . . 0.0 113.419 -179.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -118.56 10.38 12.56 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.721 0.296 . . . . 0.0 110.846 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.475 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -71.19 152.69 50.2 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.746 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.402 ' O ' HG13 ' A' ' 157' ' ' VAL . 82.4 Cg_exo -44.68 111.04 0.26 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.059 2.506 . . . . 0.0 112.722 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 96.43 14.22 45.25 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.289 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.579 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 79.41 22.11 65.6 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.674 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.475 HG22 ' HA3' ' A' ' 153' ' ' GLY . 1.2 m -85.22 125.66 40.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 117.121 0.461 . . . . 0.0 110.961 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 1.013 HD13 ' HB1' ' A' ' 146' ' ' ALA . 18.8 pt -65.33 111.74 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.532 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 55.0 p -75.15 156.43 35.94 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.523 0.678 . . . . 0.0 111.723 -177.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.467 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.33 -40.78 58.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.787 -179.503 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.416 ' O ' ' HG2' ' A' ' 165' ' ' ARG . 55.7 tt0 -64.62 -27.47 68.96 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.171 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.532 ' HB2' ' O ' ' A' ' 159' ' ' THR . 72.4 m-20 -70.74 -53.6 14.94 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.749 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.709 ' CB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -63.62 -48.15 88.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.406 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 16.9 mttp -60.24 -46.34 90.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.561 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.516 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 24.8 ptt180 -60.1 -39.23 85.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.779 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . 0.455 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 30.2 t90 -72.73 -48.15 41.03 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.843 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -52.47 -37.78 57.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.997 0.427 . . . . 0.0 110.476 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -77.26 -33.66 55.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.056 179.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.149 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.271 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.583 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 N--CA 1.453 -0.281 0 CA-C-O 121.11 0.481 . . . . 0.0 111.052 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.438 ' HB1' ' HG2' ' A' ' 136' ' ' ARG . . . -151.54 94.71 2.04 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.688 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.409 ' HE2' ' HB3' ' A' ' 134' ' ' ALA . 22.4 ptm -48.63 166.66 0.22 Allowed Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.005 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.402 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 21.7 Cg_exo -66.19 -45.25 5.84 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.878 2.385 . . . . 0.0 112.818 -178.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.409 ' HB3' ' HE2' ' A' ' 132' ' ' MET . . . -54.32 -52.2 62.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.268 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.533 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -70.28 -32.45 70.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.875 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.438 ' HG2' ' HB1' ' A' ' 131' ' ' ALA . 0.1 OUTLIER -68.02 -47.94 67.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.256 179.475 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -59.97 -54.81 41.67 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.033 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.725 HD11 ' CB ' ' A' ' 163' ' ' VAL . 4.3 pp -62.52 -40.8 97.93 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.589 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.712 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -57.08 -38.81 73.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.892 0.377 . . . . 0.0 110.683 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.97 -29.81 55.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.827 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -82.4 -21.21 35.91 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.069 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.622 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.6 mt -94.02 -28.91 15.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.925 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.75 38.39 8.11 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.461 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.521 HD13 ' CG2' ' A' ' 149' ' ' VAL . 0.6 OUTLIER -116.6 143.21 27.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.865 0.365 . . . . 0.0 111.19 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.468 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.9 OUTLIER -74.84 100.88 4.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.469 . . . . 0.0 109.852 179.185 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 1.035 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -53.27 -33.81 54.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.665 0.269 . . . . 0.0 111.109 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.9 -36.69 75.12 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.051 0.453 . . . . 0.0 109.805 179.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.512 ' HE2' ' CE2' ' A' ' 166' ' ' TRP . 0.0 OUTLIER -67.92 -30.45 69.78 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.846 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.521 ' CG2' HD13 ' A' ' 144' ' ' ILE . 8.1 t -78.2 81.79 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.379 179.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.47 ' O ' ' HG3' ' A' ' 150' ' ' LYS . 2.0 ptpp? -50.51 93.25 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.266 0.555 . . . . 0.0 111.105 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.552 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -63.1 139.04 44.18 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.605 -0.725 . . . . 0.0 113.492 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.55 13.66 13.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.752 0.311 . . . . 0.0 110.608 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.433 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -80.14 154.97 37.76 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.736 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_exo -43.23 108.79 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.161 2.574 . . . . 0.0 112.972 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 96.95 16.94 34.06 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.377 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.583 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 76.17 22.33 73.91 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.634 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.502 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -83.0 125.6 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.173 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 1.035 HD13 ' HB1' ' A' ' 146' ' ' ALA . 18.2 pt -64.4 111.23 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.493 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 25.7 p -75.29 156.32 35.75 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.639 0.733 . . . . 0.0 111.792 -177.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.537 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -56.59 -39.82 65.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.649 -179.643 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.576 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 0.4 OUTLIER -63.69 -29.75 70.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.921 179.413 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.493 ' HB2' ' O ' ' A' ' 159' ' ' THR . 91.8 m-20 -68.97 -54.07 17.31 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.9 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.725 ' CB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -63.98 -41.91 94.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.766 -178.762 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.533 ' CG ' ' HA ' ' A' ' 161' ' ' GLU . 0.0 OUTLIER -64.84 -48.83 72.92 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.024 0.44 . . . . 0.0 111.418 -178.64 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.576 ' HG3' ' O ' ' A' ' 161' ' ' GLU . 8.5 mtm105 -57.62 -43.33 84.72 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.981 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . 0.512 ' CE2' ' HE2' ' A' ' 148' ' ' LYS . 61.9 t90 -68.09 -49.86 58.57 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.606 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -50.58 -39.55 49.93 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.856 0.36 . . . . 0.0 110.746 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.429 ' HG2' ' HA ' ' A' ' 165' ' ' ARG . 11.1 pt-20 -77.17 -29.18 54.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.485 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.455 -0.195 0 CA-C-O 121.208 0.528 . . . . 0.0 109.985 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.575 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 N--CA 1.456 -0.159 0 CA-C-O 121.039 0.447 . . . . 0.0 110.973 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.422 ' HB1' ' HG2' ' A' ' 136' ' ' ARG . . . -155.11 95.21 1.71 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.801 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.667 ' HE2' ' HB3' ' A' ' 134' ' ' ALA . 19.2 ptm -47.35 168.65 0.13 Allowed Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.873 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.435 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.0 Cg_exo -66.07 -45.34 5.98 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.772 2.315 . . . . 0.0 112.949 -178.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.667 ' HB3' ' HE2' ' A' ' 132' ' ' MET . . . -54.24 -53.35 54.83 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.442 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.553 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -69.63 -32.03 70.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.823 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.422 ' HG2' ' HB1' ' A' ' 131' ' ' ALA . 0.0 OUTLIER -67.41 -48.74 66.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.434 179.371 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -59.97 -55.13 37.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.042 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.721 HD12 ' N ' ' A' ' 139' ' ' ALA . 4.3 pp -62.52 -41.11 98.63 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.83 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.721 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -55.99 -41.76 75.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.863 0.363 . . . . 0.0 110.939 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -75.42 -29.84 59.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.9 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -80.9 -22.74 39.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.075 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.607 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.6 mt -92.09 -28.91 16.83 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.879 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.46 37.48 8.12 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.439 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.496 HD13 ' CG2' ' A' ' 149' ' ' VAL . 1.4 tt -117.85 141.53 36.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.828 0.347 . . . . 0.0 111.188 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.513 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 1.2 t0 -72.94 101.05 3.1 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.978 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -49.64 -28.59 6.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.688 0.28 . . . . 0.0 111.241 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.9 -37.27 85.67 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.513 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -65.8 -22.64 66.58 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 177.399 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.515 HG21 HG13 ' A' ' 163' ' ' VAL . 20.7 t -88.22 87.94 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.404 179.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.75 91.02 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.015 0.436 . . . . 0.0 111.267 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.507 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -68.51 132.86 27.54 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.904 -0.665 . . . . 0.0 113.093 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.433 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.2 OUTLIER -118.49 16.75 13.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.952 0.406 . . . . 0.0 110.812 179.624 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.459 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -77.67 154.32 41.69 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.655 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -43.93 107.56 0.1 OUTLIER 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.087 2.524 . . . . 0.0 112.813 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.75 18.76 26.68 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.236 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.575 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 74.94 22.18 77.26 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.671 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.479 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -84.76 125.47 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 CA-C-N 117.027 0.414 . . . . 0.0 110.992 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.978 HD13 ' HB1' ' A' ' 146' ' ' ALA . 19.1 pt -65.4 112.34 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.525 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 60.8 p -75.33 156.5 35.46 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.533 0.682 . . . . 0.0 111.891 -177.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.496 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.91 -40.55 63.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.743 -179.492 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.407 ' O ' ' HG2' ' A' ' 165' ' ' ARG . 20.2 mm-40 -65.21 -27.43 68.67 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.199 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 159' ' ' THR . 81.6 m-20 -70.43 -53.98 14.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.608 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.712 ' CB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -63.39 -47.71 90.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.412 179.928 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 10.7 mttm -60.41 -48.66 80.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.502 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.512 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 10.4 ptt180 -57.8 -39.98 78.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.882 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . 0.483 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 23.7 t90 -72.04 -48.14 46.66 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.778 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -52.19 -38.4 57.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.947 0.404 . . . . 0.0 110.58 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -77.24 -33.53 56.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.262 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 . . . . . 0 C--N 1.332 -0.163 0 CA-C-O 120.974 0.416 . . . . 0.0 110.443 179.579 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.581 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 N--CA 1.453 -0.279 0 CA-C-O 120.937 0.399 . . . . 0.0 110.789 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.43 ' HB1' ' HG2' ' A' ' 136' ' ' ARG . . . -151.13 94.98 2.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.857 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.417 ' HB2' ' CD ' ' A' ' 133' ' ' PRO . 9.5 ptm -46.96 167.73 0.15 Allowed Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.98 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.417 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.8 Cg_exo -65.49 -45.58 6.77 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.794 2.329 . . . . 0.0 112.885 -178.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.2 -53.48 52.91 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.365 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.593 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -68.99 -32.13 71.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.919 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.43 ' HG2' ' HB1' ' A' ' 131' ' ' ALA . 0.0 OUTLIER -68.36 -48.69 64.13 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.486 179.418 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.2 ttp85 -59.04 -55.74 31.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.073 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.732 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.3 pp -61.36 -41.04 96.43 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.647 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.717 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -57.4 -38.15 73.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.864 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.98 -29.78 55.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.767 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -83.83 -18.15 38.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.981 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.613 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.3 mt -96.14 -28.81 14.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.828 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.36 37.66 8.09 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.555 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.482 ' CD1' ' CE3' ' A' ' 166' ' ' TRP . 1.4 tt -118.45 142.33 33.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.717 0.294 . . . . 0.0 111.28 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.525 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.3 OUTLIER -73.96 101.09 3.72 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.899 179.282 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 1.002 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -49.91 -29.0 7.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.64 0.257 . . . . 0.0 111.204 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 32.3 t -65.03 -37.09 86.46 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.525 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -66.73 -22.91 66.05 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 177.679 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.555 HG21 HG13 ' A' ' 163' ' ' VAL . 20.3 t -86.9 84.03 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.72 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.76 92.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.012 0.434 . . . . 0.0 111.066 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.537 ' HA3' ' HA ' ' A' ' 158' ' ' ILE . . . -68.59 142.1 38.02 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.795 -0.639 . . . . 0.0 113.571 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.6 10.78 12.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.73 0.3 . . . . 0.0 110.779 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.47 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -75.19 151.92 42.8 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.771 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.453 ' O ' HG13 ' A' ' 157' ' ' VAL . 93.5 Cg_exo -43.86 114.74 0.57 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.057 2.505 . . . . 0.0 112.928 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 94.03 9.06 59.86 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.542 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.581 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 84.36 22.26 54.64 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.825 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.47 HG22 ' HA3' ' A' ' 153' ' ' GLY . 1.2 m -84.3 126.08 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 CA-C-N 117.055 0.428 . . . . 0.0 111.084 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 1.002 HD13 ' HB1' ' A' ' 146' ' ' ALA . 16.9 pt -66.57 111.49 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.535 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 45.6 p -75.33 156.53 35.45 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.584 0.706 . . . . 0.0 111.773 -177.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.472 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.31 -40.76 58.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.895 -179.483 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -64.22 -27.41 69.04 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.139 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.535 ' HB2' ' O ' ' A' ' 159' ' ' THR . 77.2 m-20 -71.47 -53.02 15.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.775 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.732 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -64.61 -45.5 95.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.321 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.409 ' CG ' ' N ' ' A' ' 165' ' ' ARG . 7.7 pttt -61.58 -49.08 78.08 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.209 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.493 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 4.2 ptm180 -57.96 -39.72 78.81 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.866 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . 0.482 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 23.2 t90 -72.16 -48.12 45.76 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.818 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -52.47 -38.3 59.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.035 0.445 . . . . 0.0 110.396 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -77.27 -32.38 55.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.12 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.456 -0.167 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.321 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.57 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 N--CA 1.455 -0.182 0 CA-C-O 120.916 0.389 . . . . 0.0 110.931 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.465 ' O ' ' HG3' ' A' ' 136' ' ' ARG . . . -151.61 96.3 2.23 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.859 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.434 ' HE3' ' CG2' ' A' ' 157' ' ' VAL . 15.3 ptp -47.88 167.94 0.17 Allowed Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.718 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.409 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.0 Cg_exo -65.79 -47.29 3.99 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.81 2.34 . . . . 0.0 112.965 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.433 ' HB3' HG22 ' A' ' 160' ' ' VAL . . . -54.28 -50.76 66.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.43 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.548 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -69.2 -34.7 75.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.236 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 131' ' ' ALA . 0.9 OUTLIER -67.6 -48.54 66.52 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.265 0.555 . . . . 0.0 110.397 179.484 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 66.2 ttt180 -57.59 -54.42 47.08 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.931 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.738 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.3 pp -64.15 -40.85 97.03 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.51 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.731 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -58.92 -37.98 77.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.92 0.39 . . . . 0.0 110.803 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.02 -29.77 55.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.662 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -81.59 -24.92 36.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.966 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.661 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.7 mt -90.88 -28.93 17.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.068 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.36 38.91 7.5 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.846 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.494 HD13 ' CG2' ' A' ' 149' ' ' VAL . 1.2 tt -118.62 140.74 41.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.735 0.302 . . . . 0.0 111.229 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.569 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.6 OUTLIER -71.57 100.89 2.36 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.299 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 1.029 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -50.51 -31.12 14.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.44 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 29.5 m -64.6 -36.1 83.16 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.569 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -65.44 -25.15 67.39 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 177.31 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.541 HG21 HG13 ' A' ' 163' ' ' VAL . 21.9 t -84.2 85.99 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.449 178.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.73 90.75 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.111 0.481 . . . . 0.0 111.224 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' ' 158' ' ' ILE . . . -66.06 141.28 41.2 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.82 -0.627 . . . . 0.0 113.247 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.46 10.95 12.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.707 0.289 . . . . 0.0 110.739 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.422 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -77.42 151.91 38.85 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.569 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.554 ' O ' HG13 ' A' ' 157' ' ' VAL . 82.2 Cg_exo -41.43 122.05 1.69 Allowed 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.244 2.629 . . . . 0.0 113.244 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 88.31 -2.93 85.42 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.773 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.57 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 96.79 22.21 18.92 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.674 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.554 HG13 ' O ' ' A' ' 154' ' ' PRO . 1.2 m -83.5 127.37 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.156 0 CA-C-N 117.092 0.446 . . . . 0.0 111.221 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 1.029 HD13 ' HB1' ' A' ' 146' ' ' ALA . 15.1 pt -67.85 111.87 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 178.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.527 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 62.9 p -75.08 156.49 36.03 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.625 0.726 . . . . 0.0 111.693 -177.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.472 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.59 -41.0 62.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.917 -179.407 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.523 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 0.9 OUTLIER -64.0 -27.73 69.32 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.919 179.387 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.527 ' HB2' ' O ' ' A' ' 159' ' ' THR . 87.3 m-20 -69.98 -54.37 13.58 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.318 0.58 . . . . 0.0 110.495 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.738 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -65.19 -40.81 89.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.725 -179.59 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -65.61 -46.66 78.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.903 0.382 . . . . 0.0 111.428 -178.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.523 ' HG3' ' O ' ' A' ' 161' ' ' GLU . 26.8 mtp180 -62.6 -38.57 90.68 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.885 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . 0.478 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 19.6 t90 -71.4 -50.12 35.17 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.71 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -51.93 -38.36 56.09 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.002 0.43 . . . . 0.0 110.571 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.456 ' HG2' ' HA ' ' A' ' 165' ' ' ARG . 8.4 pt-20 -76.78 -31.35 56.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.254 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 . . . . . 0 N--CA 1.456 -0.143 0 CA-C-O 120.957 0.408 . . . . 0.0 110.535 179.524 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.575 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 N--CA 1.454 -0.234 0 CA-C-O 120.866 0.365 . . . . 0.0 110.762 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -151.44 95.79 2.19 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.983 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.736 ' HE2' ' HB3' ' A' ' 134' ' ' ALA . 18.3 ptm -47.88 167.76 0.17 Allowed Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.664 -0.244 . . . . 0.0 110.805 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.417 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.4 Cg_exo -65.75 -46.26 5.31 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.776 2.317 . . . . 0.0 112.963 -178.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.736 ' HB3' ' HE2' ' A' ' 132' ' ' MET . . . -54.28 -52.41 61.52 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.449 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.59 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -68.78 -33.56 74.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.019 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.7 mtp180 -68.37 -48.89 63.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.553 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.2 tpt85 -57.78 -55.73 31.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.734 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.716 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.4 pp -61.65 -38.71 88.74 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.329 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.704 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -58.98 -39.47 81.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.807 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.19 -29.82 57.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.757 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -81.54 -24.35 36.65 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.993 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.658 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.5 mt -90.27 -28.89 18.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.018 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.05 37.37 7.82 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.836 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.478 HD13 ' CG2' ' A' ' 149' ' ' VAL . 1.4 tt -119.07 142.47 34.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.788 0.328 . . . . 0.0 111.213 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.558 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.6 OUTLIER -73.78 101.06 3.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.871 179.394 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 1.019 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -49.49 -30.56 8.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.735 0.302 . . . . 0.0 111.303 -179.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 20.4 m -65.11 -36.46 84.37 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.558 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -66.27 -23.79 66.46 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.415 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.539 HG21 HG13 ' A' ' 163' ' ' VAL . 22.0 t -85.27 85.01 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.478 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.65 90.99 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.096 0.474 . . . . 0.0 111.175 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.502 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -66.27 142.67 43.19 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.798 -0.637 . . . . 0.0 113.394 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.46 1.27 11.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.692 0.282 . . . . 0.0 110.838 179.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.432 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -66.56 152.25 52.37 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.551 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.534 ' O ' HG13 ' A' ' 157' ' ' VAL . 86.6 Cg_exo -42.32 120.09 1.52 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.179 2.586 . . . . 0.0 113.126 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 90.12 -0.24 78.4 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.682 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.575 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 93.89 22.25 26.15 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.697 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 154' ' ' PRO . 1.2 m -83.51 126.09 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 CA-C-N 117.038 0.419 . . . . 0.0 111.214 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 1.019 HD13 ' HB1' ' A' ' 146' ' ' ALA . 16.4 pt -65.69 111.31 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 178.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.554 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 55.4 p -75.22 156.5 35.7 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.487 0.66 . . . . 0.0 111.909 -177.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.461 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.73 -41.86 58.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.888 -179.425 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.4 ' O ' ' CG ' ' A' ' 165' ' ' ARG . 21.7 tt0 -63.99 -27.48 69.15 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.069 179.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.565 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 83.9 m-20 -70.75 -52.16 22.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.648 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.716 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -65.95 -46.76 87.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.489 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.2 mtmp? -61.3 -51.22 69.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.468 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.565 ' HG3' ' O ' ' A' ' 162' ' ' ASP . 0.1 OUTLIER -57.74 -38.8 75.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.895 -179.787 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . 0.477 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 27.3 t90 -71.53 -48.2 50.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.784 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -52.22 -37.91 56.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.976 0.417 . . . . 0.0 110.559 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -77.2 -32.3 55.88 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.083 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 . . . . . 0 C--N 1.333 -0.146 0 CA-C-O 120.956 0.408 . . . . 0.0 110.383 179.487 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.608 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 N--CA 1.454 -0.244 0 CA-C-O 120.949 0.404 . . . . 0.0 110.852 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.447 ' HB1' ' HG2' ' A' ' 136' ' ' ARG . . . -147.83 94.67 2.38 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.848 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.488 ' HE3' ' CG2' ' A' ' 157' ' ' VAL . 17.9 ptp -47.3 166.56 0.19 Allowed Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.064 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.406 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 21.8 Cg_exo -65.74 -46.57 4.9 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.883 2.389 . . . . 0.0 112.867 -179.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.418 ' HB3' HG22 ' A' ' 160' ' ' VAL . . . -54.29 -50.84 66.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.259 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.594 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -70.49 -36.08 73.61 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.018 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.447 ' HG2' ' HB1' ' A' ' 131' ' ' ALA . 0.2 OUTLIER -64.87 -46.83 80.17 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.359 0.6 . . . . 0.0 110.135 179.357 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.55 -58.71 7.42 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.031 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.83 HD11 ' HB ' ' A' ' 163' ' ' VAL . 3.9 pp -59.91 -43.93 94.57 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.516 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.694 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -53.5 -41.12 65.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.982 0.42 . . . . 0.0 110.828 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -73.02 -32.55 65.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.898 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -73.88 -46.51 44.2 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.001 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.559 HD13 ' O ' ' A' ' 138' ' ' LEU . 8.9 mp -72.21 -29.03 63.57 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.082 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.83 37.71 7.22 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.772 -0.728 . . . . 0.0 113.104 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.491 ' CD1' ' CE3' ' A' ' 166' ' ' TRP . 1.5 tt -114.5 141.94 29.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.736 0.303 . . . . 0.0 111.084 179.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.498 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 1.2 t0 -72.47 101.25 2.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.06 179.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.968 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -49.31 -28.29 4.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.764 0.316 . . . . 0.0 111.353 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 37.1 t -66.42 -37.77 85.94 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.498 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -66.13 -21.04 66.33 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.4 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.61 HG21 HG13 ' A' ' 163' ' ' VAL . 21.3 t -89.48 88.29 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.565 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 6.5 ttpt -50.62 93.66 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.009 0.433 . . . . 0.0 111.17 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.523 ' HA3' HG22 ' A' ' 158' ' ' ILE . . . -72.74 130.25 14.45 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.146 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.431 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.2 OUTLIER -118.48 20.15 13.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.024 0.44 . . . . 0.0 110.702 179.585 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.451 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -78.59 156.92 43.39 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.741 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -43.82 103.95 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.086 2.524 . . . . 0.0 112.992 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.73 22.17 14.55 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.2 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.608 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 72.99 22.15 79.34 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.637 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.488 ' CG2' ' HE3' ' A' ' 132' ' ' MET . 1.2 m -85.45 125.82 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 CA-C-N 117.031 0.415 . . . . 0.0 111.191 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.968 HD13 ' HB1' ' A' ' 146' ' ' ALA . 17.6 pt -65.49 110.67 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.513 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 71.8 p -75.12 156.37 36.08 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.491 0.663 . . . . 0.0 111.62 -177.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.49 HG13 HD23 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -56.5 -39.66 63.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.511 -179.724 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.602 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 0.5 OUTLIER -63.25 -28.51 70.08 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.768 179.1 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.513 ' HB2' ' O ' ' A' ' 159' ' ' THR . 91.1 m-20 -71.35 -52.56 18.06 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.826 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.83 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -67.21 -37.16 78.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.872 -179.183 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.485 ' HG3' ' N ' ' A' ' 165' ' ' ARG . 5.3 ptpt -70.9 -51.37 26.6 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.192 0.52 . . . . 0.0 111.14 -179.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.602 ' HG3' ' O ' ' A' ' 161' ' ' GLU . 49.3 mtm180 -57.81 -37.62 74.09 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.005 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . 0.491 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 46.8 t90 -68.9 -50.04 53.0 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.716 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -50.41 -43.11 54.63 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.507 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.433 ' HG2' ' HA ' ' A' ' 165' ' ' ARG . 7.2 pt-20 -71.26 -32.37 68.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.897 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 . . . . . 0 N--CA 1.456 -0.156 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.231 179.279 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.569 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 N--CA 1.455 -0.192 0 CA-C-O 120.855 0.36 . . . . 0.0 110.682 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.42 ' HB1' ' HG2' ' A' ' 136' ' ' ARG . . . -154.62 95.42 1.78 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.045 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.671 ' HB2' ' HD2' ' A' ' 133' ' ' PRO . 19.5 ptm -46.46 167.76 0.14 Allowed Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.558 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.671 ' HD2' ' HB2' ' A' ' 132' ' ' MET . 50.4 Cg_endo -71.88 -34.35 8.79 Favored 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 122.122 1.882 . . . . 0.0 112.5 -178.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.45 ' HB3' ' CE ' ' A' ' 132' ' ' MET . . . -59.71 -54.47 45.98 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.242 0.544 . . . . 0.0 110.649 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.635 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -69.53 -33.26 72.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.507 179.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.42 ' HG2' ' HB1' ' A' ' 131' ' ' ALA . 16.6 mmm-85 -66.49 -47.76 71.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.383 179.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.02 -55.89 28.43 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.9 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.735 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.4 pp -61.04 -40.19 92.68 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.536 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.721 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -57.87 -38.44 75.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.974 0.416 . . . . 0.0 110.791 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.52 -30.05 57.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.713 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -83.08 -19.85 36.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.953 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.628 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.3 mt -94.02 -28.88 15.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.886 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.71 37.36 8.03 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.746 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.479 ' CD1' ' CE3' ' A' ' 166' ' ' TRP . 1.6 tt -118.67 143.48 29.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.788 0.327 . . . . 0.0 111.306 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.547 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 1.3 t0 -74.39 101.04 3.96 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 1.033 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -50.2 -28.57 7.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.662 0.268 . . . . 0.0 111.37 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.19 -36.92 84.35 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.547 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -66.54 -21.91 66.16 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 177.524 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.509 HG21 HG13 ' A' ' 163' ' ' VAL . 21.7 t -88.0 85.76 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.61 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -50.7 92.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.988 0.423 . . . . 0.0 111.304 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.547 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -69.47 138.14 30.1 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.809 -0.632 . . . . 0.0 113.525 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.54 12.02 13.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.795 0.331 . . . . 0.0 110.788 179.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.45 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -74.5 154.76 47.78 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.786 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -43.85 108.23 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.034 2.489 . . . . 0.0 112.878 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.16 18.79 27.95 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.296 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.569 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 74.62 22.18 77.59 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.801 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.481 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -83.68 126.09 40.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 117.069 0.435 . . . . 0.0 111.192 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 1.033 HD13 ' HB1' ' A' ' 146' ' ' ALA . 19.0 pt -64.79 111.52 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 178.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.544 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 36.9 p -75.36 156.52 35.37 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.565 0.697 . . . . 0.0 111.813 -177.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.474 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.03 -41.27 58.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.719 -179.429 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -63.94 -27.51 69.19 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.183 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.544 ' HB2' ' O ' ' A' ' 159' ' ' THR . 83.1 m-20 -71.35 -51.59 23.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.731 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.735 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -66.9 -45.3 87.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.512 -179.884 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.423 ' CG ' ' N ' ' A' ' 165' ' ' ARG . 2.0 pttt -62.85 -50.34 71.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.385 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.537 ' HG3' ' O ' ' A' ' 162' ' ' ASP . 6.8 ppt_? -58.54 -40.01 81.81 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.895 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . 0.479 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 29.4 t90 -70.08 -48.55 57.27 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.85 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -51.99 -38.81 58.04 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.937 0.399 . . . . 0.0 110.68 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -76.48 -31.43 57.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.027 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 . . . . . 0 N--CA 1.455 -0.213 0 CA-C-O 120.926 0.393 . . . . 0.0 110.364 179.398 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.627 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 N--CA 1.454 -0.229 0 CA-C-O 121.061 0.457 . . . . 0.0 111.085 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -147.83 94.2 2.31 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.712 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.446 ' HG2' ' O ' ' A' ' 158' ' ' ILE . 14.8 ptp -47.41 166.04 0.2 Allowed Pre-proline 0 CA--C 1.532 0.252 0 CA-C-O 120.665 0.269 . . . . 0.0 110.991 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -66.21 -47.97 2.95 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.883 2.389 . . . . 0.0 113.069 -178.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.26 -48.38 71.25 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.666 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.584 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -71.16 -35.13 71.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.855 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 28.8 mtt180 -68.0 -45.76 73.16 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.155 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.3 tpt180 -59.12 -56.98 15.28 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.853 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.78 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -61.1 -41.49 96.77 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.624 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.729 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -56.47 -38.37 71.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.925 0.393 . . . . 0.0 110.907 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 9.6 ttmm -77.02 -30.73 55.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.799 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 51.5 tp10 -83.23 -16.18 47.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.185 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.565 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.1 mt -98.45 -28.92 13.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.915 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.72 35.35 8.48 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.672 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.487 HD13 ' CG2' ' A' ' 149' ' ' VAL . 1.5 tt -116.56 143.53 26.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.834 0.35 . . . . 0.0 111.241 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.504 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 1.9 t0 -76.07 101.47 5.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.917 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.944 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -49.4 -28.25 4.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.673 0.273 . . . . 0.0 111.075 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.4 p -65.96 -37.76 86.83 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.504 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -66.4 -21.24 66.22 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 177.573 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.564 HG21 HG13 ' A' ' 163' ' ' VAL . 20.4 t -89.69 86.45 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.696 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.2 ptmm? -50.67 93.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.934 0.397 . . . . 0.0 110.98 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.518 ' CA ' HG22 ' A' ' 158' ' ' ILE . . . -69.56 133.39 25.5 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.969 -0.634 . . . . 0.0 113.192 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.421 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.4 OUTLIER -118.46 15.56 13.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.963 0.411 . . . . 0.0 110.739 179.545 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.466 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -74.9 155.61 48.23 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.717 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -44.74 105.84 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.138 2.559 . . . . 0.0 112.824 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.35 20.16 21.04 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.209 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.627 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 74.81 22.07 77.57 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.674 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.469 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.1 m -85.91 125.08 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-N 117.08 0.44 . . . . 0.0 111.183 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.944 HD13 ' HB1' ' A' ' 146' ' ' ALA . 15.2 pt -64.69 110.31 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.533 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 67.0 p -75.16 156.58 35.76 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.611 0.719 . . . . 0.0 111.812 -177.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.471 HG13 HD23 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.97 -41.34 67.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.67 -179.656 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -63.78 -27.44 69.19 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.056 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.533 ' HB2' ' O ' ' A' ' 159' ' ' THR . 85.1 m-20 -71.49 -53.0 15.36 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.673 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.78 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -65.49 -45.23 93.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.364 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.41 ' CG ' ' N ' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -61.6 -49.1 77.96 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.11 -179.787 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.514 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 11.5 ptm180 -57.71 -40.4 79.45 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.755 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . 0.485 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 26.2 t90 -71.05 -48.83 50.49 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.747 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -51.55 -38.34 53.8 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.9 0.381 . . . . 0.0 110.592 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -77.21 -32.28 55.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.094 179.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 . . . . . 0 N--CA 1.456 -0.16 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.227 179.386 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.564 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 N--CA 1.454 -0.232 0 CA-C-O 120.895 0.379 . . . . 0.0 110.957 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.456 ' HB1' ' HG2' ' A' ' 136' ' ' ARG . . . -151.41 94.91 2.08 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.874 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.417 ' HB2' ' CD ' ' A' ' 133' ' ' PRO . 9.5 ptm -48.09 167.5 0.19 Allowed Pre-proline 0 CA--C 1.531 0.226 0 CA-C-O 120.61 0.243 . . . . 0.0 110.941 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.417 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.3 Cg_exo -65.9 -45.55 6.03 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.879 2.386 . . . . 0.0 112.864 -179.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.28 -53.1 58.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.397 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.577 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -69.55 -32.62 71.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.865 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.456 ' HG2' ' HB1' ' A' ' 131' ' ' ALA . 14.9 mmm-85 -67.82 -48.03 67.36 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.376 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 13.8 ttt85 -59.85 -55.39 34.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.083 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.732 HD12 ' N ' ' A' ' 139' ' ' ALA . 4.3 pp -61.67 -41.13 97.13 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.678 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.732 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -56.49 -40.88 75.69 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.954 0.407 . . . . 0.0 110.998 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.3 mtmm -75.9 -29.74 58.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.97 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -82.3 -19.83 38.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.163 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.621 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.4 mt -95.0 -28.82 14.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.87 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.75 37.91 7.75 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.484 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.538 HD13 ' CG2' ' A' ' 149' ' ' VAL . 0.6 OUTLIER -117.86 143.85 27.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.738 0.304 . . . . 0.0 111.201 -179.956 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.474 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.5 OUTLIER -76.11 100.97 5.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.013 179.415 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 1.003 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -51.85 -34.83 42.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.644 0.259 . . . . 0.0 111.252 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.16 -36.59 75.56 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.524 ' HE2' ' CD1' ' A' ' 166' ' ' TRP . 0.0 OUTLIER -67.61 -30.5 70.11 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 177.666 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.538 ' CG2' HD13 ' A' ' 144' ' ' ILE . 10.7 t -78.0 83.28 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.384 178.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.53 94.39 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.142 0.496 . . . . 0.0 111.115 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.537 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -68.18 137.38 31.4 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.695 -0.684 . . . . 0.0 113.36 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.54 13.21 13.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.767 0.318 . . . . 0.0 110.748 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.45 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -76.13 155.75 46.33 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.679 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_exo -43.26 106.41 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.133 2.555 . . . . 0.0 112.92 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.81 20.15 22.44 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.362 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.564 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 73.94 22.21 78.28 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.7 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.487 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -84.01 125.58 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 117.016 0.408 . . . . 0.0 111.031 -179.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 1.003 HD13 ' HB1' ' A' ' 146' ' ' ALA . 19.9 pt -64.57 111.35 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.54 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 38.6 p -75.33 156.43 35.53 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.559 0.695 . . . . 0.0 111.689 -177.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.477 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.76 -41.06 64.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.887 -179.4 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -64.58 -27.56 69.03 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.124 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.54 ' HB2' ' O ' ' A' ' 159' ' ' THR . 89.7 m-20 -69.47 -55.34 10.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.372 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.719 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -63.25 -44.19 99.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.683 -179.917 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 160' ' ' VAL . 11.8 mttp -64.0 -40.89 97.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.391 -179.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.545 ' HG3' ' N ' ' A' ' 166' ' ' TRP . 0.0 OUTLIER -64.24 -38.48 91.2 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.83 -179.801 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . 0.545 ' N ' ' HG3' ' A' ' 165' ' ' ARG . 62.8 t90 -73.88 -47.77 35.7 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.659 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -54.14 -37.08 64.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.919 0.39 . . . . 0.0 110.443 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.415 ' HG2' ' HA ' ' A' ' 165' ' ' ARG . 8.3 pt-20 -77.25 -33.34 56.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.074 179.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.165 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.443 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.587 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 N--CA 1.456 -0.162 0 CA-C-O 121.063 0.458 . . . . 0.0 110.788 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -153.99 95.52 1.86 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.841 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.696 ' HE2' ' HB3' ' A' ' 134' ' ' ALA . 16.7 ptm -47.22 168.02 0.15 Allowed Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.673 -0.239 . . . . 0.0 110.865 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.42 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 23.3 Cg_exo -65.41 -44.84 8.11 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.669 2.246 . . . . 0.0 112.922 -178.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.696 ' HB3' ' HE2' ' A' ' 132' ' ' MET . . . -54.32 -52.9 60.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.367 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.577 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -69.09 -33.2 73.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.052 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.36 -48.54 67.16 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.274 0.559 . . . . 0.0 110.322 179.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 18.2 ttp180 -58.63 -54.23 49.36 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.188 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.75 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -64.08 -41.64 97.24 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.804 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.744 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -58.08 -38.82 77.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.925 0.393 . . . . 0.0 110.985 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.97 -29.86 55.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.671 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -83.28 -17.92 40.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.124 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.649 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.4 mt -96.88 -28.89 14.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.872 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.69 37.7 7.88 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.455 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.51 HD13 ' CG2' ' A' ' 149' ' ' VAL . 1.4 tt -117.85 141.02 38.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.831 0.348 . . . . 0.0 111.288 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.52 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.6 OUTLIER -73.09 101.06 3.18 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.159 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 1.007 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -50.16 -28.63 7.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.307 -179.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.98 -37.04 84.96 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.52 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -65.09 -23.27 67.11 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 177.237 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.51 ' CG2' HD13 ' A' ' 144' ' ' ILE . 19.0 t -88.54 90.22 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.328 179.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.62 91.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.085 0.469 . . . . 0.0 111.125 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.567 ' HA3' HG22 ' A' ' 158' ' ' ILE . . . -69.36 125.88 18.46 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.934 -0.65 . . . . 0.0 113.047 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.439 ' OG1' ' O ' ' A' ' 152' ' ' THR . 0.1 OUTLIER -118.56 31.87 6.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.159 0.504 . . . . 0.0 110.292 179.708 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.45 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -91.47 156.76 24.25 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.679 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_exo -43.46 101.1 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 123.065 2.51 . . . . 0.0 113.022 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 99.83 25.77 8.91 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.315 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.587 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 70.16 22.1 77.28 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.602 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.47 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -86.27 126.46 40.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.017 -179.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 1.007 HD13 ' HB1' ' A' ' 146' ' ' ALA . 18.9 pt -66.06 112.01 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.518 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 47.4 p -75.33 156.43 35.54 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.485 0.66 . . . . 0.0 111.668 -177.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.509 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -56.98 -40.31 71.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.681 -179.721 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.539 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 2.1 tt0 -62.76 -27.73 69.49 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.863 179.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.518 ' HB2' ' O ' ' A' ' 159' ' ' THR . 91.2 m-20 -71.45 -53.9 12.44 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.342 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.75 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -67.08 -34.48 69.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.413 -179.479 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.434 ' HB3' ' O ' ' A' ' 160' ' ' VAL . 0.0 OUTLIER -69.28 -47.84 63.42 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-O 121.047 0.451 . . . . 0.0 110.892 -179.387 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.539 ' HG3' ' O ' ' A' ' 161' ' ' GLU . 15.1 mtp180 -60.39 -41.53 94.02 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.176 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . 0.478 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 13.4 t90 -70.67 -50.16 39.66 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.826 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -50.56 -38.69 46.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.002 0.429 . . . . 0.0 110.682 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -77.28 -32.54 55.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.555 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 . . . . . 0 C--N 1.333 -0.117 0 CA-C-O 120.933 0.397 . . . . 0.0 110.564 179.714 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.584 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 N--CA 1.454 -0.252 0 CA-C-O 120.964 0.411 . . . . 0.0 111.114 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.427 ' O ' ' HG3' ' A' ' 136' ' ' ARG . . . -151.23 95.79 2.21 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.693 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.41 ' HB2' ' CD ' ' A' ' 133' ' ' PRO . 16.0 ptp -47.02 167.74 0.15 Allowed Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.917 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.41 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.1 Cg_exo -65.86 -47.66 3.58 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.811 2.341 . . . . 0.0 112.746 -179.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.478 ' HB3' HG22 ' A' ' 160' ' ' VAL . . . -54.28 -50.38 67.41 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.347 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.572 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -69.9 -33.87 72.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.013 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.427 ' HG3' ' O ' ' A' ' 131' ' ' ALA . 0.2 OUTLIER -67.75 -47.71 68.46 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.324 0.583 . . . . 0.0 110.329 179.339 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.15 -54.42 47.2 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.217 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.746 HD12 ' N ' ' A' ' 139' ' ' ALA . 4.3 pp -63.59 -42.08 98.31 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.784 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.746 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -58.59 -37.25 75.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.865 0.364 . . . . 0.0 110.791 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -77.0 -29.75 55.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.781 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -81.97 -24.78 35.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.038 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.643 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.9 mt -90.99 -28.85 17.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.876 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.53 36.62 8.57 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.545 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.5 HD13 ' CG2' ' A' ' 149' ' ' VAL . 1.4 tt -114.87 142.37 27.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.875 0.369 . . . . 0.0 111.243 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.514 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 1.9 t0 -74.45 101.03 4.0 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 1.005 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -50.22 -28.44 7.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.703 0.287 . . . . 0.0 111.301 -179.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.54 -37.27 86.22 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.514 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -65.85 -22.63 66.55 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.514 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.534 HG21 HG13 ' A' ' 163' ' ' VAL . 20.1 t -88.41 86.48 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.589 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.5 tppt? -50.78 92.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.033 0.444 . . . . 0.0 110.976 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.521 ' HA3' ' HA ' ' A' ' 158' ' ' ILE . . . -70.01 140.52 32.91 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 115.876 -0.602 . . . . 0.0 113.122 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.46 9.46 12.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.677 0.275 . . . . 0.0 110.881 179.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.462 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -70.89 150.36 47.65 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.613 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.569 ' O ' HG13 ' A' ' 157' ' ' VAL . 94.3 Cg_exo -42.77 123.86 3.2 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.137 2.558 . . . . 0.0 113.081 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 87.82 -5.86 84.3 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.601 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.584 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 100.74 22.25 11.34 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.705 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.569 HG13 ' O ' ' A' ' 154' ' ' PRO . 1.2 m -86.09 127.13 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 CA-C-N 117.087 0.443 . . . . 0.0 111.198 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 1.005 HD13 ' HB1' ' A' ' 146' ' ' ALA . 14.5 pt -67.35 111.96 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 177.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.525 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 76.1 p -75.1 156.54 35.92 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.54 0.686 . . . . 0.0 111.536 -177.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.513 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -56.37 -40.72 68.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.873 -179.348 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.535 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 0.1 OUTLIER -62.81 -29.15 70.5 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.748 179.364 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 159' ' ' THR . 87.3 m-20 -69.36 -54.38 14.77 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.371 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.746 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -65.79 -34.62 71.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.0 -179.584 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.414 ' HB3' ' O ' ' A' ' 160' ' ' VAL . 0.2 OUTLIER -67.23 -47.67 70.12 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 121.014 0.435 . . . . 0.0 110.735 -179.64 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.535 ' HG3' ' O ' ' A' ' 161' ' ' GLU . 68.6 mtt-85 -59.26 -44.48 92.41 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.043 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . 0.484 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 10.4 t90 -70.06 -50.1 44.5 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.959 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -50.53 -38.43 44.66 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.937 0.399 . . . . 0.0 110.627 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -77.31 -31.69 54.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.503 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.902 0.382 . . . . 0.0 110.593 179.698 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.556 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 CA--C 1.522 -0.126 0 CA-C-O 120.882 0.373 . . . . 0.0 110.567 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -153.07 96.64 2.1 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.206 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.679 ' HB2' ' HD2' ' A' ' 133' ' ' PRO . 14.9 ptp -45.64 168.34 0.1 Allowed Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.546 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.679 ' HD2' ' HB2' ' A' ' 132' ' ' MET . 50.0 Cg_endo -71.44 -35.64 7.92 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.062 1.841 . . . . 0.0 112.363 -179.064 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.79 -52.45 65.01 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.759 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.639 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -70.43 -32.73 70.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.672 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 2.3 mmt85 -68.3 -46.11 71.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.079 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.63 -55.66 31.6 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.831 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.752 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -62.59 -42.08 99.34 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.641 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.737 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -57.99 -36.75 73.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.92 0.391 . . . . 0.0 110.778 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 3.8 mtmt -77.02 -30.76 55.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.555 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -82.93 -18.5 39.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.1 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.621 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.5 mt -96.66 -28.83 14.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.91 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.56 38.8 8.01 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.521 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.486 HD13 ' CG2' ' A' ' 149' ' ' VAL . 1.3 tt -118.43 141.72 36.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.696 0.284 . . . . 0.0 111.33 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.559 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.7 OUTLIER -73.18 100.97 3.21 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.181 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 1.006 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -50.45 -30.46 12.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.47 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 15.8 m -64.61 -36.16 83.34 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.559 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -66.05 -24.9 66.83 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 177.417 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.595 HG21 HG13 ' A' ' 163' ' ' VAL . 20.6 t -84.46 85.2 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.458 179.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.6 91.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.045 0.45 . . . . 0.0 111.124 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.575 ' HA3' ' HA ' ' A' ' 158' ' ' ILE . . . -70.03 143.09 37.3 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.808 -0.633 . . . . 0.0 113.415 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.56 9.1 12.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.714 0.292 . . . . 0.0 110.793 179.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.428 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -72.84 151.29 45.76 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.698 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.596 ' O ' HG13 ' A' ' 157' ' ' VAL . 86.5 Cg_exo -41.57 124.59 2.54 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.2 2.6 . . . . 0.0 113.197 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 86.48 -5.66 84.07 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.631 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.556 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 100.0 22.24 12.38 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.719 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.596 HG13 ' O ' ' A' ' 154' ' ' PRO . 1.2 m -84.47 128.84 38.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 117.096 0.448 . . . . 0.0 111.236 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 1.006 HD13 ' HB1' ' A' ' 146' ' ' ALA . 14.5 pt -68.61 111.75 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 177.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.53 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 72.2 p -75.0 156.45 36.25 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.495 0.664 . . . . 0.0 111.637 -177.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.494 HG13 HD23 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.55 -40.69 60.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.877 -179.467 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.533 ' O ' ' CG ' ' A' ' 165' ' ' ARG . 0.6 OUTLIER -63.6 -27.8 69.49 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.835 179.434 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.53 ' HB2' ' O ' ' A' ' 159' ' ' THR . 86.6 m-20 -70.99 -53.71 13.87 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.593 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.752 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -65.36 -37.87 81.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.155 -179.585 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.9 pttt -65.61 -47.35 75.97 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.977 0.418 . . . . 0.0 110.793 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.533 ' CG ' ' O ' ' A' ' 161' ' ' GLU . 4.9 mmt180 -59.61 -42.54 92.85 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.089 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . 0.477 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 13.1 t90 -69.83 -50.12 45.9 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.599 -0.441 . . . . 0.0 110.952 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -50.64 -38.84 48.41 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.843 0.354 . . . . 0.0 110.614 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -77.3 -31.61 54.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.37 179.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.953 0.406 . . . . 0.0 110.435 179.577 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.616 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 C--O 1.232 0.142 0 CA-C-O 121.109 0.48 . . . . 0.0 111.157 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.412 ' O ' ' HG3' ' A' ' 136' ' ' ARG . . . -151.36 95.28 2.13 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.801 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.439 ' HG2' ' O ' ' A' ' 158' ' ' ILE . 18.1 ptp -47.47 166.54 0.19 Allowed Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.985 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -66.24 -47.31 3.41 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.814 2.342 . . . . 0.0 112.978 -178.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.511 ' HB3' HG22 ' A' ' 160' ' ' VAL . . . -54.1 -50.62 66.43 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.456 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.555 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -69.29 -34.9 75.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.22 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.412 ' HG3' ' O ' ' A' ' 131' ' ' ALA . 0.2 OUTLIER -67.93 -48.49 65.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.156 0.503 . . . . 0.0 110.453 179.495 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.8 ttp-105 -57.53 -55.2 37.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.971 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.73 HD12 ' N ' ' A' ' 139' ' ' ALA . 4.4 pp -61.93 -41.14 97.62 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.486 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.73 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -57.9 -38.04 75.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.965 0.412 . . . . 0.0 110.868 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -76.85 -29.68 55.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.784 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -83.58 -20.08 34.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.033 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.635 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.4 mt -94.5 -28.95 15.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.851 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.98 35.67 8.88 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.645 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.538 HD13 ' CG2' ' A' ' 149' ' ' VAL . 1.9 tt -115.77 142.75 27.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.792 0.33 . . . . 0.0 111.3 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.566 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.9 OUTLIER -75.22 101.11 4.52 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.2 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 1.01 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -49.15 -29.04 4.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.672 0.272 . . . . 0.0 111.301 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.29 -37.43 85.43 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.566 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -65.78 -21.07 66.47 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 177.269 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.538 ' CG2' HD13 ' A' ' 144' ' ' ILE . 19.6 t -91.17 90.15 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.403 179.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.54 93.91 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.036 0.446 . . . . 0.0 111.015 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.601 ' HA3' HG22 ' A' ' 158' ' ' ILE . . . -72.79 126.34 10.64 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.815 -0.629 . . . . 0.0 113.035 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.447 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -118.49 31.62 6.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.153 0.501 . . . . 0.0 110.42 179.707 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.434 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -89.15 158.07 27.59 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.571 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -43.82 102.06 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.043 2.496 . . . . 0.0 112.945 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.78 24.58 10.6 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.382 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.616 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 71.71 22.17 78.74 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.748 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.48 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -87.03 126.99 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 CA-C-N 117.06 0.43 . . . . 0.0 111.328 -179.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 1.01 HD13 ' HB1' ' A' ' 146' ' ' ALA . 19.7 pt -65.77 111.9 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 177.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.516 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 70.2 p -75.07 156.32 36.23 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.612 0.72 . . . . 0.0 111.595 -177.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.519 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -56.24 -40.06 63.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.876 -179.561 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.587 ' O ' ' CG ' ' A' ' 165' ' ' ARG . 1.2 tp10 -65.28 -30.22 71.06 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.781 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.516 ' HB2' ' O ' ' A' ' 159' ' ' THR . 80.5 m-20 -65.7 -56.05 14.15 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.308 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.715 ' CB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -62.14 -41.39 91.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.165 -179.988 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -65.19 -41.72 94.28 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.555 -179.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.587 ' CG ' ' O ' ' A' ' 161' ' ' GLU . 0.1 OUTLIER -62.46 -44.59 96.04 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.661 179.916 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . 0.446 ' CZ2' ' HD2' ' A' ' 148' ' ' LYS . 18.5 t90 -68.32 -50.18 55.23 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.856 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -51.19 -39.4 56.39 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.887 0.375 . . . . 0.0 110.684 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.401 ' HG2' ' HA ' ' A' ' 165' ' ' ARG . 8.8 pt-20 -76.27 -29.13 57.32 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.277 179.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.401 ' OE1' ' CD1' ' A' ' 166' ' ' TRP . 0.5 OUTLIER . . . . . 0 N--CA 1.455 -0.217 0 CA-C-O 121.194 0.521 . . . . 0.0 110.048 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.554 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 N--CA 1.456 -0.145 0 CA-C-O 120.864 0.364 . . . . 0.0 110.72 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.441 ' O ' ' HG3' ' A' ' 136' ' ' ARG . . . -153.98 96.32 1.95 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.098 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.427 ' HB2' ' CD ' ' A' ' 133' ' ' PRO . 16.6 ptp -47.24 168.52 0.13 Allowed Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.725 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.427 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.7 Cg_exo -65.54 -47.6 3.99 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.687 2.258 . . . . 0.0 112.806 -178.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.451 ' HB3' HG22 ' A' ' 160' ' ' VAL . . . -54.18 -50.78 66.25 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.398 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.57 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -69.71 -34.52 74.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.084 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.441 ' HG3' ' O ' ' A' ' 131' ' ' ALA . 0.9 OUTLIER -66.48 -47.96 71.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.314 0.578 . . . . 0.0 110.296 179.367 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 11.4 ttt-85 -59.48 -55.24 37.16 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.259 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.763 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -62.58 -42.16 99.38 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.799 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.738 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -57.8 -36.68 72.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.912 0.387 . . . . 0.0 110.726 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.07 -30.76 55.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.705 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -84.45 -15.93 44.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.203 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.589 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.1 mt -98.12 -28.85 13.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.799 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.58 36.53 8.6 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.66 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.496 HD13 ' CG2' ' A' ' 149' ' ' VAL . 1.3 tt -118.31 140.25 42.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.739 0.304 . . . . 0.0 111.258 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.567 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.6 OUTLIER -71.47 100.93 2.32 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.293 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 1.006 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -50.02 -30.36 10.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.764 0.316 . . . . 0.0 111.441 -179.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 17.0 m -65.14 -36.69 85.05 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.567 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -65.76 -23.82 66.81 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.408 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.601 HG21 HG13 ' A' ' 163' ' ' VAL . 21.9 t -84.9 85.6 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.458 179.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 5.0 ttpp -50.66 90.61 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.971 0.415 . . . . 0.0 111.29 -179.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.56 ' HA3' ' HA ' ' A' ' 158' ' ' ILE . . . -69.91 139.76 31.83 Favored Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 115.777 -0.647 . . . . 0.0 113.383 -179.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.48 13.53 13.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.764 0.316 . . . . 0.0 110.638 179.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.424 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -76.08 153.45 43.42 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.799 -179.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.406 ' O ' HG13 ' A' ' 157' ' ' VAL . 92.6 Cg_exo -43.59 109.73 0.16 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.129 2.553 . . . . 0.0 112.873 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 96.59 16.47 36.68 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.294 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.554 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 76.2 22.21 74.11 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.72 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.424 HG22 ' HA3' ' A' ' 153' ' ' GLY . 1.3 m -83.59 126.67 40.16 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 CA-C-N 117.031 0.416 . . . . 0.0 111.025 -179.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 1.006 HD13 ' HB1' ' A' ' 146' ' ' ALA . 17.3 pt -66.55 111.51 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.513 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 70.6 p -75.14 156.39 36.0 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.4 0.619 . . . . 0.0 111.261 -177.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.494 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -56.18 -39.53 59.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.583 -179.664 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.624 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 27.3 tt0 -63.6 -27.91 69.56 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.814 179.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.513 ' HB2' ' O ' ' A' ' 159' ' ' THR . 88.7 m-20 -71.92 -52.59 16.48 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.711 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.763 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -67.68 -35.89 74.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.636 -179.378 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -69.52 -49.27 56.05 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.075 0.464 . . . . 0.0 110.832 -179.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.624 ' HG3' ' O ' ' A' ' 161' ' ' GLU . 42.3 mtp180 -61.58 -36.37 80.48 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.253 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' TRP . . . . . 0.491 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 24.4 t90 -71.21 -50.32 34.24 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.948 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -51.94 -40.74 61.28 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.944 0.402 . . . . 0.0 110.39 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.43 ' HG2' ' HA ' ' A' ' 165' ' ' ARG . 8.4 pt-20 -74.28 -31.12 62.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.09 179.01 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 . . . . . 0 N--CA 1.456 -0.128 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.301 179.517 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -87.28 -18.82 29.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.615 0.245 . . . . 0.0 111.188 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 7.0 mtp180 -96.47 31.97 2.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.856 0.36 . . . . 0.0 111.066 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -152.93 137.28 16.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.886 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.1 t -93.04 126.57 45.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.917 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.582 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -96.27 154.25 17.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.936 0.398 . . . . 0.0 110.874 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -152.27 95.5 2.06 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.866 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.463 ' HE3' ' CG2' ' A' ' 157' ' ' VAL . 18.0 ptp -47.43 166.95 0.18 Allowed Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.768 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.4 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.1 Cg_exo -65.91 -47.48 3.68 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.756 2.304 . . . . 0.0 112.857 -178.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.435 ' HB3' HG22 ' A' ' 160' ' ' VAL . . . -54.19 -51.04 65.65 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.522 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.569 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -69.68 -33.57 72.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.051 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -68.49 -48.12 65.29 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.251 0.548 . . . . 0.0 110.547 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -58.88 -54.72 43.89 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.851 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.734 HD12 ' N ' ' A' ' 139' ' ' ALA . 4.3 pp -62.62 -39.48 93.93 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.527 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.734 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -58.72 -39.62 81.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.886 0.374 . . . . 0.0 110.827 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.19 -29.76 57.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.783 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -81.85 -23.94 36.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.926 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.643 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.5 mt -90.56 -28.95 18.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.843 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.17 35.55 8.81 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.72 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.498 HD13 ' CG2' ' A' ' 149' ' ' VAL . 1.5 tt -116.39 142.32 30.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.781 0.324 . . . . 0.0 111.34 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.526 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 1.9 t0 -73.95 101.02 3.69 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.993 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -49.84 -28.03 5.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.277 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.73 -37.26 84.3 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.526 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -65.94 -21.14 66.41 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 177.349 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.498 ' CG2' HD13 ' A' ' 144' ' ' ILE . 21.7 t -89.93 88.12 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.455 179.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.7 ttmt -50.82 91.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.001 0.429 . . . . 0.0 111.206 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.502 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -70.18 133.76 24.48 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 121.015 -0.612 . . . . 0.0 113.198 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.421 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.4 OUTLIER -118.47 14.18 13.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.847 0.356 . . . . 0.0 110.766 179.563 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.458 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -73.18 155.34 50.43 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.709 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -44.37 106.5 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.097 2.531 . . . . 0.0 112.851 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.14 19.79 22.67 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.245 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.582 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 74.61 22.17 77.62 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.598 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.477 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.3 m -85.77 126.29 40.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 117.042 0.421 . . . . 0.0 111.067 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.993 HD13 ' HB1' ' A' ' 146' ' ' ALA . 19.1 pt -64.98 111.94 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.509 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 61.7 p -75.02 156.48 36.16 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.558 0.694 . . . . 0.0 111.657 -177.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.502 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -56.08 -39.91 61.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.715 -179.464 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.546 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 1.2 tp10 -65.82 -28.05 68.71 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.907 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.509 ' HB2' ' O ' ' A' ' 159' ' ' THR . 82.1 m-20 -68.49 -53.41 23.49 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.198 0.523 . . . . 0.0 110.225 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.726 ' CB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -65.64 -41.27 90.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.62 -179.729 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.55 -48.03 73.83 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 120.942 0.401 . . . . 0.0 111.465 -178.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.546 ' HG3' ' O ' ' A' ' 161' ' ' GLU . 21.6 mtt180 -60.63 -40.29 91.36 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.89 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.528 ' CZ3' HG21 ' A' ' 170' ' ' THR . 27.5 t90 -70.65 -48.99 52.13 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.661 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -50.52 -39.02 47.68 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.968 0.413 . . . . 0.0 110.486 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.401 ' HG2' ' HA ' ' A' ' 165' ' ' ARG . 13.0 pt-20 -77.33 -31.3 54.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.356 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -59.58 -30.06 68.39 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 120.953 0.406 . . . . 0.0 110.402 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.528 HG21 ' CZ3' ' A' ' 166' ' ' TRP . 19.0 p -75.36 -50.74 15.01 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.351 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -66.61 -31.17 71.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.388 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 7.3 mttm -61.04 -32.78 72.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.477 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.94 116.12 9.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.012 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -87.61 -66.98 0.86 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.893 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.274 -0.869 . . . . 0.0 111.131 179.968 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 112.439 -0.264 . . . . 0.0 112.439 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 9.0 p -87.83 -55.54 3.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.786 0.327 . . . . 0.0 110.912 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.14 -66.17 1.1 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.924 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 62.58 148.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.947 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.6 t -115.12 134.94 56.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.043 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.57 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -104.21 154.69 19.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.917 0.389 . . . . 0.0 110.846 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -153.37 95.49 1.93 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.897 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.438 ' HE2' ' HB3' ' A' ' 134' ' ' ALA . 19.9 ptm -48.14 167.42 0.19 Allowed Pre-proline 0 CA--C 1.532 0.26 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.793 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.408 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.8 Cg_exo -65.54 -45.56 6.7 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.807 2.338 . . . . 0.0 112.918 -178.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.438 ' HB3' ' HE2' ' A' ' 132' ' ' MET . . . -54.29 -52.71 60.59 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.423 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.562 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -69.25 -33.3 73.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.165 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 12.1 mtm180 -67.99 -49.17 63.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.524 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -58.29 -54.33 48.2 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.893 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.721 HD11 ' CB ' ' A' ' 163' ' ' VAL . 4.4 pp -63.05 -38.92 93.1 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.417 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.712 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -58.31 -39.93 80.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.722 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -76.62 -29.81 56.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.726 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 -81.95 -20.02 39.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.059 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.654 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.3 mt -94.88 -28.85 15.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.927 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.64 35.98 8.2 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.812 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.493 ' CD1' ' CE3' ' A' ' 166' ' ' TRP . 1.5 tt -118.22 141.34 37.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.832 0.348 . . . . 0.0 111.183 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.518 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.6 OUTLIER -72.93 101.05 3.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.805 179.229 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 1.016 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -49.73 -28.71 6.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.641 0.257 . . . . 0.0 111.321 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.78 -36.98 85.06 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.518 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -66.52 -22.48 66.17 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.453 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.526 HG21 HG13 ' A' ' 163' ' ' VAL . 21.8 t -86.87 84.77 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.646 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 6.4 ttmt -50.73 90.82 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.976 0.417 . . . . 0.0 111.14 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.512 ' HA3' ' HA ' ' A' ' 158' ' ' ILE . . . -66.5 142.94 43.29 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.809 -0.632 . . . . 0.0 113.295 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.45 0.9 11.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.688 0.28 . . . . 0.0 110.885 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.438 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -65.99 151.96 51.93 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.747 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.543 ' O ' HG13 ' A' ' 157' ' ' VAL . 84.8 Cg_exo -42.04 120.67 1.58 Allowed 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.234 2.622 . . . . 0.0 113.182 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 89.55 -0.68 80.73 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.715 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.57 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 94.53 22.24 24.65 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.694 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.543 HG13 ' O ' ' A' ' 154' ' ' PRO . 1.2 m -83.49 126.38 40.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 117.017 0.408 . . . . 0.0 111.107 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 1.016 HD13 ' HB1' ' A' ' 146' ' ' ALA . 19.0 pt -65.89 111.82 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.518 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 44.0 p -75.3 156.53 35.5 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.575 0.702 . . . . 0.0 111.816 -177.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.504 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -56.01 -40.16 61.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.805 -179.431 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.49 ' O ' ' CG ' ' A' ' 165' ' ' ARG . 5.6 mt-10 -64.89 -27.61 68.98 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.834 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.518 ' HB2' ' O ' ' A' ' 159' ' ' THR . 88.1 m-20 -70.2 -53.97 14.85 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.522 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.721 ' CB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -65.16 -42.71 94.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.794 -179.37 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.9 mmtt -66.38 -52.11 50.16 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.953 0.406 . . . . 0.0 111.486 -178.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.49 ' CG ' ' O ' ' A' ' 161' ' ' GLU . 27.1 mtp180 -59.24 -35.88 74.47 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.035 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.532 ' O ' HG23 ' A' ' 170' ' ' THR . 32.9 t90 -70.66 -50.05 40.77 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.791 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -50.66 -41.26 55.29 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-O 120.97 0.414 . . . . 0.0 110.411 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.422 ' HG2' ' HA ' ' A' ' 165' ' ' ARG . 7.6 pt-20 -74.04 -31.88 63.08 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.048 179.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -61.45 -29.46 69.97 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.278 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.532 HG23 ' O ' ' A' ' 166' ' ' TRP . 3.6 p -71.5 -52.24 19.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.263 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -70.09 -26.2 63.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.594 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -69.79 -36.33 75.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.768 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -74.45 135.19 42.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.145 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 6.6 t -107.38 -31.52 8.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.861 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.109 179.991 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.214 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.27 -53.02 2.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.801 0.334 . . . . 0.0 110.844 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 27.8 mtt180 -126.57 -64.58 1.02 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.857 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -66.64 -178.44 0.71 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.884 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.1 t -83.06 145.26 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.936 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.532 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -85.91 159.06 19.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.846 0.355 . . . . 0.0 110.824 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -154.88 96.22 1.83 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.134 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.442 ' HE3' ' CG2' ' A' ' 157' ' ' VAL . 19.0 ptp -47.81 167.59 0.18 Allowed Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.57 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.405 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.4 Cg_exo -65.49 -47.12 4.52 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.778 2.319 . . . . 0.0 112.809 -179.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.465 ' HB3' HG22 ' A' ' 160' ' ' VAL . . . -54.27 -51.48 64.41 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.475 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.546 ' HA ' HD21 ' A' ' 138' ' ' LEU . . . -69.23 -33.36 73.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.277 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.69 -48.75 63.1 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.296 0.57 . . . . 0.0 110.371 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -57.77 -54.2 49.57 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.98 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.729 HD12 ' N ' ' A' ' 139' ' ' ALA . 4.3 pp -63.49 -41.23 98.57 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.553 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.729 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -58.47 -37.64 75.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.743 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.92 -29.81 55.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.754 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -83.36 -20.52 34.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.997 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.648 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.5 mt -94.22 -28.92 15.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.863 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.75 38.68 7.96 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.543 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.511 HD13 ' CG2' ' A' ' 149' ' ' VAL . 1.3 tt -118.4 140.39 42.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.742 0.306 . . . . 0.0 111.305 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.531 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 1.5 t0 -71.97 100.97 2.58 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.998 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -50.6 -28.84 9.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.681 0.277 . . . . 0.0 111.271 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.69 -36.97 85.15 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 178.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.531 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -64.97 -23.88 67.35 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 177.283 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.511 ' CG2' HD13 ' A' ' 144' ' ' ILE . 21.2 t -87.44 89.15 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.324 179.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.64 90.93 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.937 0.399 . . . . 0.0 111.14 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.512 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -68.55 130.03 25.63 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.837 -0.696 . . . . 0.0 113.104 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.479 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.1 OUTLIER -118.5 24.13 11.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.136 0.493 . . . . 0.0 110.495 179.658 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.429 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -84.63 157.16 32.44 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.758 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_exo -43.37 102.89 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.227 2.618 . . . . 0.0 112.993 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 99.3 23.52 11.18 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.212 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.532 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 71.23 22.18 78.52 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.601 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.442 ' CG2' ' HE3' ' A' ' 132' ' ' MET . 1.2 m -85.43 128.35 39.21 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.957 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.998 HD13 ' HB1' ' A' ' 146' ' ' ALA . 18.6 pt -66.65 112.11 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.504 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 55.7 p -75.14 156.35 36.05 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.532 0.682 . . . . 0.0 111.533 -177.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.521 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -56.41 -39.46 61.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.706 -179.582 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.565 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 6.1 mm-40 -65.67 -27.79 68.62 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.944 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.504 ' HB2' ' O ' ' A' ' 159' ' ' THR . 83.0 m-20 -69.31 -54.6 13.75 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.223 0.535 . . . . 0.0 110.322 179.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.715 ' CB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -64.09 -40.83 90.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.648 -179.612 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.61 -47.57 78.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.9 0.381 . . . . 0.0 111.445 -178.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.565 ' HG3' ' O ' ' A' ' 161' ' ' GLU . 65.2 mtt-85 -60.83 -42.0 96.87 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.05 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.489 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 18.1 t90 -67.98 -50.18 57.23 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.915 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -50.94 -41.1 58.75 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.919 0.39 . . . . 0.0 110.725 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.416 ' HG2' ' HA ' ' A' ' 165' ' ' ARG . 11.9 pt-20 -74.9 -29.47 61.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.321 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.406 ' OE1' ' CD1' ' A' ' 166' ' ' TRP . 0.4 OUTLIER -61.16 -43.62 98.6 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 121.224 0.535 . . . . 0.0 110.096 179.41 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.466 HG23 ' O ' ' A' ' 166' ' ' TRP . 8.2 p -59.47 -52.24 66.43 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.404 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -66.65 -21.64 66.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.365 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.1 -36.65 64.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.811 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.04 134.63 35.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.17 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 64.8 p -122.9 157.1 33.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.891 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.232 -0.89 . . . . 0.0 111.122 -179.969 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.183 0 N-CA-C 112.537 -0.225 . . . . 0.0 112.537 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 70.0 m -118.76 145.32 45.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.821 0.343 . . . . 0.0 110.949 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -69.29 -38.62 78.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.962 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -158.83 154.51 26.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.935 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.3 t -101.95 137.76 28.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.9 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.539 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -96.34 155.2 16.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.892 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.5 ' HB1' ' HG2' ' A' ' 136' ' ' ARG . . . -152.12 95.43 2.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.965 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.415 ' HG2' ' O ' ' A' ' 158' ' ' ILE . 14.0 ptp -46.91 167.74 0.15 Allowed Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.863 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.414 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.2 Cg_exo -65.76 -47.59 3.75 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.799 2.333 . . . . 0.0 112.822 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.462 ' HB3' HG22 ' A' ' 160' ' ' VAL . . . -54.3 -51.61 64.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.372 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.563 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -69.48 -34.21 74.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.911 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.5 ' HG2' ' HB1' ' A' ' 131' ' ' ALA . 9.0 mmm180 -66.53 -48.53 69.42 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.501 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.41 ' CZ ' ' HB2' ' A' ' 137' ' ' ARG . 26.4 ttm105 -59.93 -55.38 34.8 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.154 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.729 HD12 ' N ' ' A' ' 139' ' ' ALA . 4.3 pp -61.54 -41.03 96.75 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.716 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.729 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -58.11 -37.95 75.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.994 0.426 . . . . 0.0 110.809 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.3 tptt -76.48 -29.81 57.02 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.825 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -84.32 -19.38 33.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.12 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.614 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.4 mt -94.49 -28.89 15.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.719 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.72 38.28 8.19 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.505 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.481 ' CD1' ' CE3' ' A' ' 166' ' ' TRP . 1.4 tt -118.31 141.6 36.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.744 0.307 . . . . 0.0 111.248 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.529 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 1.9 t0 -72.94 101.02 3.08 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 1.004 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -50.45 -28.85 9.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.735 0.302 . . . . 0.0 111.182 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.92 -36.93 85.96 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 178.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.529 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -66.59 -23.37 66.18 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 177.666 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.536 HG21 HG13 ' A' ' 163' ' ' VAL . 20.1 t -86.7 84.15 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.625 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.74 91.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.911 0.386 . . . . 0.0 111.113 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.571 ' HA3' ' HA ' ' A' ' 158' ' ' ILE . . . -69.17 141.55 36.0 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.098 -0.572 . . . . 0.0 113.488 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.61 11.06 12.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.743 0.306 . . . . 0.0 110.786 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.448 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -73.4 152.21 46.17 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.842 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.417 ' O ' HG13 ' A' ' 157' ' ' VAL . 90.8 Cg_exo -43.83 112.29 0.31 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.092 2.528 . . . . 0.0 112.832 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 95.54 13.12 52.32 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.374 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.539 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 79.62 22.11 65.1 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.776 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.457 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.3 m -83.98 126.92 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 117.122 0.461 . . . . 0.0 111.06 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 1.004 HD13 ' HB1' ' A' ' 146' ' ' ALA . 17.7 pt -66.94 111.79 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.529 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 75.3 p -75.07 156.46 36.07 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.505 0.669 . . . . 0.0 111.735 -177.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.462 HG22 ' HB3' ' A' ' 134' ' ' ALA . 0.2 OUTLIER -55.58 -40.71 60.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.697 -179.56 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -64.29 -27.51 69.09 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.114 179.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.529 ' HB2' ' O ' ' A' ' 159' ' ' THR . 82.6 m-20 -71.45 -53.27 14.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.835 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.726 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -64.43 -45.77 94.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.687 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -61.47 -48.64 80.21 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.043 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.469 ' HG3' ' N ' ' A' ' 166' ' ' TRP . 0.8 OUTLIER -57.71 -39.75 77.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.903 -179.718 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.677 ' O ' HG23 ' A' ' 170' ' ' THR . 23.9 t90 -72.39 -48.36 42.14 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.754 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -52.21 -38.37 57.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.975 0.417 . . . . 0.0 110.445 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -77.3 -33.15 55.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.243 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -63.49 -27.61 69.39 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.577 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.677 HG23 ' O ' ' A' ' 166' ' ' TRP . 18.0 p -74.06 -52.06 13.84 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.555 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -73.14 -26.75 61.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.696 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -66.06 -34.88 79.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.79 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -67.51 -62.78 1.25 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.088 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 44.2 p -63.69 142.15 58.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.949 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.226 -0.892 . . . . 0.0 111.056 -179.989 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.193 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 11.4 p -99.14 31.76 2.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.811 0.338 . . . . 0.0 110.87 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.67 82.25 1.46 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.854 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -150.22 138.46 20.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.889 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.1 t -96.94 117.11 40.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.861 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.612 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -96.82 151.45 19.65 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.022 0.439 . . . . 0.0 111.098 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -153.83 94.33 1.75 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.645 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.48 ' HE2' ' HB3' ' A' ' 134' ' ' ALA . 20.2 ptm -47.03 166.64 0.18 Allowed Pre-proline 0 CA--C 1.533 0.306 0 CA-C-O 120.582 0.23 . . . . 0.0 110.936 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -65.62 -44.85 7.64 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.868 2.379 . . . . 0.0 112.826 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.48 ' HB3' ' HE2' ' A' ' 132' ' ' MET . . . -54.21 -53.62 51.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.372 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.571 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -68.29 -33.88 75.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.024 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.65 -49.88 64.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.587 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -58.28 -55.58 33.16 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.133 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.721 HD12 ' N ' ' A' ' 139' ' ' ALA . 4.4 pp -60.98 -40.67 94.33 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.615 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.721 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -57.55 -37.71 73.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.853 0.358 . . . . 0.0 110.66 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.8 tptp -76.9 -30.07 56.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.771 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -83.32 -19.92 35.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.061 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.613 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.5 mt -94.5 -28.89 15.21 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.864 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.53 37.76 7.95 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.607 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.488 HD13 ' CG2' ' A' ' 149' ' ' VAL . 1.4 tt -118.36 143.07 30.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.809 0.337 . . . . 0.0 111.181 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.539 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.9 OUTLIER -74.63 101.12 4.14 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.372 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.975 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -49.78 -28.81 6.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.689 0.28 . . . . 0.0 111.099 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.42 -37.65 87.56 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.539 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -66.25 -22.23 66.31 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 177.578 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.488 ' CG2' HD13 ' A' ' 144' ' ' ILE . 21.3 t -88.37 85.58 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.623 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.5 ptmt -50.7 92.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.986 0.422 . . . . 0.0 111.149 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.512 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -68.02 136.29 30.71 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.064 -0.589 . . . . 0.0 113.339 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -118.52 10.71 12.7 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.738 0.304 . . . . 0.0 110.819 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.46 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -72.29 154.68 50.82 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.771 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -43.99 107.65 0.1 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.111 2.541 . . . . 0.0 112.886 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.51 18.38 28.36 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.364 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.612 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 75.58 22.27 75.54 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.634 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.486 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -84.6 124.21 39.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 117.069 0.434 . . . . 0.0 111.063 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.975 HD13 ' HB1' ' A' ' 146' ' ' ALA . 19.6 pt -63.59 111.59 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.539 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 48.9 p -75.4 156.53 35.28 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.555 0.693 . . . . 0.0 111.904 -177.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.479 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.54 -41.48 63.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.78 -179.524 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -64.26 -27.44 69.05 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.125 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.539 ' HB2' ' O ' ' A' ' 159' ' ' THR . 84.1 m-20 -70.61 -52.58 20.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.512 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.719 ' CB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -65.98 -45.77 90.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.579 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 10.5 mttm -62.71 -50.94 69.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.616 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.535 ' HG3' ' O ' ' A' ' 162' ' ' ASP . 1.8 ppt_? -57.83 -39.07 76.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.607 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.556 ' O ' HG23 ' A' ' 170' ' ' THR . 26.6 t90 -71.49 -48.42 49.18 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.59 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -51.66 -38.3 54.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.52 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -77.24 -32.81 56.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.158 179.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -59.61 -28.55 67.29 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.983 0.421 . . . . 0.0 110.35 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.556 HG23 ' O ' ' A' ' 166' ' ' TRP . 4.0 p -75.16 -51.44 13.39 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.352 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -65.4 -30.03 70.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.517 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -63.29 -30.87 71.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.654 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -69.46 -55.83 9.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.171 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 8.8 t -59.86 -28.64 67.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.031 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.254 -0.879 . . . . 0.0 111.138 179.994 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.184 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 19.4 m -160.15 177.0 11.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.798 0.333 . . . . 0.0 110.891 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 5.9 ttt85 -147.58 89.56 1.78 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.916 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -83.31 172.04 12.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.939 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.2 t -83.75 129.3 37.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.976 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.579 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -91.61 153.4 19.74 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.977 0.418 . . . . 0.0 111.019 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -152.52 95.27 2.0 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.862 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 9.8 ptp -47.44 166.93 0.18 Allowed Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.842 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -65.67 -46.28 5.43 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.859 2.373 . . . . 0.0 112.943 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.44 ' HB3' HG22 ' A' ' 160' ' ' VAL . . . -54.28 -52.42 61.48 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.401 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.566 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -68.34 -34.19 75.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.124 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.74 -49.34 63.06 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.252 0.548 . . . . 0.0 110.585 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 7.5 tpt180 -57.37 -55.55 33.3 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.838 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.722 HD12 ' N ' ' A' ' 139' ' ' ALA . 4.3 pp -62.33 -41.14 98.32 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.562 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.722 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -56.45 -39.72 73.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.974 0.416 . . . . 0.0 110.956 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.65 -29.86 56.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.75 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -82.41 -19.04 39.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.083 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.603 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.4 mt -95.64 -28.86 14.61 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.866 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.05 37.08 7.95 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.661 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.49 HD13 ' CG2' ' A' ' 149' ' ' VAL . 1.8 tt -118.34 143.02 30.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.803 0.335 . . . . 0.0 111.232 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.565 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 1.9 t0 -74.47 101.1 4.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.803 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 1.013 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -49.6 -28.95 6.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.595 0.236 . . . . 0.0 111.294 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.08 -36.98 84.63 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.565 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -66.68 -21.44 66.09 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 177.46 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.504 HG21 HG13 ' A' ' 163' ' ' VAL . 21.4 t -89.16 86.02 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.497 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.71 93.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.965 0.412 . . . . 0.0 111.124 -179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.519 ' HA3' ' HA ' ' A' ' 158' ' ' ILE . . . -70.82 139.2 29.56 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 121.001 -0.619 . . . . 0.0 113.419 -179.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -118.56 10.38 12.56 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.721 0.296 . . . . 0.0 110.846 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.475 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -71.19 152.69 50.2 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.746 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.402 ' O ' HG13 ' A' ' 157' ' ' VAL . 82.4 Cg_exo -44.68 111.04 0.26 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.059 2.506 . . . . 0.0 112.722 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 96.43 14.22 45.25 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.289 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.579 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 79.41 22.11 65.6 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.674 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.475 HG22 ' HA3' ' A' ' 153' ' ' GLY . 1.2 m -85.22 125.66 40.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 117.121 0.461 . . . . 0.0 110.961 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 1.013 HD13 ' HB1' ' A' ' 146' ' ' ALA . 18.8 pt -65.33 111.74 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.532 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 55.0 p -75.15 156.43 35.94 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.523 0.678 . . . . 0.0 111.723 -177.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.467 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.33 -40.78 58.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.787 -179.503 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.416 ' O ' ' HG2' ' A' ' 165' ' ' ARG . 55.7 tt0 -64.62 -27.47 68.96 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.171 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.532 ' HB2' ' O ' ' A' ' 159' ' ' THR . 72.4 m-20 -70.74 -53.6 14.94 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.749 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.709 ' CB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -63.62 -48.15 88.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.406 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 16.9 mttp -60.24 -46.34 90.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.561 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.516 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 24.8 ptt180 -60.1 -39.23 85.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.779 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.59 ' O ' HG23 ' A' ' 170' ' ' THR . 30.2 t90 -72.73 -48.15 41.03 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.843 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -52.47 -37.78 57.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.997 0.427 . . . . 0.0 110.476 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -77.26 -33.66 55.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.056 179.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.04 -31.35 69.89 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.271 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.59 HG23 ' O ' ' A' ' 166' ' ' TRP . 11.9 p -70.07 -52.04 27.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.183 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.37 -26.5 64.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.685 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.28 -32.15 71.13 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.733 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -54.39 -29.02 47.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.302 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 9.6 t -112.34 31.84 6.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.825 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.24 -0.886 . . . . 0.0 111.105 179.951 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.184 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 33.1 t -92.49 140.61 29.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.833 0.349 . . . . 0.0 110.894 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -126.37 -68.29 0.82 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.779 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.51 146.29 52.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.809 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.9 t -85.55 111.22 20.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.964 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.583 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -103.08 151.28 22.73 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.11 0.481 . . . . 0.0 111.052 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.438 ' HB1' ' HG2' ' A' ' 136' ' ' ARG . . . -151.54 94.71 2.04 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.688 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.409 ' HE2' ' HB3' ' A' ' 134' ' ' ALA . 22.4 ptm -48.63 166.66 0.22 Allowed Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.005 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.402 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 21.7 Cg_exo -66.19 -45.25 5.84 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.878 2.385 . . . . 0.0 112.818 -178.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.409 ' HB3' ' HE2' ' A' ' 132' ' ' MET . . . -54.32 -52.2 62.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.268 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.533 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -70.28 -32.45 70.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.875 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.438 ' HG2' ' HB1' ' A' ' 131' ' ' ALA . 0.1 OUTLIER -68.02 -47.94 67.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.256 179.475 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -59.97 -54.81 41.67 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.033 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.725 HD11 ' CB ' ' A' ' 163' ' ' VAL . 4.3 pp -62.52 -40.8 97.93 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.589 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.712 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -57.08 -38.81 73.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.892 0.377 . . . . 0.0 110.683 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.97 -29.81 55.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.827 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -82.4 -21.21 35.91 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.069 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.622 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.6 mt -94.02 -28.91 15.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.925 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.75 38.39 8.11 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.461 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.521 HD13 ' CG2' ' A' ' 149' ' ' VAL . 0.6 OUTLIER -116.6 143.21 27.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.865 0.365 . . . . 0.0 111.19 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.468 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.9 OUTLIER -74.84 100.88 4.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.469 . . . . 0.0 109.852 179.185 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 1.035 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -53.27 -33.81 54.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.665 0.269 . . . . 0.0 111.109 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.9 -36.69 75.12 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.051 0.453 . . . . 0.0 109.805 179.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.512 ' HE2' ' CE2' ' A' ' 166' ' ' TRP . 0.0 OUTLIER -67.92 -30.45 69.78 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.846 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.521 ' CG2' HD13 ' A' ' 144' ' ' ILE . 8.1 t -78.2 81.79 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.379 179.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.47 ' O ' ' HG3' ' A' ' 150' ' ' LYS . 2.0 ptpp? -50.51 93.25 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.266 0.555 . . . . 0.0 111.105 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.552 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -63.1 139.04 44.18 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.605 -0.725 . . . . 0.0 113.492 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.55 13.66 13.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.752 0.311 . . . . 0.0 110.608 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.433 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -80.14 154.97 37.76 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.736 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_exo -43.23 108.79 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.161 2.574 . . . . 0.0 112.972 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 96.95 16.94 34.06 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.377 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.583 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 76.17 22.33 73.91 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.634 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.502 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -83.0 125.6 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.173 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 1.035 HD13 ' HB1' ' A' ' 146' ' ' ALA . 18.2 pt -64.4 111.23 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.493 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 25.7 p -75.29 156.32 35.75 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.639 0.733 . . . . 0.0 111.792 -177.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.537 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -56.59 -39.82 65.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.649 -179.643 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.576 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 0.4 OUTLIER -63.69 -29.75 70.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.921 179.413 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.493 ' HB2' ' O ' ' A' ' 159' ' ' THR . 91.8 m-20 -68.97 -54.07 17.31 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.9 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.725 ' CB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -63.98 -41.91 94.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.766 -178.762 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.533 ' CG ' ' HA ' ' A' ' 161' ' ' GLU . 0.0 OUTLIER -64.84 -48.83 72.92 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.024 0.44 . . . . 0.0 111.418 -178.64 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.576 ' HG3' ' O ' ' A' ' 161' ' ' GLU . 8.5 mtm105 -57.62 -43.33 84.72 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.981 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.623 ' CZ3' HG21 ' A' ' 170' ' ' THR . 61.9 t90 -68.09 -49.86 58.57 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.606 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -50.58 -39.55 49.93 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.856 0.36 . . . . 0.0 110.746 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.429 ' HG2' ' HA ' ' A' ' 165' ' ' ARG . 11.1 pt-20 -77.17 -29.18 54.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.485 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.27 -41.95 94.37 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.208 0.528 . . . . 0.0 109.985 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.623 HG21 ' CZ3' ' A' ' 166' ' ' TRP . 6.6 p -63.08 -52.2 63.63 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.413 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -70.91 -17.32 62.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.428 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -77.05 -32.45 56.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.608 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -63.72 -48.8 75.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.236 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 7.5 p 56.8 31.34 19.34 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.968 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.257 -0.878 . . . . 0.0 111.095 -179.977 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.185 0 N-CA-C 112.565 -0.214 . . . . 0.0 112.565 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -169.06 138.52 2.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.78 0.324 . . . . 0.0 110.946 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -119.31 97.09 5.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.803 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.33 168.9 10.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.854 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.2 t -79.99 131.52 33.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.992 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.575 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -95.86 154.67 17.11 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.039 0.447 . . . . 0.0 110.973 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.422 ' HB1' ' HG2' ' A' ' 136' ' ' ARG . . . -155.11 95.21 1.71 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.801 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.667 ' HE2' ' HB3' ' A' ' 134' ' ' ALA . 19.2 ptm -47.35 168.65 0.13 Allowed Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.873 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.435 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.0 Cg_exo -66.07 -45.34 5.98 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.772 2.315 . . . . 0.0 112.949 -178.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.667 ' HB3' ' HE2' ' A' ' 132' ' ' MET . . . -54.24 -53.35 54.83 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.442 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.553 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -69.63 -32.03 70.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.823 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.422 ' HG2' ' HB1' ' A' ' 131' ' ' ALA . 0.0 OUTLIER -67.41 -48.74 66.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.434 179.371 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -59.97 -55.13 37.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.042 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.721 HD12 ' N ' ' A' ' 139' ' ' ALA . 4.3 pp -62.52 -41.11 98.63 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.83 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.721 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -55.99 -41.76 75.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.863 0.363 . . . . 0.0 110.939 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -75.42 -29.84 59.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.9 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -80.9 -22.74 39.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.075 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.607 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.6 mt -92.09 -28.91 16.83 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.879 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.46 37.48 8.12 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.439 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.496 HD13 ' CG2' ' A' ' 149' ' ' VAL . 1.4 tt -117.85 141.53 36.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.828 0.347 . . . . 0.0 111.188 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.513 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 1.2 t0 -72.94 101.05 3.1 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.978 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -49.64 -28.59 6.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.688 0.28 . . . . 0.0 111.241 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.9 -37.27 85.67 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.513 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -65.8 -22.64 66.58 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 177.399 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.515 HG21 HG13 ' A' ' 163' ' ' VAL . 20.7 t -88.22 87.94 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.404 179.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.75 91.02 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.015 0.436 . . . . 0.0 111.267 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.507 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -68.51 132.86 27.54 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.904 -0.665 . . . . 0.0 113.093 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.433 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.2 OUTLIER -118.49 16.75 13.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.952 0.406 . . . . 0.0 110.812 179.624 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.459 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -77.67 154.32 41.69 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.655 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -43.93 107.56 0.1 OUTLIER 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.087 2.524 . . . . 0.0 112.813 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.75 18.76 26.68 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.236 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.575 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 74.94 22.18 77.26 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.671 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.479 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -84.76 125.47 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 CA-C-N 117.027 0.414 . . . . 0.0 110.992 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.978 HD13 ' HB1' ' A' ' 146' ' ' ALA . 19.1 pt -65.4 112.34 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.525 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 60.8 p -75.33 156.5 35.46 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.533 0.682 . . . . 0.0 111.891 -177.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.496 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.91 -40.55 63.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.743 -179.492 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.407 ' O ' ' HG2' ' A' ' 165' ' ' ARG . 20.2 mm-40 -65.21 -27.43 68.67 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.199 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 159' ' ' THR . 81.6 m-20 -70.43 -53.98 14.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.608 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.712 ' CB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -63.39 -47.71 90.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.412 179.928 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 10.7 mttm -60.41 -48.66 80.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.502 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.512 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 10.4 ptt180 -57.8 -39.98 78.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.882 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.658 ' O ' HG23 ' A' ' 170' ' ' THR . 23.7 t90 -72.04 -48.14 46.66 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.778 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -52.19 -38.4 57.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.947 0.404 . . . . 0.0 110.58 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -77.24 -33.53 56.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.262 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -61.73 -29.53 70.17 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.974 0.416 . . . . 0.0 110.443 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.658 HG23 ' O ' ' A' ' 166' ' ' TRP . 12.0 p -72.07 -52.08 18.53 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.423 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.59 -22.92 61.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.739 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 9.9 mttp -73.65 -38.76 64.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.919 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -62.89 -43.22 99.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.14 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 32.4 p -59.27 175.11 0.34 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.93 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.195 -0.907 . . . . 0.0 111.072 179.992 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 112.441 -0.264 . . . . 0.0 112.441 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 12.3 p -110.58 77.99 1.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.856 0.36 . . . . 0.0 110.796 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.5 mtm105 -141.9 103.31 4.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.863 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -130.33 -45.12 1.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.922 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.1 t -90.74 111.71 23.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.061 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.581 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -92.2 151.22 20.47 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.937 0.399 . . . . 0.0 110.789 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.43 ' HB1' ' HG2' ' A' ' 136' ' ' ARG . . . -151.13 94.98 2.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.857 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.417 ' HB2' ' CD ' ' A' ' 133' ' ' PRO . 9.5 ptm -46.96 167.73 0.15 Allowed Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.98 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.417 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.8 Cg_exo -65.49 -45.58 6.77 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.794 2.329 . . . . 0.0 112.885 -178.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.2 -53.48 52.91 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.365 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.593 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -68.99 -32.13 71.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.919 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.43 ' HG2' ' HB1' ' A' ' 131' ' ' ALA . 0.0 OUTLIER -68.36 -48.69 64.13 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.486 179.418 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.2 ttp85 -59.04 -55.74 31.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.073 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.732 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.3 pp -61.36 -41.04 96.43 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.647 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.717 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -57.4 -38.15 73.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.864 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.98 -29.78 55.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.767 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -83.83 -18.15 38.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.981 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.613 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.3 mt -96.14 -28.81 14.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.828 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.36 37.66 8.09 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.555 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.482 ' CD1' ' CE3' ' A' ' 166' ' ' TRP . 1.4 tt -118.45 142.33 33.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.717 0.294 . . . . 0.0 111.28 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.525 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.3 OUTLIER -73.96 101.09 3.72 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.899 179.282 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 1.002 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -49.91 -29.0 7.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.64 0.257 . . . . 0.0 111.204 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 32.3 t -65.03 -37.09 86.46 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.525 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -66.73 -22.91 66.05 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 177.679 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.555 HG21 HG13 ' A' ' 163' ' ' VAL . 20.3 t -86.9 84.03 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.72 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.76 92.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.012 0.434 . . . . 0.0 111.066 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.537 ' HA3' ' HA ' ' A' ' 158' ' ' ILE . . . -68.59 142.1 38.02 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.795 -0.639 . . . . 0.0 113.571 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.6 10.78 12.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.73 0.3 . . . . 0.0 110.779 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.47 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -75.19 151.92 42.8 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.771 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.453 ' O ' HG13 ' A' ' 157' ' ' VAL . 93.5 Cg_exo -43.86 114.74 0.57 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.057 2.505 . . . . 0.0 112.928 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 94.03 9.06 59.86 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.542 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.581 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 84.36 22.26 54.64 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.825 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.47 HG22 ' HA3' ' A' ' 153' ' ' GLY . 1.2 m -84.3 126.08 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 CA-C-N 117.055 0.428 . . . . 0.0 111.084 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 1.002 HD13 ' HB1' ' A' ' 146' ' ' ALA . 16.9 pt -66.57 111.49 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.535 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 45.6 p -75.33 156.53 35.45 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.584 0.706 . . . . 0.0 111.773 -177.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.472 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.31 -40.76 58.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.895 -179.483 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -64.22 -27.41 69.04 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.139 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.535 ' HB2' ' O ' ' A' ' 159' ' ' THR . 77.2 m-20 -71.47 -53.02 15.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.775 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.732 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -64.61 -45.5 95.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.321 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.409 ' CG ' ' N ' ' A' ' 165' ' ' ARG . 7.7 pttt -61.58 -49.08 78.08 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.209 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.493 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 4.2 ptm180 -57.96 -39.72 78.81 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.866 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.594 ' O ' HG23 ' A' ' 170' ' ' THR . 23.2 t90 -72.16 -48.12 45.76 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.818 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -52.47 -38.3 59.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.035 0.445 . . . . 0.0 110.396 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -77.27 -32.38 55.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.12 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.81 -31.12 70.53 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.321 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.594 HG23 ' O ' ' A' ' 166' ' ' TRP . 6.4 p -71.64 -51.92 20.66 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.33 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -68.82 -30.11 68.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.464 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.25 -22.62 66.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.867 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -87.68 10.15 19.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.67 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 51.43 30.09 5.88 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.827 0.346 . . . . 0.0 111.093 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.309 -0.853 . . . . 0.0 111.117 179.951 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.218 0 N-CA-C 112.459 -0.256 . . . . 0.0 112.459 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -155.18 -45.75 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.802 0.334 . . . . 0.0 110.916 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -101.7 79.8 1.97 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.042 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 61.66 168.33 0.11 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.97 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.3 t -81.57 128.33 38.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.952 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.57 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -90.17 153.52 20.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.916 0.389 . . . . 0.0 110.931 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.465 ' O ' ' HG3' ' A' ' 136' ' ' ARG . . . -151.61 96.3 2.23 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.859 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.434 ' HE3' ' CG2' ' A' ' 157' ' ' VAL . 15.3 ptp -47.88 167.94 0.17 Allowed Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.718 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.409 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.0 Cg_exo -65.79 -47.29 3.99 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.81 2.34 . . . . 0.0 112.965 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.433 ' HB3' HG22 ' A' ' 160' ' ' VAL . . . -54.28 -50.76 66.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.43 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.548 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -69.2 -34.7 75.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.236 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 131' ' ' ALA . 0.9 OUTLIER -67.6 -48.54 66.52 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.265 0.555 . . . . 0.0 110.397 179.484 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 66.2 ttt180 -57.59 -54.42 47.08 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.931 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.738 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.3 pp -64.15 -40.85 97.03 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.51 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.731 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -58.92 -37.98 77.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.92 0.39 . . . . 0.0 110.803 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.02 -29.77 55.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.662 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -81.59 -24.92 36.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.966 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.661 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.7 mt -90.88 -28.93 17.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.068 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.36 38.91 7.5 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.846 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.494 HD13 ' CG2' ' A' ' 149' ' ' VAL . 1.2 tt -118.62 140.74 41.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.735 0.302 . . . . 0.0 111.229 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.569 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.6 OUTLIER -71.57 100.89 2.36 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.299 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 1.029 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -50.51 -31.12 14.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.44 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 29.5 m -64.6 -36.1 83.16 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.569 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -65.44 -25.15 67.39 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 177.31 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.541 HG21 HG13 ' A' ' 163' ' ' VAL . 21.9 t -84.2 85.99 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.449 178.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.73 90.75 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.111 0.481 . . . . 0.0 111.224 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' ' 158' ' ' ILE . . . -66.06 141.28 41.2 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.82 -0.627 . . . . 0.0 113.247 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.46 10.95 12.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.707 0.289 . . . . 0.0 110.739 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.422 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -77.42 151.91 38.85 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.569 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.554 ' O ' HG13 ' A' ' 157' ' ' VAL . 82.2 Cg_exo -41.43 122.05 1.69 Allowed 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.244 2.629 . . . . 0.0 113.244 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 88.31 -2.93 85.42 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.773 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.57 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 96.79 22.21 18.92 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.674 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.554 HG13 ' O ' ' A' ' 154' ' ' PRO . 1.2 m -83.5 127.37 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.156 0 CA-C-N 117.092 0.446 . . . . 0.0 111.221 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 1.029 HD13 ' HB1' ' A' ' 146' ' ' ALA . 15.1 pt -67.85 111.87 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 178.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.527 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 62.9 p -75.08 156.49 36.03 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.625 0.726 . . . . 0.0 111.693 -177.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.472 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.59 -41.0 62.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.917 -179.407 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.523 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 0.9 OUTLIER -64.0 -27.73 69.32 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.919 179.387 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.527 ' HB2' ' O ' ' A' ' 159' ' ' THR . 87.3 m-20 -69.98 -54.37 13.58 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.318 0.58 . . . . 0.0 110.495 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.738 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -65.19 -40.81 89.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.725 -179.59 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -65.61 -46.66 78.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.903 0.382 . . . . 0.0 111.428 -178.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.523 ' HG3' ' O ' ' A' ' 161' ' ' GLU . 26.8 mtp180 -62.6 -38.57 90.68 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.885 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.522 ' O ' HG23 ' A' ' 170' ' ' THR . 19.6 t90 -71.4 -50.12 35.17 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.71 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -51.93 -38.36 56.09 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.002 0.43 . . . . 0.0 110.571 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.456 ' HG2' ' HA ' ' A' ' 165' ' ' ARG . 8.4 pt-20 -76.78 -31.35 56.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.254 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -61.45 -26.88 68.17 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 120.957 0.408 . . . . 0.0 110.535 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.522 HG23 ' O ' ' A' ' 166' ' ' TRP . 3.7 p -75.95 -51.61 12.05 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.531 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -73.67 -28.04 61.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.772 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.59 -30.61 71.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.759 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -70.96 64.61 0.33 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.173 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 15.9 p 54.08 175.18 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.126 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.211 -0.9 . . . . 0.0 111.077 179.922 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 112.481 -0.247 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.7 -47.29 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.857 0.361 . . . . 0.0 110.894 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 5.9 mmt85 -105.12 131.17 52.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.933 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.51 136.57 40.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.917 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.1 t -98.96 114.7 37.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.129 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.575 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -91.47 152.32 20.41 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.866 0.365 . . . . 0.0 110.762 179.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -151.44 95.79 2.19 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.983 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.736 ' HE2' ' HB3' ' A' ' 134' ' ' ALA . 18.3 ptm -47.88 167.76 0.17 Allowed Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.664 -0.244 . . . . 0.0 110.805 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.417 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.4 Cg_exo -65.75 -46.26 5.31 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.776 2.317 . . . . 0.0 112.963 -178.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.736 ' HB3' ' HE2' ' A' ' 132' ' ' MET . . . -54.28 -52.41 61.52 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.449 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.59 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -68.78 -33.56 74.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.019 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.7 mtp180 -68.37 -48.89 63.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.553 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.2 tpt85 -57.78 -55.73 31.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.734 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.716 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.4 pp -61.65 -38.71 88.74 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.329 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.704 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -58.98 -39.47 81.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.807 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.19 -29.82 57.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.757 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -81.54 -24.35 36.65 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.993 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.658 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.5 mt -90.27 -28.89 18.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.018 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.05 37.37 7.82 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.836 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.478 HD13 ' CG2' ' A' ' 149' ' ' VAL . 1.4 tt -119.07 142.47 34.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.788 0.328 . . . . 0.0 111.213 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.558 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.6 OUTLIER -73.78 101.06 3.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.871 179.394 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 1.019 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -49.49 -30.56 8.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.735 0.302 . . . . 0.0 111.303 -179.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 20.4 m -65.11 -36.46 84.37 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.558 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -66.27 -23.79 66.46 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.415 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.539 HG21 HG13 ' A' ' 163' ' ' VAL . 22.0 t -85.27 85.01 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.478 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.65 90.99 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.096 0.474 . . . . 0.0 111.175 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.502 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -66.27 142.67 43.19 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.798 -0.637 . . . . 0.0 113.394 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.46 1.27 11.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.692 0.282 . . . . 0.0 110.838 179.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.432 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -66.56 152.25 52.37 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.551 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.534 ' O ' HG13 ' A' ' 157' ' ' VAL . 86.6 Cg_exo -42.32 120.09 1.52 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.179 2.586 . . . . 0.0 113.126 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 90.12 -0.24 78.4 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.682 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.575 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 93.89 22.25 26.15 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.697 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 154' ' ' PRO . 1.2 m -83.51 126.09 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 CA-C-N 117.038 0.419 . . . . 0.0 111.214 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 1.019 HD13 ' HB1' ' A' ' 146' ' ' ALA . 16.4 pt -65.69 111.31 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 178.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.554 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 55.4 p -75.22 156.5 35.7 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.487 0.66 . . . . 0.0 111.909 -177.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.461 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.73 -41.86 58.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.888 -179.425 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.4 ' O ' ' CG ' ' A' ' 165' ' ' ARG . 21.7 tt0 -63.99 -27.48 69.15 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.069 179.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.565 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 83.9 m-20 -70.75 -52.16 22.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.648 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.716 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -65.95 -46.76 87.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.489 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.2 mtmp? -61.3 -51.22 69.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.468 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.565 ' HG3' ' O ' ' A' ' 162' ' ' ASP . 0.1 OUTLIER -57.74 -38.8 75.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.895 -179.787 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.542 ' O ' HG23 ' A' ' 170' ' ' THR . 27.3 t90 -71.53 -48.2 50.32 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.784 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -52.22 -37.91 56.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.976 0.417 . . . . 0.0 110.559 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -77.2 -32.3 55.88 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.083 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -60.05 -29.91 68.84 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.956 0.408 . . . . 0.0 110.383 179.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.542 HG23 ' O ' ' A' ' 166' ' ' TRP . 4.4 p -73.11 -52.04 15.74 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.324 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.11 -28.75 66.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.528 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.16 -26.86 67.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.808 179.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -94.19 43.15 1.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.087 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 7.6 p 55.86 -177.94 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.937 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.148 -179.963 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.182 0 N-CA-C 112.54 -0.224 . . . . 0.0 112.54 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.7 -42.98 2.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.821 0.343 . . . . 0.0 110.819 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -96.05 -27.43 15.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.982 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 69.25 -68.17 0.2 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.003 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.0 t -95.71 88.25 2.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.022 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.608 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -85.21 148.78 25.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.949 0.404 . . . . 0.0 110.852 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.447 ' HB1' ' HG2' ' A' ' 136' ' ' ARG . . . -147.83 94.67 2.38 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.848 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.488 ' HE3' ' CG2' ' A' ' 157' ' ' VAL . 17.9 ptp -47.3 166.56 0.19 Allowed Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.064 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.406 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 21.8 Cg_exo -65.74 -46.57 4.9 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.883 2.389 . . . . 0.0 112.867 -179.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.418 ' HB3' HG22 ' A' ' 160' ' ' VAL . . . -54.29 -50.84 66.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.259 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.594 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -70.49 -36.08 73.61 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.018 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.447 ' HG2' ' HB1' ' A' ' 131' ' ' ALA . 0.2 OUTLIER -64.87 -46.83 80.17 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.359 0.6 . . . . 0.0 110.135 179.357 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.55 -58.71 7.42 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.031 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.83 HD11 ' HB ' ' A' ' 163' ' ' VAL . 3.9 pp -59.91 -43.93 94.57 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.516 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.694 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -53.5 -41.12 65.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.982 0.42 . . . . 0.0 110.828 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -73.02 -32.55 65.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.898 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -73.88 -46.51 44.2 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.001 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.559 HD13 ' O ' ' A' ' 138' ' ' LEU . 8.9 mp -72.21 -29.03 63.57 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.082 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.83 37.71 7.22 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.772 -0.728 . . . . 0.0 113.104 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.491 ' CD1' ' CE3' ' A' ' 166' ' ' TRP . 1.5 tt -114.5 141.94 29.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.736 0.303 . . . . 0.0 111.084 179.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.498 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 1.2 t0 -72.47 101.25 2.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.06 179.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.968 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -49.31 -28.29 4.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.764 0.316 . . . . 0.0 111.353 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 37.1 t -66.42 -37.77 85.94 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.498 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -66.13 -21.04 66.33 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.4 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.61 HG21 HG13 ' A' ' 163' ' ' VAL . 21.3 t -89.48 88.29 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.565 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 6.5 ttpt -50.62 93.66 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.009 0.433 . . . . 0.0 111.17 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.523 ' HA3' HG22 ' A' ' 158' ' ' ILE . . . -72.74 130.25 14.45 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.146 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.431 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.2 OUTLIER -118.48 20.15 13.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.024 0.44 . . . . 0.0 110.702 179.585 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.451 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -78.59 156.92 43.39 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.741 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -43.82 103.95 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.086 2.524 . . . . 0.0 112.992 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.73 22.17 14.55 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.2 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.608 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 72.99 22.15 79.34 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.637 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.488 ' CG2' ' HE3' ' A' ' 132' ' ' MET . 1.2 m -85.45 125.82 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 CA-C-N 117.031 0.415 . . . . 0.0 111.191 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.968 HD13 ' HB1' ' A' ' 146' ' ' ALA . 17.6 pt -65.49 110.67 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.513 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 71.8 p -75.12 156.37 36.08 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.491 0.663 . . . . 0.0 111.62 -177.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.49 HG13 HD23 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -56.5 -39.66 63.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.511 -179.724 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.602 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 0.5 OUTLIER -63.25 -28.51 70.08 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.768 179.1 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.513 ' HB2' ' O ' ' A' ' 159' ' ' THR . 91.1 m-20 -71.35 -52.56 18.06 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.826 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.83 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -67.21 -37.16 78.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.872 -179.183 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.485 ' HG3' ' N ' ' A' ' 165' ' ' ARG . 5.3 ptpt -70.9 -51.37 26.6 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.192 0.52 . . . . 0.0 111.14 -179.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.602 ' HG3' ' O ' ' A' ' 161' ' ' GLU . 49.3 mtm180 -57.81 -37.62 74.09 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.005 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.505 ' O ' HG23 ' A' ' 170' ' ' THR . 46.8 t90 -68.9 -50.04 53.0 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.716 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -50.41 -43.11 54.63 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.507 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.433 ' HG2' ' HA ' ' A' ' 165' ' ' ARG . 7.2 pt-20 -71.26 -32.37 68.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.897 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -62.31 -27.04 68.76 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.231 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.505 HG23 ' O ' ' A' ' 166' ' ' TRP . 2.5 p -71.17 -52.14 20.88 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.367 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -68.65 -23.3 64.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.693 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.42 -35.49 63.41 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.922 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -58.32 -55.5 34.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.164 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 34.0 p -74.39 73.6 1.87 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.845 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.258 -0.877 . . . . 0.0 111.166 -179.973 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.182 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.9 t -105.01 94.14 5.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.843 0.354 . . . . 0.0 110.925 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -95.56 171.5 8.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.794 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -154.71 -45.68 0.09 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.987 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.1 t -96.9 134.69 33.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.037 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.569 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -107.83 156.19 19.42 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.682 179.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.42 ' HB1' ' HG2' ' A' ' 136' ' ' ARG . . . -154.62 95.42 1.78 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.045 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.671 ' HB2' ' HD2' ' A' ' 133' ' ' PRO . 19.5 ptm -46.46 167.76 0.14 Allowed Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.558 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.671 ' HD2' ' HB2' ' A' ' 132' ' ' MET . 50.4 Cg_endo -71.88 -34.35 8.79 Favored 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 122.122 1.882 . . . . 0.0 112.5 -178.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.45 ' HB3' ' CE ' ' A' ' 132' ' ' MET . . . -59.71 -54.47 45.98 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.242 0.544 . . . . 0.0 110.649 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.635 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -69.53 -33.26 72.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.507 179.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.42 ' HG2' ' HB1' ' A' ' 131' ' ' ALA . 16.6 mmm-85 -66.49 -47.76 71.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.383 179.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.02 -55.89 28.43 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.9 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.735 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.4 pp -61.04 -40.19 92.68 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.536 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.721 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -57.87 -38.44 75.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.974 0.416 . . . . 0.0 110.791 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.52 -30.05 57.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.713 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -83.08 -19.85 36.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.953 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.628 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.3 mt -94.02 -28.88 15.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.886 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.71 37.36 8.03 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.746 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.479 ' CD1' ' CE3' ' A' ' 166' ' ' TRP . 1.6 tt -118.67 143.48 29.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.788 0.327 . . . . 0.0 111.306 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.547 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 1.3 t0 -74.39 101.04 3.96 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 1.033 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -50.2 -28.57 7.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.662 0.268 . . . . 0.0 111.37 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.19 -36.92 84.35 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.547 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -66.54 -21.91 66.16 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 177.524 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.509 HG21 HG13 ' A' ' 163' ' ' VAL . 21.7 t -88.0 85.76 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.61 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -50.7 92.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.988 0.423 . . . . 0.0 111.304 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.547 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -69.47 138.14 30.1 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.809 -0.632 . . . . 0.0 113.525 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.54 12.02 13.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.795 0.331 . . . . 0.0 110.788 179.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.45 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -74.5 154.76 47.78 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.786 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -43.85 108.23 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.034 2.489 . . . . 0.0 112.878 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.16 18.79 27.95 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.296 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.569 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 74.62 22.18 77.59 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.801 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.481 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -83.68 126.09 40.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 117.069 0.435 . . . . 0.0 111.192 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 1.033 HD13 ' HB1' ' A' ' 146' ' ' ALA . 19.0 pt -64.79 111.52 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 178.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.544 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 36.9 p -75.36 156.52 35.37 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.565 0.697 . . . . 0.0 111.813 -177.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.474 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.03 -41.27 58.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.719 -179.429 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -63.94 -27.51 69.19 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.183 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.544 ' HB2' ' O ' ' A' ' 159' ' ' THR . 83.1 m-20 -71.35 -51.59 23.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.731 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.735 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -66.9 -45.3 87.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.512 -179.884 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.423 ' CG ' ' N ' ' A' ' 165' ' ' ARG . 2.0 pttt -62.85 -50.34 71.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.385 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.537 ' HG3' ' O ' ' A' ' 162' ' ' ASP . 6.8 ppt_? -58.54 -40.01 81.81 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.895 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.539 ' O ' HG23 ' A' ' 170' ' ' THR . 29.4 t90 -70.08 -48.55 57.27 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.85 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -51.99 -38.81 58.04 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.937 0.399 . . . . 0.0 110.68 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -76.48 -31.43 57.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.027 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -61.72 -27.64 68.85 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 120.926 0.393 . . . . 0.0 110.364 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.539 HG23 ' O ' ' A' ' 166' ' ' TRP . 4.6 p -74.37 -52.07 13.22 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.373 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -73.98 -19.19 60.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.84 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 13.2 ttpt -78.11 -32.04 50.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.835 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -75.58 -77.5 0.13 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.234 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 9.7 t -96.41 41.16 1.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.014 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.256 -0.878 . . . . 0.0 111.142 179.959 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.183 0 N-CA-C 112.481 -0.247 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.02 -30.7 44.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.866 0.365 . . . . 0.0 110.915 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.9 90.64 6.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.954 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -93.93 154.79 17.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.858 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.0 t -81.43 83.58 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.919 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.627 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -85.95 146.82 26.52 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.061 0.457 . . . . 0.0 111.085 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -147.83 94.2 2.31 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.712 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.446 ' HG2' ' O ' ' A' ' 158' ' ' ILE . 14.8 ptp -47.41 166.04 0.2 Allowed Pre-proline 0 CA--C 1.532 0.252 0 CA-C-O 120.665 0.269 . . . . 0.0 110.991 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -66.21 -47.97 2.95 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.883 2.389 . . . . 0.0 113.069 -178.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.26 -48.38 71.25 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.666 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.584 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -71.16 -35.13 71.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.855 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 28.8 mtt180 -68.0 -45.76 73.16 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.155 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.3 tpt180 -59.12 -56.98 15.28 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.853 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.78 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -61.1 -41.49 96.77 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.624 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.729 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -56.47 -38.37 71.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.925 0.393 . . . . 0.0 110.907 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 9.6 ttmm -77.02 -30.73 55.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.799 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 51.5 tp10 -83.23 -16.18 47.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.185 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.565 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.1 mt -98.45 -28.92 13.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.915 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.72 35.35 8.48 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.672 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.487 HD13 ' CG2' ' A' ' 149' ' ' VAL . 1.5 tt -116.56 143.53 26.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.834 0.35 . . . . 0.0 111.241 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.504 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 1.9 t0 -76.07 101.47 5.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.917 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.944 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -49.4 -28.25 4.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.673 0.273 . . . . 0.0 111.075 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.4 p -65.96 -37.76 86.83 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.504 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -66.4 -21.24 66.22 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 177.573 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.564 HG21 HG13 ' A' ' 163' ' ' VAL . 20.4 t -89.69 86.45 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.696 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.2 ptmm? -50.67 93.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.934 0.397 . . . . 0.0 110.98 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.518 ' CA ' HG22 ' A' ' 158' ' ' ILE . . . -69.56 133.39 25.5 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.969 -0.634 . . . . 0.0 113.192 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.421 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.4 OUTLIER -118.46 15.56 13.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.963 0.411 . . . . 0.0 110.739 179.545 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.466 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -74.9 155.61 48.23 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.717 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -44.74 105.84 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.138 2.559 . . . . 0.0 112.824 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.35 20.16 21.04 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.209 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.627 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 74.81 22.07 77.57 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.674 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.469 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.1 m -85.91 125.08 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-N 117.08 0.44 . . . . 0.0 111.183 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.944 HD13 ' HB1' ' A' ' 146' ' ' ALA . 15.2 pt -64.69 110.31 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.533 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 67.0 p -75.16 156.58 35.76 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.611 0.719 . . . . 0.0 111.812 -177.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.471 HG13 HD23 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.97 -41.34 67.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.67 -179.656 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -63.78 -27.44 69.19 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.056 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.533 ' HB2' ' O ' ' A' ' 159' ' ' THR . 85.1 m-20 -71.49 -53.0 15.36 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.673 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.78 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -65.49 -45.23 93.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.364 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.41 ' CG ' ' N ' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -61.6 -49.1 77.96 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.11 -179.787 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.514 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 11.5 ptm180 -57.71 -40.4 79.45 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.755 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.547 ' O ' HG23 ' A' ' 170' ' ' THR . 26.2 t90 -71.05 -48.83 50.49 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.747 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -51.55 -38.34 53.8 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.9 0.381 . . . . 0.0 110.592 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -77.21 -32.28 55.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.094 179.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -60.31 -30.13 69.3 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.227 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.547 HG23 ' O ' ' A' ' 166' ' ' TRP . 4.2 p -72.35 -52.12 17.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.304 179.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -67.61 -26.56 66.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.601 179.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -68.77 -36.92 78.93 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.777 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -79.96 -52.8 7.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.148 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 17.2 p -106.71 107.77 18.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.902 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.236 -0.888 . . . . 0.0 111.094 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.227 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 56.9 m -84.51 -71.08 0.53 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.839 0.352 . . . . 0.0 110.914 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 5.3 mmt85 -111.98 -48.84 3.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.937 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -177.47 -38.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.02 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.1 t -77.83 125.1 37.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.989 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.564 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -106.34 153.47 22.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.957 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.456 ' HB1' ' HG2' ' A' ' 136' ' ' ARG . . . -151.41 94.91 2.08 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.874 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.417 ' HB2' ' CD ' ' A' ' 133' ' ' PRO . 9.5 ptm -48.09 167.5 0.19 Allowed Pre-proline 0 CA--C 1.531 0.226 0 CA-C-O 120.61 0.243 . . . . 0.0 110.941 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.417 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.3 Cg_exo -65.9 -45.55 6.03 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.879 2.386 . . . . 0.0 112.864 -179.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.28 -53.1 58.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.397 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.577 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -69.55 -32.62 71.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.865 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.456 ' HG2' ' HB1' ' A' ' 131' ' ' ALA . 14.9 mmm-85 -67.82 -48.03 67.36 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.376 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 13.8 ttt85 -59.85 -55.39 34.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.083 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.732 HD12 ' N ' ' A' ' 139' ' ' ALA . 4.3 pp -61.67 -41.13 97.13 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.678 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.732 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -56.49 -40.88 75.69 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.954 0.407 . . . . 0.0 110.998 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.3 mtmm -75.9 -29.74 58.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.97 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -82.3 -19.83 38.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.163 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.621 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.4 mt -95.0 -28.82 14.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.87 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.75 37.91 7.75 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.484 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.538 HD13 ' CG2' ' A' ' 149' ' ' VAL . 0.6 OUTLIER -117.86 143.85 27.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.738 0.304 . . . . 0.0 111.201 -179.956 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.474 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.5 OUTLIER -76.11 100.97 5.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.013 179.415 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 1.003 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -51.85 -34.83 42.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.644 0.259 . . . . 0.0 111.252 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.16 -36.59 75.56 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.524 ' HE2' ' CD1' ' A' ' 166' ' ' TRP . 0.0 OUTLIER -67.61 -30.5 70.11 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 177.666 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.538 ' CG2' HD13 ' A' ' 144' ' ' ILE . 10.7 t -78.0 83.28 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.384 178.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.53 94.39 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.142 0.496 . . . . 0.0 111.115 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.537 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -68.18 137.38 31.4 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.695 -0.684 . . . . 0.0 113.36 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.54 13.21 13.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.767 0.318 . . . . 0.0 110.748 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.45 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -76.13 155.75 46.33 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.679 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_exo -43.26 106.41 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.133 2.555 . . . . 0.0 112.92 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.81 20.15 22.44 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.362 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.564 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 73.94 22.21 78.28 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.7 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.487 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -84.01 125.58 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 117.016 0.408 . . . . 0.0 111.031 -179.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 1.003 HD13 ' HB1' ' A' ' 146' ' ' ALA . 19.9 pt -64.57 111.35 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.54 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 38.6 p -75.33 156.43 35.53 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.559 0.695 . . . . 0.0 111.689 -177.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.477 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.76 -41.06 64.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.887 -179.4 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -64.58 -27.56 69.03 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.124 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.54 ' HB2' ' O ' ' A' ' 159' ' ' THR . 89.7 m-20 -69.47 -55.34 10.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.372 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.719 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -63.25 -44.19 99.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.683 -179.917 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 160' ' ' VAL . 11.8 mttp -64.0 -40.89 97.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.391 -179.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.545 ' HG3' ' N ' ' A' ' 166' ' ' TRP . 0.0 OUTLIER -64.24 -38.48 91.2 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.83 -179.801 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.654 ' O ' HG23 ' A' ' 170' ' ' THR . 62.8 t90 -73.88 -47.77 35.7 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.659 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -54.14 -37.08 64.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.919 0.39 . . . . 0.0 110.443 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.415 ' HG2' ' HA ' ' A' ' 165' ' ' ARG . 8.3 pt-20 -77.25 -33.34 56.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.074 179.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.12 -26.98 68.61 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.443 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.654 HG23 ' O ' ' A' ' 166' ' ' TRP . 6.3 p -73.81 -52.12 14.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.556 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.52 -24.68 59.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.728 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.93 -29.87 66.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.809 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -55.58 107.18 0.31 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.217 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 10.1 t -148.82 138.38 21.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.887 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.24 -0.886 . . . . 0.0 111.137 179.952 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.195 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 44.8 p -153.04 36.63 0.48 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.843 0.354 . . . . 0.0 110.898 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 5.3 ttm-85 -100.16 48.19 0.93 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.907 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -61.81 -24.25 66.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.147 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.5 t -70.25 130.04 34.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.924 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.587 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -95.96 154.32 17.3 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.063 0.458 . . . . 0.0 110.788 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -153.99 95.52 1.86 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.841 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.696 ' HE2' ' HB3' ' A' ' 134' ' ' ALA . 16.7 ptm -47.22 168.02 0.15 Allowed Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.673 -0.239 . . . . 0.0 110.865 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.42 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 23.3 Cg_exo -65.41 -44.84 8.11 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.669 2.246 . . . . 0.0 112.922 -178.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.696 ' HB3' ' HE2' ' A' ' 132' ' ' MET . . . -54.32 -52.9 60.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.367 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.577 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -69.09 -33.2 73.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.052 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.36 -48.54 67.16 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.274 0.559 . . . . 0.0 110.322 179.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 18.2 ttp180 -58.63 -54.23 49.36 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.188 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.75 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -64.08 -41.64 97.24 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.804 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.744 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -58.08 -38.82 77.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.925 0.393 . . . . 0.0 110.985 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.97 -29.86 55.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.671 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -83.28 -17.92 40.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.124 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.649 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.4 mt -96.88 -28.89 14.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.872 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.69 37.7 7.88 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.455 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.51 HD13 ' CG2' ' A' ' 149' ' ' VAL . 1.4 tt -117.85 141.02 38.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.831 0.348 . . . . 0.0 111.288 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.52 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.6 OUTLIER -73.09 101.06 3.18 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.159 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 1.007 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -50.16 -28.63 7.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.307 -179.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.98 -37.04 84.96 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.52 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -65.09 -23.27 67.11 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 177.237 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.51 ' CG2' HD13 ' A' ' 144' ' ' ILE . 19.0 t -88.54 90.22 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.328 179.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.62 91.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.085 0.469 . . . . 0.0 111.125 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.567 ' HA3' HG22 ' A' ' 158' ' ' ILE . . . -69.36 125.88 18.46 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.934 -0.65 . . . . 0.0 113.047 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.439 ' OG1' ' O ' ' A' ' 152' ' ' THR . 0.1 OUTLIER -118.56 31.87 6.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.159 0.504 . . . . 0.0 110.292 179.708 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.45 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -91.47 156.76 24.25 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.679 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_exo -43.46 101.1 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 123.065 2.51 . . . . 0.0 113.022 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 99.83 25.77 8.91 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.315 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.587 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 70.16 22.1 77.28 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.602 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.47 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -86.27 126.46 40.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.017 -179.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 1.007 HD13 ' HB1' ' A' ' 146' ' ' ALA . 18.9 pt -66.06 112.01 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.518 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 47.4 p -75.33 156.43 35.54 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.485 0.66 . . . . 0.0 111.668 -177.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.509 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -56.98 -40.31 71.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.681 -179.721 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.539 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 2.1 tt0 -62.76 -27.73 69.49 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.863 179.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.518 ' HB2' ' O ' ' A' ' 159' ' ' THR . 91.2 m-20 -71.45 -53.9 12.44 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.342 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.75 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -67.08 -34.48 69.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.413 -179.479 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.434 ' HB3' ' O ' ' A' ' 160' ' ' VAL . 0.0 OUTLIER -69.28 -47.84 63.42 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-O 121.047 0.451 . . . . 0.0 110.892 -179.387 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.539 ' HG3' ' O ' ' A' ' 161' ' ' GLU . 15.1 mtp180 -60.39 -41.53 94.02 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.176 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.496 ' O ' HG23 ' A' ' 170' ' ' THR . 13.4 t90 -70.67 -50.16 39.66 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.826 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -50.56 -38.69 46.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.002 0.429 . . . . 0.0 110.682 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -77.28 -32.54 55.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.555 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -59.63 -28.22 67.03 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.933 0.397 . . . . 0.0 110.564 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.496 HG23 ' O ' ' A' ' 166' ' ' TRP . 7.2 p -77.16 -50.32 13.25 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.395 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.754 ' O ' HG23 ' A' ' 174' ' ' THR . . . -67.81 -30.07 69.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.447 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 11.7 mttp -64.19 -30.21 71.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.635 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -79.28 61.23 3.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.992 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.754 HG23 ' O ' ' A' ' 171' ' ' ALA . 9.7 p -101.96 125.21 48.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.98 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.114 179.964 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.248 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.74 134.38 33.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.802 0.334 . . . . 0.0 110.896 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.95 -50.99 2.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.966 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -96.16 -36.96 10.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.967 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.1 t -90.73 128.01 42.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.901 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.584 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -100.85 153.47 19.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.964 0.411 . . . . 0.0 111.114 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.427 ' O ' ' HG3' ' A' ' 136' ' ' ARG . . . -151.23 95.79 2.21 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.693 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.41 ' HB2' ' CD ' ' A' ' 133' ' ' PRO . 16.0 ptp -47.02 167.74 0.15 Allowed Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.917 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.41 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.1 Cg_exo -65.86 -47.66 3.58 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.811 2.341 . . . . 0.0 112.746 -179.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.478 ' HB3' HG22 ' A' ' 160' ' ' VAL . . . -54.28 -50.38 67.41 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.347 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.572 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -69.9 -33.87 72.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.013 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.427 ' HG3' ' O ' ' A' ' 131' ' ' ALA . 0.2 OUTLIER -67.75 -47.71 68.46 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.324 0.583 . . . . 0.0 110.329 179.339 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.15 -54.42 47.2 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.217 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.746 HD12 ' N ' ' A' ' 139' ' ' ALA . 4.3 pp -63.59 -42.08 98.31 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.784 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.746 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -58.59 -37.25 75.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.865 0.364 . . . . 0.0 110.791 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -77.0 -29.75 55.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.781 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -81.97 -24.78 35.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.038 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.643 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.9 mt -90.99 -28.85 17.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.876 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.53 36.62 8.57 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.545 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.5 HD13 ' CG2' ' A' ' 149' ' ' VAL . 1.4 tt -114.87 142.37 27.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.875 0.369 . . . . 0.0 111.243 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.514 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 1.9 t0 -74.45 101.03 4.0 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 1.005 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -50.22 -28.44 7.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.703 0.287 . . . . 0.0 111.301 -179.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.54 -37.27 86.22 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.514 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -65.85 -22.63 66.55 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.514 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.534 HG21 HG13 ' A' ' 163' ' ' VAL . 20.1 t -88.41 86.48 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.589 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.5 tppt? -50.78 92.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.033 0.444 . . . . 0.0 110.976 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.521 ' HA3' ' HA ' ' A' ' 158' ' ' ILE . . . -70.01 140.52 32.91 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 115.876 -0.602 . . . . 0.0 113.122 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.46 9.46 12.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.677 0.275 . . . . 0.0 110.881 179.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.462 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -70.89 150.36 47.65 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.613 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.569 ' O ' HG13 ' A' ' 157' ' ' VAL . 94.3 Cg_exo -42.77 123.86 3.2 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.137 2.558 . . . . 0.0 113.081 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 87.82 -5.86 84.3 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.601 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.584 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 100.74 22.25 11.34 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.705 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.569 HG13 ' O ' ' A' ' 154' ' ' PRO . 1.2 m -86.09 127.13 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 CA-C-N 117.087 0.443 . . . . 0.0 111.198 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 1.005 HD13 ' HB1' ' A' ' 146' ' ' ALA . 14.5 pt -67.35 111.96 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 177.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.525 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 76.1 p -75.1 156.54 35.92 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.54 0.686 . . . . 0.0 111.536 -177.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.513 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -56.37 -40.72 68.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.873 -179.348 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.535 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 0.1 OUTLIER -62.81 -29.15 70.5 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.748 179.364 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 159' ' ' THR . 87.3 m-20 -69.36 -54.38 14.77 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.371 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.746 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -65.79 -34.62 71.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.0 -179.584 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.414 ' HB3' ' O ' ' A' ' 160' ' ' VAL . 0.2 OUTLIER -67.23 -47.67 70.12 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 121.014 0.435 . . . . 0.0 110.735 -179.64 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.535 ' HG3' ' O ' ' A' ' 161' ' ' GLU . 68.6 mtt-85 -59.26 -44.48 92.41 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.043 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.484 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 10.4 t90 -70.06 -50.1 44.5 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.959 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -50.53 -38.43 44.66 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.937 0.399 . . . . 0.0 110.627 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -77.31 -31.69 54.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.503 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -60.1 -28.07 67.54 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.902 0.382 . . . . 0.0 110.593 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.449 HG23 ' O ' ' A' ' 166' ' ' TRP . 8.0 p -77.6 -50.21 13.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.439 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.27 -28.41 66.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.427 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 10.3 mtpt -66.83 -32.61 74.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.77 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -84.67 -48.87 9.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.011 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 8.9 t -129.08 146.94 50.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.842 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.231 -0.89 . . . . 0.0 111.163 179.999 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.216 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.57 -67.55 0.79 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.809 0.338 . . . . 0.0 110.853 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.62 79.78 1.89 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.888 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -76.42 133.88 39.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.873 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.1 t -99.23 136.21 31.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.999 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.556 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -87.64 157.17 19.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.882 0.373 . . . . 0.0 110.567 179.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -153.07 96.64 2.1 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.206 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.679 ' HB2' ' HD2' ' A' ' 133' ' ' PRO . 14.9 ptp -45.64 168.34 0.1 Allowed Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.546 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.679 ' HD2' ' HB2' ' A' ' 132' ' ' MET . 50.0 Cg_endo -71.44 -35.64 7.92 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.062 1.841 . . . . 0.0 112.363 -179.064 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.79 -52.45 65.01 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.759 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.639 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -70.43 -32.73 70.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.672 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 2.3 mmt85 -68.3 -46.11 71.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.079 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.63 -55.66 31.6 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.831 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.752 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -62.59 -42.08 99.34 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.641 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.737 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -57.99 -36.75 73.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.92 0.391 . . . . 0.0 110.778 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 3.8 mtmt -77.02 -30.76 55.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.555 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -82.93 -18.5 39.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.1 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.621 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.5 mt -96.66 -28.83 14.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.91 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.56 38.8 8.01 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.521 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.486 HD13 ' CG2' ' A' ' 149' ' ' VAL . 1.3 tt -118.43 141.72 36.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.696 0.284 . . . . 0.0 111.33 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.559 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.7 OUTLIER -73.18 100.97 3.21 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.181 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 1.006 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -50.45 -30.46 12.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.47 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 15.8 m -64.61 -36.16 83.34 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.559 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -66.05 -24.9 66.83 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 177.417 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.595 HG21 HG13 ' A' ' 163' ' ' VAL . 20.6 t -84.46 85.2 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.458 179.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.6 91.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.045 0.45 . . . . 0.0 111.124 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.575 ' HA3' ' HA ' ' A' ' 158' ' ' ILE . . . -70.03 143.09 37.3 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.808 -0.633 . . . . 0.0 113.415 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.56 9.1 12.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.714 0.292 . . . . 0.0 110.793 179.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.428 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -72.84 151.29 45.76 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.698 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.596 ' O ' HG13 ' A' ' 157' ' ' VAL . 86.5 Cg_exo -41.57 124.59 2.54 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.2 2.6 . . . . 0.0 113.197 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 86.48 -5.66 84.07 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.631 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.556 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 100.0 22.24 12.38 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.719 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.596 HG13 ' O ' ' A' ' 154' ' ' PRO . 1.2 m -84.47 128.84 38.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 117.096 0.448 . . . . 0.0 111.236 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 1.006 HD13 ' HB1' ' A' ' 146' ' ' ALA . 14.5 pt -68.61 111.75 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 177.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.53 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 72.2 p -75.0 156.45 36.25 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.495 0.664 . . . . 0.0 111.637 -177.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.494 HG13 HD23 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.55 -40.69 60.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.877 -179.467 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.533 ' O ' ' CG ' ' A' ' 165' ' ' ARG . 0.6 OUTLIER -63.6 -27.8 69.49 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.835 179.434 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.53 ' HB2' ' O ' ' A' ' 159' ' ' THR . 86.6 m-20 -70.99 -53.71 13.87 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.593 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.752 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -65.36 -37.87 81.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.155 -179.585 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.9 pttt -65.61 -47.35 75.97 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.977 0.418 . . . . 0.0 110.793 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.533 ' CG ' ' O ' ' A' ' 161' ' ' GLU . 4.9 mmt180 -59.61 -42.54 92.85 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.089 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.477 ' CE3' ' CD1' ' A' ' 144' ' ' ILE . 13.1 t90 -69.83 -50.12 45.9 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.599 -0.441 . . . . 0.0 110.952 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -50.64 -38.84 48.41 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.843 0.354 . . . . 0.0 110.614 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -77.3 -31.61 54.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.37 179.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -60.15 -29.99 69.02 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.953 0.406 . . . . 0.0 110.435 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 166' ' ' TRP . 20.7 p -74.56 -51.34 14.9 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.305 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -67.1 -28.21 67.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.472 179.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.6 -34.39 76.91 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.664 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -84.66 103.46 13.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.233 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 2.9 p -145.98 80.55 1.58 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.883 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.127 179.987 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.267 0 N-CA-C 112.506 -0.238 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.2 p -98.84 38.51 1.37 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.883 0.373 . . . . 0.0 110.897 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -90.05 149.8 22.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.956 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -99.34 -167.49 1.48 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.694 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.4 t -71.57 117.64 15.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.766 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.616 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -89.63 151.37 21.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.109 0.48 . . . . 0.0 111.157 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.412 ' O ' ' HG3' ' A' ' 136' ' ' ARG . . . -151.36 95.28 2.13 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.801 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.439 ' HG2' ' O ' ' A' ' 158' ' ' ILE . 18.1 ptp -47.47 166.54 0.19 Allowed Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.985 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -66.24 -47.31 3.41 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.814 2.342 . . . . 0.0 112.978 -178.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.511 ' HB3' HG22 ' A' ' 160' ' ' VAL . . . -54.1 -50.62 66.43 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.456 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.555 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -69.29 -34.9 75.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.22 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.412 ' HG3' ' O ' ' A' ' 131' ' ' ALA . 0.2 OUTLIER -67.93 -48.49 65.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.156 0.503 . . . . 0.0 110.453 179.495 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.8 ttp-105 -57.53 -55.2 37.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.971 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.73 HD12 ' N ' ' A' ' 139' ' ' ALA . 4.4 pp -61.93 -41.14 97.62 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.486 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.73 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -57.9 -38.04 75.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.965 0.412 . . . . 0.0 110.868 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -76.85 -29.68 55.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.784 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -83.58 -20.08 34.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.033 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.635 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.4 mt -94.5 -28.95 15.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.851 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.98 35.67 8.88 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.645 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.538 HD13 ' CG2' ' A' ' 149' ' ' VAL . 1.9 tt -115.77 142.75 27.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.792 0.33 . . . . 0.0 111.3 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.566 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.9 OUTLIER -75.22 101.11 4.52 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.2 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 1.01 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -49.15 -29.04 4.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.672 0.272 . . . . 0.0 111.301 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.29 -37.43 85.43 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.566 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -65.78 -21.07 66.47 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 177.269 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.538 ' CG2' HD13 ' A' ' 144' ' ' ILE . 19.6 t -91.17 90.15 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.403 179.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.54 93.91 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.036 0.446 . . . . 0.0 111.015 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.601 ' HA3' HG22 ' A' ' 158' ' ' ILE . . . -72.79 126.34 10.64 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.815 -0.629 . . . . 0.0 113.035 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.447 ' O ' ' OG1' ' A' ' 152' ' ' THR . 0.0 OUTLIER -118.49 31.62 6.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.153 0.501 . . . . 0.0 110.42 179.707 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.434 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -89.15 158.07 27.59 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.571 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -43.82 102.06 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.043 2.496 . . . . 0.0 112.945 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.78 24.58 10.6 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.382 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.616 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 71.71 22.17 78.74 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.748 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.48 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -87.03 126.99 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 CA-C-N 117.06 0.43 . . . . 0.0 111.328 -179.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 1.01 HD13 ' HB1' ' A' ' 146' ' ' ALA . 19.7 pt -65.77 111.9 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 177.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.516 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 70.2 p -75.07 156.32 36.23 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.612 0.72 . . . . 0.0 111.595 -177.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.519 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -56.24 -40.06 63.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.876 -179.561 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.587 ' O ' ' CG ' ' A' ' 165' ' ' ARG . 1.2 tp10 -65.28 -30.22 71.06 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.781 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.516 ' HB2' ' O ' ' A' ' 159' ' ' THR . 80.5 m-20 -65.7 -56.05 14.15 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.308 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.715 ' CB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -62.14 -41.39 91.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.165 -179.988 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -65.19 -41.72 94.28 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.555 -179.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.587 ' CG ' ' O ' ' A' ' 161' ' ' GLU . 0.1 OUTLIER -62.46 -44.59 96.04 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.661 179.916 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.446 ' CZ2' ' HD2' ' A' ' 148' ' ' LYS . 18.5 t90 -68.32 -50.18 55.23 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.856 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -51.19 -39.4 56.39 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.887 0.375 . . . . 0.0 110.684 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.401 ' HG2' ' HA ' ' A' ' 165' ' ' ARG . 8.8 pt-20 -76.27 -29.13 57.32 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.277 179.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.401 ' OE1' ' CD1' ' A' ' 166' ' ' TRP . 0.5 OUTLIER -61.21 -42.52 98.74 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 121.194 0.521 . . . . 0.0 110.048 179.302 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.444 HG23 ' O ' ' A' ' 166' ' ' TRP . 7.4 p -60.91 -52.27 65.74 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.447 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.25 -22.27 62.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.356 179.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -71.47 -31.45 67.17 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.669 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -57.59 -34.97 69.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.196 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 7.5 t -150.69 140.1 21.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.946 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.199 -0.905 . . . . 0.0 111.121 179.989 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.184 0 N-CA-C 112.539 -0.224 . . . . 0.0 112.539 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.4 m -60.25 175.21 0.44 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.885 0.374 . . . . 0.0 110.817 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.09 -51.73 4.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.864 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -142.24 130.35 22.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.953 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.2 t -101.11 138.55 24.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.886 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.554 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -82.62 157.04 23.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.864 0.364 . . . . 0.0 110.72 179.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.441 ' O ' ' HG3' ' A' ' 136' ' ' ARG . . . -153.98 96.32 1.95 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.098 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.427 ' HB2' ' CD ' ' A' ' 133' ' ' PRO . 16.6 ptp -47.24 168.52 0.13 Allowed Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.725 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.427 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.7 Cg_exo -65.54 -47.6 3.99 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.687 2.258 . . . . 0.0 112.806 -178.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.451 ' HB3' HG22 ' A' ' 160' ' ' VAL . . . -54.18 -50.78 66.25 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.398 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.57 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -69.71 -34.52 74.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.084 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.441 ' HG3' ' O ' ' A' ' 131' ' ' ALA . 0.9 OUTLIER -66.48 -47.96 71.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.314 0.578 . . . . 0.0 110.296 179.367 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 11.4 ttt-85 -59.48 -55.24 37.16 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.259 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.763 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -62.58 -42.16 99.38 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.799 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.738 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -57.8 -36.68 72.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.912 0.387 . . . . 0.0 110.726 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.07 -30.76 55.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.705 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -84.45 -15.93 44.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.203 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.589 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.1 mt -98.12 -28.85 13.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.799 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.58 36.53 8.6 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.66 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.496 HD13 ' CG2' ' A' ' 149' ' ' VAL . 1.3 tt -118.31 140.25 42.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.739 0.304 . . . . 0.0 111.258 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.567 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.6 OUTLIER -71.47 100.93 2.32 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.293 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 1.006 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -50.02 -30.36 10.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.764 0.316 . . . . 0.0 111.441 -179.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 17.0 m -65.14 -36.69 85.05 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.567 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -65.76 -23.82 66.81 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.408 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.601 HG21 HG13 ' A' ' 163' ' ' VAL . 21.9 t -84.9 85.6 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.458 179.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 5.0 ttpp -50.66 90.61 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.971 0.415 . . . . 0.0 111.29 -179.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.56 ' HA3' ' HA ' ' A' ' 158' ' ' ILE . . . -69.91 139.76 31.83 Favored Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 115.777 -0.647 . . . . 0.0 113.383 -179.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.48 13.53 13.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.764 0.316 . . . . 0.0 110.638 179.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.424 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -76.08 153.45 43.42 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.799 -179.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.406 ' O ' HG13 ' A' ' 157' ' ' VAL . 92.6 Cg_exo -43.59 109.73 0.16 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.129 2.553 . . . . 0.0 112.873 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 96.59 16.47 36.68 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.294 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.554 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 76.2 22.21 74.11 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.72 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.424 HG22 ' HA3' ' A' ' 153' ' ' GLY . 1.3 m -83.59 126.67 40.16 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 CA-C-N 117.031 0.416 . . . . 0.0 111.025 -179.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 1.006 HD13 ' HB1' ' A' ' 146' ' ' ALA . 17.3 pt -66.55 111.51 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.513 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 70.6 p -75.14 156.39 36.0 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.4 0.619 . . . . 0.0 111.261 -177.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.494 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -56.18 -39.53 59.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.583 -179.664 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.624 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 27.3 tt0 -63.6 -27.91 69.56 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.814 179.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.513 ' HB2' ' O ' ' A' ' 159' ' ' THR . 88.7 m-20 -71.92 -52.59 16.48 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.711 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.763 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -67.68 -35.89 74.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.636 -179.378 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -69.52 -49.27 56.05 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.075 0.464 . . . . 0.0 110.832 -179.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.624 ' HG3' ' O ' ' A' ' 161' ' ' GLU . 42.3 mtp180 -61.58 -36.37 80.48 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.253 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.581 ' O ' HG23 ' A' ' 170' ' ' THR . 24.4 t90 -71.21 -50.32 34.24 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.948 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -51.94 -40.74 61.28 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.944 0.402 . . . . 0.0 110.39 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.43 ' HG2' ' HA ' ' A' ' 165' ' ' ARG . 8.4 pt-20 -74.28 -31.12 62.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.09 179.01 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -63.01 -31.17 72.25 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.301 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.581 HG23 ' O ' ' A' ' 166' ' ' TRP . 5.0 p -68.92 -52.02 33.78 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.259 179.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -67.04 -24.57 66.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.617 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.85 -39.53 76.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.872 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -58.98 -42.1 89.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.181 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.449 ' O ' HG23 ' A' ' 174' ' ' THR . 12.0 t -88.19 117.39 27.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.953 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.173 -0.918 . . . . 0.0 111.163 -179.995 . . . . . . . . 0 0 . 1 stop_ save_